Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23412.Phospholipids in VLDL,AGRP,Agouti-related protein,42754,0.238445823347478,0.00476781936838622,0.229100897385441,0.247790749309515,0
NMR metabolomics,X23412.Phospholipids in VLDL,CCN1,CCN family member 1,42569,0.331107657306716,0.00679856105254589,0.317782477643726,0.344432836969706,0
NMR metabolomics,X23412.Phospholipids in VLDL,LDLR,Low-density lipoprotein receptor,42644,0.37582969561123,0.00397362408736481,0.368041392399995,0.383617998822465,0
NMR metabolomics,X23412.Phospholipids in VLDL,MFGE8,Lactadherin,42611,0.180388847459727,0.00408898682002709,0.172374433292474,0.18840326162698,0
NMR metabolomics,X23412.Phospholipids in VLDL,NPY,Pro-neuropeptide Y,42721,0.290118091052674,0.00595920627572318,0.278438046752256,0.301798135353091,0
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.192981764534191,0.00288028608966751,0.187336403798443,0.198627125269939,0
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI,Tissue factor pathway inhibitor,42618,0.110793069260481,0.00295266960150971,0.105005836841522,0.11658030167944,4.02402817134413e-293
NMR metabolomics,X23412.Phospholipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.262179167131303,0.00715242301349625,0.248160418024851,0.276197916237756,4.87423944637153e-278
NMR metabolomics,X23412.Phospholipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0751751062518261,0.00211528621065853,0.0710291452789354,0.0793210672247169,2.19420887615704e-262
NMR metabolomics,X23412.Phospholipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.141366188163178,0.00405651062088783,0.133415427346238,0.149316948980118,7.23194900213721e-255
NMR metabolomics,X23412.Phospholipids in VLDL,CES1,Liver carboxylesterase 1,42661,0.263151119212013,0.00779483240451302,0.247873247699168,0.278428990724859,6.6248312370314e-240
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.104963982099652,0.00316191834098491,0.0987666221513212,0.111161342047982,2.24226418810926e-232
NMR metabolomics,X23412.Phospholipids in VLDL,F7,Coagulation factor VII,42671,0.0991840311859867,0.00298916465527688,0.093325268461644,0.105042793910329,3.84444078685711e-232
NMR metabolomics,X23412.Phospholipids in VLDL,GHR,Growth hormone receptor,40283,0.090291984431596,0.0027227738655662,0.0849553476550862,0.0956286212081057,5.19998182579001e-230
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.104258253340524,0.0031904079483483,0.0980050537617612,0.110511452919286,1.72820392161074e-225
NMR metabolomics,X23412.Phospholipids in VLDL,CCL27,C-C motif chemokine 27,42636,0.185178284038757,0.00569128464932298,0.174023366126084,0.19633320195143,1.32662723924222e-223
NMR metabolomics,X23412.Phospholipids in VLDL,CCL23,C-C motif chemokine 23,42676,0.13170832351556,0.00405102375314296,0.1237683169594,0.13964833007172,2.65290794591631e-223
NMR metabolomics,X23412.Phospholipids in VLDL,PROC,Vitamin K-dependent protein C,42663,0.0783967077651953,0.00242686498881939,0.0736400523871093,0.0831533631432813,1.44059820012489e-220
NMR metabolomics,X23412.Phospholipids in VLDL,LPL,Lipoprotein lipase,42636,-0.144046977803429,0.00450648155005848,-0.152879681641544,-0.135214273965315,3.76761739853208e-216
NMR metabolomics,X23412.Phospholipids in VLDL,FURIN,Furin,42679,0.100001109050403,0.00315321815257704,0.0938208014713516,0.106181416629454,5.96140943769095e-213
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.180629274999946,0.00570945165968318,-0.191819800252925,-0.169438749746967,7.32824791071445e-212
NMR metabolomics,X23412.Phospholipids in VLDL,APCS,Serum amyloid P-component,40419,0.104321022160937,0.00329800777235832,0.0978569269271152,0.11078511739476,1.97777767171183e-210
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.105007230135342,0.0033362092984565,0.0984682599103673,0.111546200360317,6.4421978842856e-210
NMR metabolomics,X23412.Phospholipids in VLDL,NRP1,Neuropilin-1,42705,-0.0845335018029552,0.00268924414668975,-0.0898044203304671,-0.0792625832754433,2.19297573040559e-209
NMR metabolomics,X23412.Phospholipids in VLDL,PTH,Parathyroid hormone,40182,0.241411986805988,0.00791545905423495,0.225897687059687,0.256926286552288,3.50871041649871e-196
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.238709068800285,0.00787731318188459,0.223269534963792,0.254148602636779,4.82059489726124e-195
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.253909033033131,0.00838421792205231,0.237475965905909,0.270342100160354,6.38152967495329e-195
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA5,Plasma serine protease inhibitor,40387,0.0888729670603597,0.00306116752709147,0.0828730787072604,0.094872855413459,9.75787016095044e-179
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,42705,0.132200322115219,0.00457477780074601,0.123233757625757,0.141166886604681,3.1818963848196e-178
NMR metabolomics,X23412.Phospholipids in VLDL,CFP,Properdin,40539,0.0623528549501753,0.00216879644662872,0.058102013914783,0.0666036959855676,1.62076853255625e-175
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.28986754103538,0.0101651008578043,0.269943943354083,0.309791138716676,1.08795411394008e-173
NMR metabolomics,X23412.Phospholipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.219469215340689,0.00772754695985214,0.204323223299379,0.234615207382,2.39480003842413e-172
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.411511192775466,0.0146197734508464,0.382856436811807,0.440165948739125,2.27698921550152e-169
NMR metabolomics,X23412.Phospholipids in VLDL,SNCA,Alpha-synuclein,40283,0.315280329135375,0.011188053239678,0.293351744785606,0.337208913485144,8.33202816527963e-169
NMR metabolomics,X23412.Phospholipids in VLDL,CD4,T-cell surface glycoprotein CD4,42570,0.0832197917891175,0.00302806184909214,0.0772847905648969,0.0891547930133381,8.40868125491398e-162
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0505764815346938,0.00185048660204644,0.0469495277946828,0.0542034352747049,4.24907089701974e-160
NMR metabolomics,X23412.Phospholipids in VLDL,GCG,Pro-glucagon,42346,0.337046940286101,0.0123298937137275,0.312880348607195,0.361213531965006,4.5375455310093e-160
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF9,Protein turtle homolog A,40511,0.219146442255604,0.00808489197102525,0.203300053992395,0.234992830518814,8.03784411673457e-157
NMR metabolomics,X23412.Phospholipids in VLDL,PAMR1,Inactive serine protease PAMR1,42611,0.069957196144662,0.00261561144758299,0.0648305977073993,0.0750837945819247,1.4080469430893e-153
NMR metabolomics,X23412.Phospholipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.181378443617814,0.00680865111836372,0.168033487425821,0.194723399809807,2.14120918532021e-152
NMR metabolomics,X23412.Phospholipids in VLDL,P4HB,Protein disulfide-isomerase,42563,0.0993579270911348,0.0037374656759186,0.0920324943663343,0.106683359815935,8.77391497567557e-152
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP6,Charged multivesicular body protein 6,40511,0.145350720156452,0.00545885961061832,0.13465135531964,0.156050084993264,1.46988628297828e-151
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A5,Zinc transporter ZIP5,42594,0.139680949702489,0.00526699632516906,0.129357636905158,0.15000426249982,4.35951156643417e-151
NMR metabolomics,X23412.Phospholipids in VLDL,GUSB,Beta-glucuronidase,42711,0.15640575392811,0.00593283559494034,0.144777396162027,0.168034111694193,2.12305562555788e-149
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL6,C-X-C motif chemokine 6,42754,0.196900643906583,0.00748521620827229,0.182229620138369,0.211571667674797,8.73987020781358e-149
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN3,Contactin-3,42611,0.0798030421452209,0.00305385873238883,0.0738174790297388,0.085788605260703,7.25720857754966e-147
NMR metabolomics,X23412.Phospholipids in VLDL,TTR,Transthyretin,40424,0.0646338941610607,0.00246991344064641,0.0597928638173937,0.0694749245047276,1.42458011519788e-146
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0504820827941878,0.00193525735131033,0.0466889783856195,0.0542751872027561,2.90251962498911e-146
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.131657318017027,0.00507090059688072,0.121718352847141,0.141596283186913,4.49783876513171e-145
NMR metabolomics,X23412.Phospholipids in VLDL,SYAP1,Synapse-associated protein 1,40283,0.143516509369025,0.00559554457035229,0.132549242011134,0.154483776726915,5.41578602136369e-141
NMR metabolomics,X23412.Phospholipids in VLDL,ADIPOQ,Adiponectin,40539,-0.173037537538392,0.0067706109935428,-0.186307935085736,-0.159767139991048,4.0266134860448e-140
NMR metabolomics,X23412.Phospholipids in VLDL,INHBC,Inhibin beta C chain,42611,0.102256149177897,0.00401834374028098,0.0943801954469467,0.110132102908848,1.501467650504e-139
NMR metabolomics,X23412.Phospholipids in VLDL,BCHE,Cholinesterase,40346,0.0695189738847696,0.0027279238868817,0.0641722430664815,0.0748657047030578,2.72727484702935e-139
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0636314102405715,0.00250488316585861,0.0587218392354886,0.0685409812456543,4.08687797362304e-139
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA4,Kallistatin,40342,0.059740239797963,0.00236117377867677,0.0551123391917565,0.0643681404041695,2.23435328540343e-137
NMR metabolomics,X23412.Phospholipids in VLDL,DSG2,Desmoglein-2,42611,-0.0672204731217168,0.00267008093993462,-0.0724538317639887,-0.061987114479445,1.08032229835491e-136
NMR metabolomics,X23412.Phospholipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.178949745957071,0.00714158813352873,0.164952233215354,0.192947258698787,1.9560113389986e-135
NMR metabolomics,X23412.Phospholipids in VLDL,CRIP2,Cysteine-rich protein 2,42495,0.0898377202964557,0.00359393273358829,0.0827936121386226,0.0968818284542887,8.29811533512281e-135
NMR metabolomics,X23412.Phospholipids in VLDL,GPR37,Prosaposin receptor GPR37,42357,0.167236944995524,0.00669388763171775,0.154116925237358,0.180356964753691,1.23258471661131e-134
NMR metabolomics,X23412.Phospholipids in VLDL,KLKB1,Plasma kallikrein,40293,0.0595356938975535,0.00241744508928997,0.0547975015225452,0.0642738862725619,1.95363589300148e-130
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,42640,0.0966378897785347,0.00393569131887228,0.0889239347935451,0.104351844763524,2.8220950685423e-130
NMR metabolomics,X23412.Phospholipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0614337236637631,0.00250242214300925,0.0565289762634649,0.0663384710640612,3.24800602944652e-130
NMR metabolomics,X23412.Phospholipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,42346,0.263006236823999,0.0107658235977425,0.241905222572423,0.284107251075574,6.04246373206688e-129
NMR metabolomics,X23412.Phospholipids in VLDL,NUMB,Protein numb homolog,40199,0.194687723206008,0.00805989471443038,0.178890329565724,0.210485116846291,1.18863617875299e-125
NMR metabolomics,X23412.Phospholipids in VLDL,CFH,Complement factor H,39956,0.0541054530125513,0.00224437495331592,0.0497064781040521,0.0585044279210505,4.20622823509366e-125
NMR metabolomics,X23412.Phospholipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,40199,0.198714076578881,0.00827763670766496,0.182489908631858,0.214938244525905,3.61146510745347e-124
NMR metabolomics,X23412.Phospholipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.13886743791217,0.00579976794839887,0.127499892733308,0.150234983091032,4.7677478482801e-124
NMR metabolomics,X23412.Phospholipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.324645618151684,0.013545682683908,0.298096080091225,0.351195156212144,7.59803076899702e-124
NMR metabolomics,X23412.Phospholipids in VLDL,AGR3,Anterior gradient protein 3,42326,0.140598917367302,0.00587875233042282,0.129076562799673,0.152121271934931,8.97873715433823e-124
NMR metabolomics,X23412.Phospholipids in VLDL,PLTP,Phospholipid transfer protein,42752,-0.0841222587569325,0.00352157844633424,-0.0910245525117477,-0.0772199650021174,1.44518121186e-123
NMR metabolomics,X23412.Phospholipids in VLDL,CREG1,Protein CREG1,42445,0.0901010894106886,0.00378744937369808,0.0826776886382404,0.0975244901831368,1.56511871300167e-122
NMR metabolomics,X23412.Phospholipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.264348004959283,0.0111652690493569,0.242464077622543,0.286231932296023,1.93961683007344e-121
NMR metabolomics,X23412.Phospholipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,42679,0.0573795005102239,0.00242667566592952,0.052623216205002,0.0621357848154457,3.78800015035704e-121
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.160668439833743,0.00678532645273451,0.147369199986383,0.173967679681103,5.25980908306301e-121
NMR metabolomics,X23412.Phospholipids in VLDL,SNAPIN,SNARE-associated protein Snapin,40482,0.133298221369741,0.005641627750496,0.122240630978769,0.144355811760713,1.64077231649523e-120
NMR metabolomics,X23412.Phospholipids in VLDL,LAT2,Linker for activation of T-cells family member 2,42587,0.284617225230366,0.0121042800275883,0.260892836376293,0.308341614084439,7.77199347872657e-120
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0724933410108274,0.00312130590641489,0.0663755814342542,0.0786111005874006,4.91438364833725e-117
NMR metabolomics,X23412.Phospholipids in VLDL,ENO3,Beta-enolase,40223,0.134471193226666,0.00579600146151364,0.1231110303621,0.145831356091233,2.6576635242425e-116
NMR metabolomics,X23412.Phospholipids in VLDL,SORT1,Sortilin,42613,0.0840972317612244,0.00363260367184855,0.0769773285644012,0.0912171349580475,2.68045700035554e-116
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.084187871707984,0.00363511856138621,0.077063039327667,0.091312704088301,5.73009243427623e-116
NMR metabolomics,X23412.Phospholipids in VLDL,ATRN,"Attractin, Isoform 2",40539,0.0379465075981871,0.00164938067944007,0.0347137214664845,0.0411792937298896,1.6358182209699e-114
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS15,Enteropeptidase,42587,0.205307246324124,0.00898079677975104,0.187704884635812,0.222909608012436,1.67838273963384e-113
NMR metabolomics,X23412.Phospholipids in VLDL,PLAT,Tissue-type plasminogen activator,42760,0.113199453883361,0.00496811160663022,0.103461955134365,0.122936952632356,8.31521762869096e-113
NMR metabolomics,X23412.Phospholipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.181643331966163,0.00799457462849995,0.165973965694303,0.197312698238022,3.94623357097623e-112
NMR metabolomics,X23412.Phospholipids in VLDL,CFI,Complement factor I,40539,0.0438234700119502,0.00192630850291155,0.0400479053462436,0.0475990346776568,4.51802132874979e-112
NMR metabolomics,X23412.Phospholipids in VLDL,DTYMK,Thymidylate kinase,40511,0.151269787258749,0.00667819576801202,0.138180523553446,0.164359050964053,3.91949035961508e-111
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL13,C-X-C motif chemokine 13,42711,0.138774733113048,0.00617138163339457,0.126678825111594,0.150870641114501,5.74215087976398e-110
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0427383067819754,0.00190114529049013,0.0390120620126148,0.0464645515513361,6.50887922443088e-110
NMR metabolomics,X23412.Phospholipids in VLDL,C9,Complement component C9,40532,-0.117356676328028,0.00522470181931158,-0.127597091893879,-0.107116260762177,2.33371768870402e-109
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.136587072417552,0.00610715783417716,-0.148557101772539,-0.124617043062564,7.86993582026326e-109
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,42652,0.0784986721931919,0.00352203436997698,0.071595484828037,0.0854018595583468,4.32682083272413e-108
NMR metabolomics,X23412.Phospholipids in VLDL,EEF1D,Elongation factor 1-delta,40511,0.200583773021908,0.0089875700394651,0.182968135744557,0.21819941029926,5.19574366017832e-108
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0515788874857376,0.00232277760724313,0.047026243375541,0.0561315315959341,2.51087181997493e-107
NMR metabolomics,X23412.Phospholipids in VLDL,APOC1,Apolipoprotein C-I,40516,0.0808903878251226,0.00364006590675763,0.0737558586478776,0.0880249170023675,4.00837989650676e-107
NMR metabolomics,X23412.Phospholipids in VLDL,PROS1,Vitamin K-dependent protein S,40539,0.0571550632586695,0.00257713684708962,0.0521038750383738,0.0622062514789651,1.02430745589508e-106
NMR metabolomics,X23412.Phospholipids in VLDL,PRAP1,Proline-rich acidic protein 1,40527,0.0905481744378751,0.00408737641431708,0.0825369166658136,0.0985594322099365,1.73885830338985e-106
NMR metabolomics,X23412.Phospholipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,42476,0.0511561865782355,0.00231374046863283,0.0466212552597151,0.0556911178967558,2.09292399398723e-106
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP29,Synaptosomal-associated protein 29,42679,0.198178388718918,0.00896895404054656,0.180599238799447,0.215757538638389,2.62844806336814e-106
NMR metabolomics,X23412.Phospholipids in VLDL,NAA80,N-alpha-acetyltransferase 80,40182,0.262238014446845,0.0118483869832079,0.239015175959757,0.285460852933932,3.13644217932083e-106
NMR metabolomics,X23412.Phospholipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.147623921187365,0.00668332923823795,0.134524595880419,0.160723246494312,3.44530627784477e-106
NMR metabolomics,X23412.Phospholipids in VLDL,IL16,Pro-interleukin-16,42754,0.089632516787528,0.00407118936691873,0.0816529856283673,0.0976120479466887,1.40751320675059e-105
NMR metabolomics,X23412.Phospholipids in VLDL,NOMO1,Nodal modulator 1,42611,0.0500346289068964,0.00228002566736322,0.0455657785988645,0.0545034792149283,6.73176994312114e-105
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,42594,0.0907825249366907,0.00415603447363861,0.082636697368359,0.0989283525050223,5.77509954111072e-104
NMR metabolomics,X23412.Phospholipids in VLDL,AFM,Afamin,40539,0.042757899746961,0.00196676492777242,0.0389030404885271,0.046612759005395,1.04962052068922e-102
NMR metabolomics,X23412.Phospholipids in VLDL,GRP,Gastrin-releasing peptide,40223,0.11973428821468,0.0055322095817276,0.108891157434494,0.130577418994866,9.08600735281359e-102
NMR metabolomics,X23412.Phospholipids in VLDL,CPM,Carboxypeptidase M,42655,0.0716621476683852,0.00332724110406677,0.0651407551044144,0.0781835402323561,3.47082306528562e-101
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR5,Cadherin-related family member 5,42636,0.0822901847376431,0.00382160568314388,0.0747998375986811,0.0897805318766051,3.88360200370868e-101
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.0921739021460226,0.00429792786319881,0.0837499635341529,0.100597840757892,2.39722221066307e-100
NMR metabolomics,X23412.Phospholipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0457735079298169,0.00213360247832047,0.0415916470723088,0.049955368787325,4.49801257212372e-100
NMR metabolomics,X23412.Phospholipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.166766967280956,0.00777735019096101,0.151523360906673,0.18201057365524,5.27264367383005e-100
NMR metabolomics,X23412.Phospholipids in VLDL,TJAP1,Tight junction-associated protein 1,42679,0.173463184292551,0.00810370291316974,0.157579926582738,0.189346442002364,5.43936549765434e-100
NMR metabolomics,X23412.Phospholipids in VLDL,YES1,Tyrosine-protein kinase Yes,42587,0.238091096227626,0.0111587867974165,0.21621987410469,0.259962318350562,2.31911109408071e-99
NMR metabolomics,X23412.Phospholipids in VLDL,FYB1,FYN-binding protein 1,42590,0.192764060577045,0.00905183942877968,0.175022455296637,0.210505665857453,5.41477392480095e-99
NMR metabolomics,X23412.Phospholipids in VLDL,FCN2,Ficolin-2,42597,0.0862596832761269,0.00405241134234474,0.0783169570451312,0.0942024095071226,6.58239170124632e-99
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA3,Glutathione S-transferase A3,42346,0.159944503862783,0.00752690863149423,0.145191762945055,0.174697244780512,1.49243427649213e-98
NMR metabolomics,X23412.Phospholipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,42587,0.139455155724829,0.00658337178286073,0.126551747030422,0.152358564419236,5.51077650625303e-98
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF2,Alpha-2-antiplasmin,40317,0.0283178015793082,0.00133655755733949,0.0256981487669228,0.0309374543916936,1.05432476532201e-97
NMR metabolomics,X23412.Phospholipids in VLDL,MYH9,Myosin-9,40527,0.238335783941077,0.0112856220187645,0.216215964784298,0.260455603097855,3.94183411008119e-97
NMR metabolomics,X23412.Phospholipids in VLDL,SARG,Specifically androgen-regulated gene protein,40456,0.225379632801673,0.0107039422332469,0.204399906024509,0.246359359578837,1.45025502899396e-96
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0777115410129047,0.00370330347849681,-0.0849700158307584,-0.0704530661950509,3.11444324752358e-96
NMR metabolomics,X23412.Phospholipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.183936470714872,0.00877645265121436,0.166734623518492,0.201138317911253,5.63780117451337e-96
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0559588731368677,0.0026733372876897,0.0507191320529959,0.0611986142207395,9.2506274545095e-96
NMR metabolomics,X23412.Phospholipids in VLDL,FGF21,Fibroblast growth factor 21,42689,0.241817991057166,0.0115655708342325,0.219149472222071,0.264486509892262,1.45893981783733e-95
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0823994569697628,0.00393616357187677,0.0746845763688843,0.0901143375706412,1.69214373157741e-95
NMR metabolomics,X23412.Phospholipids in VLDL,APOM,Apolipoprotein M,42663,0.058247612579764,0.00278920518961318,0.0527807704081221,0.0637144547514058,2.44882807979424e-95
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.151327927646644,0.00727792746559336,0.137063189814081,0.165592665479207,1.60211580452199e-94
NMR metabolomics,X23412.Phospholipids in VLDL,F10,Coagulation factor X,40532,0.0582935712151363,0.00280179862958828,0.0528020459011433,0.0637850965291293,2.19890185946541e-94
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB1,BPI fold-containing family B member 1,42573,-0.128054604412804,0.00617290863777122,-0.140153505342835,-0.115955703482772,4.12454764040623e-94
NMR metabolomics,X23412.Phospholipids in VLDL,STAB2,Stabilin-2,40527,0.0574609581705593,0.00276927929614419,0.0520331707501167,0.0628887455910019,6.82074931641603e-94
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS1,Protein MTSS 1,40449,0.227881406643018,0.0110076267120741,0.206306458287352,0.249456354998683,1.80529360695226e-93
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.196624691840794,0.00951538527252457,0.177974536706645,0.215274846974942,2.08091275864886e-93
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0446098805794724,0.00216066933227008,0.0403749686882231,0.0488447924707218,3.06741572667061e-93
NMR metabolomics,X23412.Phospholipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.137893792996633,0.0066959578161448,0.124769715676989,0.151017870316276,1.76669972860382e-92
NMR metabolomics,X23412.Phospholipids in VLDL,LEFTY2,Left-right determination factor 2,42689,0.101273531619335,0.00493820917077409,0.0915946416446174,0.110952421594052,4.58376975202775e-92
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.225815581733001,0.0110307237787874,0.204195363126578,0.247435800339424,1.86127559341734e-91
NMR metabolomics,X23412.Phospholipids in VLDL,KYNU,Kynureninase,42754,0.0897102783213537,0.00439199650953211,0.0811019651626708,0.0983185914800367,2.3222551383879e-91
NMR metabolomics,X23412.Phospholipids in VLDL,DPY30,Protein dpy-30 homolog,42651,0.121110368479828,0.00595057176323285,0.109447247823892,0.132773489135765,1.01350792540945e-90
NMR metabolomics,X23412.Phospholipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",42311,0.109951016283079,0.00541277607285537,0.0993419751802825,0.120560057385876,2.39497655190814e-90
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.161946689992151,0.0080013628502708,0.14626401880562,0.177629361178682,9.25729218701578e-90
NMR metabolomics,X23412.Phospholipids in VLDL,GLA,Alpha-galactosidase A,40267,0.0745538053434482,0.00368307444558829,0.0673349794300952,0.0817726312568012,1.71090940405843e-89
NMR metabolomics,X23412.Phospholipids in VLDL,SERPIND1,Heparin cofactor 2,40516,0.0561674959424033,0.00277863326302144,0.0507213747468813,0.0616136171379253,2.74309047428428e-89
NMR metabolomics,X23412.Phospholipids in VLDL,YTHDF3,YTH domain-containing family protein 3,42370,0.168891549316245,0.00837444402914422,0.152477639019123,0.185305459613368,4.15665800650636e-89
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.114001408786122,0.00565010651884905,0.102927200009178,0.125075617563066,6.23016471692275e-89
NMR metabolomics,X23412.Phospholipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.110269758043127,0.00547424935402662,0.099540229309235,0.120999286777019,6.69116494976106e-89
NMR metabolomics,X23412.Phospholipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0604146111766115,0.00299788498911971,0.0545387565979369,0.0662904657552862,9.33822267138378e-89
NMR metabolomics,X23412.Phospholipids in VLDL,CCL22,C-C motif chemokine 22,42509,0.105111864435373,0.00523765621806298,0.0948460582479695,0.115377670622776,2.79604680348495e-88
NMR metabolomics,X23412.Phospholipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.105520666356248,0.00527847262802197,0.0951748600053246,0.115866472707171,1.27619154330285e-87
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.16614035999029,0.00830788242692957,0.149856910433508,0.182423809547072,2.01450886871448e-87
NMR metabolomics,X23412.Phospholipids in VLDL,STC1,Stanniocalcin-1,42711,0.0890986095277788,0.00446902952837582,0.0803393116521622,0.0978579074033954,3.47111152903416e-87
NMR metabolomics,X23412.Phospholipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.19144720354108,0.00959362348989408,0.172643701500888,0.210250705581273,4.21137068950801e-87
NMR metabolomics,X23412.Phospholipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.190495636059157,0.00956827293947653,0.171741821097783,0.209249451020531,6.11102435659181e-87
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,42679,0.0439388522122349,0.00221164533677392,0.0396040273521581,0.0482736770723118,1.35347903277721e-86
NMR metabolomics,X23412.Phospholipids in VLDL,FN1,Fibronectin,40539,0.052418856533667,0.00263794637154495,0.0472484816454389,0.0575892314218951,2.11673824534873e-86
NMR metabolomics,X23412.Phospholipids in VLDL,CPB2,Carboxypeptidase B2,40516,0.0436095542771306,0.00219802467599224,0.0393014259121858,0.0479176826420754,3.8497611711899e-86
NMR metabolomics,X23412.Phospholipids in VLDL,AXIN1,Axin-1,42594,0.184937120912244,0.00934663204653129,0.166617722101043,0.203256519723446,6.52563800652648e-86
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.157469170977069,0.00794757367774731,0.141891926568684,0.173046415385454,6.54412816212209e-86
NMR metabolomics,X23412.Phospholipids in VLDL,CES3,Carboxylesterase 3,42587,0.137566702020616,0.00696540348144926,0.123914511196975,0.151218892844256,1.31980753953462e-85
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF1,Pigment epithelium-derived factor,40351,0.051952292572817,0.00264098164009201,0.0467759685582366,0.0571286165873973,1.02106719120919e-84
NMR metabolomics,X23412.Phospholipids in VLDL,HJV,Hemojuvelin,40482,0.0857135869668036,0.00435852303440729,0.0771708818193654,0.0942562921142419,1.09947542002507e-84
NMR metabolomics,X23412.Phospholipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.0940966206117931,0.00479179492085856,0.0847047025669104,0.103488538656676,1.18738859151198e-84
NMR metabolomics,X23412.Phospholipids in VLDL,SOST,Sclerostin,42613,0.0756421869314668,0.00385416044470481,0.0680880324598453,0.0831963414030882,1.41373978348096e-84
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS2,Protein MTSS 2,40451,0.191199795491955,0.00973061193482171,0.172127796099705,0.210271794884206,1.51696812153943e-84
NMR metabolomics,X23412.Phospholipids in VLDL,MLN,Promotilin,42594,0.172174573812815,0.0087858062782723,0.154954393507401,0.189394754118229,2.48029219431885e-84
NMR metabolomics,X23412.Phospholipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.161417474282297,0.00822997222355112,0.145286728724137,0.177548219840457,3.15351257265514e-84
NMR metabolomics,X23412.Phospholipids in VLDL,EHBP1,EH domain-binding protein 1,40511,0.143798694785083,0.00733317584784274,0.129425670123311,0.158171719446854,3.19197058928765e-84
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL17,C-X-C motif chemokine 17,42754,0.0784980344283498,0.00401823539209718,0.0706222930598393,0.0863737757968603,7.76270767385032e-84
NMR metabolomics,X23412.Phospholipids in VLDL,BECN1,Beclin-1,40223,0.115892347397998,0.00592375237021634,0.104281792752374,0.127502902043622,8.18851006076945e-84
NMR metabolomics,X23412.Phospholipids in VLDL,F9,Coagulation factor IX,42663,0.0348066343722457,0.00178536189711447,0.0313073250539013,0.0383059436905901,1.68759568997775e-83
NMR metabolomics,X23412.Phospholipids in VLDL,TXLNA,Alpha-taxilin,42495,0.168609266848765,0.00866927025968116,0.15161749713979,0.18560103655774,4.21472642458991e-83
NMR metabolomics,X23412.Phospholipids in VLDL,HEG1,Protein HEG homolog 1,40283,0.0519693395895148,0.00266992065620051,0.0467362951033618,0.0572023840756678,5.26164294387683e-83
NMR metabolomics,X23412.Phospholipids in VLDL,KAZN,Kazrin,40449,0.200160873077967,0.0102894634353576,0.179993524744666,0.220328221411268,6.27420901230352e-83
NMR metabolomics,X23412.Phospholipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.205727365682796,0.0105875686491661,0.184975731130431,0.226479000235162,9.40752836307527e-83
NMR metabolomics,X23412.Phospholipids in VLDL,CCL16,C-C motif chemokine 16,42794,0.100140560486085,0.00516668376746861,0.0900138603018464,0.110267260670323,1.41846064445477e-82
NMR metabolomics,X23412.Phospholipids in VLDL,DAB2,Disabled homolog 2,42721,0.20874048546168,0.0107766152733452,0.187618319525923,0.229862651397436,1.81134441008847e-82
NMR metabolomics,X23412.Phospholipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.202221702010161,0.0104498166490179,0.181740061378086,0.222703342642236,2.60933249047505e-82
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,42676,0.235990940958155,0.0121967914940541,0.212085229629809,0.259896652286501,2.723744866046e-82
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0565066184281088,0.00292237011844741,0.0507787729959519,0.0622344638602657,5.5905528927922e-82
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0762280097326312,0.00395449205748414,-0.0839788141653001,-0.0684772052999623,1.0715723632896e-81
NMR metabolomics,X23412.Phospholipids in VLDL,GHRL,Appetite-regulating hormone,42636,0.161406662002672,0.0084130247374658,0.144917133517239,0.177896190488105,5.90878652176234e-81
NMR metabolomics,X23412.Phospholipids in VLDL,BTD,Biotinidase,40539,0.0391966481913641,0.00204060550613667,0.0351970613993363,0.043196234983392,6.03557603049961e-81
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFC,Platelet-derived growth factor C,42346,0.0541502418667554,0.00282481351118383,0.0486136073848351,0.0596868763486757,8.3860906569154e-81
NMR metabolomics,X23412.Phospholipids in VLDL,S100A4,Protein S100-A4,42679,0.107745903306821,0.00562748189825191,0.0967160387862477,0.118775767827395,1.21503108510827e-80
NMR metabolomics,X23412.Phospholipids in VLDL,ARF6,ADP-ribosylation factor 6,40449,0.202738464953031,0.0105853869401912,0.181991106550256,0.223485823355805,1.74181827562785e-80
NMR metabolomics,X23412.Phospholipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.124734537799261,0.00652190468786092,0.111951604611054,0.137517470987469,1.9081743174144e-80
NMR metabolomics,X23412.Phospholipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,42311,0.147195792428261,0.00771636974211464,0.132071707733716,0.162319877122806,4.84887851365331e-80
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.135794213186058,0.00711890352091597,0.121841162285063,0.149747264087053,4.87370135687028e-80
NMR metabolomics,X23412.Phospholipids in VLDL,ISM1,Isthmin-1,42594,0.0726343989704975,0.00381158399824336,0.0651636943339405,0.0801051036070545,6.62668135009708e-80
NMR metabolomics,X23412.Phospholipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0750485201728568,0.0039401665180551,0.0673257937974688,0.0827712465482448,7.87051097589159e-80
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN1,Dynactin subunit 1,42721,0.121586740298898,0.00639060979171038,0.109061145107146,0.13411233549065,1.14000311634149e-79
NMR metabolomics,X23412.Phospholipids in VLDL,CD63,CD63 antigen,42475,0.0961403138240527,0.00505480551249023,0.0862328950195718,0.106047732628534,1.33740465033157e-79
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.13576849234417,0.00716176119293253,0.121731440406023,0.149805544282318,6.84303199249665e-79
NMR metabolomics,X23412.Phospholipids in VLDL,TPD52L2,Tumor protein D54,40283,0.200906075482121,0.0105989790289242,0.18013207658543,0.221680074378813,7.01638766561903e-79
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL10,C-X-C motif chemokine 10,42676,0.126682820244855,0.00669282966969476,0.113564874092253,0.139800766397457,7.0267923609364e-79
NMR metabolomics,X23412.Phospholipids in VLDL,NFX1,Transcriptional repressor NF-X1,40116,0.127150436911545,0.00673510554196872,0.113949630049287,0.140351243773804,2.98354530266189e-78
NMR metabolomics,X23412.Phospholipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,40483,0.0886514954841603,0.00470485552491734,0.0794299786553223,0.0978730123129983,5.29002246560457e-78
NMR metabolomics,X23412.Phospholipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.198515980298713,0.0105539710517809,0.177830197037222,0.219201763560204,9.60605732132245e-78
NMR metabolomics,X23412.Phospholipids in VLDL,PAXX,Protein PAXX,40283,0.0846186163648044,0.00450060518026643,0.0757974302114822,0.0934398025181266,1.17436170084412e-77
NMR metabolomics,X23412.Phospholipids in VLDL,ATG16L1,Autophagy-related protein 16-1,40449,0.156646903966444,0.00834520701917984,0.140290298208851,0.173003509724036,1.97759686062189e-77
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R9B,Neurabin-2,42754,0.173492357064758,0.00925819502642492,0.155346294812965,0.191638419316551,2.2397470809464e-77
NMR metabolomics,X23412.Phospholipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0510763704366426,0.00272564642194596,0.0457341034496285,0.0564186374236567,2.30600919616554e-77
NMR metabolomics,X23412.Phospholipids in VLDL,MINK1,Misshapen-like kinase 1,40483,0.171277150076057,0.00916160776113763,0.153320398864228,0.189233901287887,7.804132778701e-77
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.201142033218265,0.0107637795803179,0.180045025240842,0.222239041195688,9.2121748659782e-77
NMR metabolomics,X23412.Phospholipids in VLDL,ERBIN,Erbin,42587,0.188000309243775,0.0100741185206687,0.168255036943265,0.207745581544286,9.51096875108944e-77
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.106225067435054,0.00569227440656053,0.0950682095981957,0.117381925271913,9.73522376671853e-77
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.190853111895661,0.010246192010411,0.170770575555255,0.210935648236066,1.79708091083158e-76
NMR metabolomics,X23412.Phospholipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0378218243917587,0.00203072945388538,0.0338415946621433,0.041802054121374,1.86757230633474e-76
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,42495,0.0562901369475975,0.00302502042559008,0.050361096913441,0.0622191769817541,2.55995783728967e-76
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0368950828916345,0.0019870325163007,0.0330004991596851,0.0407896666235839,5.2406704927235e-76
NMR metabolomics,X23412.Phospholipids in VLDL,RLN2,Prorelaxin H2,40257,0.0920510254835627,0.00495090122077425,0.0823472590908452,0.10175479187628,5.26015357913962e-76
NMR metabolomics,X23412.Phospholipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0574654738775755,0.00309182112771377,-0.0635254432878945,-0.0514055044672565,5.87951414366223e-76
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.153401052686867,0.00826827909197544,0.137195225666595,0.169606879707139,1.02565072163517e-75
NMR metabolomics,X23412.Phospholipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,40483,0.162249166668122,0.00877043252766153,0.145059118913905,0.179439214422338,2.68572092603405e-75
NMR metabolomics,X23412.Phospholipids in VLDL,DKK1,Dickkopf-related protein 1,42711,0.107084141567616,0.00580880867042725,0.095698876573579,0.118469406561654,5.71778918720039e-75
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0623008069459117,0.00338206637769101,-0.0689296570461861,-0.0556719568456373,7.24807569995972e-75
NMR metabolomics,X23412.Phospholipids in VLDL,CEP85,Centrosomal protein of 85 kDa,42346,0.116507749972115,0.00632935293496666,0.10410221821958,0.128913281724649,9.89607180490185e-75
NMR metabolomics,X23412.Phospholipids in VLDL,TCTN3,Tectonic-3,40511,0.0546771476704281,0.00297362825759642,0.0488488362855391,0.0605054590553171,2.00211843501451e-74
NMR metabolomics,X23412.Phospholipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0572536961222138,0.00311909484711103,0.0511402702218762,0.0633671220225514,2.35862058991439e-74
NMR metabolomics,X23412.Phospholipids in VLDL,CEP20,Centrosomal protein 20,42346,0.135522338548591,0.00740153834860689,0.121015323385322,0.150029353711861,5.69772052557718e-74
NMR metabolomics,X23412.Phospholipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.209472227576675,0.011450588613827,-0.231915381259776,-0.187029073893574,7.31374084490566e-74
NMR metabolomics,X23412.Phospholipids in VLDL,F11R,Junctional adhesion molecule A,42611,0.100452242411926,0.0054956094421346,0.0896808479053424,0.11122363691851,9.59178165262559e-74
NMR metabolomics,X23412.Phospholipids in VLDL,GH1,Somatotropin,42613,-0.310920011187776,0.0170113457990995,-0.344262248954011,-0.277577773421541,9.83580481184041e-74
NMR metabolomics,X23412.Phospholipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,40116,0.115119038987392,0.00629157467885379,0.102787552616838,0.127450525357945,1.09026297706513e-73
NMR metabolomics,X23412.Phospholipids in VLDL,NCK2,Cytoplasmic protein NCK2,42676,0.188810365330475,0.0103359748621036,0.168551854600752,0.209068876060198,1.16330906083231e-73
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.185260031617822,0.0101427667228301,0.165380208841075,0.205139854394569,1.88433012489281e-73
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.122920827189771,0.0067397971897034,0.109710824697952,0.136130829681589,2.05455681028044e-73
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD7B,OTU domain-containing protein 7B,40482,0.111768779767518,0.00612483910122947,0.0997640951291079,0.123773464405927,2.40190403206083e-73
NMR metabolomics,X23412.Phospholipids in VLDL,C1S,Complement C1s subcomponent,40539,0.0376544545133004,0.00206600403860376,0.033605086597637,0.0417038224289637,3.55286785740114e-73
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA1,Glutathione S-transferase A1,42611,0.148438644876077,0.00815664427871685,0.132451622089792,0.164425667662362,4.01036590026377e-73
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0529828545070139,0.00290810796416905,0.0472829628972425,0.0586827461167852,4.07973358091986e-73
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNA4,Plexin-A4,42594,0.147584370712508,0.00811289330437819,0.131683099835927,0.163485641589089,4.56714675405001e-73
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR2,Cadherin-related family member 2,42587,0.12716705134321,0.0069947501399345,0.113457341068939,0.140876761617482,5.55878353799052e-73
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,42636,0.0552363884852368,0.00303845108006605,0.0492810243683073,0.0611917526021662,5.64075853889364e-73
NMR metabolomics,X23412.Phospholipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0890700315206195,0.00490705758872488,0.0794521986467187,0.0986878643945202,9.64279233525312e-73
NMR metabolomics,X23412.Phospholipids in VLDL,IKBKG,NF-kappa-B essential modulator,42594,0.162972123478105,0.00900313345672954,0.145325981902915,0.180618265053295,2.24446391571763e-72
NMR metabolomics,X23412.Phospholipids in VLDL,CD6,T-cell differentiation antigen CD6,42746,0.0947049126701113,0.0052325572196998,0.0844491005194997,0.104960724820723,2.29728253562634e-72
NMR metabolomics,X23412.Phospholipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0716808930591445,0.00395591923669567,0.063927291355221,0.079434494763068,2.35860172637736e-72
NMR metabolomics,X23412.Phospholipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,42587,0.244968985051906,0.0135417462806784,0.218427162341777,0.271510807762036,2.76920575966725e-72
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFC,Vascular endothelial growth factor C,42679,0.0993370811145651,0.00549677921602285,0.0885633938511603,0.11011076837797,3.76110078974281e-72
NMR metabolomics,X23412.Phospholipids in VLDL,SLA2,Src-like-adapter 2,40482,0.185622199415328,0.0102652925328598,0.165502226050923,0.205742172779733,4.53233259436289e-72
NMR metabolomics,X23412.Phospholipids in VLDL,CD2AP,CD2-associated protein,42636,0.113522867692929,0.00629949399639773,0.10117585945999,0.125869875925869,9.3073234300759e-72
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.131517170146645,0.0073011269564521,0.117206961311999,0.145827378981291,1.65286680271142e-71
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.169945959320229,0.00945341318939558,0.151417269469014,0.188474649171445,2.00041912273895e-71
NMR metabolomics,X23412.Phospholipids in VLDL,RBP5,Retinol-binding protein 5,42587,0.0993660718458139,0.00552990343116488,0.0885274611207308,0.110204682570897,2.34717699797432e-71
NMR metabolomics,X23412.Phospholipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0597546050982546,0.00332586656038613,0.0532359066398978,0.0662733035566115,2.44132589382373e-71
NMR metabolomics,X23412.Phospholipids in VLDL,CKB,Creatine kinase B-type,40527,-0.107567575584261,0.00598670703110876,-0.119301521365234,-0.0958336298032878,3.37618343571589e-71
NMR metabolomics,X23412.Phospholipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.197234678036267,0.0109987505332771,0.175677126991044,0.21879222908149,4.44708317161366e-71
NMR metabolomics,X23412.Phospholipids in VLDL,ACY1,Aminoacylase-1,42636,0.107376278215548,0.00599107032249548,0.0956337803834571,0.119118776047639,5.24600762673682e-71
NMR metabolomics,X23412.Phospholipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.107623150839508,0.00601527204200099,0.095833217637186,0.11941308404183,9.47422689770426e-71
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0732720506632128,0.0040982322273348,-0.081304585828789,-0.0652395154976366,1.13445907813906e-70
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.172937607097954,0.00970464085785895,0.15391651101655,0.191958703179357,3.11445377954034e-70
NMR metabolomics,X23412.Phospholipids in VLDL,ELN,Elastin,40511,0.0649176418271671,0.00364112391710797,0.0577810389496355,0.0720542447046987,3.81674141129888e-70
NMR metabolomics,X23412.Phospholipids in VLDL,PCBP2,Poly(rC)-binding protein 2,40482,0.127035446760814,0.00712688732258692,0.113066747608544,0.141004145913085,4.12868417262687e-70
NMR metabolomics,X23412.Phospholipids in VLDL,F13B,Coagulation factor XIII B chain,40479,0.0458590405159484,0.00257397476003094,0.0408140499862878,0.0509040310456091,4.77945652508306e-70
NMR metabolomics,X23412.Phospholipids in VLDL,NCS1,Neuronal calcium sensor 1,42721,0.0509628511079176,0.0028687865913963,0.0453400293887809,0.0565856728270544,8.2338891507664e-70
NMR metabolomics,X23412.Phospholipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.127901880110072,0.00720176444404415,0.113786421799745,0.142017338420398,9.00842336528813e-70
NMR metabolomics,X23412.Phospholipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.199818771677428,0.0112434386612244,0.177781631901428,0.221855911453428,1.0386444498468e-69
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,42711,0.167337354838911,0.00943023308324566,0.148854097995749,0.185820611682072,1.16427450518391e-69
NMR metabolomics,X23412.Phospholipids in VLDL,BCR,Breakpoint cluster region protein,42594,0.159696466384143,0.00902174395125278,0.142013848239687,0.177379084528598,2.51732553330824e-69
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.211001056831983,0.0119224973763027,-0.234369151689536,-0.187632961974429,2.61652786015506e-69
NMR metabolomics,X23412.Phospholipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,40283,0.130748892268515,0.00738092398671723,0.11628228125455,0.145215503282481,2.90776983629245e-69
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL5,C-X-C motif chemokine 5,42605,0.198446297112356,0.0112186743439095,0.176457695398293,0.220434898826419,3.11468745424135e-69
NMR metabolomics,X23412.Phospholipids in VLDL,SHBG,Sex hormone-binding globulin,40532,-0.0887524937082983,0.0050125815010919,-0.0985771534504385,-0.0789278339661582,3.2118601171453e-69
NMR metabolomics,X23412.Phospholipids in VLDL,NUCB2,Nucleobindin-2,42683,0.0645716980496003,0.00366337673876215,0.0573914796416265,0.0717519164575741,9.12013492107458e-69
NMR metabolomics,X23412.Phospholipids in VLDL,NPPC,C-type natriuretic peptide,42594,0.087698615798324,0.00497992537000714,0.07793796207311,0.097459269523538,1.21326130566122e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0902228773670166,0.00513350653794762,0.0801612045526392,0.100284550181394,2.20710726160774e-68
NMR metabolomics,X23412.Phospholipids in VLDL,DOK2,Docking protein 2,42636,0.209120264040385,0.0119044882480918,0.185787467074125,0.232453061006645,2.57384512549592e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LG,CMRF35-like molecule 9,42611,-0.0670448520690389,0.00381776794689559,-0.0745276772449542,-0.0595620268931235,2.82587305611687e-68
NMR metabolomics,X23412.Phospholipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0659755850192518,0.00376052304234208,0.0586049598562613,0.0733462101822423,3.79905146010152e-68
NMR metabolomics,X23412.Phospholipids in VLDL,RGCC,Regulator of cell cycle RGCC,40482,0.13109472776269,0.00746457331751916,0.116464164060353,0.145725291465028,3.84742105188804e-68
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN1,Perilipin-1,42311,0.0606837920492566,0.00346418880204163,0.053893981997255,0.0674736021012582,6.24370401433243e-68
NMR metabolomics,X23412.Phospholipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,40482,0.196698337570173,0.011221592284312,0.174704016692922,0.218692658447425,6.85346445831796e-68
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO1,Forkhead box protein O1,42594,0.147143719850017,0.00840397105588738,0.130671936580477,0.163615503119556,6.97813450221533e-68
NMR metabolomics,X23412.Phospholipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,42357,0.0607817495529098,0.00347245500707593,0.0539757377390409,0.0675877613667786,7.82287550511781e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CMIP,C-Maf-inducing protein,40451,0.143598260704717,0.00820165157810787,0.127523023611625,0.159673497797808,9.72077635914593e-68
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.145213570066613,0.00829382100487732,0.128957680897054,0.161469459236173,1.0180210882062e-67
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3F,Semaphorin-3F,42636,0.0470394192309156,0.00269238921160901,0.041762336376162,0.0523165020856693,1.32251168475647e-67
NMR metabolomics,X23412.Phospholipids in VLDL,FAM20A,Pseudokinase FAM20A,40511,0.0488816429137618,0.002805779536802,0.0433823150216299,0.0543809708058937,4.2207298007262e-67
NMR metabolomics,X23412.Phospholipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.11581180928699,0.00664979886488663,0.102778203511813,0.128845415062168,4.66915181294262e-67
NMR metabolomics,X23412.Phospholipids in VLDL,USO1,General vesicular transport factor p115,42587,0.154906767128707,0.00890541037871735,0.137452162786421,0.172361371470993,4.929811132031e-67
NMR metabolomics,X23412.Phospholipids in VLDL,SRPK2,SRSF protein kinase 2,42594,0.143514980939676,0.00825873723590445,0.127327855957303,0.159702105922048,6.61955584514978e-67
NMR metabolomics,X23412.Phospholipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.128190664800353,0.00738514856279857,0.113715773617267,0.142665555983438,1.31472859907934e-66
NMR metabolomics,X23412.Phospholipids in VLDL,CCL17,C-C motif chemokine 17,42604,0.157358880341309,0.00907909963702209,0.139563845052745,0.175153915629872,1.43140400223556e-66
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.186762842666891,0.0107748016119261,0.165644231507516,0.207881453826266,1.91646564979175e-66
NMR metabolomics,X23412.Phospholipids in VLDL,EZR,Ezrin,42711,0.040988248495562,0.00236804636046009,0.0363468776290602,0.0456296193620637,2.09262507842562e-66
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.154151234503722,0.00890610301090877,0.13669527260234,0.171607196405103,2.89935849260994e-66
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.176258239725716,0.0101996193745439,0.15626698575161,0.196249493699822,3.38931661623725e-66
NMR metabolomics,X23412.Phospholipids in VLDL,AAMDC,Mth938 domain-containing protein,40223,0.0911116121326775,0.00527686478677915,0.0807689571505904,0.101454267114765,6.19403488926109e-66
NMR metabolomics,X23412.Phospholipids in VLDL,KLK10,Kallikrein-10,42636,0.0694496237097691,0.00403430391064377,0.0615423880449073,0.0773568593746309,1.0403498882162e-65
NMR metabolomics,X23412.Phospholipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.0938269860533967,0.00545455379147574,0.0831360606221043,0.104517911484689,1.28201721000933e-65
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINH1,Serpin H1,40302,0.220113895505538,0.0127907531682309,0.195044019295806,0.245183771715271,1.60660390356464e-65
NMR metabolomics,X23412.Phospholipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.117842306553805,0.00685103860185041,0.104414270894178,0.131270342213432,1.78777997869274e-65
NMR metabolomics,X23412.Phospholipids in VLDL,SELP,P-selectin,42689,0.0951320349265396,0.00554644333029177,0.0842610059991677,0.106003063853911,2.98645018349975e-65
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0560004267054722,0.00327415127519407,0.0495830902060918,0.0624177632048526,6.78969687497905e-65
NMR metabolomics,X23412.Phospholipids in VLDL,UPB1,Beta-ureidopropionase,40511,0.152389613165648,0.00892597922229993,0.13489469388994,0.169884532441356,1.52178945116975e-64
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA1,Ephrin type-A receptor 1,42658,0.0557452531558035,0.00327447598891468,0.0493272802175307,0.0621632260940763,2.55638010770191e-64
NMR metabolomics,X23412.Phospholipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.152496069870835,0.00895306373293792,0.134948064954277,0.170044074787393,2.98348828674271e-64
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0756820759164426,0.00445284231573641,-0.0844096468552859,-0.0669545049775992,5.44714882242847e-64
NMR metabolomics,X23412.Phospholipids in VLDL,CTBS,Di-N-acetylchitobiase,40383,0.045105724430991,0.0026629562240134,0.0398863302319248,0.0503251186300573,1.45271106000819e-63
NMR metabolomics,X23412.Phospholipids in VLDL,SNX15,Sorting nexin-15,40283,0.0912246900587381,0.00538686337338318,0.0806664378469071,0.101782942270569,1.56595473737387e-63
NMR metabolomics,X23412.Phospholipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,40449,0.159259046801905,0.0094159050781239,0.140803872848782,0.177714220755028,2.1527941393129e-63
NMR metabolomics,X23412.Phospholipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.158803698218558,0.00939998982679042,0.140379718158049,0.177227678279067,2.27645966766869e-63
NMR metabolomics,X23412.Phospholipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.176317001660046,0.0104410484738947,0.155852546651212,0.196781456668879,3.43977293579426e-63
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD5,Programmed cell death protein 5,42711,0.0962673952441807,0.00570812933217493,0.0850794617531178,0.107455328735244,3.59956246051427e-63
NMR metabolomics,X23412.Phospholipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.185439680026045,0.0110283067105916,0.163824198873285,0.207055161178805,8.46014258280903e-63
NMR metabolomics,X23412.Phospholipids in VLDL,IST1,IST1 homolog,40375,0.164603670477369,0.00978702599310124,0.145421099530891,0.183786241423848,1.04960605939592e-62
NMR metabolomics,X23412.Phospholipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,40199,0.161652254663597,0.00961708472424467,0.142802768604078,0.180501740723117,1.26589674285254e-62
NMR metabolomics,X23412.Phospholipids in VLDL,CD99L2,CD99 antigen-like protein 2,42611,0.0403841111748265,0.00241012229572457,0.0356602714752064,0.0451079508744467,2.2005472867136e-62
NMR metabolomics,X23412.Phospholipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.170769666348435,0.0101833495238786,0.150810301281632,0.190729031415237,2.32462314332125e-62
NMR metabolomics,X23412.Phospholipids in VLDL,IL18R1,Interleukin-18 receptor 1,42754,0.0548821237692711,0.00327730755271853,0.0484586009659428,0.0613056465725994,2.55296358090125e-62
NMR metabolomics,X23412.Phospholipids in VLDL,SORD,Sorbitol dehydrogenase,42658,0.11093775088656,0.00663143990516057,0.0979401286724451,0.123935373100675,3.41371859726473e-62
NMR metabolomics,X23412.Phospholipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.142050025321456,0.00848891653523807,0.12541174891239,0.158688301730523,4.1812673305936e-62
NMR metabolomics,X23412.Phospholipids in VLDL,AP3B1,AP-3 complex subunit beta-1,40449,0.126580100753628,0.007582722732834,0.111717964197274,0.141442237309983,8.11047734372972e-62
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.0900016477273775,0.00539902652130648,0.0794195557456168,0.100583739709138,9.07504337800582e-62
NMR metabolomics,X23412.Phospholipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.126589371900713,0.0075984354714157,0.111696438376738,0.141482305424688,1.06974082499357e-61
NMR metabolomics,X23412.Phospholipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0922412944023501,0.00553386977952017,0.0813949096344905,0.10308767917021,1.25980195557392e-61
NMR metabolomics,X23412.Phospholipids in VLDL,BID,BH3-interacting domain death agonist,42594,0.110958163062119,0.00666638826499649,0.0978920420627261,0.124024284061512,1.37790674952756e-61
NMR metabolomics,X23412.Phospholipids in VLDL,BACH1,Transcription regulator protein BACH1,42594,0.120510371741883,0.0072430580405011,0.106313977982501,0.134706765501265,1.52923268271201e-61
NMR metabolomics,X23412.Phospholipids in VLDL,METAP2,Methionine aminopeptidase 2,42689,0.0939614800670741,0.00565126588784284,0.0828849989269022,0.105037961207246,1.82539137239782e-61
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,40283,0.135722675302623,0.00817470484191182,0.119700253812476,0.15174509679277,3.63395017772631e-61
NMR metabolomics,X23412.Phospholipids in VLDL,GAS6,Growth arrest-specific protein 6,42718,-0.0417543956826785,0.00251858087625339,-0.0466908142001351,-0.0368179771652219,3.99089746784378e-61
NMR metabolomics,X23412.Phospholipids in VLDL,TOP2B,DNA topoisomerase 2-beta,40199,0.131121491034597,0.00790854945905046,0.115620734094858,0.146622247974336,5.35194862954082e-61
NMR metabolomics,X23412.Phospholipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,40283,0.128489535992083,0.0077562386945946,0.113287308150677,0.143691763833488,6.60638566421916e-61
NMR metabolomics,X23412.Phospholipids in VLDL,STAMBP,STAM-binding protein,42476,0.103813537082549,0.00627529625580765,0.0915139564211662,0.116113117743932,7.27412284309848e-61
NMR metabolomics,X23412.Phospholipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.109251603907388,0.00660670207489804,0.0963024678405881,0.122200739974188,8.25735664883412e-61
NMR metabolomics,X23412.Phospholipids in VLDL,OPHN1,Oligophrenin-1,40483,0.175185427485161,0.0105968018125637,0.154415695932536,0.195955159037786,1.11422964372661e-60
NMR metabolomics,X23412.Phospholipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.172033468950138,0.0104193901676361,0.151611464221571,0.192455473678704,1.21807922835128e-60
NMR metabolomics,X23412.Phospholipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.113535018643263,0.00688100587151343,0.100048247135096,0.127021790151429,1.48960606892022e-60
NMR metabolomics,X23412.Phospholipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.116294706112766,0.00704732262817126,0.102481953761551,0.130107458463982,1.86217836440162e-60
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH2,Neutral ceramidase,42495,0.0877552441919241,0.00532449869401561,0.0773192267516535,0.0981912616321947,1.98051163613056e-60
NMR metabolomics,X23412.Phospholipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,40511,0.148083650593635,0.00898219756244222,0.130478543371249,0.165688757816022,2.31960798554789e-60
NMR metabolomics,X23412.Phospholipids in VLDL,PLSCR3,Phospholipid scramblase 3,40457,0.0948055896233886,0.00575194045249327,0.0835317863365018,0.106079392910275,2.49274795161583e-60
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP23,Synaptosomal-associated protein 23,42636,0.141410075103806,0.00858820205593428,0.124577199074175,0.158242951133437,2.52181218653242e-60
NMR metabolomics,X23412.Phospholipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.112335341592767,0.00681553119442156,0.0989769004517004,0.125693782733833,2.58324468372218e-60
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL3,C-X-C motif chemokine 3,42620,0.151933036624976,0.00923525974684836,0.133831927521153,0.170034145728798,3.17938134947434e-60
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.060241638378486,0.00366460835288197,0.0530590060068373,0.0674242707501346,3.87836541502823e-60
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.144969972692704,0.00881609355822076,0.127690429318591,0.162249516066816,4.6505146055096e-60
NMR metabolomics,X23412.Phospholipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.126903769662035,0.0077279204918858,0.111757045497939,0.142050493826131,6.60547181227301e-60
NMR metabolomics,X23412.Phospholipids in VLDL,CEP43,Centrosomal protein 43,42255,0.112274785721391,0.00684955689581034,0.0988496542056027,0.125699917237179,8.67861072787793e-60
NMR metabolomics,X23412.Phospholipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.116237839468161,0.00708651963995295,0.102348260973853,0.130127417962468,9.01255514199612e-60
NMR metabolomics,X23412.Phospholipids in VLDL,DNMBP,Dynamin-binding protein,42495,0.0975796473343698,0.00595590554081944,0.0859060724743637,0.109253222194376,9.61324652562711e-60
NMR metabolomics,X23412.Phospholipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.150357307109651,0.00917707635607072,0.132370237451753,0.16834437676755,9.6963322112426e-60
NMR metabolomics,X23412.Phospholipids in VLDL,STK11,Serine/threonine-protein kinase STK11,42357,0.117623870474593,0.00717952732168137,0.103551996924098,0.131695744025089,9.81841384327717e-60
NMR metabolomics,X23412.Phospholipids in VLDL,NPL,N-acetylneuraminate lyase,40511,0.0739555688332112,0.0045295412829007,0.0650776679187259,0.0828334697476966,2.99129943752519e-59
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0616604664531001,0.00378036692494778,0.0542509472802025,0.0690699856259978,3.0345963286766e-59
NMR metabolomics,X23412.Phospholipids in VLDL,OGFR,Opioid growth factor receptor,42587,0.0526510602101099,0.00322957209003853,0.0463210989136344,0.0589810215065854,3.49827529060224e-59
NMR metabolomics,X23412.Phospholipids in VLDL,FGF19,Fibroblast growth factor 19,42676,0.125312859400001,0.00770313939420815,0.110214706187353,0.140411012612649,6.08200112040767e-59
NMR metabolomics,X23412.Phospholipids in VLDL,AGRN,Agrin,42676,0.0587466616863652,0.00361248117274687,0.0516661985877813,0.065827124784949,6.65556240206633e-59
NMR metabolomics,X23412.Phospholipids in VLDL,KHK,Ketohexokinase,40223,0.101471272558278,0.00623778573798815,0.0892452125118209,0.113697332604734,8.14337703530643e-59
NMR metabolomics,X23412.Phospholipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.100917018593115,0.0062165870540707,0.0887325079671366,0.113101529219094,1.08600879515653e-58
NMR metabolomics,X23412.Phospholipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.0889246521336055,0.00548322121696536,0.0781775385483534,0.0996717657188576,1.41356418034151e-58
NMR metabolomics,X23412.Phospholipids in VLDL,GPC5,Glypican-5,42495,0.0906726084707391,0.00560281567541285,0.0796910897469299,0.101654127194548,2.38083373385288e-58
NMR metabolomics,X23412.Phospholipids in VLDL,SH2B3,SH2B adapter protein 3,42346,0.156111720493544,0.0096560199750744,0.137185921342398,0.17503751964469,3.1211094864011e-58
NMR metabolomics,X23412.Phospholipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.100760918208063,0.00623511871109101,0.0885400855343246,0.112981750881801,3.49267847030165e-58
NMR metabolomics,X23412.Phospholipids in VLDL,AZI2,5-azacytidine-induced protein 2,40482,0.0883265965319821,0.00546378700560639,0.0776175740009936,0.0990356190629706,3.94176208007288e-58
NMR metabolomics,X23412.Phospholipids in VLDL,NIT2,Omega-amidase NIT2,40462,0.117143657079739,0.00725713207187845,0.102919678218858,0.131367635940621,5.77692096175541e-58
NMR metabolomics,X23412.Phospholipids in VLDL,MITD1,MIT domain-containing protein 1,42495,0.153185510524617,0.00950523646713682,0.134555247049029,0.171815774000206,6.96252578257931e-58
NMR metabolomics,X23412.Phospholipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0412267038702237,0.00255905929475718,0.0362109476524997,0.0462424600879478,9.85643077814812e-58
NMR metabolomics,X23412.Phospholipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0468118708313707,0.00290911792597754,0.0411099996964547,0.0525137419662867,9.98837404932561e-58
NMR metabolomics,X23412.Phospholipids in VLDL,SYTL4,Synaptotagmin-like protein 4,40511,0.117991310174228,0.00732800741853904,0.103628415633892,0.132354204714565,1.08850090614239e-57
NMR metabolomics,X23412.Phospholipids in VLDL,CCN2,CCN family member 2,42624,0.0879834116490195,0.00547047819052062,0.0772612743955991,0.0987055489024399,1.15348920246779e-57
NMR metabolomics,X23412.Phospholipids in VLDL,CCL13,C-C motif chemokine 13,42734,0.110388185764473,0.00686510812732701,0.0969325738349123,0.123843797694034,1.21127949203273e-57
NMR metabolomics,X23412.Phospholipids in VLDL,ST13,Hsc70-interacting protein,40283,0.09019010123287,0.00560649904552289,0.0792013631036452,0.101178839362095,1.4146757196124e-57
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0372312023068757,0.002317017038159,0.032689848912084,0.0417725557016673,1.45796346525819e-57
NMR metabolomics,X23412.Phospholipids in VLDL,TBCC,Tubulin-specific chaperone C,42495,0.127791584393767,0.00796174233585789,0.112186569415485,0.143396599372048,1.95532066347303e-57
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR,GMP reductase 1,42754,0.0787115811313194,0.00490487258674578,0.0690980308612977,0.0883251314013411,2.0052560947824e-57
NMR metabolomics,X23412.Phospholipids in VLDL,SEC31A,Protein transport protein Sec31A,40223,0.122179130002358,0.0076222135305225,0.107239591482534,0.137118668522182,3.5196679940711e-57
NMR metabolomics,X23412.Phospholipids in VLDL,DBNL,Drebrin-like protein,42676,0.145417917432088,0.00908233683310448,0.127616537239204,0.163219297624973,3.59679462006515e-57
NMR metabolomics,X23412.Phospholipids in VLDL,CRKL,Crk-like protein,42636,0.165585102720861,0.0103690492488698,0.145261766193076,0.185908439248645,6.98403137606138e-57
NMR metabolomics,X23412.Phospholipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.122769480656148,0.00768352334045,0.107709774908866,0.13782918640343,7.59197484486557e-57
NMR metabolomics,X23412.Phospholipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0703585563482069,0.00440820965654447,0.0617184654213798,0.0789986472750341,8.00121210150752e-57
NMR metabolomics,X23412.Phospholipids in VLDL,FAM13A,Protein FAM13A,40449,0.106596499892493,0.00668358939844835,0.0934966646715341,0.119696335113452,1.20639573512291e-56
NMR metabolomics,X23412.Phospholipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.100655726339683,0.00631317948436474,0.0882818945503282,0.113029558129038,1.30409605674688e-56
NMR metabolomics,X23412.Phospholipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.133497851906762,0.00838467700676463,0.117063884973504,0.149931818840021,1.47988753029286e-56
NMR metabolomics,X23412.Phospholipids in VLDL,MYDGF,Myeloid-derived growth factor,40511,0.155421824591551,0.00975493201980587,0.136302157832731,0.17454149135037,1.54624430429614e-56
NMR metabolomics,X23412.Phospholipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.182174502668837,0.0114507594621696,0.159731014122985,0.20461799121469,1.79368626127413e-56
NMR metabolomics,X23412.Phospholipids in VLDL,NT5E,5'-nucleotidase,42679,0.0893698963369884,0.00562626334722873,0.0783424201764201,0.100397372497557,2.63106396166304e-56
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.164054923364697,0.0103287825073059,0.143810509650377,0.184299337079016,2.67896322227937e-56
NMR metabolomics,X23412.Phospholipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.0997480320691817,0.00628219009989027,0.0874349394733968,0.112061124664967,3.63525603849619e-56
NMR metabolomics,X23412.Phospholipids in VLDL,CDH2,Cadherin-2,42636,0.0560236386471967,0.00353154316399538,0.0491018140457658,0.0629454632486276,3.64669009143285e-56
NMR metabolomics,X23412.Phospholipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.125329700883946,0.00789457763947861,0.109856328710568,0.140803073057324,3.79262483524771e-56
NMR metabolomics,X23412.Phospholipids in VLDL,NSFL1C,NSFL1 cofactor p47,42711,0.101825803427018,0.00643768395652807,0.0892079428722233,0.114443663981813,7.50468398596593e-56
NMR metabolomics,X23412.Phospholipids in VLDL,APPL2,DCC-interacting protein 13-beta,40283,0.174442571222483,0.0110268997499635,0.152829847712555,0.196055294732412,9.24528418480772e-56
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY4,Protein canopy homolog 4,42587,0.116024282270251,0.00734146086413732,0.101635018976542,0.13041354556396,9.31202490538913e-56
NMR metabolomics,X23412.Phospholipids in VLDL,LAT,Linker for activation of T-cells family member 1,42754,0.118079519984669,0.00747642295476205,0.103425730993336,0.132733308976003,1.07948039300802e-55
NMR metabolomics,X23412.Phospholipids in VLDL,RILPL2,RILP-like protein 2,40511,0.152095839156327,0.00962564754455992,0.13322956996899,0.170962108343665,1.20078091207336e-55
NMR metabolomics,X23412.Phospholipids in VLDL,APOA2,Apolipoprotein A-II,40532,-0.0772775114141745,0.0049003336281726,-0.0868821653253928,-0.0676728575029562,1.94480713077323e-55
NMR metabolomics,X23412.Phospholipids in VLDL,FETUB,Fetuin-B,42663,0.0503394009834712,0.00319572136883087,0.0440757871005627,0.0566030148663797,2.07249075214322e-55
NMR metabolomics,X23412.Phospholipids in VLDL,FKBPL,FK506-binding protein-like,40449,0.0917025004869027,0.00581749805284106,0.0803002043033342,0.103104796670471,2.17634695225017e-55
NMR metabolomics,X23412.Phospholipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.156957803507845,0.00996944707059162,0.137417687249485,0.176497919766204,2.36904408861694e-55
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,42676,0.20341867231993,0.0129222985160367,0.178090967228498,0.228746377411362,2.43471762615273e-55
NMR metabolomics,X23412.Phospholipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.168157516201534,0.0106797543445026,0.147225197686309,0.189089834716759,2.85415712072925e-55
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH9,Protocadherin-9,40449,0.0540333554107854,0.00343218094302965,0.0473062807624473,0.0607604300591236,2.96879059322536e-55
NMR metabolomics,X23412.Phospholipids in VLDL,THPO,Thrombopoietin,42357,0.0609076487999862,0.003875522760391,0.0533116241896199,0.0685036734103526,3.72578080591424e-55
NMR metabolomics,X23412.Phospholipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.139158327301292,0.0088528901703379,0.12180666256743,0.156509992035154,4.44620434698185e-55
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D23,TBC1 domain family member 23,42587,0.139393469085941,0.00887820944538518,0.121992178572986,0.156794759598896,4.63427940604388e-55
NMR metabolomics,X23412.Phospholipids in VLDL,ARSB,Arylsulfatase B,42587,0.0856813875305548,0.00546001015534985,0.0749797676260691,0.0963830074350405,5.25282723342988e-55
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM5,Tripartite motif-containing protein 5,42594,0.132896511022223,0.00846897941297342,0.116297311372795,0.149495710671651,5.28078979881238e-55
NMR metabolomics,X23412.Phospholipids in VLDL,CES2,Cocaine esterase,42587,0.0855849612297987,0.0054550633703593,0.0748930370238945,0.0962768854357029,5.54045412392514e-55
NMR metabolomics,X23412.Phospholipids in VLDL,LSP1,Lymphocyte-specific protein 1,42594,0.0620242192648819,0.00395369711047264,0.0542749729283555,0.0697734656014082,5.66158394149143e-55
NMR metabolomics,X23412.Phospholipids in VLDL,HEXIM1,Protein HEXIM1,42594,0.125572684038434,0.00800601541182833,0.10988089383125,0.141264474245617,5.91753305679447e-55
NMR metabolomics,X23412.Phospholipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.146685286049239,0.00936332599262244,0.128333167103699,0.165037404994779,8.0785409611115e-55
NMR metabolomics,X23412.Phospholipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0678585837724001,0.00433408776708393,0.0593637717489156,0.0763533957958846,9.29004430520399e-55
NMR metabolomics,X23412.Phospholipids in VLDL,BRAP,BRCA1-associated protein,40342,0.168528127014059,0.0108220732032702,0.14731686353565,0.189739390492469,4.14366461547336e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,40482,0.18034879642086,0.011590625963484,0.157631169532432,0.203066423309289,4.95582142833725e-54
NMR metabolomics,X23412.Phospholipids in VLDL,MMP10,Stromelysin-2,42608,-0.0908435914764449,0.00584655213904767,-0.102302833668978,-0.0793843492839115,5.66563789758227e-54
NMR metabolomics,X23412.Phospholipids in VLDL,EREG,Proepiregulin,42476,0.124356987937343,0.00800578216533751,0.108665654893281,0.140048320981404,6.14245678856704e-54
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0435676556988347,0.00280547244024486,0.0380689297159548,0.0490663816817146,6.37521298290027e-54
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GLB2,Endophilin-B2,40483,0.102860502835038,0.00662646980467982,0.0898726220178655,0.11584838365221,8.7496825914255e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.126557191312564,0.00815301237768017,0.110577287052311,0.142537095572818,8.77004731247787e-54
NMR metabolomics,X23412.Phospholipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,40482,0.115918480392053,0.00747056911783998,0.101276164921086,0.130560795863019,9.58711197420089e-54
NMR metabolomics,X23412.Phospholipids in VLDL,CCL5,C-C motif chemokine 5,42689,0.153233412187314,0.00988795344335188,0.133853023438345,0.172613800936284,1.05444011308321e-53
NMR metabolomics,X23412.Phospholipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,42594,0.099106399213914,0.00639569498585333,0.0865708370416415,0.111641961386187,1.08169299066554e-53
NMR metabolomics,X23412.Phospholipids in VLDL,LYN,Tyrosine-protein kinase Lyn,42587,0.128951084645514,0.00832867055806305,0.11262689035171,0.145275278939317,1.3202112757922e-53
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.101348500877102,0.00654632747088897,0.0885176990341598,0.114179302720045,1.63309003823948e-53
NMR metabolomics,X23412.Phospholipids in VLDL,RTBDN,Retbindin,42587,0.0459383490087544,0.00297448232428543,0.0401083636531549,0.0517683343643538,2.38051148477348e-53
NMR metabolomics,X23412.Phospholipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.102924047886772,0.00666509844090894,0.0898604549425905,0.115987640830954,2.97710053020195e-53
NMR metabolomics,X23412.Phospholipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,42794,0.0354841269077752,0.0022999764469283,0.0309761730717957,0.0399920807437546,2.994576734866e-53
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R2,Interleukin-1 receptor type 2,42600,0.030494173487968,0.00197865067458326,0.0266160181657848,0.0343723288101512,3.90304342009843e-53
NMR metabolomics,X23412.Phospholipids in VLDL,CLUL1,Clusterin-like protein 1,42621,-0.0687498676508615,0.00446621102716977,-0.0775036412641142,-0.0599960940376087,5.14378536916697e-53
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF2,TNF receptor-associated factor 2,42594,0.106195889589145,0.00690009165125903,0.0926717099526778,0.119720069225613,5.38064092299949e-53
NMR metabolomics,X23412.Phospholipids in VLDL,DAG1,Dystroglycan,42676,0.0700519126125015,0.00455257935088014,0.0611288570847764,0.0789749681402266,5.6134635750851e-53
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,40199,0.134818339737981,0.00876069865088666,0.117647370382243,0.151989309093719,6.88617706922635e-53
NMR metabolomics,X23412.Phospholipids in VLDL,TWF2,Twinfilin-2,40527,0.126593228773348,0.00824651372347188,0.110430061875344,0.142756395671353,1.17749784873598e-52
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD1,COMM domain-containing protein 1,40223,0.0922587790941984,0.00601080256112887,0.0804776060743858,0.104039952114011,1.25999107155805e-52
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.119924964638569,0.00782723526519712,0.104583583518783,0.135266345758356,1.53103634423071e-52
NMR metabolomics,X23412.Phospholipids in VLDL,STAT2,Signal transducer and activator of transcription 2,40199,0.115953282184433,0.00756704616293507,0.10112187170508,0.130784692663785,1.85226970006466e-52
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,42676,0.129730865919596,0.00848214932846857,0.113105853235798,0.146355878603395,2.2855110333617e-52
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.165999032535715,0.0108768765907612,0.144680354417823,0.187317710653607,3.75551684739734e-52
NMR metabolomics,X23412.Phospholipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.0755492047684379,0.00494649886088574,0.0658540670011019,0.085244342535774,3.90468809987501e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.090277219233885,0.00591319719477362,0.0786873527321287,0.101867085735641,4.21010604653213e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP4,Secreted frizzled-related protein 4,40283,0.061306492903199,0.00401575434205323,0.0534356143927747,0.0691773714136233,4.32282985339921e-52
NMR metabolomics,X23412.Phospholipids in VLDL,RBM17,Splicing factor 45,40482,0.115811762796202,0.00758763178741241,0.100940004492874,0.130683521099531,4.44497905520044e-52
NMR metabolomics,X23412.Phospholipids in VLDL,HGF,Hepatocyte growth factor,42754,0.0527875357474163,0.00346439905946113,0.0459973135908725,0.0595777579039601,5.40037261627147e-52
NMR metabolomics,X23412.Phospholipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0800250746211712,0.00524971505068408,0.0697356331218304,0.090314516120512,6.07345110059524e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SPART,Spartin,40283,0.116125542845604,0.00761895454156598,0.101192391944134,0.131058693747073,6.27442767364937e-52
NMR metabolomics,X23412.Phospholipids in VLDL,UBXN1,UBX domain-containing protein 1,40283,0.103586908092051,0.00680319227809135,0.0902526512269915,0.11692116495711,7.90819517764772e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.132281636251441,0.00872001972072388,0.115190397598823,0.14937287490406,1.50033519781986e-51
NMR metabolomics,X23412.Phospholipids in VLDL,HS1BP3,HCLS1-binding protein 3,40223,0.133716580685374,0.00880873087384466,0.116451468172639,0.15098169319811,1.5887264809045e-51
NMR metabolomics,X23412.Phospholipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0757900279375445,0.00500417732219375,0.0659818403860447,0.0855982154890442,2.16524457886076e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0770975557755245,0.00509026412810506,0.0671206380844386,0.0870744734666104,2.18632214928489e-51
NMR metabolomics,X23412.Phospholipids in VLDL,TAX1BP1,Tax1-binding protein 1,40483,0.0951997484930919,0.00628237950459523,0.0828862846640852,0.107513212322099,2.29808840819478e-51
NMR metabolomics,X23412.Phospholipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,40199,0.0739257305924097,0.00487924044331295,0.0643624193235163,0.0834890418613031,2.4525883770516e-51
NMR metabolomics,X23412.Phospholipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.10789811248883,0.00713079557364495,0.0939217531644854,0.121874471813174,2.65492575943106e-51
NMR metabolomics,X23412.Phospholipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.127788108478478,0.00844598594708228,0.111233976022196,0.144342240934759,3.33099948683263e-51
NMR metabolomics,X23412.Phospholipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,40482,0.0917004602105999,0.00606187562615159,0.0798191839833428,0.103581736437857,3.38841549968679e-51
NMR metabolomics,X23412.Phospholipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.107047197053425,0.00708225292544225,0.093165981319558,0.120928412787292,3.4142064166792e-51
NMR metabolomics,X23412.Phospholipids in VLDL,CASC3,Protein CASC3,40182,0.0630066635845698,0.00417153555898999,0.0548304538889494,0.0711828732801901,4.9545550653901e-51
NMR metabolomics,X23412.Phospholipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.111562574815801,0.00738909280091036,0.0970799529260166,0.126045196705585,5.21133203810641e-51
NMR metabolomics,X23412.Phospholipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.180735401612778,0.0119898121382383,0.157235369821831,0.204235433403725,6.4573271847082e-51
NMR metabolomics,X23412.Phospholipids in VLDL,LBR,Delta(14)-sterol reductase LBR,42711,0.0996379061818743,0.00661123648815936,0.086679882665082,0.112595929698667,6.51052969168491e-51
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.062517835488296,0.00414881507172147,0.0543861579477219,0.07064951302887,6.84377311021726e-51
NMR metabolomics,X23412.Phospholipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.096553135557002,0.00640845823006422,0.0839925574260761,0.109113713687928,7.1432698738849e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.114352115201052,0.00760309830998076,0.0994500425134901,0.129254187888615,1.03948825282884e-50
NMR metabolomics,X23412.Phospholipids in VLDL,GOLGA3,Golgin subfamily A member 3,40482,0.117091296004074,0.00778618362974009,0.101830376089784,0.132352215918365,1.2716641439162e-50
NMR metabolomics,X23412.Phospholipids in VLDL,NIT1,Deaminated glutathione amidase,40223,0.0710748511954292,0.00472884080883357,0.0618063232101154,0.080343379180743,1.47510154772857e-50
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD1,Sushi domain-containing protein 1,42357,0.0734471288435284,0.00490040926999701,0.0638423266743342,0.0830519310127225,2.28979715767038e-50
NMR metabolomics,X23412.Phospholipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.125739672801769,0.00838986584286502,0.109295535749754,0.142183809853785,2.32124948683756e-50
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0627881448835983,0.00418883540528823,0.0545780274892334,0.0709982622779633,2.62976546302667e-50
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB3,Plexin-B3,42597,0.0696239408846649,0.00465321803535149,0.060503633535376,0.0787442482339538,3.27929375250538e-50
NMR metabolomics,X23412.Phospholipids in VLDL,GLB1,Beta-galactosidase,42495,0.0616249271283012,0.00412024485025801,0.0535492472217955,0.0697006070348069,3.60439462968033e-50
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA11,Annexin A11,42570,0.0991179755940444,0.0066284897291132,0.0861261357249826,0.112109815463106,3.7643104068679e-50
NMR metabolomics,X23412.Phospholipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0498045095339889,0.00332763066810921,0.0432823534244949,0.056326665643483,3.82096563273109e-50
NMR metabolomics,X23412.Phospholipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0613236381522586,0.00410199734270979,0.0532837233605474,0.0693635529439698,3.93923141767879e-50
NMR metabolomics,X23412.Phospholipids in VLDL,SCLY,Selenocysteine lyase,42674,0.0693313044154064,0.00464839241553855,0.0602204552809509,0.078442153549862,6.56881860676899e-50
NMR metabolomics,X23412.Phospholipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0645843056140909,0.00432946518800137,0.0560985538456082,0.0730700573825736,7.6200006534328e-50
NMR metabolomics,X23412.Phospholipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.114417779202817,0.00768194817175109,0.0993611607861845,0.129474397619449,9.11875511467168e-50
NMR metabolomics,X23412.Phospholipids in VLDL,FABP5,Fatty acid-binding protein 5,42678,0.100133395611741,0.0067261601604767,0.0869501216972065,0.113316669526275,9.91210106651272e-50
NMR metabolomics,X23412.Phospholipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,42586,0.095654404577691,0.00642569054971734,0.083060051100245,0.108248758055137,1.01080473185588e-49
NMR metabolomics,X23412.Phospholipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.215686419121439,0.0144810568823914,0.187303547631952,0.244069290610926,1.06486320094247e-49
NMR metabolomics,X23412.Phospholipids in VLDL,THOP1,Thimet oligopeptidase,42571,0.0456942325779362,0.00307061250113524,0.0396758320757111,0.0517126330801613,1.09062907005139e-49
NMR metabolomics,X23412.Phospholipids in VLDL,GASK1A,Golgi-associated kinase 1A,40116,0.064318971672061,0.00431844518846781,0.0558548191026641,0.072783124241458,1.1063443023011e-49
NMR metabolomics,X23412.Phospholipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,40532,0.0402887054033276,0.00270606595037457,0.0349848161405934,0.0455925946660617,1.15525573927939e-49
NMR metabolomics,X23412.Phospholipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0577691927719344,0.00388605630631422,0.0501525224115585,0.0653858631323102,1.36518240459702e-49
NMR metabolomics,X23412.Phospholipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0695458642696623,0.00467493013696021,0.0603830012012203,0.0787087273381043,1.38733318857779e-49
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,42794,0.0975347463801589,0.00656338490690902,0.0846705119626173,0.110398980797701,1.45696136819934e-49
NMR metabolomics,X23412.Phospholipids in VLDL,GOLM2,Protein GOLM2,42711,0.0341228469752524,0.00229633836067604,0.0296220237883274,0.0386236701621775,1.48126843021656e-49
NMR metabolomics,X23412.Phospholipids in VLDL,DDHD2,Phospholipase DDHD2,40482,0.0968622234254542,0.00651677369817176,0.0840893469770376,0.109635099873871,1.66870395113179e-49
NMR metabolomics,X23412.Phospholipids in VLDL,CDC27,Cell division cycle protein 27 homolog,42346,0.0888133191171768,0.00598520212983779,0.0770823229426948,0.100544315291659,2.06189640439466e-49
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0472390617653918,0.00318240428183357,0.041001549372998,0.0534765741577856,2.28213749256682e-49
NMR metabolomics,X23412.Phospholipids in VLDL,FST,Follistatin,42654,0.0724804470255811,0.00489184477255702,0.0628924312713694,0.0820684627797929,2.79709163712383e-49
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0889392404994383,0.00600556774474866,0.0771683277197309,0.100710153279146,3.11686455536115e-49
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR2,GMP reductase 2,40283,0.0993269824371274,0.00670224283577161,0.0861905864790151,0.11246337839524,3.21529551467622e-49
NMR metabolomics,X23412.Phospholipids in VLDL,CNST,Consortin,42636,0.159518674511433,0.0107756797033961,0.138398342292776,0.180639006730089,3.38759659218022e-49
NMR metabolomics,X23412.Phospholipids in VLDL,MTDH,Protein LYRIC,40199,0.138469114597399,0.00934839410329392,0.120146262154943,0.156791967039855,3.63700668064733e-49
NMR metabolomics,X23412.Phospholipids in VLDL,F2,Prothrombin,40539,0.0219641873359043,0.0014847863739771,0.0190540060429091,0.0248743686288994,4.66331512044199e-49
NMR metabolomics,X23412.Phospholipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,40283,0.182981736216693,0.0123801910513209,0.158716561756104,0.207246910677282,5.74060681211241e-49
NMR metabolomics,X23412.Phospholipids in VLDL,TP53,Cellular tumor antigen p53,42346,0.0632310638482109,0.00428265643629637,0.05483705723307,0.0716250704633518,6.11809175210047e-49
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2L,Ataxin-2-like protein,40482,0.0709189651966833,0.00480033880034374,0.0615103011480095,0.080327629245357,6.19041779512694e-49
NMR metabolomics,X23412.Phospholipids in VLDL,GTPBP2,GTP-binding protein 2,40182,0.118557612063943,0.00802871623730036,0.102821328238834,0.134293895889051,7.05568401023417e-49
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0566946919897885,0.00384525819836367,0.0491579859209957,0.0642313980585813,8.22361164089672e-49
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,42611,0.0740088571635247,0.00502344005537951,0.0641629146549809,0.0838547996720685,9.54917294760386e-49
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4D,Semaphorin-4D,42711,0.043806823286401,0.00297401499211588,0.0379777539018539,0.0496358926709481,9.88947939007087e-49
NMR metabolomics,X23412.Phospholipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.0909009531827638,0.00617021138256537,0.0788073388729357,0.102994567492592,1.17165746234476e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0405008312824055,0.0027530741298856,0.0351048059878297,0.0458968565769813,1.30507728955145e-48
NMR metabolomics,X23412.Phospholipids in VLDL,RWDD1,RWD domain-containing protein 1,42711,0.0917680361271316,0.00624891918540812,0.0795201545237317,0.104015917730532,1.88713961516522e-48
NMR metabolomics,X23412.Phospholipids in VLDL,DOK1,Docking protein 1,40483,0.198437605508391,0.0135028959740384,0.171971929399275,0.224903281617506,1.91625943686694e-48
NMR metabolomics,X23412.Phospholipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,42357,0.109788023207546,0.00748898282578698,0.0951096168690036,0.124466429546089,2.79424375661559e-48
NMR metabolomics,X23412.Phospholipids in VLDL,IFNLR1,Interferon lambda receptor 1,42594,0.0531079231747569,0.00362725500068262,0.045998503373419,0.0602173429760949,3.60185650295616e-48
NMR metabolomics,X23412.Phospholipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0480152813950487,0.00328409504097047,0.0415784551147466,0.0544521076753509,4.84085382187071e-48
NMR metabolomics,X23412.Phospholipids in VLDL,IDUA,Alpha-L-iduronidase,42721,0.0674138955587944,0.00461252985044225,0.0583733370519276,0.0764544540656612,5.20282108802223e-48
NMR metabolomics,X23412.Phospholipids in VLDL,EGLN1,Egl nine homolog 1,42594,0.0805969550403725,0.00551846147803925,0.0697807705434156,0.0914131395373294,6.09571899213044e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,42594,0.0838692283127813,0.00574743638662421,0.0726042529949978,0.0951342036305647,7.30228282400047e-48
NMR metabolomics,X23412.Phospholipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",42357,0.133929644655512,0.00917943024221047,0.115937961380779,0.151921327930244,7.6595000961096e-48
NMR metabolomics,X23412.Phospholipids in VLDL,CTSD,Cathepsin D,41747,0.0612714991897748,0.00420017991973414,0.0530391465470958,0.0695038518324537,8.25915276883515e-48
NMR metabolomics,X23412.Phospholipids in VLDL,PPY,Pancreatic prohormone,42600,0.150359924291413,0.0103138930778795,0.130144693858769,0.170575154724057,8.9422790940576e-48
NMR metabolomics,X23412.Phospholipids in VLDL,AMN,Protein amnionless,42370,0.0683733803991814,0.00468999166286229,0.0591809967399713,0.0775657640583915,9.04902482387357e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SIAE,Sialate O-acetylesterase,42646,0.0664617030670963,0.0045596338328742,0.0575248207546628,0.0753985853795297,9.21505219881019e-48
NMR metabolomics,X23412.Phospholipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0812548330537712,0.00558595220407336,0.0703063667337875,0.092203299373755,1.42106549690574e-47
NMR metabolomics,X23412.Phospholipids in VLDL,WASHC3,WASH complex subunit 3,40483,0.108336750986612,0.00744341506121989,0.0937476574666207,0.122925844506603,1.4683551287012e-47
NMR metabolomics,X23412.Phospholipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0752061334675869,0.00516792533363804,0.0650769998136564,0.0853352671215175,1.52032755662777e-47
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA5,Integrin alpha-5,42611,0.0362359584192921,0.00249321394869397,0.0313492590798519,0.0411226577587323,1.69713052500321e-47
NMR metabolomics,X23412.Phospholipids in VLDL,DCXR,L-xylulose reductase,42679,0.0758522034378641,0.00522573583785904,0.0656097611956604,0.0860946456800678,2.21139241634202e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0547799859207648,0.00377148712747036,0.0473878711509229,0.0621721006906067,2.29552791276325e-47
NMR metabolomics,X23412.Phospholipids in VLDL,RAB27B,Ras-related protein Rab-27B,40511,0.118987639189497,0.00819901653585171,0.102917566779228,0.135057711599766,2.68532694170382e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PSME1,Proteasome activator complex subunit 1,42480,0.0535921240718232,0.00369828535359209,0.0463434847787827,0.0608407633648637,3.16071895908288e-47
NMR metabolomics,X23412.Phospholipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.108870149207303,0.00751309840331421,0.0941444763368067,0.123595822077798,3.20376378659494e-47
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.126033278913836,0.00871638497671358,0.108949164359478,0.143117393468195,5.76206257893743e-47
NMR metabolomics,X23412.Phospholipids in VLDL,QDPR,Dihydropteridine reductase,42581,0.0610395931786424,0.00422536066330552,0.0527578862785636,0.0693213000787212,5.98729629591358e-47
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.100395670817229,0.00695309909749071,0.086767596586147,0.114023745048311,6.5892558582593e-47
NMR metabolomics,X23412.Phospholipids in VLDL,OGA,Protein O-GlcNAcase,40449,0.100633902082845,0.00696793886400703,0.0869767419093909,0.114291062256298,7.3362335091049e-47
NMR metabolomics,X23412.Phospholipids in VLDL,PXN,Paxillin,42311,0.0733926721171776,0.00509160224419783,0.0634131317185499,0.0833722125158054,9.54981942819527e-47
NMR metabolomics,X23412.Phospholipids in VLDL,KIFBP,KIF-binding protein,42587,0.116875307573789,0.00811330913310732,0.100973221672898,0.132777393474679,1.06881140718958e-46
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS8,Galectin-8,42711,0.0856940183470631,0.00594946149008717,0.0740330738264923,0.097354962867634,1.08739680294843e-46
NMR metabolomics,X23412.Phospholipids in VLDL,DLG4,Disks large homolog 4,40483,0.10032073786413,0.00696790716671975,0.086663639817359,0.1139778359109,1.38518903103809e-46
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0895422581131771,0.00622407824864346,0.0773430647458359,0.101741451480518,1.64956150610534e-46
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP5,Microfibrillar-associated protein 5,42794,0.0588946673872521,0.00409848895625553,0.0508616290329912,0.0669277057415129,1.75138329547486e-46
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.148278215698913,0.0103229800183845,0.128045174862879,0.168511256534947,1.92824062369799e-46
NMR metabolomics,X23412.Phospholipids in VLDL,NUDC,Nuclear migration protein nudC,42754,0.08852652941394,0.00616529168823539,0.0764425577049987,0.100610501122881,2.05236975747033e-46
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.115095496000452,0.00801479483009897,0.0993864981334585,0.130804493867446,2.34710465323753e-46
NMR metabolomics,X23412.Phospholipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.082510539910445,0.00575344874146826,0.0712337803771672,0.0937872994437228,3.1373415029521e-46
NMR metabolomics,X23412.Phospholipids in VLDL,NEXN,Nexilin,40532,0.0983813195196041,0.00686825324995092,0.0849195431497003,0.111843095889508,3.90818995708684e-46
NMR metabolomics,X23412.Phospholipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,42587,0.0841863557467999,0.00589464873598481,0.0726328442242697,0.0957398672693301,6.17394245336313e-46
NMR metabolomics,X23412.Phospholipids in VLDL,CD36,Platelet glycoprotein 4,40199,0.0638198366932909,0.00446944653786208,0.0550597214790812,0.0725799519075006,7.57357619735087e-46
NMR metabolomics,X23412.Phospholipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0681129907171231,0.00477372153276144,0.0587564965129106,0.0774694849213355,8.63822084388687e-46
NMR metabolomics,X23412.Phospholipids in VLDL,ICA1,Islet cell autoantigen 1,42370,0.111447391608378,0.00782342426650929,0.0961134800460202,0.126781303170737,1.04637788483023e-45
NMR metabolomics,X23412.Phospholipids in VLDL,DLK1,Protein delta homolog 1,42794,0.0780886912684788,0.00548238010366318,0.0673432262652989,0.0888341562716586,1.04729803142262e-45
NMR metabolomics,X23412.Phospholipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.108151663584123,0.00759703884849895,0.0932614674410654,0.123041859727181,1.17680340468167e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CETN3,Centrin-3,40449,0.107294861885734,0.0075378861792039,0.0925206049744939,0.122069118796973,1.39858159522016e-45
NMR metabolomics,X23412.Phospholipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0407900928623522,0.00286835783255367,0.035168111510547,0.0464120742141574,1.48554788145906e-45
NMR metabolomics,X23412.Phospholipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0540936070220564,0.00380198090545278,0.0466417244473689,0.0615454895967438,1.52851388663516e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,42346,0.128201103419005,0.00901939009405032,0.110523098834667,0.145879108003344,1.63064583671817e-45
NMR metabolomics,X23412.Phospholipids in VLDL,FOXJ3,Forkhead box protein J3,40199,0.0620292562606721,0.00436155673399792,0.0534806050620362,0.070577907459308,1.6956008998804e-45
NMR metabolomics,X23412.Phospholipids in VLDL,COCH,Cochlin,40511,0.0664977031121439,0.00467707032206729,0.057330645280892,0.0756647609433958,1.74890935282469e-45
NMR metabolomics,X23412.Phospholipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0848727014803189,0.00597867703964377,0.0731544944826171,0.0965909084780207,2.09857835630278e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CRADD,Death domain-containing protein CRADD,42476,0.105760431039892,0.0074515187603792,0.0911554542695486,0.120365407810235,2.16839762039392e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MAX,Protein max,42311,0.14783264338563,0.0104232978259731,0.127402979646723,0.168262307124537,2.52738871349191e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.116880055079038,0.00825049034082861,0.100709094011014,0.133051016147062,3.12629247743378e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0655962232592278,0.00463509249875701,0.0565114419616641,0.0746810045567916,4.47269320889685e-45
NMR metabolomics,X23412.Phospholipids in VLDL,DGKA,Diacylglycerol kinase alpha,40199,0.07717315524957,0.00545333027574684,0.0664846279091062,0.0878616825900338,4.53391216793858e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MGLL,Monoglyceride lipase,42654,0.120496290907151,0.00852392472184419,0.103789398452336,0.137203183361965,4.76802615862708e-45
NMR metabolomics,X23412.Phospholipids in VLDL,AMBP,Protein AMBP,42706,0.0294344942214462,0.00208660318231628,0.0253447519841063,0.0335242364587861,7.21569419435325e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,42495,0.110775600716102,0.00785468535692487,0.0953804174165291,0.126170784015675,7.64275649097062e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.136214175727053,0.00966694937762584,0.117266954946907,0.1551613965072,1.03563166179702e-44
NMR metabolomics,X23412.Phospholipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0847015627003235,0.00602636804321962,0.0728898813356131,0.0965132440650339,1.47693140667984e-44
NMR metabolomics,X23412.Phospholipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,40532,0.10102600871409,0.00718350302429815,0.0869463427864655,0.115105674641714,1.50387697065665e-44
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,42587,0.050648620514178,0.00360627214760218,0.0435803271048777,0.0577169139234782,1.71933556756111e-44
NMR metabolomics,X23412.Phospholipids in VLDL,AP2B1,AP-2 complex subunit beta,40182,0.0675269748699015,0.00481396724223972,0.0580915990751117,0.0769623506646914,2.55659946113749e-44
NMR metabolomics,X23412.Phospholipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0917257251713585,0.00655645804512641,0.0788750674029107,0.104576382939806,4.23556485029095e-44
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,42636,0.108995605334417,0.0078237202807033,0.0936611135842385,0.124330097084595,8.22696990949447e-44
NMR metabolomics,X23412.Phospholipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,40451,0.0766310453802416,0.00550071759489192,0.0658496388942534,0.0874124518662297,9.45450775623671e-44
NMR metabolomics,X23412.Phospholipids in VLDL,CD244,Natural killer cell receptor 2B4,42754,0.0379847724250235,0.00273173282749604,0.0326305760831312,0.0433389687669157,1.17723734561665e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.116862667841655,0.00840486321264162,0.100389135944877,0.133336199738433,1.38629019282822e-43
NMR metabolomics,X23412.Phospholipids in VLDL,IL7,Interleukin-7,42594,0.0877339044598488,0.0063214949137358,0.0753437744289267,0.100124034490771,1.7057024522281e-43
NMR metabolomics,X23412.Phospholipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0278615688156525,0.0020063883828377,0.0239290475852906,0.0317940900460144,1.74288849582201e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0680929644840286,0.00490726404422531,0.058474726957347,0.0777112020107102,2.05947042744521e-43
NMR metabolomics,X23412.Phospholipids in VLDL,YJU2,Splicing factor YJU2,40451,0.0448535237007527,0.00323288339816375,0.0385170722403518,0.0511899751611537,2.06724463681203e-43
NMR metabolomics,X23412.Phospholipids in VLDL,EHD3,EH domain-containing protein 3,40223,0.162066112883843,0.0116982534269338,0.139137536167052,0.184994689600633,2.77544621624018e-43
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0920502199838978,0.00665239813655772,0.0790115196362446,0.105088920331551,2.99882962774329e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SPRY2,Protein sprouty homolog 2,42370,0.126477081071019,0.00915499740282504,0.108533286161482,0.144420875980556,4.12820945305293e-43
NMR metabolomics,X23412.Phospholipids in VLDL,YWHAQ,14-3-3 protein theta,40283,0.101210713732828,0.00732244242785273,0.0868587265742366,0.115562700891419,4.27299295415535e-43
NMR metabolomics,X23412.Phospholipids in VLDL,LPP,Lipoma-preferred partner,40116,0.0905806213875186,0.00656646623772747,0.0777103475615727,0.103450895213464,6.30133076324899e-43
NMR metabolomics,X23412.Phospholipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0835169391296805,0.00606091083717747,0.0716375538888126,0.0953963243705483,6.62458062374538e-43
NMR metabolomics,X23412.Phospholipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0603622436533989,0.00438162666067861,0.0517742553984688,0.068950231908329,6.94620081169624e-43
NMR metabolomics,X23412.Phospholipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0332452262871571,0.00241650715205343,0.0285088722691323,0.0379815803051818,8.91490118594958e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.03740667488861,0.00272843122075352,0.0320589496959331,0.0427544000812869,1.71047065680018e-42
NMR metabolomics,X23412.Phospholipids in VLDL,TMED8,Protein TMED8,40449,0.139332347552498,0.010162786392567,0.119413286223066,0.159251408881929,1.93678910253361e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0705633383415576,0.00514804231531595,0.0604731754035383,0.0806535012795769,2.02302902412908e-42
NMR metabolomics,X23412.Phospholipids in VLDL,KLK13,Kallikrein-13,42381,0.062872743211871,0.00459719967384005,0.0538622318511445,0.0718832545725975,2.73224796489708e-42
NMR metabolomics,X23412.Phospholipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0776503667093697,0.00567852817224664,0.0665204514917663,0.0887802819269731,3.19447306611265e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CACYBP,Calcyclin-binding protein,40267,0.138976993404194,0.0101645232025362,0.119054527927223,0.158899458881165,3.25001063409659e-42
NMR metabolomics,X23412.Phospholipids in VLDL,OXT,Oxytocin-neurophysin 1,42711,0.188085026151392,0.0137817531900743,0.161072789898847,0.215097262403938,3.97818736329949e-42
NMR metabolomics,X23412.Phospholipids in VLDL,PON3,Serum paraoxonase/lactonase 3,42676,-0.0386799179032922,0.00283432198044229,-0.0442351889849591,-0.0331246468216253,4.00753155246958e-42
NMR metabolomics,X23412.Phospholipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.133299356966218,0.00976693260591702,0.11415616905862,0.152442544873815,4.01462598152404e-42
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC4,Apical endosomal glycoprotein,40451,0.0748508955026682,0.00548244707409965,0.0641052992374329,0.0855964917679035,4.20013797369115e-42
NMR metabolomics,X23412.Phospholipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,40283,0.161001780157763,0.0117936464478541,0.137886233119969,0.184117327195557,4.32165685838893e-42
NMR metabolomics,X23412.Phospholipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0829531102237898,0.00607905191446026,0.0710381684714477,0.0948680519761319,4.69556512824089e-42
NMR metabolomics,X23412.Phospholipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0614481012270597,0.0045070924761951,0.0526141999737173,0.0702820024804021,4.81404012181944e-42
NMR metabolomics,X23412.Phospholipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.0944054241539272,0.00692173263406413,0.0808388281911616,0.107972020116693,5.1575989419625e-42
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.0975683530013819,0.00715423476528103,0.0835460528614311,0.111590653141333,5.2375736195324e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0704308838807925,0.00516527235739684,0.0603069500602947,0.0805548177012903,5.30966690613548e-42
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,42346,0.080591122837846,0.00591609123645518,0.0689955840143939,0.0921866616612982,5.67957718798237e-42
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,40449,0.079357408842959,0.00583008634177903,0.0679304396130721,0.0907843780728459,7.31311698224734e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CTF1,Cardiotrophin-1,42357,0.11368861618616,0.0083613881703104,0.0973002953723516,0.130076936999968,8.00767622930315e-42
NMR metabolomics,X23412.Phospholipids in VLDL,ADD1,Alpha-adducin,40283,0.0964886066999247,0.007093942343242,0.0825844797071704,0.110392733692679,8.47892456253206e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SPON2,Spondin-2,42562,-0.0484942305834341,0.00358002792342687,-0.0555110853133508,-0.0414773758535174,1.57703867246266e-41
NMR metabolomics,X23412.Phospholipids in VLDL,LEP,Leptin,42636,0.0894085561103218,0.00661122016794409,0.0764505645811514,0.102366547639492,2.11186441735433e-41
NMR metabolomics,X23412.Phospholipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0469364201845107,0.00347346657376465,0.040128425699932,0.0537444146690895,2.44850550966497e-41
NMR metabolomics,X23412.Phospholipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0785045317383064,0.00581015418564711,0.067116629534438,0.0898924339421747,2.48386307429426e-41
NMR metabolomics,X23412.Phospholipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.148957694531507,0.0110279259539271,0.12734295966181,0.170572429401204,2.67310801827092e-41
NMR metabolomics,X23412.Phospholipids in VLDL,GRAP2,GRB2-related adapter protein 2,42636,0.170463397636316,0.0126323021968432,0.145704085330503,0.195222709942128,3.13636868964752e-41
NMR metabolomics,X23412.Phospholipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0691591704817285,0.00512650202437691,0.0591112265139498,0.0792071144495073,3.34716498385913e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.113315440723762,0.0084094534560879,0.0968329119498299,0.129797969497695,4.12488951446521e-41
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE4,Ribonuclease 4,40169,0.0393040381574597,0.00291972768759185,0.0335813718897796,0.0450267044251397,5.56451518945168e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ELOA,Elongin-A,42587,0.0717132953275465,0.0053357443872369,0.0612552363285622,0.0821713543265308,6.47398986186135e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.113804771636588,0.00846277645192029,0.0972177297908242,0.130391813482352,6.55587112734293e-41
NMR metabolomics,X23412.Phospholipids in VLDL,PMVK,Phosphomevalonate kinase,42303,0.144268465623746,0.0107575936661905,0.123183582038013,0.165353349209479,9.69193658490053e-41
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,40287,0.0868066556935326,0.00646902354947872,0.0741273695365543,0.0994859418505109,9.74390807092974e-41
NMR metabolomics,X23412.Phospholipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.142389416628009,0.0106128670413257,0.121588197227011,0.163190636029007,1.02614875533673e-40
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2,Microtubule-associated protein 2,40483,0.0621032477897798,0.00463277090775688,0.0530230168105764,0.0711834787689833,1.15281008054065e-40
NMR metabolomics,X23412.Phospholipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.0975544625606778,0.00728329474333998,0.0832792048637315,0.111829720257624,1.20762907442082e-40
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0656806452243358,0.0049006821302988,0.0560753082489501,0.0752859821997214,1.21124326590551e-40
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.124218323610669,0.00927635300395861,0.10603667172291,0.142399975498428,1.39449881990009e-40
NMR metabolomics,X23412.Phospholipids in VLDL,KITLG,Kit ligand,42636,-0.050125521700885,0.00374579690545313,-0.0574672836355731,-0.0427837597661969,1.40440508271024e-40
NMR metabolomics,X23412.Phospholipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,42754,0.0887982974870598,0.00664930550472195,0.0757656586978047,0.101830936276315,2.00655608453695e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CD226,CD226 antigen,40199,0.0565641956827615,0.00423611499194279,0.0482614102985536,0.0648669810669694,2.34802747846543e-40
NMR metabolomics,X23412.Phospholipids in VLDL,FGL1,Fibrinogen-like protein 1,40532,-0.0877043513392997,0.00656912387519381,-0.10057983413468,-0.0748288685439198,2.35615996994948e-40
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP1,Syntaxin-binding protein 1,40482,0.102099553338968,0.00765032548802418,0.0871049153824407,0.117094191295495,2.53210958499453e-40
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN3,Ataxin-3,40483,0.0827685130921384,0.0062030135434374,0.0706106065470011,0.0949264196372757,2.61712134691054e-40
NMR metabolomics,X23412.Phospholipids in VLDL,RRAS,Ras-related protein R-Ras,40182,0.172231814649778,0.0129122296193415,0.146923844595868,0.197539784703687,2.83505051509279e-40
NMR metabolomics,X23412.Phospholipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.131690698942734,0.00987538220853368,0.112334949814008,0.15104644807146,2.97433106595423e-40
NMR metabolomics,X23412.Phospholipids in VLDL,TALDO1,Transaldolase,40499,0.0585677760030232,0.0043940425064311,0.0499554526904182,0.0671800993156281,3.16073203837676e-40
NMR metabolomics,X23412.Phospholipids in VLDL,NUB1,NEDD8 ultimate buster 1,42594,0.110139192314395,0.00826949138611182,0.0939309891976157,0.126347395431174,3.24455691815791e-40
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB2,BPI fold-containing family B member 2,40473,0.0916041168238511,0.00688043804445333,0.0781184582567225,0.10508977539098,3.8685076070336e-40
NMR metabolomics,X23412.Phospholipids in VLDL,MPI,Mannose-6-phosphate isomerase,42587,0.111823593052533,0.0084043908182563,0.0953509870487506,0.128296199056315,3.87211370573301e-40
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4R,Reticulon-4 receptor,42721,0.0456495815871595,0.00343284999845051,0.0389211955901965,0.0523779675841225,4.25123393930787e-40
NMR metabolomics,X23412.Phospholipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0625390411331566,0.00470562830319243,-0.0717620726074137,-0.0533160096588994,4.70187849684601e-40
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.103277105499854,0.0077758128609044,0.0880365122924817,0.118517698707227,5.30335887666375e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CD207,C-type lectin domain family 4 member K,42365,0.0526632666110783,0.00396890063825375,0.0448842213601009,0.0604423118620556,6.31851209504164e-40
NMR metabolomics,X23412.Phospholipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.112158004612496,0.00845515185032876,0.095585906985852,0.128730102239141,6.57126853150342e-40
NMR metabolomics,X23412.Phospholipids in VLDL,TBCB,Tubulin-folding cofactor B,42495,0.131506830952848,0.00991364386605298,0.112076088975384,0.150937572930312,6.60001515634786e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CCL3,C-C motif chemokine 3,42594,0.0760825909285351,0.0057357414110178,0.0648405377629402,0.08732464409413,6.62299382208365e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CD22,B-cell receptor CD22,42754,0.0576738385360992,0.00435066988161324,0.0491465255681372,0.0662011515040611,7.34123817733664e-40
NMR metabolomics,X23412.Phospholipids in VLDL,FUS,RNA-binding protein FUS,42336,0.0525063484822692,0.00396545301462364,0.0447340605736068,0.0602786363909315,9.14803186527522e-40
NMR metabolomics,X23412.Phospholipids in VLDL,DNM3,Dynamin-3,40482,0.0724458954589893,0.00547264113744442,0.0617195188295982,0.0831722720883804,1.04822116815165e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,42611,0.0706608974219699,0.00534195072214945,0.060190674006557,0.0811311208373828,1.07797612543487e-39
NMR metabolomics,X23412.Phospholipids in VLDL,NHLRC3,NHL repeat-containing protein 3,40013,0.0426305376839559,0.00322067810271921,0.0363180086026262,0.0489430667652855,1.09811382402509e-39
NMR metabolomics,X23412.Phospholipids in VLDL,IMPACT,Protein IMPACT,40483,0.0737962160000315,0.0055846571496936,0.062850287986632,0.0847421440134309,1.43025895169157e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,42594,0.0436442543827429,0.00330581169723775,0.037164863456157,0.0501236453093289,1.50267811197407e-39
NMR metabolomics,X23412.Phospholipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",42603,0.142862461506114,0.0108302240874512,0.121635222294709,0.164089700717518,1.73930511196381e-39
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0481866842137504,0.00365500336299555,0.0410228776222791,0.0553504908052217,2.15206104076319e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CCL7,C-C motif chemokine 7,42594,0.0777231597811025,0.00590035710438898,0.0661584598565001,0.0892878597057049,2.21574410684401e-39
NMR metabolomics,X23412.Phospholipids in VLDL,TDRKH,Tudor and KH domain-containing protein,42311,0.110916002251919,0.00842210681353736,0.0944086728973859,0.127423331606452,2.33208972114567e-39
NMR metabolomics,X23412.Phospholipids in VLDL,VNN1,Pantetheinase,40532,0.0957021944300136,0.00727008799196325,0.0814528219657657,0.109951566894262,2.75020508056977e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,42594,-0.046207146969147,0.00351277807977285,-0.0530921920055018,-0.0393221019327922,2.8255345328181e-39
NMR metabolomics,X23412.Phospholipids in VLDL,UROD,Uroporphyrinogen decarboxylase,40283,0.0904254697690098,0.00687437196559061,0.0769517007164522,0.103899238821567,3.17250883363498e-39
NMR metabolomics,X23412.Phospholipids in VLDL,MESD,LRP chaperone MESD,42611,0.157381466655487,0.0119745721281932,0.133911305284229,0.180851628026746,3.26156501128588e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0761395495254106,0.00580179065832176,0.0647680398351,0.0875110592157213,4.20973041423412e-39
NMR metabolomics,X23412.Phospholipids in VLDL,SUGT1,Protein SGT1 homolog,42346,0.1046614338059,0.00797701220176903,0.0890264898904329,0.120296377721367,4.42757704615324e-39
NMR metabolomics,X23412.Phospholipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0739605758438239,0.00564009809312788,0.0629059835812932,0.0850151681063545,4.79706024812117e-39
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.129250532118261,0.00986182865796074,0.109921347948658,0.148579716287864,5.2744980565478e-39
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0569711112606377,0.00434877171118563,0.0484475187067138,0.0654947038145615,5.69899764298276e-39
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB9,Serpin B9,42495,0.0429356367870234,0.00327805288893912,0.0365106531247027,0.0493606204493441,5.8948541732368e-39
NMR metabolomics,X23412.Phospholipids in VLDL,GET3,ATPase GET3,40511,0.0706969042868232,0.00539775389633272,0.0601173066500111,0.0812765019236353,6.52806972515948e-39
NMR metabolomics,X23412.Phospholipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0749701044469618,0.00572923748021768,0.0637407989857351,0.0861994099081884,6.98226327152445e-39
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS9,Galectin-9,42620,0.0419456030877315,0.00321271425753311,0.0356486831429666,0.0482425230324963,1.00904626078541e-38
NMR metabolomics,X23412.Phospholipids in VLDL,CCL8,C-C motif chemokine 8,42706,0.0785994814963301,0.00602929413668139,0.0667820649884346,0.0904168980042256,1.30075502476125e-38
NMR metabolomics,X23412.Phospholipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0617242310237678,0.00473338243175458,0.0524468014575288,0.0710016605900068,1.37268688723091e-38
NMR metabolomics,X23412.Phospholipids in VLDL,TADA3,Transcriptional adapter 3,40451,0.0513952755566536,0.00394349571699229,0.0436660239513487,0.0591245271619585,1.51052719506706e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.120677906547709,0.00927933722340122,0.102490405589843,0.138865407505576,1.95253147069579e-38
NMR metabolomics,X23412.Phospholipids in VLDL,FIS1,Mitochondrial fission 1 protein,42624,0.0973760075272833,0.00749323750104379,0.0826892620252375,0.112062753029329,2.2195597075546e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PF4,Platelet factor 4,40463,0.12745040876633,0.00980400811996252,0.108234552851204,0.146666264681457,2.31327965380042e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.134074512479559,0.010334476376745,0.113818938781138,0.154330086177979,3.27851001852358e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0681672621396583,0.00525465696774264,0.0578681344828827,0.0784663897964338,3.28095308430515e-38
NMR metabolomics,X23412.Phospholipids in VLDL,F11,Coagulation factor XI,40383,0.03903676602204,0.00301438012423915,0.0331285809785313,0.0449449510655488,4.39954912444018e-38
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0628147315759597,0.00485103140499036,0.0533067100221786,0.0723227531297408,4.45029615035207e-38
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0658640217067028,0.00509215725865866,0.0558833934797318,0.0758446499336738,4.90920150234892e-38
NMR metabolomics,X23412.Phospholipids in VLDL,APOE,Apolipoprotein E,40539,0.0940827602828231,0.00727787162243515,0.0798181319028502,0.108347388662796,5.85452088129474e-38
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0694589541294577,0.00537363699581418,0.0589266256176619,0.0799912826412535,6.04210660436219e-38
NMR metabolomics,X23412.Phospholipids in VLDL,SDC4,Syndecan-4,42636,0.0607364565549113,0.00470217694215753,0.0515201897482825,0.06995272336154,6.09501854837689e-38
NMR metabolomics,X23412.Phospholipids in VLDL,SNCG,Gamma-synuclein,42495,0.0888000887351432,0.00687682815711854,0.0753215055471908,0.102278671923096,6.42839658197825e-38
NMR metabolomics,X23412.Phospholipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.115084800306061,0.00891562859357446,0.0976101682626553,0.132559432349467,7.48097174252785e-38
NMR metabolomics,X23412.Phospholipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.122682259303753,0.00951072693706711,0.104041234507101,0.141323284100404,7.62247420886932e-38
NMR metabolomics,X23412.Phospholipids in VLDL,APOL1,Apolipoprotein L1,40532,0.0750636182233749,0.0058169416361922,0.0636624126164382,0.0864648238303116,7.85481374663297e-38
NMR metabolomics,X23412.Phospholipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,40500,0.0613071291919625,0.00475680835711925,0.0519837848120088,0.0706304735719162,9.65666183795993e-38
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB1,Heat shock protein beta-1,42448,0.0868221592882871,0.00674443191188065,0.073603072741001,0.100041245835573,1.07202438204045e-37
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0621549402730283,0.00483310314716376,0.0526820581045873,0.0716278224414693,1.38245717327266e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CERT,Ceramide transfer protein,42311,0.0781582350265311,0.00609157451235799,0.0662187489823094,0.0900977210707528,1.85711939848638e-37
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.115449509186457,0.00900518558580426,0.0977993454382802,0.133099672934633,2.33346086643276e-37
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO3,Forkhead box protein O3,42346,0.121222151698406,0.00946138403949267,0.102677838981001,0.139766464415812,2.33972510745438e-37
NMR metabolomics,X23412.Phospholipids in VLDL,RFC4,Replication factor C subunit 4,40451,0.0269803688950764,0.00210934030748213,0.0228460618924115,0.0311146758977414,3.3449334925673e-37
NMR metabolomics,X23412.Phospholipids in VLDL,THTPA,Thiamine-triphosphatase,40436,0.112046023642347,0.0087654414732729,0.0948657583547322,0.129226288929962,3.71446179587214e-37
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0807270183035182,0.00631634705065283,0.0683469780842386,0.0931070585227977,3.80974938952059e-37
NMR metabolomics,X23412.Phospholipids in VLDL,GPI,Glucose-6-phosphate isomerase,40532,0.0598622528601237,0.00468475984159715,0.0506801235705933,0.0690443821496541,3.91876524440204e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0625960979633413,0.00490496289897843,0.0529823706813436,0.072209825245339,4.40036094481276e-37
NMR metabolomics,X23412.Phospholipids in VLDL,PENK,Proenkephalin-A,40283,0.0418544919851849,0.00327808495959531,0.0354294454643781,0.0482795385059917,4.5129736801615e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CTSO,Cathepsin O,42754,0.0391214349908174,0.00306670760037821,0.0331106880940761,0.0451321818875587,4.66389839670406e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0428464336478231,0.003360036079319,0.0362607629323578,0.0494321043632883,5.00197287035029e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CIAPIN1,Anamorsin,42679,0.0786705638693001,0.00617253301827686,0.0665723991534774,0.0907687285851227,5.41421348328743e-37
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1A,Meprin A subunit alpha,40449,0.0921870545380103,0.007236865244345,0.0780027986590941,0.106371310416927,6.49148839488076e-37
NMR metabolomics,X23412.Phospholipids in VLDL,CASP7,Caspase-7,40483,0.106030389989569,0.00833058635810927,0.0897024407276747,0.122358339251463,7.41697997945749e-37
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX2,Heme oxygenase 2,42311,0.0579408619770595,0.00455863097863165,0.0490059452589415,0.0668757786951776,8.55846306906224e-37
NMR metabolomics,X23412.Phospholipids in VLDL,BIN2,Bridging integrator 2,42611,0.114321524426702,0.00899662279678887,0.0966881437449956,0.131954905108408,8.78951442857638e-37
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.077201406119127,0.00607447903929146,0.0652954272021158,0.0891073850361383,9.37724813429061e-37
NMR metabolomics,X23412.Phospholipids in VLDL,FUOM,Fucose mutarotase,40283,0.0802771583820098,0.00632254274312951,0.0678849746054759,0.0926693421585436,1.10598962108785e-36
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.0985484695400571,0.00776883499822241,0.0833215529435412,0.113775386136573,1.1741336553962e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN9,Septin-9,42587,0.0359972223355634,0.00284116007282317,0.03042854859283,0.0415658960782968,1.40751912525506e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6AP2,Renin receptor,42346,0.0510128760560741,0.0040285567326603,0.0431169048600599,0.0589088472520883,1.55244315242282e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MME,Neprilysin,42587,0.102460421794066,0.00809797083145725,0.0865883989644099,0.118332444623722,1.74995856400452e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,42569,0.11169350599472,0.00883413656678222,0.0943785983238271,0.129008413665613,1.96601599109453e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,42346,0.0578767605306421,0.00458021102022448,0.0488995469310021,0.066853974130282,2.16779144630642e-36
NMR metabolomics,X23412.Phospholipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.113956417600944,0.00902595118048162,0.0962655532872002,0.131647281914688,2.46203691782929e-36
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.117474256660745,0.00930509332789394,0.0992362737380726,0.135712239583417,2.49229391169521e-36
NMR metabolomics,X23412.Phospholipids in VLDL,TSC22D1,TSC22 domain family protein 1,40482,0.0820370938679421,0.00650053666183111,0.0692960420107531,0.094778145725131,2.87632959682567e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINC1,Antithrombin-III,40516,0.0185729853828868,0.0014727522785623,0.0156863909169047,0.0214595798488689,3.2130270950136e-36
NMR metabolomics,X23412.Phospholipids in VLDL,EGF,Pro-epidermal growth factor,42597,0.128763803070295,0.0102173576698677,0.108737782037354,0.148789824103236,3.28351819881133e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CASP10,Caspase-10,42311,0.0897097138095148,0.00712906724283211,0.0757367420135639,0.103682685605466,4.19775169438754e-36
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS1,Galectin-1,42636,0.0440244716896279,0.00350038763282534,0.0371637119292903,0.0508852314499656,4.50837206504265e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC3B,Tetranectin,40269,0.0264860069828592,0.00210515377311236,0.0223599055875589,0.0306121083781594,4.7068958987574e-36
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0914571482753154,0.00727054493786582,0.0772068801970984,0.105707416353532,4.79058044751254e-36
NMR metabolomics,X23412.Phospholipids in VLDL,BAG6,Large proline-rich protein BAG6,42357,0.0446084881434523,0.00354816507594998,0.0376540845945904,0.0515628916923143,4.83197904247728e-36
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA4,Protein disulfide-isomerase A4,40527,0.0751488559070883,0.00597506341142678,0.0634377316206918,0.0868599801934848,4.91103351087192e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.107478888255714,0.00854989373257504,0.0907210965398672,0.124236679971561,4.95202379280959e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.100193979235045,0.00796672387528592,0.0845792004394843,0.115808758030605,5.02197289395502e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MIF,Macrophage migration inhibitory factor,42586,0.0847342907617112,0.00674537522745045,0.0715133553159083,0.0979552262075141,5.46073221590567e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB6,Serpin B6,42679,0.0723958756850087,0.00576479464573671,0.0610968781793647,0.0836948731906526,5.69086345553431e-36
NMR metabolomics,X23412.Phospholipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.108029010593361,0.00859727641176272,0.0911783488263056,0.124879672360415,5.74362121879478e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0829667520390247,0.0066036307225833,0.0700236358227614,0.095909868255288,5.86545098305158e-36
NMR metabolomics,X23412.Phospholipids in VLDL,AMOT,Angiomotin,40283,0.0486641007112223,0.00387385702255283,0.0410713409470187,0.0562568604754258,5.98550533294814e-36
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L1,Bcl-2-like protein 1,40483,0.12408290932917,0.0098794093405748,0.104719267021643,0.143446551636696,6.10913224358034e-36
NMR metabolomics,X23412.Phospholipids in VLDL,A1BG,Alpha-1B-glycoprotein,40539,0.0213524451235736,0.00170074285917628,0.0180189891195881,0.0246859011275591,6.48227078183171e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0925730612247224,0.00737556836601111,0.0781169472273406,0.107029175222104,6.84706698982925e-36
NMR metabolomics,X23412.Phospholipids in VLDL,PARK7,Parkinson disease protein 7,42611,0.0647474386935169,0.00516301146632347,0.0546279362195229,0.0748669411675109,7.10909697851841e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0323842360272623,0.00258461842511027,0.0273183839140462,0.0374500881404785,8.15005818987941e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MICALL2,MICAL-like protein 2,40182,0.0861043333327274,0.00686914198128523,0.0726408150494084,0.0995678516160465,8.44454655787686e-36
NMR metabolomics,X23412.Phospholipids in VLDL,LACTB2,Endoribonuclease LACTB2,42636,0.0811733259452454,0.00648252905165659,0.0684675690039985,0.0938790828864924,8.97571551236087e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SELE,E-selectin,42794,0.0633284467121469,0.00506226510149166,0.0534064071132232,0.0732504863110705,1.03616505463459e-35
NMR metabolomics,X23412.Phospholipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,40449,0.108455179011398,0.00866960900448555,0.0914627453626061,0.125447612660189,1.13891393899643e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ATOX1,Copper transport protein ATOX1,42679,0.0866384032394657,0.0069307926947734,0.0730540495577099,0.100222756921222,1.16915257950641e-35
NMR metabolomics,X23412.Phospholipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.074916906056918,0.00599038812071278,0.063175745340321,0.0866580667735151,1.20103180555612e-35
NMR metabolomics,X23412.Phospholipids in VLDL,GZMA,Granzyme A,42754,0.0443370051726862,0.00354784531569136,0.0373832283539312,0.0512907819914413,1.21996094676332e-35
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE2,Glia-derived nexin,40511,0.0801831265213651,0.00641338844153975,0.0676128851759472,0.092753367866783,1.24406940533463e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.115870058352202,0.00927551400278336,0.0976900509067468,0.134050065797658,1.30295998710974e-35
NMR metabolomics,X23412.Phospholipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0651955989561575,0.0052203396085406,0.054963733323418,0.0754274645888971,1.35557857746667e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,42679,0.0314208172702079,0.0025166086994127,0.026488264219359,0.0363533703210568,1.41091483058809e-35
NMR metabolomics,X23412.Phospholipids in VLDL,SPARC,SPARC,42679,0.0870455408537833,0.006973487404246,0.0733775055414611,0.100713576166105,1.46495096925095e-35
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,40429,0.107733222070835,0.00863356902730203,0.0908114267773231,0.124655017364347,1.68276464546482e-35
NMR metabolomics,X23412.Phospholipids in VLDL,MVK,Mevalonate kinase,42370,0.0993780592332538,0.0079704490642211,0.0837559790673804,0.115000139399127,1.76220004359932e-35
NMR metabolomics,X23412.Phospholipids in VLDL,DCTD,Deoxycytidylate deaminase,40283,0.11706528720411,0.00938482773280639,0.0986710248478098,0.135459549560411,1.79231011758689e-35
NMR metabolomics,X23412.Phospholipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.0692792056285152,0.00555960544490452,0.0583823789565023,0.080176032300528,1.92531752302961e-35
NMR metabolomics,X23412.Phospholipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.112265027813991,0.00900690367608239,0.0946114966088695,0.129918559019112,1.99544400551079e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CASP2,Caspase-2,42594,0.0834677391860892,0.00670943044682481,0.0703172555103126,0.0966182228618659,2.47255894717868e-35
NMR metabolomics,X23412.Phospholipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0827951719563955,0.00665800198224865,0.0697454880711881,0.0958448558416028,2.62422205949644e-35
NMR metabolomics,X23412.Phospholipids in VLDL,PLG,Plasminogen,40285,0.0266717844029568,0.00214497328541452,0.0224676367635443,0.0308759320423692,2.91423387673337e-35
NMR metabolomics,X23412.Phospholipids in VLDL,GDF2,Growth/differentiation factor 2,42636,0.0444658597127937,0.00358181092819235,0.0374455102935367,0.0514862091320507,3.40575400326204e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0718453596985077,0.00579398004744536,0.0604891588055147,0.0832015605915006,4.10537631244526e-35
NMR metabolomics,X23412.Phospholipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.112893089049582,0.00910249675341085,0.0950521954128965,0.130733982686267,4.34796268368475e-35
NMR metabolomics,X23412.Phospholipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.047475391159685,0.00383319208944242,0.0399623346643779,0.0549884476549922,4.91865009099484e-35
NMR metabolomics,X23412.Phospholipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.145151110841108,0.0117371963368723,0.122146206020839,0.168156015661378,6.11614156768262e-35
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D5,TBC1 domain family member 5,42594,0.0966358745230659,0.00781739813734073,0.0813137741738781,0.111957974872254,6.5311041228178e-35
NMR metabolomics,X23412.Phospholipids in VLDL,RP2,Protein XRP2,42587,0.0517559365787361,0.00418726488222024,0.0435488974095845,0.0599629757478878,6.63960465996235e-35
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0644038287255588,0.0052110292812049,0.0541902113343972,0.0746174461167204,6.79076739620904e-35
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0565202723496484,0.00457076404882979,0.0475615748139421,0.0654789698853548,6.82924775585038e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.112916992465648,0.00914719485861379,0.0949884905427648,0.130845494388531,8.85374016879648e-35
NMR metabolomics,X23412.Phospholipids in VLDL,GMFG,Glia maturation factor gamma,40511,0.087835374854839,0.00713475260728443,0.0738512597445615,0.101819489965116,1.31693242017036e-34
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.136022580198121,0.0110579929754943,0.114348913966153,0.15769624643009,1.3741908539029e-34
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0340322540720031,0.00277086878293338,0.0286013512574537,0.0394631568865525,1.73134660783674e-34
NMR metabolomics,X23412.Phospholipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0795868126439718,0.0064824350742798,0.0668812398983834,0.0922923853895602,1.8515730444298e-34
NMR metabolomics,X23412.Phospholipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0652498633502166,0.00531495415065504,0.0548325532149327,0.0756671734855004,1.8518272478532e-34
NMR metabolomics,X23412.Phospholipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.060221715997103,0.00490269028274039,0.0506124430429318,0.0698309889512741,1.86730511511676e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA3,Annexin A3,42681,0.0849617421259239,0.00692376193632814,0.0713911687307208,0.0985323155211271,1.97756779618137e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.0997813789769352,0.00813466131346692,0.08383744280254,0.11572531515133,2.12043568444855e-34
NMR metabolomics,X23412.Phospholipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.11502882931933,0.00938794118343571,0.0966284645997963,0.133429194038864,2.68225512705384e-34
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.056333159937291,0.00460878010922368,0.0472999509232126,0.0653663689513694,3.5865280995371e-34
NMR metabolomics,X23412.Phospholipids in VLDL,KLB,Beta-klotho,42311,-0.0911192404466551,0.0074589984300103,-0.105738877369475,-0.0764996035238349,3.91234847060284e-34
NMR metabolomics,X23412.Phospholipids in VLDL,COMT,Catechol O-methyltransferase,42214,0.101112663890521,0.00828040514503344,0.0848830698062559,0.117342257974787,4.16752983489103e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ESYT2,Extended synaptotagmin-2,40483,0.100193402883143,0.00820557851787161,0.0841104689881148,0.116276336778171,4.48522843070376e-34
NMR metabolomics,X23412.Phospholipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0561056222186944,0.00459985305535435,0.0470899102301999,0.0651213342071889,4.85249562550959e-34
NMR metabolomics,X23412.Phospholipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,40058,0.0647384758034057,0.00531246527827375,0.0543260438579892,0.0751509077488223,6.13352590184484e-34
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.105637253806486,0.00868198346015587,-0.122653941388391,-0.0886205662245802,6.9820316788012e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB1,Beta-crystallin B1,40511,0.0775373342036186,0.00637391007784115,0.0650444704510499,0.0900301979561873,7.78188978659974e-34
NMR metabolomics,X23412.Phospholipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.152439985653604,0.0125371247497494,0.127867221144095,0.177012750163113,8.34838791185349e-34
NMR metabolomics,X23412.Phospholipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.130448012863345,0.0107397476349281,0.109398107498886,0.151497918227804,9.75721610939452e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0383003711187106,0.00315696046230344,0.0321127286125959,0.0444880136248254,1.0692689427994e-33
NMR metabolomics,X23412.Phospholipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,42475,0.0492446540848798,0.00405887094255672,0.0412892670374686,0.0572000411322909,1.06965400115559e-33
NMR metabolomics,X23412.Phospholipids in VLDL,IL18,Interleukin-18,42566,0.0561526788263542,0.00463013524543252,0.0470776137453065,0.065227743907402,1.13234568546425e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,42676,0.104482236267766,0.0086272062017489,0.0875729121123381,0.121391560423194,1.3834707597591e-33
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,40182,0.0974469162494505,0.00804336136326836,0.0816819279774445,0.113211904521456,1.43591256624379e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0642330838081982,0.00530637068561567,0.0538325972643914,0.0746335703520049,1.49899741467957e-33
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.063607425482159,0.00525587915685169,0.0533059023347297,0.0739089486295883,1.65836103397329e-33
NMR metabolomics,X23412.Phospholipids in VLDL,FMNL1,Formin-like protein 1,42311,0.0746185516055556,0.00617574381517231,0.0625140937278179,0.0867230094832933,1.96617901544208e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PKD2,Polycystin-2,40116,0.0704949470408878,0.00583538414891289,0.0590575941090185,0.0819322999727571,2.18267886482947e-33
NMR metabolomics,X23412.Phospholipids in VLDL,STK24,Serine/threonine-protein kinase 24,42311,0.0737093575254481,0.00613045545961512,0.0616936648246024,0.0857250502262937,3.99399575876833e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CCS,Copper chaperone for superoxide dismutase,42495,0.0570698632901627,0.00474974070776566,0.047760371502942,0.0663793550773834,4.37692999859404e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PGF,Placenta growth factor,42754,0.0319011857159032,0.00265762085607176,0.0266922488380026,0.0371101225938039,4.99711683725277e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ATG4A,Cysteine protease ATG4A,42346,0.0704123333008643,0.0058711842075803,0.0589048122540069,0.0819198543477217,5.75308582118587e-33
NMR metabolomics,X23412.Phospholipids in VLDL,TTF2,Transcription termination factor 2,40182,0.0586641031364518,0.00489171564740593,0.0490763404675362,0.0682518658053675,6.23949087109791e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0677730258411739,0.00565719058142724,0.0566849323015765,0.0788611193807712,6.65832943076747e-33
NMR metabolomics,X23412.Phospholipids in VLDL,RILP,Rab-interacting lysosomal protein,42674,0.0710433339846258,0.00593640522268311,0.0594079797481669,0.0826786882210847,7.72251157212553e-33
NMR metabolomics,X23412.Phospholipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0563759506422426,0.00471614010892524,0.0471323160287491,0.065619585255736,9.76881488903877e-33
NMR metabolomics,X23412.Phospholipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.087539709320261,0.0073232083783527,0.0731862208986897,0.101893197741832,9.88439902094309e-33
NMR metabolomics,X23412.Phospholipids in VLDL,MATN2,Matrilin-2,42638,0.0352845371577368,0.00295531681118306,0.029492116207818,0.0410769581076556,1.07974465453869e-32
NMR metabolomics,X23412.Phospholipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0730627881397629,0.00612037953977895,0.0610668442417961,0.0850587320377296,1.09948544185051e-32
NMR metabolomics,X23412.Phospholipids in VLDL,C1R,Complement C1r subcomponent,40539,0.0232556391972673,0.00194728206980679,0.019438966340446,0.0270723120540886,1.11368242458164e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CASP3,Caspase-3,42794,0.10315149129733,0.00864422916935484,0.0862088021253941,0.120094180469265,1.15945588929016e-32
NMR metabolomics,X23412.Phospholipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0675132199611818,0.00565931399250084,0.0564209645358802,0.0786054753864835,1.22463246218467e-32
NMR metabolomics,X23412.Phospholipids in VLDL,NPPB,Natriuretic peptides B,42357,-0.168874301228991,0.0141565549179156,-0.196621148868106,-0.141127453589877,1.23010130561039e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0773540639532806,0.00648893840769526,0.0646357446741978,0.0900723832323633,1.34147364829355e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CETN2,Centrin-2,42311,0.0797366520234851,0.00670706592925243,0.0665908028021504,0.0928825012448199,1.99386781054841e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,42721,0.043156651183735,0.00363394781837659,0.0360341134597169,0.0502791889077532,2.2850637468245e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.0905238429727931,0.00762195535783435,0.0755848104714378,0.105462875474148,2.46123095394131e-32
NMR metabolomics,X23412.Phospholipids in VLDL,F12,Coagulation factor XII,40539,0.0492639483740042,0.00415484737852054,0.0411204475121039,0.0574074492359045,3.06833582972163e-32
NMR metabolomics,X23412.Phospholipids in VLDL,PYY,Peptide YY,40116,0.121747271420544,0.0102671633693334,0.101623631216651,0.141870911624438,3.08581426499842e-32
NMR metabolomics,X23412.Phospholipids in VLDL,STX4,Syntaxin-4,42587,0.0702308260828145,0.00592697830129378,0.0586139486122787,0.0818477035533503,3.14174470448944e-32
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0593469981602717,0.00500618233973518,0.0495348807743908,0.0691591155461527,3.19300225635902e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.0945585996808996,0.00798375930115292,0.0789104314506399,0.110206767911159,3.62938960231074e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,42679,0.0982070800694645,0.00831409830467184,0.0819114473923077,0.114502712746621,4.86131758654023e-32
NMR metabolomics,X23412.Phospholipids in VLDL,RASSF2,Ras association domain-containing protein 2,42346,0.0669434444015063,0.00566987329806798,0.0558304927372931,0.0780563960657196,5.2184131150864e-32
NMR metabolomics,X23412.Phospholipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0564993767580533,0.0047905457492596,0.0471099070895045,0.0658888464266022,6.45576006842074e-32
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.116710065868178,0.00990565023761889,0.0972949914024449,0.136125140333911,7.41059931925314e-32
NMR metabolomics,X23412.Phospholipids in VLDL,WDR46,WD repeat-containing protein 46,40451,0.0422798365695172,0.00359294158090818,0.0352376710709371,0.0493220020680972,8.81348415243498e-32
NMR metabolomics,X23412.Phospholipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",42587,0.0946441811083002,0.00804829326703797,0.0788695263049058,0.110418835911695,9.03838912739371e-32
NMR metabolomics,X23412.Phospholipids in VLDL,SULT2A1,Bile salt sulfotransferase,42594,0.0658720104433173,0.00560291700940092,0.0548902931048915,0.0768537277817431,9.33812785969238e-32
NMR metabolomics,X23412.Phospholipids in VLDL,MYO9B,Unconventional myosin-IXb,42370,0.0774564843335243,0.00658834384099672,0.0645433304051707,0.0903696382618778,9.41043988266753e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CD274,Programmed cell death 1 ligand 1,42495,0.0411772331440842,0.00350310522367451,0.0343111469056821,0.0480433193824862,9.61194878136136e-32
NMR metabolomics,X23412.Phospholipids in VLDL,PPP3R1,Calcineurin subunit B type 1,42495,0.0469812479650238,0.00400201520911927,0.03913729815515,0.0548251977748976,1.14706172877e-31
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFA,Vascular endothelial growth factor A,42716,0.0685798016173066,0.00584314827687307,0.0571272309946354,0.0800323722399778,1.1757275047375e-31
NMR metabolomics,X23412.Phospholipids in VLDL,HPSE,Heparanase,40408,0.109817643634804,0.00936202527287895,0.0914680740999612,0.128167213169647,1.36610586173374e-31
NMR metabolomics,X23412.Phospholipids in VLDL,CD69,Early activation antigen CD69,42585,0.102200391034666,0.00871822163882102,0.0851126766225773,0.119288105446756,1.39239629858808e-31
NMR metabolomics,X23412.Phospholipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0519466261165909,0.0044292694401312,0.0432652580139337,0.060627994219248,1.40961175617926e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.119343095246994,0.0101834439084776,0.0993835451863775,0.13930264530761,1.56030961114241e-31
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0460205606871367,0.00393171153720911,0.0383144060742068,0.0537267153000665,1.70707911661708e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.113681264914261,0.00971552160712347,0.0946388425642985,0.132723687264223,1.91102218339433e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PKN3,Serine/threonine-protein kinase N3,40302,0.0874940740916453,0.00748385414455129,0.0728257199683248,0.102162428214966,2.16236173081787e-31
NMR metabolomics,X23412.Phospholipids in VLDL,NRGN,Neurogranin,40532,0.105985096858582,0.0090715268376106,0.0882049042568651,0.123765289460299,2.34695286835099e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PPBP,Platelet basic protein,40471,0.0982776250294289,0.00841314528619727,0.0817878602684822,0.114767389790376,2.40283421284124e-31
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM106A,Transmembrane protein 106A,40451,0.0817057489910743,0.00699828808641593,0.0679891043416991,0.0954223936404495,2.58821245655041e-31
NMR metabolomics,X23412.Phospholipids in VLDL,SWAP70,Switch-associated protein 70,40449,0.0416390635464483,0.00356753868486133,0.0346466877241201,0.0486314393687765,2.69440420920707e-31
NMR metabolomics,X23412.Phospholipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0463210046382842,0.00396887387147595,0.0385420118501914,0.0540999974263771,2.70946097485605e-31
NMR metabolomics,X23412.Phospholipids in VLDL,RAB33A,Ras-related protein Rab-33A,40116,0.0766511898033799,0.00656715302853366,0.0637795698674539,0.0895228097393058,2.72034469182664e-31
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0806845005685056,0.00691398160809692,0.0671330966166356,0.0942359045203756,2.78898711946978e-31
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0773743047346976,0.00663583286971481,0.0643680723100565,0.0903805371593386,2.90480582999739e-31
NMR metabolomics,X23412.Phospholipids in VLDL,REEP4,Receptor expression-enhancing protein 4,40482,0.0721077672022546,0.00618443196131193,0.0599862805580832,0.084229253846426,3.0966485030442e-31
NMR metabolomics,X23412.Phospholipids in VLDL,DXO,Decapping and exoribonuclease protein,40483,0.0531052951261121,0.00456094142198983,0.0441658499390121,0.0620447403132122,3.73077280393055e-31
NMR metabolomics,X23412.Phospholipids in VLDL,BLNK,B-cell linker protein,40199,0.0475968617166999,0.00408982996829426,0.0395807949788432,0.0556129284545567,4.02442841491624e-31
NMR metabolomics,X23412.Phospholipids in VLDL,CALCA,Calcitonin,42476,0.0735597737333292,0.00632806851775345,0.0611567594385324,0.0859627880281259,4.38180876855451e-31
NMR metabolomics,X23412.Phospholipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0798853872510406,0.00686861649490196,0.0664228989210327,0.0933478755810484,4.39653125651831e-31
NMR metabolomics,X23412.Phospholipids in VLDL,CCL11,Eotaxin,42754,0.0425644848508134,0.00366596615698606,0.0353791911831208,0.0497497785185061,5.09659175117184e-31
NMR metabolomics,X23412.Phospholipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0706679587816082,0.00608779545844418,0.0587358796830576,0.0826000378801588,5.67903093125024e-31
NMR metabolomics,X23412.Phospholipids in VLDL,C3,Complement C3,39989,0.0546899358638921,0.0047127585211726,0.0454529291623938,0.0639269425653904,5.95573402483073e-31
NMR metabolomics,X23412.Phospholipids in VLDL,SMTN,Smoothelin,40460,0.106675256150914,0.00921386271823205,0.0886160852231791,0.124734427078649,7.98803146461791e-31
NMR metabolomics,X23412.Phospholipids in VLDL,BMP6,Bone morphogenetic protein 6,42342,0.0468814573179886,0.00405238018728774,0.0389387921509046,0.0548241224850726,8.35343843333218e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA2,Integrin alpha-2,40283,0.040349553028061,0.00349560367609845,0.033498169822908,0.047200936233214,1.19908828475912e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CCL24,C-C motif chemokine 24,42654,0.0952710758434218,0.00826518626084952,0.0790713107721567,0.111470840914687,1.34565778432174e-30
NMR metabolomics,X23412.Phospholipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0606984787926414,0.00528109722099164,0.0503475282394978,0.071049429345785,1.97461378508795e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0592012522581408,0.00514962249536464,0.0491079921672261,0.0692945123490555,2.03148569321709e-30
NMR metabolomics,X23412.Phospholipids in VLDL,ABHD14B,Protein ABHD14B,42460,0.0654046035447952,0.00569742351017388,0.0542376534648544,0.076571553624736,2.32158558267393e-30
NMR metabolomics,X23412.Phospholipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0866526015487037,0.0075486493191713,0.0718572488831279,0.101447954214279,2.32288339148534e-30
NMR metabolomics,X23412.Phospholipids in VLDL,DBN1,Drebrin,40199,0.057445157557878,0.00500502148420302,0.0476353154488401,0.0672549996669159,2.54567192298786e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.079032385112334,0.00691271705203541,0.0654834596903446,0.0925813105343234,4.20065655296103e-30
NMR metabolomics,X23412.Phospholipids in VLDL,LARP1,La-related protein 1,40451,0.0699251535564327,0.00611858736296068,0.0579327223250297,0.0819175847878356,4.42210308413561e-30
NMR metabolomics,X23412.Phospholipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0761552662570694,0.00666541561383964,0.0630910516539437,0.0892194808601951,4.62291514061025e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0392334531171581,0.0034372863413568,0.0324963718880988,0.0459705343462175,5.19965729192404e-30
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.124508899859487,0.0109188666733459,0.103107921179729,0.145909878539245,5.5786019423646e-30
NMR metabolomics,X23412.Phospholipids in VLDL,TBCA,Tubulin-specific chaperone A,40283,0.0965976855112711,0.00846825324208311,0.0799999091567882,0.113195461865754,5.66495005635057e-30
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,40449,0.110754509329281,0.00971150537837841,0.0917199587876589,0.129789059870902,5.80033354292358e-30
NMR metabolomics,X23412.Phospholipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0925829946812927,0.00812633247338799,0.0766553830334522,0.108510606329133,6.22473297547434e-30
NMR metabolomics,X23412.Phospholipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0787284290065088,0.00690873326284151,0.0651873118113394,0.0922695462016782,6.49598074866759e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,42794,0.0814378899119744,0.00715308748697061,0.067417838437512,0.0954579413864368,6.78297139643705e-30
NMR metabolomics,X23412.Phospholipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.135093646225666,0.0119322642238862,0.111706408346849,0.158480884104483,1.39594165153646e-29
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0867382620749895,0.00766719231509043,0.0717105651374123,0.101765959012567,1.63446104745855e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ACYP1,Acylphosphatase-1,40250,0.0740986151509354,0.00655454533762786,0.0612517062891847,0.086945524012686,1.8001620549653e-29
NMR metabolomics,X23412.Phospholipids in VLDL,STX8,Syntaxin-8,42594,0.0539501842787355,0.00477474429211608,0.0445916854661879,0.063308683091283,1.80244541581512e-29
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0722190580844379,0.00639208867373694,0.0596905642839135,0.0847475518849623,1.92917527557066e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CD5,T-cell surface glycoprotein CD5,42706,0.0406436621757994,0.00360466334212258,0.0335785220252392,0.0477088023263597,2.35017506223335e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CEP170,Centrosomal protein of 170 kDa,40223,0.0871418616562806,0.00772445227894977,0.0720019351895391,0.102281788123022,2.35024935988257e-29
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0973299856245728,0.00866338742654466,0.0803497462685452,0.1143102249806,3.72278216282609e-29
NMR metabolomics,X23412.Phospholipids in VLDL,JAM3,Junctional adhesion molecule C,40283,0.0570093961555785,0.00507635458981177,0.0470597411595474,0.0669590511516095,4.15202991652329e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,40223,0.0627045659292705,0.00558588532969082,0.0517562306830765,0.0736529011754645,4.3917863878139e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL2,Chordin-like protein 2,42636,0.0529830796330695,0.00472279671943461,0.0437263980629776,0.0622397612031613,4.45015702863207e-29
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0827471854531592,0.00737689751662606,0.0682884663205722,0.0972059045857463,4.55564510876314e-29
NMR metabolomics,X23412.Phospholipids in VLDL,BLMH,Bleomycin hydrolase,42794,0.0349845279533013,0.00312748070113117,0.0288546657790842,0.0411143901275184,6.3732098637959e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PQBP1,Polyglutamine-binding protein 1,42346,0.063620842694984,0.00568967794007265,0.0524690739324416,0.0747726114575264,6.75796505184302e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0335243262569404,0.00300162281912,0.0276411455314652,0.0394075069824156,8.26190247606341e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0734959078243613,0.0065958771962714,0.0605679885196693,0.0864238271290532,1.0356302236087e-28
NMR metabolomics,X23412.Phospholipids in VLDL,C4BPB,C4b-binding protein beta chain,42679,0.0448695956752609,0.00402800733943518,0.036974701289968,0.0527644900605539,1.07608755812384e-28
NMR metabolomics,X23412.Phospholipids in VLDL,C2,Complement C2,42663,0.0254664803350318,0.00228999739135235,0.0209780854479812,0.0299548752220824,1.32453289796661e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL1,Growth-regulated alpha protein,42607,0.105888020910006,0.00953502402991295,0.0871993738113767,0.124576668008635,1.5764672992997e-28
NMR metabolomics,X23412.Phospholipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",40483,0.1169192925221,0.0105357413048489,0.0962692395645965,0.137569345479604,1.81243417927249e-28
NMR metabolomics,X23412.Phospholipids in VLDL,MIA,Melanoma-derived growth regulatory protein,42679,0.0417533635842328,0.00376937640912868,0.0343653858223406,0.049141341346125,2.15063359006345e-28
NMR metabolomics,X23412.Phospholipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0516083113630073,0.00466508895748497,0.0424647370063368,0.0607518857196778,2.53779939486098e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CCL2,C-C motif chemokine 2,42475,0.0587439837989165,0.0053219846786242,0.0483128938288131,0.0691750737690199,3.32321085649774e-28
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.063543309974575,0.00575692594609958,0.0522597351202198,0.0748268848289302,3.3316770813081e-28
NMR metabolomics,X23412.Phospholipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.063459609587238,0.00574963757010362,0.0521903199498349,0.0747288992246411,3.33755527393069e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0236709901121206,0.0021448356486874,0.0194671122406933,0.0278748679835479,3.37427952852207e-28
NMR metabolomics,X23412.Phospholipids in VLDL,DBI,Acyl-CoA-binding protein,42562,0.0840881836217853,0.0076193314568945,0.0691542939662721,0.0990220732772985,3.38443845153958e-28
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0443773322010467,0.0040213787445258,0.0364954298617761,0.0522592345403173,3.59139808460093e-28
NMR metabolomics,X23412.Phospholipids in VLDL,F2R,Proteinase-activated receptor 1,42654,0.0615435915469097,0.0055793988890893,0.0506079697242946,0.0724792133695247,3.59535318913026e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CST3,Cystatin-C,42659,0.0332817990270659,0.00301921310981808,0.0273641413318225,0.0391994567223094,3.89047851345812e-28
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRD2,Protein ZNRD2,40449,0.0768560219179598,0.00697112607026683,0.0631926148202368,0.0905194290156828,4.03597143903659e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CTSZ,Cathepsin Z,42648,0.0354772610728495,0.00322012640496065,0.0291658133191267,0.0417887088265724,4.15642001904016e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0418143403899817,0.00380281763511281,0.0343608178251606,0.0492678629548028,5.31027677189285e-28
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1,Allograft inflammatory factor 1,42346,0.0571420598161474,0.00520365173350193,0.0469429024184836,0.0673412172138112,6.22620796358615e-28
NMR metabolomics,X23412.Phospholipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.077143550235074,0.00702371451761247,0.0633770697805536,0.0909100306895945,6.36081508664227e-28
NMR metabolomics,X23412.Phospholipids in VLDL,FADD,FAS-associated death domain protein,42636,0.0827179852504434,0.00753473869121356,0.0679498974156648,0.097486073085222,6.39124410480404e-28
NMR metabolomics,X23412.Phospholipids in VLDL,GNAS,Neuroendocrine secretory protein 55,40482,0.0944091949034612,0.00859850745800397,0.0775561202857734,0.111262269521149,6.62063267444292e-28
NMR metabolomics,X23412.Phospholipids in VLDL,POMC,Pro-opiomelanocortin,40223,0.0770205998922576,0.00701486530471411,0.0632714638950179,0.0907697358894972,6.67773745517675e-28
NMR metabolomics,X23412.Phospholipids in VLDL,DTNB,Dystrobrevin beta,40430,0.0469042280002876,0.00427905548496256,0.038517279249761,0.0552911767508142,8.10666718718226e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0670489633998748,0.00612232208249127,0.055049212118192,0.0790487146815577,8.56643113320796e-28
NMR metabolomics,X23412.Phospholipids in VLDL,GP5,Platelet glycoprotein V,40283,0.0394815151203121,0.00361994873225713,0.0323864156050881,0.0465766146355361,1.47838890509553e-27
NMR metabolomics,X23412.Phospholipids in VLDL,C1RL,Complement C1r subcomponent-like protein,40519,0.0216140707449304,0.00198882592449407,0.017715971932922,0.0255121695569388,2.24084398842705e-27
NMR metabolomics,X23412.Phospholipids in VLDL,SCRN1,Secernin-1,42594,0.0598345609667294,0.00552409752408895,0.0490073298195151,0.0706617921139438,3.16314189782467e-27
NMR metabolomics,X23412.Phospholipids in VLDL,REN,Renin,42636,-0.0926483500740659,0.00856317184262333,-0.109432166885608,-0.0758645332625242,3.60502873835613e-27
NMR metabolomics,X23412.Phospholipids in VLDL,RAB2B,Ras-related protein Rab-2B,40451,0.0653155374298435,0.0060547471334429,0.0534482330482954,0.0771828418113916,5.34423952668162e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0270403217387939,0.00250794346323053,0.022124752550862,0.0319558909267257,5.41112523194719e-27
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0714594465225248,0.00662988451990823,0.0584648728635047,0.0844540201815449,5.60575992667779e-27
NMR metabolomics,X23412.Phospholipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0477432034798541,0.00443169533267017,0.0390570806278206,0.0564293263318876,6.26502001547542e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.0991992604542335,0.00921818995382344,0.0811316081447395,0.117266912763727,6.78634932294753e-27
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.036589957324796,0.00340133333436577,0.0299233439894391,0.0432565706601529,7.03228864906692e-27
NMR metabolomics,X23412.Phospholipids in VLDL,BAP18,Chromatin complexes subunit BAP18,40483,0.0727363214199832,0.00677521515311524,0.0594568997198773,0.086015743120089,9.31958198636552e-27
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0346737425339021,0.00323081389483966,0.0283413473000164,0.0410061377677878,9.67026685773927e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CCL4,C-C motif chemokine 4,42642,0.0732379046495594,0.00683081975840749,0.0598494979230807,0.0866263113760381,1.03238039717962e-26
NMR metabolomics,X23412.Phospholipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.112056712215801,0.0104510463077096,0.0915726614526903,0.132540762978912,1.07895545802897e-26
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0566293929173482,0.00528397619357928,0.0462727995779329,0.0669859862567636,1.14347504693691e-26
NMR metabolomics,X23412.Phospholipids in VLDL,RBKS,Ribokinase,42317,0.0532415880210259,0.0049719379437364,0.0434965896513026,0.0629865863907493,1.19737437463924e-26
NMR metabolomics,X23412.Phospholipids in VLDL,ACE2,Angiotensin-converting enzyme 2,42357,0.057418917595856,0.00536399164965926,0.0469054939625238,0.0679323412291881,1.24753123667402e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CCL26,C-C motif chemokine 26,42594,0.0997849391168261,0.00933622658824482,0.0814859350038662,0.118083943229786,1.48306446947418e-26
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT1,Angiopoietin-1,42554,0.0893507844179268,0.00836394145802562,0.0729574591601966,0.105744109675657,1.56684707196162e-26
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0579854899818405,0.00542697375993224,0.0473486214123733,0.0686223585513077,1.61825663045423e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,42711,0.0491381398006662,0.00461035792449126,0.0401018382686633,0.0581744413326691,2.0325973427925e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.073299594307156,0.00687961829528584,0.0598155424483958,0.0867836461659162,2.23190038079169e-26
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO2,Amphoterin-induced protein 2,42587,0.0249517644384122,0.00234959292123938,0.020346562312783,0.0295569665640414,3.07167608175201e-26
NMR metabolomics,X23412.Phospholipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0397810905722545,0.00374673073025291,0.0324374983409588,0.0471246828035502,3.13704370996899e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0577329274073832,0.0054364473483243,0.0470774906046676,0.0683883642100989,3.23513053186153e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CA13,Carbonic anhydrase 13,42483,0.108761570286125,0.0102525147857566,0.0886666413060422,0.128856499266208,3.47075768903036e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MUC13,Mucin-13,42311,0.0553893646324215,0.00522167510111092,0.0451548814342441,0.0656238478305989,3.50752076369496e-26
NMR metabolomics,X23412.Phospholipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,40511,0.0291076446612826,0.00274360340355368,0.0237301819903174,0.0344851073322478,3.58079722210234e-26
NMR metabolomics,X23412.Phospholipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,40182,0.045602661063928,0.00429905013124601,0.0371765228066858,0.0540287993211702,3.6752063602898e-26
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.030186478096103,0.0028480008514053,0.0246043964273487,0.0357685597648574,3.98484437037018e-26
NMR metabolomics,X23412.Phospholipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0283843682455236,0.00268094714720816,-0.0336390246540516,-0.0231297118369956,4.50886164992229e-26
NMR metabolomics,X23412.Phospholipids in VLDL,GP6,Platelet glycoprotein VI,42590,0.0919098983192996,0.00868820444376148,0.0748810176095271,0.108938779029072,4.73966788805403e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MCAM,Cell surface glycoprotein MUC18,42689,-0.0354908428300618,0.00335936258862093,-0.0420751935037588,-0.0289064921563648,5.48340341027071e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP25,Synaptosomal-associated protein 25,40136,0.0501733106433543,0.0047519582368233,0.0408594724991806,0.059487148787528,6.18653178482016e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0671340037151166,0.00636402608013028,0.0546605125980613,0.079607494832172,6.52065987200213e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS2,Trypsin-2,42689,0.0588680046995158,0.0055831236768351,0.047925082292919,0.0698109271061125,6.83296389686816e-26
NMR metabolomics,X23412.Phospholipids in VLDL,HNMT,Histamine N-methyltransferase,42439,0.0506233327763036,0.00480711941251278,0.0412013787277785,0.0600452868248286,7.87171420823134e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,42346,0.0542731678357411,0.00515916782110283,0.0441611989063795,0.0643851367651026,8.86754740688837e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.125819628481629,0.0119619605642945,0.102374185775611,0.149265071187646,8.96407719391309e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0454980223610283,0.00432756280576823,0.0370159992617226,0.0539800454603341,9.42993456743212e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CCL18,C-C motif chemokine 18,42477,0.0731892032280178,0.00696176423059577,0.0595441453360501,0.0868342611199856,9.49600034417364e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.124007196798217,0.0118492147121699,0.100782735962364,0.14723165763407,1.55990456623771e-25
NMR metabolomics,X23412.Phospholipids in VLDL,BGLAP,Osteocalcin,40527,0.0949314304113619,0.00907382920233722,0.0771467251747809,0.112716135647943,1.68474048175314e-25
NMR metabolomics,X23412.Phospholipids in VLDL,TSNAX,Translin-associated protein X,40116,0.041415155664339,0.00395978958948057,0.033653968068957,0.0491763432597209,1.75925420831793e-25
NMR metabolomics,X23412.Phospholipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,40449,0.086308294889317,0.00825530614962484,0.0701278948360523,0.102488694942582,1.82024791238585e-25
NMR metabolomics,X23412.Phospholipids in VLDL,NBN,Nibrin,42370,0.0559493487319933,0.0053546056182857,0.0454543217201534,0.0664443757438333,1.86530628981316e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL11,C-X-C motif chemokine 11,42711,0.0833042661237564,0.00797887233724569,0.0676656763427548,0.0989428559047579,2.0210571075857e-25
NMR metabolomics,X23412.Phospholipids in VLDL,SF3B4,Splicing factor 3B subunit 4,42587,0.075875946020899,0.00727097768572936,0.0616248297568694,0.0901270622849285,2.13722740502407e-25
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN6,Dynactin subunit 6,42311,0.0747932957645169,0.00717181537855658,0.060736537622546,0.0888500539064878,2.3021630795297e-25
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0400290542287744,0.00383948185661727,0.0325036697898046,0.0475544386677443,2.47953539027055e-25
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA12,Serpin A12,42249,0.107769402083025,0.0103492024964653,0.0874849651899534,0.128053838976098,2.70831121949521e-25
NMR metabolomics,X23412.Phospholipids in VLDL,C19orf12,Protein C19orf12,42311,0.0662066845065698,0.0063600957501901,0.0537408968361972,0.0786724721769424,2.80898511006192e-25
NMR metabolomics,X23412.Phospholipids in VLDL,NID1,Nidogen-1,42652,0.0398664970383274,0.0038339963834681,0.0323518641267299,0.0473811299499248,3.14973050418901e-25
NMR metabolomics,X23412.Phospholipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",40223,0.090320288469164,0.00868744870050952,0.0732928890161653,0.107347687922163,3.35752361809512e-25
NMR metabolomics,X23412.Phospholipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0397298330947308,0.00382417080133978,0.0322344583241049,0.0472252078653568,3.47933266029012e-25
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0254963971845351,0.00245453806511984,0.0206855025769002,0.0303072917921699,3.5249862987542e-25
NMR metabolomics,X23412.Phospholipids in VLDL,ARFIP1,Arfaptin-1,40482,0.0710165907119968,0.0068369467576795,0.057616175066945,0.0844170063570486,3.68171411931835e-25
NMR metabolomics,X23412.Phospholipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0900141400063665,0.00867222869177697,0.0730165717704836,0.107011708242249,4.01018685267802e-25
NMR metabolomics,X23412.Phospholipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0337101631130766,0.0032492644934669,-0.0400787215202717,-0.0273416047058815,4.01813696512852e-25
NMR metabolomics,X23412.Phospholipids in VLDL,KLF4,Krueppel-like factor 4,40136,0.0415829753421157,0.00402311814049703,0.0336976637867416,0.0494682868974899,6.3057128360112e-25
NMR metabolomics,X23412.Phospholipids in VLDL,RGS10,Regulator of G-protein signaling 10,40482,0.0613405872597084,0.00593721408004245,0.0497036476628252,0.0729775268565916,6.5503699184534e-25
NMR metabolomics,X23412.Phospholipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0906773788644417,0.00878374787729198,0.0734612330249494,0.107893524703934,7.13666604109018e-25
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFA2,BPI fold-containing family A member 2,39838,-0.117221477171857,0.0113549621034362,-0.139477202894592,-0.0949657514491221,7.23709132209219e-25
NMR metabolomics,X23412.Phospholipids in VLDL,EPCAM,Epithelial cell adhesion molecule,42616,-0.102067955653237,0.00989329515252766,-0.121458814152192,-0.0826770971542833,7.32055461657259e-25
NMR metabolomics,X23412.Phospholipids in VLDL,TMSB10,Thymosin beta-10,42611,0.0763222647511008,0.0073989184603272,0.0618203845688595,0.0908241449333421,7.43963966204488e-25
NMR metabolomics,X23412.Phospholipids in VLDL,LBP,Lipopolysaccharide-binding protein,42689,-0.0606127870592061,0.00587885234967296,-0.072135337664565,-0.0490902364538471,7.82566965809278e-25
NMR metabolomics,X23412.Phospholipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0494059291577232,0.00479729335775552,0.0400032341765224,0.058808624138924,8.86646520266588e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CRLF1,Cytokine receptor-like factor 1,42676,0.0258914785703982,0.00251440543575928,0.02096324391631,0.0308197132244864,8.95567633979207e-25
NMR metabolomics,X23412.Phospholipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0688902725124208,0.00669071870458561,0.055776463851433,0.0820040811734086,9.41205121998898e-25
NMR metabolomics,X23412.Phospholipids in VLDL,AFP,Alpha-fetoprotein,42459,0.0690642391729513,0.0067114642684362,0.0559097692068163,0.0822187091390862,9.63591162391698e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CD72,B-cell differentiation antigen CD72,40283,0.0457325858434673,0.00444542667508801,0.0370195495602948,0.0544456221266398,1.03541960356594e-24
NMR metabolomics,X23412.Phospholipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0343176015349164,0.00333844835609956,0.0277742427569613,0.0408609603128715,1.07389274631224e-24
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD4B,FERM domain-containing protein 4B,40116,0.0722603749553304,0.0070346974727211,0.058472367908797,0.0860483820018637,1.21971823140621e-24
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0361730964285362,0.00352612673142771,0.0292618880349379,0.0430843048221345,1.39718692344893e-24
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0325975784926695,0.00318185012653295,0.0263611522446649,0.0388340047406741,1.53625153782926e-24
NMR metabolomics,X23412.Phospholipids in VLDL,TREML2,Trem-like transcript 2 protein,42611,0.0356647304303305,0.00348138298602036,0.0288412197777306,0.0424882410829304,1.54377870920253e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CEMIP2,Cell surface hyaluronidase,40199,0.0353746862097013,0.00345536253781159,0.0286021756355906,0.0421471967838121,1.73173191437227e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BP1,SH3 domain-binding protein 1,40449,0.0489119278684143,0.00478925572210232,0.0395249866530937,0.0582988690837348,2.21862590704089e-24
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0391381242793971,0.00383450505371937,0.0316224943741071,0.0466537541846871,2.35755942636082e-24
NMR metabolomics,X23412.Phospholipids in VLDL,APP,Amyloid-beta precursor protein,42592,0.0676226464965194,0.00663857526310728,0.0546110389808292,0.0806342540122097,2.79811027845526e-24
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1B,Meprin A subunit beta,42636,0.12026297971851,0.0118182519015364,0.0970992059914989,0.143426753445521,3.1053874183824e-24
NMR metabolomics,X23412.Phospholipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0356653675313138,0.00350950298671836,-0.0425439933852818,-0.0287867416773458,3.56188765618647e-24
NMR metabolomics,X23412.Phospholipids in VLDL,RAB10,Ras-related protein Rab-10,40511,0.0544057284307504,0.00535412286036077,0.0439116476244433,0.0648998092370575,3.7401667472722e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP1,Secreted frizzled-related protein 1,42457,0.0448538972665974,0.00442751363571148,0.0361759705406029,0.0535318239925919,4.93715733195484e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SDHB,Succinate dehydrogenase,40449,0.0674146059319049,0.00665457418535699,0.0543716405286052,0.0804575713352046,5.12457230706412e-24
NMR metabolomics,X23412.Phospholipids in VLDL,FAP,Prolyl endopeptidase FAP,42794,0.0276163472739579,0.00273473714122814,0.0222562624771508,0.0329764320707651,6.81988563081289e-24
NMR metabolomics,X23412.Phospholipids in VLDL,FEN1,Flap endonuclease 1,42346,0.064270039266941,0.00636880118943391,0.0517871889356505,0.0767528895982314,7.36609162130179e-24
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0281419994555514,0.00279222796650195,0.0226692326412076,0.0336147662698952,8.70647049893239e-24
NMR metabolomics,X23412.Phospholipids in VLDL,FRZB,Secreted frizzled-related protein 3,42454,0.0251189355556177,0.00249661105994272,0.0202255778781299,0.0300122932331054,9.9733594647656e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0422740458161688,0.004202838131911,0.0340364830776232,0.0505116085547143,1.06530919344502e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ANG,Angiogenin,42618,0.0336999645441991,0.00335416564569676,0.0271257998786334,0.0402741292097647,1.14587503724355e-23
NMR metabolomics,X23412.Phospholipids in VLDL,KLK7,Kallikrein-7,40009,0.039463126581035,0.00392729034977878,0.0317656374954686,0.0471606156666014,1.18516714234354e-23
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP3,Syntaxin-binding protein 3,42346,0.0434932974969288,0.00433314697477544,0.035000329426369,0.0519862655674887,1.27030772247178e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CORO1A,Coronin-1A,42353,0.0895124789577869,0.00892008442864973,0.0720291134776334,0.10699584443794,1.30133999685736e-23
NMR metabolomics,X23412.Phospholipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0660989861172919,0.00658744947975316,0.0531875851369757,0.0790103870976081,1.31228201317543e-23
NMR metabolomics,X23412.Phospholipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0514158998435338,0.00512553392434498,0.0413698533518177,0.06146194633525,1.34097571861604e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1F,Protein phosphatase 1F,40511,0.0522687199159133,0.00521351021453331,0.042050239895428,0.0624871999363986,1.47470270874021e-23
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA1,GDNF family receptor alpha-1,42689,0.0297799950752485,0.00297387044759934,0.0239512089979538,0.0356087811525432,1.60010402505762e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CD40LG,CD40 ligand,42754,0.0776068779378018,0.00775013982571453,0.0624166038794013,0.0927971519962023,1.60307139821235e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH7,Protocadherin-7,40449,0.0364262991725118,0.00363794919427625,0.0292959187517304,0.0435566795932933,1.67812432149077e-23
NMR metabolomics,X23412.Phospholipids in VLDL,BTC,Probetacellulin,42346,0.0748273053298184,0.00747981554091357,0.0601668668696278,0.089487743790009,1.77740053803442e-23
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF6,SLAM family member 6,42346,0.0388655666490729,0.00388580910302673,0.0312493808071405,0.0464817524910053,1.81291100881684e-23
NMR metabolomics,X23412.Phospholipids in VLDL,SNX9,Sorting nexin-9,42636,0.0668478987280042,0.00668992206934667,0.0537356514720847,0.0799601459839237,1.98762809224156e-23
NMR metabolomics,X23412.Phospholipids in VLDL,GSR,"Glutathione reductase, mitochondrial",40490,0.0225504553546093,0.00225603328991167,0.0181286301063824,0.0269722806028361,1.99279916715645e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.0969833917393102,0.00971956311526859,0.0779330480333837,0.116033735445237,2.38552468450659e-23
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0578989017931398,0.00580529295103673,0.0465205276091078,0.0692772759771718,2.41036614430426e-23
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0377383653882069,0.00378570450545652,0.0303183845575121,0.0451583462189017,2.61995044518156e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL16,C-X-C motif chemokine 16,42778,0.0238065880271354,0.00238971383290059,0.0191227489146503,0.0284904271396206,2.6838516012798e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0435971940903142,0.00437652247200417,0.035019210045186,0.0521751781354423,2.81407430989366e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CR1,Complement receptor type 1,40509,0.0361215546521297,0.00362807375277715,0.0290105300966865,0.0432325792075729,2.95529161721824e-23
NMR metabolomics,X23412.Phospholipids in VLDL,KLRD1,Natural killer cells antigen CD94,42754,0.0468802394221099,0.00471160648126868,0.0376454907188232,0.0561149881253965,3.03119221593231e-23
NMR metabolomics,X23412.Phospholipids in VLDL,LAP3,Cytosol aminopeptidase,42370,0.0481298074373977,0.00484709555189031,0.0386295001556927,0.0576301147191027,3.73160274035739e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TST,Thiosulfate sulfurtransferase,42277,0.0739943210408141,0.00745449852133752,0.0593835039389926,0.0886051381426356,3.86852993467564e-23
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0431980753552398,0.00435063132195,0.0346708379642178,0.0517253127462618,3.86985514806165e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG3,Proteasome assembly chaperone 3,42594,0.0508087202043191,0.00511906214029348,0.0407753584093439,0.0608420819992943,3.87964097482723e-23
NMR metabolomics,X23412.Phospholipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.0295516074909228,0.00298800773626727,0.023695112327839,0.0354081026540067,5.52067665811476e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0750948161464771,0.00759211700232261,0.0602142668219248,0.0899753654710295,5.64210928214003e-23
NMR metabolomics,X23412.Phospholipids in VLDL,IL32,Interleukin-32,42594,-0.0437976414772696,0.00443318973320702,-0.0524866933543553,-0.0351085896001838,6.12000927879788e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0595840098994323,0.00603255099382123,0.0477602099515427,0.0714078098473219,6.2887178857354e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0233284929564524,0.00236203608874378,0.0186989022225145,0.0279580836903902,6.29131645018755e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0454480265913747,0.00461792543834751,0.0363968927322136,0.0544991604505358,9.20135958890811e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ERMAP,Erythroid membrane-associated protein,40199,0.0441897138934973,0.00449085213104673,0.0353876437166457,0.0529917840703489,9.40296170177001e-23
NMR metabolomics,X23412.Phospholipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0375053356701772,0.0038129795860706,0.0300318956814789,0.0449787756588756,9.70083271962987e-23
NMR metabolomics,X23412.Phospholipids in VLDL,MMP7,Matrilysin,42333,0.0496475844175569,0.00505014375580241,0.0397493026561842,0.0595458661789296,9.92449106942837e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CCN4,CCN family member 4,42721,0.0394034339092853,0.00400862769559248,0.031546523625924,0.0472603441926466,9.99772453966654e-23
NMR metabolomics,X23412.Phospholipids in VLDL,BMPER,BMP-binding endothelial regulator protein,40283,0.0228828194146464,0.00232784276164465,0.0183202476018229,0.02744539122747,1.03476669904201e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SCRG1,Scrapie-responsive protein 1,40511,0.028109989180366,0.00286532249424946,0.0224939570916371,0.033726021269095,1.24996316856994e-22
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0618354642607732,0.00630843535068412,0.0494709309734323,0.074199997548114,1.31373764962839e-22
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,42676,0.029511483832943,0.00301104286203025,0.0236098398233637,0.0354131278425222,1.32531404662627e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0296916186552729,0.00303334000269988,0.0237462722499811,0.0356369650605646,1.55359737374737e-22
NMR metabolomics,X23412.Phospholipids in VLDL,BDNF,Brain-derived neurotrophic factor,40527,0.0821304845410202,0.0084005059151589,0.0656654929473088,0.0985954761347317,1.7368495572844e-22
NMR metabolomics,X23412.Phospholipids in VLDL,MAGED1,Melanoma-associated antigen D1,42346,0.0472421215548064,0.00483520393667639,0.0377651218389207,0.0567191212706922,1.79793524306207e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ESM1,Endothelial cell-specific molecule 1,42618,-0.0335698852761208,0.00343664487935136,-0.0403057092396494,-0.0268340613125921,1.8312549107961e-22
NMR metabolomics,X23412.Phospholipids in VLDL,DNM1,Dynamin-1,40449,0.111445041954443,0.0114106144037537,0.0890802377230862,0.133809846185801,1.91935036146869e-22
NMR metabolomics,X23412.Phospholipids in VLDL,MSTN,Growth/differentiation factor 8,42357,0.0520412456941399,0.0053363397459532,0.0415820197920717,0.0625004715962082,2.14862417427048e-22
NMR metabolomics,X23412.Phospholipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0498926412791806,0.00512177777489202,0.0398539568403923,0.059931325717969,2.38246143021643e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS27,Serine protease 27,42603,0.0392353307489863,0.00403644166634184,0.0313239050829563,0.0471467564150163,2.92651873164938e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF1,Scavenger receptor class F member 1,42794,0.0406054520275298,0.00418269733152878,0.0324073652577334,0.0488035387973262,3.29208395126961e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PSPN,Persephin,42594,0.0904772647413708,0.00932856149590114,0.0721932842094046,0.108761245273337,3.60268383862963e-22
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0258526634452431,0.00266860659495533,0.0206221945191307,0.0310831323713556,4.0130005470095e-22
NMR metabolomics,X23412.Phospholipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0706067760009927,0.00729240740906218,0.0563136574792308,0.0848998945227545,4.24495243045155e-22
NMR metabolomics,X23412.Phospholipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0330029405155571,0.00341048874867583,0.0263183825681525,0.0396874984629617,4.46486817054129e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PARD3,Partitioning defective 3 homolog,40302,0.0721252641481183,0.00745141275863906,0.0575204951411858,0.0867300331550509,4.50795239932995e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0650421521594065,0.00673767173130684,0.0518363155660451,0.0782479887527679,5.81303448562653e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0225488519249723,0.0023366232415208,0.0179690703715915,0.0271286334783531,5.95911490868853e-22
NMR metabolomics,X23412.Phospholipids in VLDL,DDT,D-dopachrome decarboxylase,40527,0.0401772900903517,0.00416496930755204,0.0320139502475496,0.0483406299331537,6.1766750457674e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0380960766589926,0.00395080667013395,0.0303524955855301,0.0458396577324552,6.20938618878139e-22
NMR metabolomics,X23412.Phospholipids in VLDL,AMOTL2,Angiomotin-like protein 2,40404,0.0465990226778402,0.00483690298499798,0.0371186928272442,0.0560793525284363,6.97876163390921e-22
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0884334638432926,0.0091900715007938,0.0704209237017367,0.106446003984848,7.77575805522463e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0433372223003754,0.00452184144010572,0.0344744130777682,0.0522000315229826,1.09920461491518e-21
NMR metabolomics,X23412.Phospholipids in VLDL,SPOCK1,Testican-1,42495,0.0247561418672551,0.00258334669238715,0.0196927823501762,0.0298195013843339,1.10784923634185e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.03504452071032,0.00365845851483464,0.0278739420212441,0.0422150993993959,1.15055430746027e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0272656982599213,0.00284909439447616,0.021681473246748,0.0328499232730945,1.25219850086551e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CDCP1,CUB domain-containing protein 1,42495,0.0520769519158472,0.00544517463538084,0.0414044096305008,0.0627494942011937,1.33105863851237e-21
NMR metabolomics,X23412.Phospholipids in VLDL,IMPA1,Inositol monophosphatase 1,42495,0.0578549520880611,0.00605351191374101,0.0459900687371288,0.0697198354389935,1.41833487931495e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,42689,0.0440609375763244,0.00461726432784107,0.0350110994937559,0.0531107756588929,1.62778585141402e-21
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0841719319068376,0.00883882454475267,0.0668478357991224,0.101496028014553,2.03186448648025e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0603509874939516,0.00633848355967935,0.0479275597169801,0.0727744152709231,2.0551770453551e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0507997807797749,0.00534059695512721,0.0403322107477256,0.0612673508118242,2.25938893690269e-21
NMR metabolomics,X23412.Phospholipids in VLDL,STX16,Syntaxin-16,42346,0.0549761928106728,0.00578990964331934,0.0436279699097669,0.0663244157115787,2.57272519435521e-21
NMR metabolomics,X23412.Phospholipids in VLDL,TSHB,Thyrotropin subunit beta,42636,0.0751937642151125,0.00794369473449384,0.0596241225355046,0.0907634058947204,3.38995091616148e-21
NMR metabolomics,X23412.Phospholipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.0186593294275073,0.00197139717632044,-0.0225232678930954,-0.0147953909619193,3.41819417080482e-21
NMR metabolomics,X23412.Phospholipids in VLDL,TPMT,Thiopurine S-methyltransferase,42346,0.0689193841878781,0.00728456497174919,0.0546416368432497,0.0831971315325065,3.56091120877111e-21
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0494072980761577,0.00523197698965777,0.0391526231764284,0.0596619729758869,4.21164435603038e-21
NMR metabolomics,X23412.Phospholipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.082797674285132,0.00876935657221853,0.0656097354035837,0.0999856131666803,4.27660858287635e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ACRBP,Acrosin-binding protein,40451,0.0369600095877981,0.00392742457132909,0.0292622574279931,0.0446577617476032,5.88098884393623e-21
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0552203186133236,0.00587398190038208,0.0437073140885747,0.0667333231380724,6.28588750303941e-21
NMR metabolomics,X23412.Phospholipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.037995242524045,0.00404743033524159,0.0300622790669715,0.0459282059811186,7.35198649237998e-21
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0309419224686432,0.00329900927104103,-0.0374079806398836,-0.0244758642974028,7.6868326976001e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ING1,Inhibitor of growth protein 1,42292,0.0442421414746753,0.00471917020734385,0.0349925678682814,0.0534917150810693,8.03924680918157e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH1,Acid ceramidase,40418,0.0429075599708581,0.00458277276098013,0.0339253253593371,0.0518897945823792,9.24275281567973e-21
NMR metabolomics,X23412.Phospholipids in VLDL,IL17D,Interleukin-17D,42370,0.0322989074912758,0.00345487752518652,0.0255273475419103,0.0390704674406414,1.027602184208e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.064292308292617,0.00687852494512465,0.0508103994001727,0.0777742171850614,1.07576057479093e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CPB1,Carboxypeptidase B,42794,0.0566699477452732,0.00607153717602049,0.044769734880273,0.0685701606102734,1.17841156090824e-20
NMR metabolomics,X23412.Phospholipids in VLDL,HAO1,Hydroxyacid oxidase 1,42721,0.116644744643518,0.0124992495756587,0.092146215475227,0.141143273811809,1.19676848784127e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0193671152028915,0.00207578076439971,-0.0234356455011149,-0.0152985849046681,1.22115446610549e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CPA1,Carboxypeptidase A1,42794,0.0583118943555395,0.00625008598692258,0.0460617258211713,0.0705620628899078,1.22266917409091e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0455799201353994,0.00488570135731118,0.0360039454750695,0.0551558947957293,1.26534232342544e-20
NMR metabolomics,X23412.Phospholipids in VLDL,LAMB1,Laminin subunit beta-1,40223,0.0284750220048697,0.00305303534242813,0.0224910727337106,0.0344589712760288,1.29934628405255e-20
NMR metabolomics,X23412.Phospholipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.053023571797988,0.00569310485244575,0.0418650862871944,0.0641820573087817,1.4641478117735e-20
NMR metabolomics,X23412.Phospholipids in VLDL,FXN,"Frataxin, mitochondrial",42721,0.0680996030805401,0.00731723966492382,0.0537578133372894,0.0824413928237908,1.51820969540392e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CD164,Sialomucin core protein 24,42611,0.0254704576240191,0.00273890685220473,0.0201022001936979,0.0308387150543404,1.62633723950183e-20
NMR metabolomics,X23412.Phospholipids in VLDL,XCL1,Lymphotactin,42721,0.0522436140461832,0.00562068454586146,0.0412270723362948,0.0632601557560717,1.69601050536341e-20
NMR metabolomics,X23412.Phospholipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,42346,0.0370268219147735,0.00398639905459725,0.0292134797677629,0.0448401640617841,1.81095123762477e-20
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0757466272238717,0.00815821758445273,0.0597565207583443,0.091736733689399,1.86759100888869e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN3,Calsyntenin-3,40483,0.0285278854424145,0.00307794303937364,0.0224951170852422,0.0345606537995868,2.22973915688871e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CD84,SLAM family member 5,42594,0.0290685642031859,0.00314010740181555,0.0229139536956274,0.0352231747107444,2.41330761606663e-20
NMR metabolomics,X23412.Phospholipids in VLDL,OPLAH,5-oxoprolinase,40223,0.062737304359928,0.00678477501685169,0.0494391453268987,0.0760354633929573,2.73880815847231e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CASP8,Caspase-8,42674,0.0566178843346817,0.00613111694123719,0.0446008951298568,0.0686348735395066,2.97687920076074e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0375327633850969,0.00406489122291639,0.0295655765881808,0.0454999501820131,3.10566726391234e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR5,Complement factor H-related protein 5,40382,0.0391907290979158,0.00424647498553564,0.030867638126266,0.0475138200695657,3.22187043989104e-20
NMR metabolomics,X23412.Phospholipids in VLDL,RBP2,Retinol-binding protein 2,42587,-0.0712596092584794,0.00774035478862635,-0.086430704644187,-0.0560885138727717,3.87188072063222e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ENO2,Gamma-enolase,42711,0.059302700274843,0.00644398100615123,0.0466724975027866,0.0719329030468995,3.9921492530964e-20
NMR metabolomics,X23412.Phospholipids in VLDL,GRK5,G protein-coupled receptor kinase 5,42357,0.0467639076334861,0.00508413033268042,0.0367990121814325,0.0567288030855397,4.18808350163736e-20
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3BP,Galectin-3-binding protein,40539,0.0282940218462337,0.00307540430581513,0.022266229406836,0.0343218142856314,4.20004613521059e-20
NMR metabolomics,X23412.Phospholipids in VLDL,FCN1,Ficolin-1,40515,0.0514077363954099,0.0055881257402618,0.0404550099444968,0.0623604628463231,4.22633458302706e-20
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0279525288914017,0.0030455069837277,0.0219833352032954,0.033921722579508,5.13850829703011e-20
NMR metabolomics,X23412.Phospholipids in VLDL,MMP3,Stromelysin-1,42611,-0.046417007039537,0.00506013140233807,-0.0563348645881196,-0.0364991494909544,5.25851444387062e-20
NMR metabolomics,X23412.Phospholipids in VLDL,C7orf50,Uncharacterized protein C7orf50,40483,0.0209196167630355,0.00228209297853704,0.0164467145251029,0.0253925190009681,5.71115192747538e-20
NMR metabolomics,X23412.Phospholipids in VLDL,HPCAL1,Hippocalcin-like protein 1,42754,0.0663265400484314,0.00724174537910256,0.0521327191053904,0.0805203609914724,5.98342107302999e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0275388150276977,0.00300890715734867,0.0216413569992943,0.0334362730561011,6.36041534728369e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA6,Integrin alpha-6,42594,0.0464886105793074,0.00509304977647634,0.0365062330174138,0.056470988141201,7.97352111212916e-20
NMR metabolomics,X23412.Phospholipids in VLDL,SCRIB,Protein scribble homolog,40223,0.0831525668744527,0.00911422632235395,0.0652886832826389,0.101016450466266,8.54501518978102e-20
NMR metabolomics,X23412.Phospholipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.054907410691088,0.00603777985679649,0.0430733621717669,0.0667414592104091,1.11378385068475e-19
NMR metabolomics,X23412.Phospholipids in VLDL,DPP4,Dipeptidyl peptidase 4,42441,0.0256899619502499,0.00282726213060054,0.0201485281742728,0.031231395726227,1.16601541808336e-19
NMR metabolomics,X23412.Phospholipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0565288360927117,0.00622866157766589,0.0443206594004866,0.0687370127849368,1.31762940564469e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN4,Cerebellin-4,42721,0.0295471041483821,0.00326029327537103,0.0231569293286548,0.0359372789681093,1.44501979080594e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0505388284933924,0.00559845268938198,0.0395658612222037,0.0615117957645811,2.04873446611867e-19
NMR metabolomics,X23412.Phospholipids in VLDL,FGF2,Fibroblast growth factor 2,42594,0.0617887878202016,0.00684939495452152,0.0483639737093394,0.0752136019310638,2.11310601184845e-19
NMR metabolomics,X23412.Phospholipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0358436949423604,0.00397778949365795,0.0280472275347908,0.04364016234993,2.32072663357814e-19
NMR metabolomics,X23412.Phospholipids in VLDL,LY75,Lymphocyte antigen 75,42594,0.0351265534590779,0.00390513153511953,0.0274724956502437,0.0427806112679122,2.67654339474539e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0257341686516398,0.0028609442678794,0.0201267178865962,0.0313416194166834,2.75248140408857e-19
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6A,Ras-related protein Rab-6A,42594,0.0413434316648896,0.00460227114663867,0.0323229802174778,0.0503638831123014,2.97542113687982e-19
NMR metabolomics,X23412.Phospholipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0389163842368888,0.0043316970690219,0.0304262579816059,0.0474065104921717,3.02217807444305e-19
NMR metabolomics,X23412.Phospholipids in VLDL,EGFR,Epidermal growth factor receptor,42794,0.0146556289543947,0.00163338909047472,0.0114541863370643,0.0178570715717252,3.27258559595477e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,40223,0.0214276033342394,0.00238824644217919,0.0167466403075682,0.0261085663609106,3.37901003780508e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM1,Probable carboxypeptidase X1,42679,0.0623445259961011,0.00695389552133239,0.0487148907742896,0.0759741612179126,3.49328315019833e-19
NMR metabolomics,X23412.Phospholipids in VLDL,PRG2,Bone marrow proteoglycan,40527,-0.0475819809721192,0.00530825675741974,-0.0579861642166619,-0.0371777977275765,3.62823482660476e-19
NMR metabolomics,X23412.Phospholipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0507658090824145,0.00566554748466519,0.0396613360124707,0.0618702821523583,3.664615046797e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CTRB1,Chymotrypsinogen B,42611,0.0520084408830157,0.00581076285032435,0.04061934569638,0.0633975360696514,4.00311645626961e-19
NMR metabolomics,X23412.Phospholipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0708408918928521,0.00792630265911802,-0.0863764451047234,-0.0553053386809808,4.49565523789936e-19
NMR metabolomics,X23412.Phospholipids in VLDL,SCARA5,Scavenger receptor class A member 5,42711,0.027578188719399,0.00309101516723683,0.0215197989916148,0.0336365784471832,5.15923822987397e-19
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX6,Peroxiredoxin-6,42721,-0.0541779212143894,0.00607739778672576,-0.0660896208763719,-0.0422662215524069,5.51260606822531e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAL,Integrin alpha-L,40199,0.0399835490559946,0.00448387321444943,0.0311951575556737,0.0487719405563154,5.53742609581815e-19
NMR metabolomics,X23412.Phospholipids in VLDL,APRT,Adenine phosphoribosyltransferase,42480,0.0422543015194418,0.00474062159443004,0.0329626831943589,0.0515459198445247,5.5951550027975e-19
NMR metabolomics,X23412.Phospholipids in VLDL,NAA10,N-alpha-acetyltransferase 10,40116,0.0458914708282673,0.00516571603694941,0.0357666673958464,0.0560162742606881,7.46952476181203e-19
NMR metabolomics,X23412.Phospholipids in VLDL,UNC79,Protein unc-79 homolog,40080,0.0494192909187623,0.00558173071449923,0.0384790987183438,0.0603594831191808,9.77285478091881e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ARSA,Arylsulfatase A,42611,0.0394404091046145,0.00445698944553041,0.0307047097913749,0.0481761084178541,9.91369601882796e-19
NMR metabolomics,X23412.Phospholipids in VLDL,C5,Complement C5,40539,0.0133690393918088,0.00151314623042761,0.0104032727801706,0.0163348060034469,1.14538202455272e-18
NMR metabolomics,X23412.Phospholipids in VLDL,MARCO,Macrophage receptor MARCO,42636,0.0231980051561574,0.00262774291336047,0.0180476290459709,0.0283483812663439,1.19481576974498e-18
NMR metabolomics,X23412.Phospholipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0289680337567512,0.00328280587964452,0.022533734232648,0.0354023332808545,1.26433710354537e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0587729399013602,0.00667261952665438,0.0456946056291176,0.0718512741736027,1.43142428823868e-18
NMR metabolomics,X23412.Phospholipids in VLDL,GBP1,Guanylate-binding protein 1,40466,0.0577762361195666,0.00657770832929902,0.0448839277941405,0.0706685444449927,1.81105407996942e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,42501,0.025736153886846,0.00293164348965978,0.0199901326471128,0.0314821751265791,1.85272543530501e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR4,Complement factor H-related protein 4,40509,0.065844277737977,0.0075007779049247,0.0511427530443246,0.0805458024316294,1.89713695470398e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0225710902023432,0.00257151234066677,0.0175309260146364,0.0276112543900501,1.91271660111159e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ECE1,Endothelin-converting enzyme 1,42311,0.0312767582201507,0.00356802153362276,0.0242834360142501,0.0382700804260513,2.0795594777672e-18
NMR metabolomics,X23412.Phospholipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.060043658859555,0.00686625598943745,0.0465857971202576,0.0735015205988524,2.49902734365528e-18
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0373216150234111,0.00427857020159717,0.0289356174282806,0.0457076126185415,3.02542729696399e-18
NMR metabolomics,X23412.Phospholipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0224991748393005,0.00257880088838565,0.0174447250980646,0.0275536245805364,3.04480811225574e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0351801044836101,0.00403851153396067,0.0272646218770471,0.043095587090173,3.35487996560453e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0284368112778902,0.00326616207050271,0.0220351336197049,0.0348384889360756,3.5694206982757e-18
NMR metabolomics,X23412.Phospholipids in VLDL,LTA,Lymphotoxin-alpha,42594,0.0356257116925409,0.00409315323439689,0.027603131353123,0.0436482920319588,3.58293914667173e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA4,Annexin A4,42584,0.0621132088840807,0.00714395400776249,0.0481110590288662,0.0761153587392952,3.88465997481129e-18
NMR metabolomics,X23412.Phospholipids in VLDL,GLO1,Lactoylglutathione lyase,42357,0.0504116578003893,0.00579955002808676,0.0390445397453393,0.0617787758554394,3.96675742442249e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.104218763602693,0.0120085222158133,-0.127755467145687,-0.0806820600596992,4.46304413832769e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SMS,Spermine synthase,40136,0.0555356050690246,0.00640630216416158,0.0429792528272679,0.0680919573107813,4.97797847429858e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0452363276945963,0.00522235190099553,0.0350005179686451,0.0554721374205475,5.17043541598992e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0980388208210758,0.0113423013392491,0.0758079101961476,0.120269731446004,6.1804289321426e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PTX3,Pentraxin-related protein PTX3,42594,-0.0423176011980908,0.0049052780303514,-0.0519319461375795,-0.0327032562586021,7.0033687719679e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.101208341066912,0.0117296815433187,0.0782181652420068,0.124198516891816,7.05625297743757e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TNF,Tumor necrosis factor,42339,0.0332462267281265,0.00385406980721731,0.0256922499059805,0.0408002035502724,7.05976511319352e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ERI1,3'-5' exoribonuclease 1,40302,0.0297648134631505,0.00345603157333127,0.0229909915794212,0.0365386353468798,8.1183625263487e-18
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA4,Laminin subunit alpha-4,42676,0.0285126684125648,0.00331492545122987,0.0220154145281543,0.0350099222969754,8.74430040585113e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TCOF1,Treacle protein,40511,0.0278252118971976,0.00323438216168639,0.0214858228602923,0.034164600934103,8.79285048251998e-18
NMR metabolomics,X23412.Phospholipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0456641597762765,0.00531077852685236,0.0352550338636459,0.0560732856889071,8.99067319524829e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SERPING1,Plasma protease C1 inhibitor,40516,0.0158165754832415,0.00183990516658634,0.0122103613567323,0.0194227896097507,9.30425593568412e-18
NMR metabolomics,X23412.Phospholipids in VLDL,STK4,Serine/threonine-protein kinase 4,42636,0.0735405727316274,0.0085666533206807,0.0567499322230932,0.0903312132401616,1.01151924416971e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DGKZ,Diacylglycerol kinase zeta,42370,0.0299747282180271,0.00349648647537949,0.0231216147262833,0.0368278417097709,1.12151911422168e-17
NMR metabolomics,X23412.Phospholipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,40302,0.0600876994223207,0.00701083849389593,0.0463464559742847,0.0738289428703568,1.16471737042449e-17
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA1,BolA-like protein 1,40136,0.0466054798175938,0.00544203149875432,0.0359390980800354,0.0572718615551523,1.23631778052602e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DENR,Density-regulated protein,40199,0.0489548512098012,0.00572603103914546,0.0377318303730761,0.0601778720465263,1.39929258617701e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,40482,0.0310333993429327,0.00363214985952484,0.023914385618264,0.0381524130676013,1.46182138391491e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA3,Protein disulfide-isomerase A3,40283,0.0212222033019749,0.00248541996336562,0.0163507801737783,0.0260936264301715,1.53469360056906e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CA4,Carbonic anhydrase 4,42794,-0.0206241526625927,0.00241728225696014,-0.0253620258862346,-0.0158862794389508,1.5897799501357e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CLTA,Clathrin light chain A,42357,0.0406983451562583,0.0047723961899175,0.03134444862402,0.0500522416884965,1.65218118488065e-17
NMR metabolomics,X23412.Phospholipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0312598787350425,0.00366683606906388,0.0240728800396773,0.0384468774304077,1.68788030745691e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0471714791309735,0.00553557288292467,0.0363217562804412,0.0580212019815059,1.77519249945441e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0602051348271128,0.00707794831794224,0.046332356123946,0.0740779135302796,2.03114978585391e-17
NMR metabolomics,X23412.Phospholipids in VLDL,IL12A_IL12B,Interleukin-12,42587,0.069742221370004,0.00820939220799669,0.0536518126423305,0.0858326300976775,2.17865679556863e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL,Podocalyxin,42587,0.0130126219895633,0.00153181051436927,0.0100102733813996,0.0160149705977271,2.18780103323766e-17
NMR metabolomics,X23412.Phospholipids in VLDL,MENT,Protein MENT,40283,-0.0197472136963447,0.00232781273661557,-0.0243097266601112,-0.0151847007325781,2.46964144295186e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TLR3,Toll-like receptor 3,42754,0.0518325718586239,0.00611706671637153,0.0398431210945357,0.0638220226227121,2.62615703210729e-17
NMR metabolomics,X23412.Phospholipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0825455504892274,0.00976390597577905,0.0634082947767005,0.101682806201754,3.09755939539898e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DHPS,Deoxyhypusine synthase,40451,0.0342399657090705,0.00405777030304712,0.0262867359150981,0.0421931955030428,3.61865209870636e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.036587409098945,0.00434084438581685,0.0280793541027439,0.045095464095146,3.85750886532773e-17
NMR metabolomics,X23412.Phospholipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0183588162741881,0.0021784926628605,0.0140889706549815,0.0226286618933947,3.89539542468605e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA9,Serpin A9,42538,0.0605660296439392,0.00718745967474297,0.046478608681443,0.0746534506064354,3.91925195555886e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0298759728603901,0.00355852279987856,0.0229012681726281,0.0368506775481521,5.09237694831989e-17
NMR metabolomics,X23412.Phospholipids in VLDL,AK1,Adenylate kinase isoenzyme 1,42636,0.05294632244955,0.0063080190497148,0.0405826051121089,0.065310039786991,5.18716370493413e-17
NMR metabolomics,X23412.Phospholipids in VLDL,HDGF,Hepatoma-derived growth factor,42700,0.0781484851464985,0.00931526252354476,0.0598905706003508,0.0964063996926462,5.37243356558251e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0304742352539344,0.00363193897965115,0.0233556348538181,0.0375928356540506,5.43131086547787e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0253362382129178,0.00302269067544342,-0.0312607119367869,-0.0194117644890487,5.71748363904672e-17
NMR metabolomics,X23412.Phospholipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0348558034677911,0.00415856146503802,0.0267050229963166,0.0430065839392656,5.83803465899678e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB6,Integrin beta-6,42370,0.0262523630612336,0.00313363776813261,0.0201104330356936,0.0323942930867735,5.94471300122035e-17
NMR metabolomics,X23412.Phospholipids in VLDL,C7,Complement component C7,40251,-0.0277670723396866,0.00331517422199349,-0.0342648138147938,-0.0212693308645793,6.1495898972649e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CD276,CD276 antigen,42618,-0.0307594973626985,0.00367814867378833,-0.0379686687633236,-0.0235503259620734,6.72592824044829e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CCN5,CCN family member 5,42611,0.032374680955712,0.00387276309711545,0.0247840652853658,0.0399652966260583,6.90932597202625e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0358586358230691,0.00429067619516434,0.027448910480547,0.0442683611655912,7.19062052078775e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0761456153915636,0.00912410222830423,0.0582623750240873,0.0940288557590399,7.92726334260958e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB2,Lysosome membrane protein 2,42302,0.0292152789530406,0.00351041116928368,0.0223348730612446,0.0360956848448366,9.4623232710548e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0392212650547032,0.00471337590527487,0.0299830482803645,0.048459481829042,9.7028493243805e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PTN,Pleiotrophin,42357,0.0412138515091337,0.00495662123239477,0.0314988738936399,0.0509288291246274,1.00779551938463e-16
NMR metabolomics,X23412.Phospholipids in VLDL,EPPK1,Epiplakin,40223,0.0606251071640207,0.00729121560816512,0.0463343245720171,0.0749158897560243,1.02683762635462e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0634629091482385,0.007649078476112,0.0484707153350589,0.078455102961418,1.19298662916518e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0596514228517295,0.00719486886078031,0.0455494798846001,0.0737533658188589,1.23184377814123e-16
NMR metabolomics,X23412.Phospholipids in VLDL,FGR,Tyrosine-protein kinase Fgr,42311,0.0473522511437698,0.00573417388698678,0.0361132703252757,0.0585912319622639,1.62361932868699e-16
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS7_LGALS7B,Galectin-7,42524,0.0358703394069919,0.0043469172495002,0.0273503815979715,0.0443902972160123,1.70436096828145e-16
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL1,Fc receptor-like protein 1,42636,0.0388051580198571,0.00471170576007417,0.0295702147301117,0.0480401013096025,1.94556945322486e-16
NMR metabolomics,X23412.Phospholipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0533086821747197,0.00647141994296258,0.040624699086513,0.0659926652629263,1.95613501687898e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA2,Annexin A2,40054,0.0600582437376871,0.00729290768558405,0.0457641446739423,0.0743523428014318,1.99878501783726e-16
NMR metabolomics,X23412.Phospholipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,42370,0.054719513390132,0.00664882392842013,0.0416878184904286,0.0677512082898355,2.04778830828119e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0285539522088302,0.00347482029611669,0.0217433044284415,0.0353645999892189,2.26887299551957e-16
NMR metabolomics,X23412.Phospholipids in VLDL,LEPR,Leptin receptor,42636,-0.0256399370405574,0.00312211799037139,-0.0317592883016854,-0.0195205857794295,2.36561841246647e-16
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM3,Myomesin-3,40283,-0.0764793474487037,0.00931303170082819,-0.0947328895823269,-0.0582258053150804,2.41490993070874e-16
NMR metabolomics,X23412.Phospholipids in VLDL,FGF23,Fibroblast growth factor 23,42711,0.0447007353800117,0.00545679492967165,0.0340054173178553,0.0553960534421681,2.80412277064812e-16
NMR metabolomics,X23412.Phospholipids in VLDL,VSNL1,Visinin-like protein 1,40483,0.0315036159325352,0.00385075134229995,0.0239561433016272,0.0390510885634431,3.11233475928875e-16
NMR metabolomics,X23412.Phospholipids in VLDL,TPP1,Tripeptidyl-peptidase 1,42545,0.0368772812770057,0.00451118010524169,0.028035368270732,0.0457191942832794,3.23337706624775e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SPAG1,Sperm-associated antigen 1,40482,0.0470090604101756,0.00575094221696749,0.0357372136649193,0.0582809071554319,3.29765091122233e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM1,Intercellular adhesion molecule 1,42595,0.0238505717944588,0.00292220029997424,0.0181230592065093,0.0295780843824083,3.5918209562086e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0390632834015293,0.00478628760347932,0.0296821596987099,0.0484444071043488,3.60810653754907e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.0130452567946414,0.00159980396829569,0.00990964101678189,0.016180872572501,3.81815534145319e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0559939792570791,0.00686765318652703,0.0425333790114861,0.069454579502672,3.8519851254465e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0472289519388415,0.00582514729896396,0.0358116632328721,0.0586462406448108,5.68782505726152e-16
NMR metabolomics,X23412.Phospholipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0385796534678847,0.00476403231429553,-0.0479171568039039,-0.0292421501318655,6.06073106006547e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ENAH,Protein enabled homolog,42370,0.0383212320039879,0.00473435483961619,0.0290418965183401,0.0476005674896356,6.26251416905463e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,40532,0.021920644816597,0.0027079853251157,0.0166129935793702,0.0272282960538238,6.32033216167288e-16
NMR metabolomics,X23412.Phospholipids in VLDL,PDZD2,PDZ domain-containing protein 2,40116,0.0490331246858914,0.00607264261564359,0.0371307451592299,0.0609355042125528,7.49124831420552e-16
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX,Glutaredoxin-1,42546,0.0450887279115696,0.00561327821039822,0.034086702619189,0.0560907532039501,1.03459410192308e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0594294086495535,0.00740710468333466,0.0449114834702176,0.0739473338288894,1.13090646499994e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,42439,0.0233693738078893,0.00291507110886233,0.0176558344345192,0.0290829131812595,1.17643852021907e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CTSS,Cathepsin S,39872,0.0196946630333314,0.00245631793554489,0.0148802798796634,0.0245090461869993,1.18745246821553e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,42292,0.0531599288543068,0.00665700703280483,0.0401121950700093,0.0662076626386043,1.51502791877631e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0581073434558548,0.00728706694186219,0.0438246922498049,0.0723899946619047,1.66232635240577e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G15,Phospholipase A2 group XV,42679,0.0212135404639725,0.00266332563270964,0.0159934222238616,0.0264336587040834,1.78315627782892e-15
NMR metabolomics,X23412.Phospholipids in VLDL,OCLN,Occludin,40482,0.0359603123084737,0.00451562762413012,0.0271096821651786,0.0448109424517687,1.83231781864094e-15
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,40302,0.027892756489719,0.0035049680748237,0.0210230190630645,0.0347624939163734,1.91737113164492e-15
NMR metabolomics,X23412.Phospholipids in VLDL,STX6,Syntaxin-6,42346,0.0525357633053741,0.00662721830239808,0.0395464154326739,0.0655251111780743,2.41989332591674e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0280220519994529,0.00353693720737119,0.0210896550730053,0.0349544489259004,2.54824216269694e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD300A,CMRF35-like molecule 8,40283,0.0248302922912108,0.00313422881626899,0.0186872038113236,0.030973380771098,2.55445814166588e-15
NMR metabolomics,X23412.Phospholipids in VLDL,NGRN,Neugrin,40483,0.0184083371139278,0.00232544967355375,0.0138504557537625,0.0229662184740932,2.68135712165066e-15
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN2,Dynactin subunit 2,42587,0.0741708734377871,0.00937571474090231,0.0557944725456186,0.0925472743299556,2.75365820137945e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0279283747637695,0.00353160602283437,0.0210064269590141,0.0348503225685248,2.81721257379057e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0566379918104645,0.00716880658847814,0.0425871308970473,0.0706888527238816,2.99453542843136e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SLIT2,Slit homolog 2 protein,42311,0.0415598431696326,0.00527058645389672,0.031229493719995,0.0518901926192701,3.38650011845695e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0386869253148194,0.0049249502160596,0.0290340228913426,0.0483398277382962,4.28989443260984e-15
NMR metabolomics,X23412.Phospholipids in VLDL,GIP,Gastric inhibitory polypeptide,40223,0.0462116493024479,0.0058942255267251,0.0346589672700667,0.0577643313348291,4.91422204699011e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LF,CMRF35-like molecule 1,42721,0.0479060595344106,0.00611259993467897,0.0359253636624398,0.0598867554063813,4.94729320550671e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CASP9,Caspase-9,40199,0.0492409157520684,0.00628986783993842,0.0369127747857891,0.0615690567183478,5.38550165038045e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PPME1,Protein phosphatase methylesterase 1,42587,0.046725897685996,0.0059740357541597,0.035016787607843,0.058435007764149,5.6091009323649e-15
NMR metabolomics,X23412.Phospholipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0201294292163104,0.00257913202179931,0.0150743304535838,0.0251845279790371,6.40256270928897e-15
NMR metabolomics,X23412.Phospholipids in VLDL,LPA,Apolipoprotein(a),40324,-0.142707561797381,0.0182819531279846,-0.178540189928231,-0.106874933666531,6.43583504559204e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PALM2,Paralemmin-2,40483,0.0295305452516695,0.00378789344788638,0.0221062740938122,0.0369548164095268,6.94936599886868e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CFB,Complement factor B,40344,0.0253200179907499,0.00325415142637237,0.0189418811950601,0.0316981547864397,7.84051900515504e-15
NMR metabolomics,X23412.Phospholipids in VLDL,TREH,Trehalase,40527,0.0579693148719692,0.00745589441431542,0.043355761819911,0.0725828679240274,8.19968332915064e-15
NMR metabolomics,X23412.Phospholipids in VLDL,S100P,Protein S100-P,42357,0.0424382959885667,0.00545988352406124,0.0317369242814067,0.0531396676957267,8.24846991695494e-15
NMR metabolomics,X23412.Phospholipids in VLDL,TXN,Thioredoxin,40384,0.0347197102132385,0.0044720300083869,0.0259545313968002,0.0434848890296768,8.96410505961428e-15
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0341841319006967,0.00440545066629418,0.0255494485947601,0.0428188152066333,9.28011253507956e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CTSE,Cathepsin E,40283,0.0399356058113033,0.0051506332439501,0.0298403646531611,0.0500308469694455,9.71891417660937e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PTGES2,Prostaglandin E synthase 2,40102,0.0423711425441266,0.0054680397391291,0.0316537846554336,0.0530885004328197,1.00942744100718e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TREML1,Trem-like transcript 1 protein,40532,0.0407737400989819,0.00526589313973337,0.0304525895451045,0.0510948906528593,1.05364180394155e-14
NMR metabolomics,X23412.Phospholipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0711596031587213,0.00919044572703005,0.0531463295337424,0.0891728767837002,1.0577500806877e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PMM2,Phosphomannomutase 2,40116,0.0467156569327129,0.00604033206633674,0.0348766060826928,0.0585547077827329,1.13426279403881e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0278858072604224,0.00360664445546287,0.0208167841277152,0.0349548303931296,1.13561548525603e-14
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0323699256866364,0.00418764692695873,0.0241621377097973,0.0405777136634755,1.17019244643752e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CDA,Cytidine deaminase,40494,0.0364072951085861,0.00471190086190245,0.0271719694192573,0.0456426207979149,1.19735361818316e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.020766561507194,0.00268860664253275,0.0154968924878298,0.0260362305265582,1.22325656977441e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0442284946124972,0.00572681848718858,0.0330039303776076,0.0554530588473868,1.23313397352148e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CPQ,Carboxypeptidase Q,40516,0.0277189152956184,0.00359006014239339,0.0206823974165273,0.0347554331747094,1.25117490477454e-14
NMR metabolomics,X23412.Phospholipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,40527,0.0217355063857571,0.00281634677719456,0.0162154667024558,0.0272555460690584,1.2846424404283e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0662023579942828,0.00858339707428712,0.04937889972868,0.0830258162598856,1.33391591259673e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SDK2,Protein sidekick-2,40283,0.0313594630903466,0.00406707461872212,0.0233879968376513,0.039330929343042,1.35968988691e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0431479542199853,0.00559739530716264,0.0321770594179465,0.054118849022024,1.36168803351613e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DAPK2,Death-associated protein kinase 2,40199,0.0419075248839616,0.00544487458550438,0.0312355706963731,0.0525794790715502,1.51581001498667e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CTSL,Cathepsin L1,42636,0.0189945306354481,0.00248688891700203,0.0141202283581242,0.0238688329127721,2.35740499163137e-14
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0293141013194477,0.00383731710313575,0.0217929597973016,0.0368352428415937,2.36506027062422e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TPR,Nucleoprotein TPR,40116,0.0372614309378952,0.00488257789748426,0.027691578258826,0.0468312836169643,2.51349271433122e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CSTB,Cystatin-B,42437,0.0325280427899562,0.00426905922388148,0.0241606867111485,0.0408953988687639,2.71956614446306e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0289589382920486,0.0038093852395358,0.0214925432225584,0.0364253333615388,3.1132413866977e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NCF2,Neutrophil cytosol factor 2,42578,0.0631698983132007,0.00830997684361074,0.0468823436997237,0.0794574529266778,3.11700785003083e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0504902638032841,0.00664554288742166,0.0374649997439376,0.0635155278626305,3.25485761035572e-14
NMR metabolomics,X23412.Phospholipids in VLDL,RPL14,60S ribosomal protein L14,40223,0.0305708889141542,0.00402725857787323,0.0226774621015227,0.0384643157267858,3.43077813071446e-14
NMR metabolomics,X23412.Phospholipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0447821977785116,0.00590355239409565,0.0332112350860841,0.0563531604709391,3.52797519520879e-14
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RB,Interleukin-17 receptor B,42416,-0.0405746900758457,0.0053581068355961,-0.0510765794736141,-0.0300728006780773,3.90123273302647e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PRELP,Prolargin,42618,0.0184796478573931,0.00244128395713176,0.0136947313014149,0.0232645644133714,3.98621633319352e-14
NMR metabolomics,X23412.Phospholipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0180297030383656,0.00238264012854851,0.0133597283864105,0.0226996776903207,4.06444231413207e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CLU,Clusterin,40539,0.0240134136519565,0.00317421828337854,0.0177919458165345,0.0302348814873784,4.17378182312471e-14
NMR metabolomics,X23412.Phospholipids in VLDL,GNLY,Granulysin,42611,0.040621450811211,0.00537301811525778,0.0300903353053057,0.0511525663171162,4.28318895301846e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK1D,Casein kinase I isoform delta,40199,0.0478117663501174,0.00632478284141261,0.0354151919809487,0.0602083407192861,4.37016906740112e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0418313586106926,0.00553899342837787,0.030974931491072,0.0526877857303132,4.62056365102533e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB8,Serpin B8,42754,0.0436100339329975,0.00578361039071186,0.0322741575672023,0.0549459102987928,4.98718979002544e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NADK,NAD kinase,42636,0.0413195435655239,0.00548019128575329,0.0305783686454474,0.0520607184856003,5.00816581377079e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0720832988568541,0.00956547949753425,0.0533349590416869,0.0908316386720212,5.16826883683217e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DPT,Dermatopontin,42794,0.0190332946992184,0.00253643613843101,0.0140618798678936,0.0240047095305432,6.57626051976832e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0440234935772934,0.00587330448028297,0.0325118167959388,0.0555351703586481,7.10938308040197e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CD302,CD302 antigen,42587,0.0240926375235618,0.00321574727270943,0.0177897728690513,0.0303955021780723,7.20343462419006e-14
NMR metabolomics,X23412.Phospholipids in VLDL,HRG,Histidine-rich glycoprotein,40479,0.0232498335208964,0.00310640691739666,0.0171612759627989,0.0293383910789938,7.71750248513567e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0283869157792515,0.00379612301272044,0.0209465146743195,0.0358273168841836,8.11328261323626e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DMD,Dystrophin,40223,0.0387173279352154,0.00518204098101175,0.0285605276124324,0.0488741282579984,8.53182397703495e-14
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0205806584240632,0.0027600752649409,0.015170910904779,0.0259904059433474,9.55062833651528e-14
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,40223,0.039198893323257,0.00526986692105267,0.0288699541579938,0.0495278324885202,1.09557366405282e-13
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO2,Roundabout homolog 2,42711,0.0174282161971653,0.00234903592429825,0.0128241057855407,0.0220323266087899,1.24754534983296e-13
NMR metabolomics,X23412.Phospholipids in VLDL,FABP6,Gastrotropin,42334,0.0436699475501928,0.00589228903953239,0.0321210610327093,0.0552188340676763,1.32637564442622e-13
NMR metabolomics,X23412.Phospholipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0203048678488452,0.00274875921910955,0.0149172997793905,0.0256924359182999,1.60893210484533e-13
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA4,Ephrin-A4,42475,0.0251596198198497,0.00341094165223047,0.018474174181478,0.0318450654582214,1.72591624024439e-13
NMR metabolomics,X23412.Phospholipids in VLDL,STAM,Signal transducing adapter molecule 1,40451,0.0276878108998382,0.00375795422698124,0.020322220614955,0.0350534011847214,1.85618606808389e-13
NMR metabolomics,X23412.Phospholipids in VLDL,GPR15L,Protein GPR15L,40449,0.0450174259371484,0.00611388678335669,0.0330342078417693,0.0570006440325275,1.92165786596642e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NID2,Nidogen-2,42611,0.0545148920804797,0.00741075792617623,0.0399898065451743,0.0690399776157851,2.00226000773923e-13
NMR metabolomics,X23412.Phospholipids in VLDL,VCAM1,Vascular cell adhesion protein 1,42663,-0.0205953827669777,0.00280456815018998,-0.0260923363413501,-0.0150984291926054,2.20002477706967e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS4,Galectin-4,42618,-0.0415540122508337,0.00566604266257828,-0.0526594558694872,-0.0304485686321803,2.36413979662007e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CSDE1,Cold shock domain-containing protein E1,40116,0.0858475127650266,0.0117280951615256,0.0628604462484363,0.108834579281617,2.6576107595213e-13
NMR metabolomics,X23412.Phospholipids in VLDL,BRDT,Bromodomain testis-specific protein,40116,0.0273953695792029,0.0037449730167797,0.0200552224663147,0.0347355166920911,2.7493719086013e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0275554500952552,0.00377211237625706,0.0201621098377914,0.034948790352719,2.92783653210563e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0445058844555742,0.0060955238090062,-0.0564531111212263,-0.032558657789922,3.04393250967633e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CD83,CD83 antigen,42594,0.025870113320587,0.00354481980691279,0.0189222664990379,0.0328179601421361,3.08502208807775e-13
NMR metabolomics,X23412.Phospholipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0709694677010129,0.0097320059762872,0.0518947359874899,0.0900441994145358,3.21593921070488e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0289994496241302,0.00398147900302673,0.0211957507781978,0.0368031484700626,3.43032355970256e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.031771487932616,0.00436280182744453,0.0232203963508247,0.0403225795144073,3.4992633430469e-13
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0429002211558371,0.00589318977677399,0.03134956919336,0.0544508731183141,3.57574311135454e-13
NMR metabolomics,X23412.Phospholipids in VLDL,AHCY,Adenosylhomocysteinase,42636,0.048875819767153,0.00672134966310925,0.0357019744274588,0.0620496651068471,3.74543169633438e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.025861637493414,0.00356617668243974,-0.0328513437909959,-0.0188719311958321,4.33853934113403e-13
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0730932322806891,0.0101470113498256,0.0532050900350309,0.0929813745263472,6.18792254789122e-13
NMR metabolomics,X23412.Phospholipids in VLDL,GGH,Gamma-glutamyl hydrolase,42437,0.0246673063678574,0.00342897901782124,0.0179465074929278,0.031388105242787,6.64114392358425e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0378659081799858,0.00526660096368421,0.0275433702911647,0.0481884460688069,6.82757669461982e-13
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,40527,0.024635792870493,0.0034320575833736,0.0179089600070808,0.0313626257339053,7.50833154856046e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0178621629176086,0.00250492416472169,0.0129525115547541,0.0227718142804631,1.04890453183142e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0389718902486384,0.0054714110904388,0.0282479245113783,0.0496958559858984,1.11138145404249e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CD14,Monocyte differentiation antigen CD14,42416,0.0298464118955988,0.00419044369233147,0.0216331422586291,0.0380596815325684,1.11473699751372e-12
NMR metabolomics,X23412.Phospholipids in VLDL,LGMN,Legumain,42676,0.0253767992296097,0.00357314099068042,0.018373442887876,0.0323801555713433,1.29036035870231e-12
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0234678672488229,0.00330872223761085,0.0169827716631056,0.0299529628345402,1.3821837424021e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PVR,Poliovirus receptor,42711,0.0260907393289163,0.0036834617224955,0.0188711543528252,0.0333103243050075,1.47818060824063e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.042302174669092,0.0059769805507264,0.0305872927896683,0.0540170565485158,1.55542339886548e-12
NMR metabolomics,X23412.Phospholipids in VLDL,IL12B,Interleukin-12 subunit beta,42754,0.0402465371469806,0.00569050709628358,0.0290931432382648,0.0513999310556965,1.59537976670158e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0582635957187618,0.00824044345270513,0.0421123265514597,0.0744148648860638,1.63557971438745e-12
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0343577291470014,0.00486075889799285,0.0248306417069354,0.0438848165870674,1.6468340004681e-12
NMR metabolomics,X23412.Phospholipids in VLDL,IMMT,MICOS complex subunit MIC60,40451,0.0320356687933839,0.00453596846623459,0.0231451705995641,0.0409261669872037,1.73067087705409e-12
NMR metabolomics,X23412.Phospholipids in VLDL,INSR,Insulin receptor,40199,0.0123291223643197,0.00175006161992487,0.008899001589267,0.0157592431393725,1.96590285931098e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0315041204402508,0.00447621699684629,0.0227307351264321,0.0402775057540695,2.06455701665766e-12
NMR metabolomics,X23412.Phospholipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0334775505110296,0.00476842461486873,0.0241314382658869,0.0428236627561723,2.3164031492511e-12
NMR metabolomics,X23412.Phospholipids in VLDL,THBD,Thrombomodulin,42636,0.0212467999254338,0.00302955071263725,0.0153088805286648,0.0271847193222028,2.44088124524502e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0369697721276067,0.00527932739597083,0.0266222904315038,0.0473172538237095,2.65220870213599e-12
NMR metabolomics,X23412.Phospholipids in VLDL,S100A12,Protein S100-A12,42434,0.0526336446280505,0.00754219385440929,0.0378509446734083,0.0674163445826927,3.12415752680371e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI1,Neuroserpin,40267,0.0212313223553677,0.00304364890547042,0.0152657705006457,0.0271968742100897,3.2190726306261e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0512899852514751,0.00735641415371921,0.0368714135101854,0.0657085569927647,3.29857033944907e-12
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0335462419666442,0.00482045860382362,0.0240981431031499,0.0429943408301385,3.58502889104797e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GRSF1,G-rich sequence factor 1,40014,0.0564167194180206,0.0081082868114091,0.0405244772676588,0.0723089615683824,3.65327754735749e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CRYGD,Gamma-crystallin D,40483,0.067791950255372,0.00977845890577385,0.0486261708000553,0.0869577297106888,4.35147293726383e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0379439398264746,0.00548935339254712,0.0271848071770822,0.0487030724758669,5.03362392924354e-12
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.040018555586048,0.00580617685930261,0.0286384489418149,0.0513986622302811,5.73534031498452e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PALM,Paralemmin-1,40384,0.0218174762961406,0.00317026852565359,0.0156037499858596,0.0280312026064217,6.22150541055203e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ACAN,Aggrecan core protein,42488,0.0191691287444954,0.00278876004855389,0.0137031590493298,0.0246350984396611,6.53433808995382e-12
NMR metabolomics,X23412.Phospholipids in VLDL,LTB,Lymphotoxin-beta,40451,0.0247384745885883,0.00360228320385381,0.0176779995090349,0.0317989496681418,6.88055667286822e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0223524877301982,0.00325557134666093,0.0159715678907428,0.0287334075696537,6.89310026383532e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.046478197863585,0.00677352086461152,0.0332020969689464,0.0597542987582235,7.15935534758157e-12
NMR metabolomics,X23412.Phospholipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0580807128132835,0.00846623340961232,0.0414868953304434,0.0746745302961237,7.18103276752015e-12
NMR metabolomics,X23412.Phospholipids in VLDL,EDF1,Endothelial differentiation-related factor 1,40482,0.0460204397185688,0.00672550008928334,0.0328384595435734,0.0592024198935641,8.17491595805535e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CD46,Membrane cofactor protein,42580,0.0198280566069568,0.00290004125098838,0.0141439757550196,0.025512137458894,8.42788009765949e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.02586340208696,0.00378738700991665,0.0184401235475233,0.0332866806263966,9.00214703234438e-12
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0460079086752697,0.00674262920498236,0.0327923554335043,0.0592234619170351,9.35931403718582e-12
NMR metabolomics,X23412.Phospholipids in VLDL,DKK4,Dickkopf-related protein 4,42477,0.0317575397759822,0.00465661519192424,0.0226305739998107,0.0408845055521537,9.50608092169589e-12
NMR metabolomics,X23412.Phospholipids in VLDL,MYL3,Myosin light chain 3,40223,-0.0504148255750892,0.00739315918040197,-0.0649054175686771,-0.0359242335815014,9.63901146903578e-12
NMR metabolomics,X23412.Phospholipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0210607098748874,0.00309282765363708,0.0149987676737587,0.0271226520760161,1.02084045526722e-11
NMR metabolomics,X23412.Phospholipids in VLDL,KIF22,Kinesin-like protein KIF22,40116,0.08558481221771,0.0125698272064266,0.0609479508931139,0.110221673542306,1.03617378441699e-11
NMR metabolomics,X23412.Phospholipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0266179508755118,0.00391002630838505,0.0189542993110771,0.0342816024399465,1.043948620383e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0404444112729308,0.00596083353607791,0.0287611775422181,0.0521276450036435,1.20872794956686e-11
NMR metabolomics,X23412.Phospholipids in VLDL,APOB,Apolipoprotein B-100,40532,0.0152372065518923,0.00224548049066105,0.0108360647901967,0.019638348313588,1.21263526126324e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ASPN,Asporin,40511,0.0192003515337635,0.00282979075016935,0.0136539616634316,0.0247467414040954,1.2181434747994e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CCL20,C-C motif chemokine 20,42754,0.0623771847593037,0.00919703328885726,0.0443509995131434,0.0804033700054639,1.23165027164357e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0353905115718912,0.00521887100310106,0.0251615244058131,0.0456194987379693,1.24083173158359e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ZBP1,Z-DNA-binding protein 1,40199,0.0273225396771506,0.00402971123612557,0.0194243056543445,0.0352207736999568,1.26092235445291e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0355344844561316,0.00524948410745465,0.0252454956055204,0.0458234733067427,1.36127741493197e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CALB2,Calretinin,42311,0.0217270744882095,0.00321692316974416,0.015421905075511,0.0280322439009081,1.49894058830682e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0310661752055939,0.00460636716673271,0.0220376955587978,0.04009465485239,1.61666281502841e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0333171331463618,0.0049406673389112,0.0236334251620959,0.0430008411306278,1.62245297448758e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CD300C,CMRF35-like molecule 6,42711,0.024315614173262,0.00360683663713373,0.0172462143644799,0.0313850139820442,1.63082419176218e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CST5,Cystatin-D,42357,0.0386354334357878,0.0057329630508136,0.0273988258561932,0.0498720410153825,1.65921965646271e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.025644917720197,0.00380643812160094,0.0181842990018592,0.0331055364385349,1.67994475684171e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0199431521679183,0.0029606484296708,0.0141402812457635,0.025746023090073,1.69306140778513e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CABP2,Calcium-binding protein 2,40182,0.0437306074561805,0.00649765425732391,0.0309952051118256,0.0564660098005353,1.77848167522572e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS8,Prostasin,42568,0.0282774634459643,0.00420274903386267,0.0200400753395934,0.0365148515523351,1.78612494508043e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PSAP,Prosaposin,40440,0.0195462461247637,0.00291509620824297,0.0138326575566075,0.0252598346929199,2.10793789613482e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO1,Roundabout homolog 1,42638,0.0163922612656509,0.00245881230198128,0.0115729891537676,0.0212115333775342,2.71756824458796e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0412979928341891,0.00619890385245898,0.0291481412833695,0.0534478443850087,2.82840623549734e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CAT,Catalase,40361,0.0363180862693023,0.00545472692503881,0.0256268214962262,0.0470093510423784,2.90413047069729e-11
NMR metabolomics,X23412.Phospholipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0236847709811273,0.00355758438948778,-0.0306576363845234,-0.0167119055777313,2.91666578874752e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SNX5,Sorting nexin-5,40223,0.0194359791520669,0.00292490265583877,0.0137031699466229,0.0251687883575109,3.1750823948285e-11
NMR metabolomics,X23412.Phospholipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0205455805444494,0.00309472855242493,0.0144799125816965,0.0266112485072022,3.28131494306752e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MDK,Midkine,42638,0.0339753048853112,0.00511804003078968,0.0239439464249634,0.044006663345659,3.29401710106089e-11
NMR metabolomics,X23412.Phospholipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0364765297962227,0.00550163872108187,0.0256933179029022,0.0472597416895431,3.48268547655786e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IDS,Iduronate 2-sulfatase,42754,0.00581418492113034,0.000877252486207754,0.00409477004816315,0.00753359979409754,3.53793490907946e-11
NMR metabolomics,X23412.Phospholipids in VLDL,XRCC4,DNA repair protein XRCC4,42311,0.0244654844584449,0.00369774494515001,0.0172179043659509,0.0317130645509389,3.82534457925424e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF2,Scavenger receptor class F member 2,42711,-0.020108884962534,0.00304106591502486,-0.0260693741559827,-0.0141483957690852,3.92223091340117e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ADM,Pro-adrenomedullin,42721,0.0177929875253414,0.00269192730898246,0.0125168099997357,0.023069165050947,3.99378128179249e-11
NMR metabolomics,X23412.Phospholipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0257921390849598,0.00390296417189182,0.0181423293080518,0.0334419488618677,4.03312518424067e-11
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0384648006160423,0.00583786065567788,0.0270225937309136,0.0499070075011709,4.60106614748082e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD6,MICOS complex subunit MIC25,40451,0.0191033954716904,0.00290319442980538,0.0134131343892718,0.0247936565541089,4.90901559003253e-11
NMR metabolomics,X23412.Phospholipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.023492588274094,0.00357301016579695,-0.0304956881990561,-0.016489488349132,5.08019326299613e-11
NMR metabolomics,X23412.Phospholipids in VLDL,STX7,Syntaxin-7,40199,0.0330797567094983,0.00503290250140865,0.0232152678067374,0.0429442456122593,5.16453065256044e-11
NMR metabolomics,X23412.Phospholipids in VLDL,C2orf69,UPF0565 protein C2orf69,40182,0.0402903818386606,0.00613125315452779,0.0282731256557862,0.0523076380215351,5.21304104665902e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CTSC,Dipeptidyl peptidase 1,42616,0.0290044582826418,0.00441497952760847,0.0203510984085292,0.0376578181567544,5.23261310840364e-11
NMR metabolomics,X23412.Phospholipids in VLDL,SCG2,Secretogranin-2,42636,0.0225484341621031,0.00343354492624476,0.0158186861066634,0.0292781822175428,5.31905927999503e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MMP1,Interstitial collagenase,42136,0.0600180845749068,0.00915882479340737,0.0420667879798284,0.0779693811699853,5.85157200131587e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CHGA,Chromogranin-A,40527,-0.0644019416399492,0.00985480760486507,-0.0837173645454847,-0.0450865187344136,6.63029587123775e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CIT,Citron Rho-interacting kinase,40182,0.0297780511510141,0.00455866468411377,0.0208430683701511,0.038713033931877,6.76799269868945e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.032310175984279,0.00495129603313806,0.0226056357593284,0.0420147162092296,7.07666098611442e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ELOB,Elongin-B,40116,0.0263301723724064,0.00403929539848235,0.018413153391381,0.0342471913534319,7.41415676343534e-11
NMR metabolomics,X23412.Phospholipids in VLDL,DSG3,Desmoglein-3,42651,0.0230101141126217,0.00353132188413775,0.0160887232197117,0.0299315050055317,7.47745006606986e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR2,Interferon gamma receptor 2,42495,0.0340074760182786,0.00522995116499172,0.0237567717348948,0.0442581803016624,8.18474550648128e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0359063887877123,0.00552879837098936,0.0250699439805732,0.0467428335948515,8.69695599085266e-11
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE3,Eosinophil cationic protein,42578,0.0715203455659188,0.0110191298848179,0.0499228509916757,0.0931178401401619,8.85306422925664e-11
NMR metabolomics,X23412.Phospholipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0296801775402201,0.00457585375355281,0.0207115041832566,0.0386488508971836,9.10840966144921e-11
NMR metabolomics,X23412.Phospholipids in VLDL,RGMB,RGM domain family member B,42711,0.0185425662736494,0.00285903556592093,0.0129388565644443,0.0241462759828544,9.14525433958783e-11
NMR metabolomics,X23412.Phospholipids in VLDL,COL2A1,Collagen alpha-1(II) chain,40223,0.0527466627541885,0.00813476002644765,0.0368025331023511,0.0686907924060259,9.30730289775335e-11
NMR metabolomics,X23412.Phospholipids in VLDL,LACRT,Extracellular glycoprotein lacritin,40419,0.0336220789264778,0.00518939223675134,0.0234508701424452,0.0437932877105104,9.61955401053972e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PER3,Period circadian protein homolog 3,40199,0.0802520215457034,0.0123968289891943,0.0559542367268826,0.104549806364524,9.97723699339827e-11
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.029038791436249,0.00448701911656477,0.0202442339677821,0.037833348904716,1.00910269935956e-10
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL3,Fc receptor-like protein 3,42370,0.0366951101639897,0.0056720036227235,0.0255779830634516,0.0478122372645278,1.01793662531829e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GAS2,Growth arrest-specific protein 2,40302,0.0342857298401515,0.00530081615887724,0.0238961301687521,0.0446753295115509,1.03473933985307e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL1,Chordin-like protein 1,42654,0.0209672481445027,0.00324225949924114,0.0146124195259901,0.0273220767630153,1.03513802654096e-10
NMR metabolomics,X23412.Phospholipids in VLDL,S100A11,Protein S100-A11,42531,0.0294538018864644,0.0045706158302137,0.0204953948592456,0.0384122089136833,1.20234408945879e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CCL19,C-C motif chemokine 19,42711,0.0846955635898475,0.0131480138270205,0.0589254564888872,0.110465670690808,1.22142664821583e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0658298369513609,0.0102386818885144,0.0457620204498728,0.0858976534528491,1.33186713914605e-10
NMR metabolomics,X23412.Phospholipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0258318378103174,0.00401871666116191,0.0179551531544401,0.0337085224661948,1.33723837543461e-10
NMR metabolomics,X23412.Phospholipids in VLDL,VGF,Neurosecretory protein VGF,40482,0.0203730147933677,0.00317229805651504,0.0141553106025982,0.0265907189841372,1.3974901042986e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CRYM,Ketimine reductase mu-crystallin,40136,0.048955712910475,0.00763012587741984,0.0340006661907321,0.0639107596302179,1.45577601966469e-10
NMR metabolomics,X23412.Phospholipids in VLDL,BGN,Biglycan,42328,-0.0773422534782009,0.0120595210678521,-0.100978914771191,-0.0537055921852108,1.47206861888845e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.037154298043607,0.00579355823827507,0.0257989238965878,0.0485096721906261,1.4752861884542e-10
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0363330258036247,0.0056703358425441,0.0252191675522382,0.0474468840550111,1.53889534857575e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0218352113738128,0.0034102819538723,0.0151510587442231,0.0285193640034025,1.57634638787111e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ADA,Adenosine deaminase,42754,0.0222351280445293,0.00347670621576645,0.0154207838616271,0.0290494722274316,1.65316996450921e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS22,Brain-specific serine protease 4,40199,0.0235334433017913,0.00368449730271206,0.0163118285884757,0.030755058015107,1.75821194139691e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0339756764829787,0.0053207289595773,0.0235470477222072,0.0444043052437502,1.77511849707818e-10
NMR metabolomics,X23412.Phospholipids in VLDL,POSTN,Periostin,40527,-0.0247448270551475,0.00387871777701667,-0.0323471138981002,-0.0171425402121949,1.84420486305219e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NFIC,Nuclear factor 1 C-type,40482,0.0304221871102945,0.0047771071927186,0.0210590570125661,0.039785317208023,1.98523798934757e-10
NMR metabolomics,X23412.Phospholipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0367074864802473,0.00576896514023569,0.0254003148053854,0.0480146581551093,2.04511361838534e-10
NMR metabolomics,X23412.Phospholipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0533501725013104,0.00843033490931942,0.0368267160790444,0.0698736289235765,2.57493118392344e-10
NMR metabolomics,X23412.Phospholipids in VLDL,AFAP1,Actin filament-associated protein 1,40283,0.0528948399450567,0.00836126131797685,0.0365067677618221,0.0692829121282913,2.60987863242101e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB1A1,Uteroglobin,42646,0.0353597883842324,0.00559317425369292,0.0243971668469943,0.0463224099214706,2.6643432392494e-10
NMR metabolomics,X23412.Phospholipids in VLDL,THBS4,Thrombospondin-4,42652,0.0289969480690503,0.00459301949076407,0.0199946298671527,0.0379992662709479,2.8178781619315e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CA2,Carbonic anhydrase 2,42573,0.0439364612421623,0.00696830187145232,0.0302785895741157,0.0575943329102088,2.96888029310461e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1A,Protein phosphatase 1A,42346,0.0200241954645642,0.00319752956613236,0.0137570375149448,0.0262913534141837,3.9090711622812e-10
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL2,Fc receptor-like protein 2,42681,0.0330880612310407,0.00528693127743099,0.0227256759272759,0.0434504465348054,4.00558628643526e-10
NMR metabolomics,X23412.Phospholipids in VLDL,APLP1,Amyloid-like protein 1,42636,-0.0323761528283353,0.00517723920729788,-0.0425235416746391,-0.0222287639820314,4.13358481807908e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MDM1,Nuclear protein MDM1,40182,0.0196914492326125,0.00315081441776696,0.0135158529737893,0.0258670454914358,4.2664876091738e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0159627458633731,0.0025683462245993,0.0109287872631584,0.0209967044635877,5.27790234628701e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ICOSLG,ICOS ligand,42587,0.0120757495247692,0.00194382797422806,0.0082658466952822,0.0158856523542562,5.37414600478402e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA7A,Semaphorin-7A,42760,0.0177087052932698,0.0028564673549273,0.0121100292776123,0.0233073813089273,5.8279779211564e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0368186430685101,0.0059432885837454,0.0251697974443691,0.0484674886926511,5.99933153779855e-10
NMR metabolomics,X23412.Phospholipids in VLDL,BSG,Basigin,42746,0.0135141053649558,0.00218233726387579,0.00923672432775921,0.0177914864021523,6.09309110199427e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0243341473720197,0.00393139223659189,-0.0320396761557398,-0.0166286185882996,6.23696026745755e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CTSH,Pro-cathepsin H,42332,0.0462588094372308,0.00747552330616087,0.0316067837571555,0.0609108351173061,6.27287762827481e-10
NMR metabolomics,X23412.Phospholipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0212933266764871,0.00344315692465235,0.0145447391041685,0.0280419142488057,6.45805771389874e-10
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP8,GTPase IMAP family member 8,40080,0.032787901653767,0.00530301346306969,0.0223939952661504,0.0431818080413836,6.51982184490727e-10
NMR metabolomics,X23412.Phospholipids in VLDL,C8B,Complement component C8 beta chain,40539,0.018899277202306,0.00305926691850421,0.0129031140420378,0.0248954403625743,6.72642891514409e-10
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFB,Vascular endothelial growth factor B,40199,0.0184120602665821,0.00298179408730561,0.0125677438554631,0.0242563766777011,6.85722869303168e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PVALB,Parvalbumin alpha,42654,0.0680387614036128,0.0110208032919571,0.0464379869513769,0.0896395358558487,6.86415943298316e-10
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_E,,42594,0.0191054800589554,0.00309511904007147,0.0130390467404153,0.0251719133774955,6.90364988243173e-10
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0207460941052158,0.00336924766787364,0.0141423686761835,0.0273498195342482,7.64280889772681e-10
NMR metabolomics,X23412.Phospholipids in VLDL,RCOR1,REST corepressor 1,42357,0.0273438525899851,0.00444630023072455,0.018629104137765,0.0360586010422052,7.98267357820919e-10
NMR metabolomics,X23412.Phospholipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0277437983162583,0.00453286988752197,0.0188593733367153,0.0366282232958014,9.64097951236243e-10
NMR metabolomics,X23412.Phospholipids in VLDL,COPB2,Coatomer subunit beta',40116,0.0266844163860402,0.00436780939750684,0.0181235099669268,0.0352453228051536,1.03454807685841e-09
NMR metabolomics,X23412.Phospholipids in VLDL,VIT,Vitrin,40511,0.0236594858180114,0.00388007551445339,0.0160545378096828,0.03126443382634,1.11124154134256e-09
NMR metabolomics,X23412.Phospholipids in VLDL,HGFAC,Hepatocyte growth factor activator,40428,0.016965931988092,0.00279148019265775,0.0114946308104828,0.0224372331657012,1.25830295686051e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0265491631829408,0.00436841121140907,0.017987077208579,0.0351112491573026,1.26087345735363e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NFASC,Neurofascin,42754,0.0176713233379114,0.0029121310996452,0.0119635463826068,0.023379100293216,1.32818102780749e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TEK,Angiopoietin-1 receptor,42679,0.013364299297483,0.00220240937690414,0.00904757691875088,0.0176810216762151,1.32952826565129e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.0135539622583985,0.00223666231873642,0.00917010411367511,0.0179378204031219,1.39850879702757e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0188519062046531,0.00311856685133746,-0.0249642972332745,-0.0127395151760317,1.53399071144111e-09
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0202487651501989,0.00335167606462592,0.0136794800635321,0.0268180502368657,1.57601001668534e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN1,Tetraspanin-1,42357,0.0411593660385056,0.00681582404836284,0.0278003509037144,0.0545183811732968,1.59451236943898e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TPM3,Tropomyosin alpha-3 chain,40116,-0.0266493829561696,0.00442179050101808,-0.035316092338165,-0.0179826735741741,1.72603983041122e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0226824313590118,0.00376836460225556,0.0152964367385909,0.0300684259794327,1.8094382576997e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LIPF,Gastric triacylglycerol lipase,40223,0.0377061560333334,0.00627518618457233,0.0254067911115716,0.0500055209550951,1.92840212575521e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0186237715922947,0.00310026270047277,-0.0247002864852213,-0.0125472566993681,1.94839233318383e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0230514717629518,0.00384399340459015,0.0155172446899551,0.0305856988359485,2.06484583332248e-09
NMR metabolomics,X23412.Phospholipids in VLDL,MTPN,Myotrophin,42357,0.0199152086156792,0.00333387226161733,0.0133808189829092,0.0264495982484491,2.38068007578536e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0297527853799325,0.00499582508038235,0.0199609682223831,0.0395446025374819,2.65846453660213e-09
NMR metabolomics,X23412.Phospholipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0391653620741573,0.00657699849465779,0.026274445024628,0.0520562791236865,2.68271117966419e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,42443,0.0182812886714344,0.00307812323966482,0.0122481671216914,0.0243144102211775,2.93768413547585e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PPL,Periplakin,40199,0.0198751585766705,0.00335772261777947,0.0132940222458228,0.0264562949075183,3.33087134631178e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI2,Serpin I2,40449,0.0331726044308033,0.00563354347228445,0.0221308592251258,0.0442143496364808,4.01073207272126e-09
NMR metabolomics,X23412.Phospholipids in VLDL,DPP7,Dipeptidyl peptidase 2,42551,0.035502456441086,0.00604454606252087,0.0236551461585451,0.0473497667236269,4.3692034893084e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ENSA,Alpha-endosulfine,40451,0.0313739792381,0.00534131686690584,0.0209049981789646,0.0418429602972355,4.37889916116762e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SCT,Secretin,40182,0.0295180798726119,0.00502980784067128,0.0196596565048962,0.0393765032403276,4.52104889185776e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PRTG,Protogenin,42721,0.0146568206530403,0.00249995907637123,0.00975690086335274,0.0195567404427279,4.6567205005427e-09
NMR metabolomics,X23412.Phospholipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0139420071330145,0.00237880730455516,-0.0186044694499426,-0.00927954481608634,4.73478925720235e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.033136611638245,0.00565408279172777,0.0220546093664585,0.0442186139100314,4.7432014902385e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0397347518522838,0.00678157670748836,0.0264428615056066,0.053026642198961,4.75994285128937e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0454685834252761,0.0077638611483637,0.0302514155744833,0.060685751276069,4.84192859345913e-09
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2,Brorin,42456,0.024153198523567,0.00414090241811241,0.0160370297840667,0.0322693672630673,5.57641813042927e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GC,Vitamin D-binding protein,40539,0.015193876243725,0.00260597798299059,0.0100861593970634,0.0203015930903865,5.68041152166925e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0341919446684513,0.00586781576542387,0.0226910257682205,0.0456928635686821,5.77164492880595e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX1,Peroxiredoxin-1,42261,-0.0524103933361666,0.00899654629453351,-0.0700436240734522,-0.0347771625988809,5.82436923367143e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,42587,0.0225519394701433,0.00387442476082647,0.0149580669389235,0.0301458120013632,5.99365496145485e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0176731735236462,0.00303804476094331,0.0117186057921973,0.023627741255095,6.14773022877354e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM5,Intercellular adhesion molecule 5,42636,0.0267642007042831,0.00460571826879851,0.017736992897438,0.0357914085111282,6.34776710532657e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ECM1,Extracellular matrix protein 1,40269,0.021860773275783,0.00376250254867179,0.0144862682803863,0.0292352782711797,6.41293662497869e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CHAD,Chondroadherin,40283,0.0302780230049963,0.00523407075920635,0.0200192443169518,0.0405368016930407,7.45644662754301e-09
NMR metabolomics,X23412.Phospholipids in VLDL,APOA1,Apolipoprotein A-I,40539,-0.0160740231852436,0.00278002458830129,-0.0215228713783141,-0.0106251749921731,7.57774954460387e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CDH5,Cadherin-5,42794,-0.0174540252691194,0.0030248777931567,-0.0233827857437065,-0.0115252647945322,8.09222454693504e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH1,Protocadherin-1,42721,0.0125701787512228,0.00218137905259239,0.00829467580814169,0.0168456816943039,8.46871365449315e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CA6,Carbonic anhydrase 6,42581,-0.036177677239737,0.00627965253073613,-0.0484857961999798,-0.0238695582794942,8.54082993559009e-09
NMR metabolomics,X23412.Phospholipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.036276993008562,0.0063046622547906,0.0239198549891724,0.0486341310279516,8.9106756031067e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0376515865361318,0.00656502069589751,0.0247841459721727,0.0505190271000909,9.98977690074257e-09
NMR metabolomics,X23412.Phospholipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.031066093102086,0.00542563845160695,0.0204318417369363,0.0417003444672356,1.05156407817955e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0360091633296548,0.00629370191507931,0.0236735075760993,0.0483448190832102,1.0837300489219e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR2,Complement factor H-related protein 2,40451,0.0333359959412141,0.0058283996648316,0.0219123325981442,0.044759659284284,1.0950815306417e-08
NMR metabolomics,X23412.Phospholipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0246904639298466,0.00432383847912856,0.0162157405107546,0.0331651873489386,1.15219165417652e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.021511152393573,0.00376880820477267,0.0141242883122186,0.0288980164749274,1.16999125076352e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0324452520423207,0.00568424067674729,0.0213041403158961,0.0435863637687454,1.17286920430325e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CTSV,Cathepsin L2,42677,0.0239982938225434,0.00420758788344509,0.0157514215709911,0.0322451660740958,1.19783738516605e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TF,Serotransferrin,40539,0.0122418199882941,0.0021461119275214,0.00803544061035216,0.016448199366236,1.19824244367189e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0505083986868626,0.0088560490607829,0.0331505425277281,0.0678662548459971,1.20005416372383e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SNX2,Sorting nexin-2,40451,0.0470834106155075,0.0082550852210825,0.0309034435821858,0.0632633776488292,1.20283583493327e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0184646223916187,0.00323918588133734,0.0121158180641975,0.0248134267190399,1.22522569353701e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0212534942617385,0.00373161841777913,0.0139395221628914,0.0285674663605856,1.26151983905817e-08
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0185037700202458,0.00325044623004112,0.0121328954093652,0.0248746446311264,1.27678577526217e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR2,Folate receptor beta,42711,-0.0169128582210514,0.00297268537747425,-0.0227393215609009,-0.0110863948812018,1.3011487532357e-08
NMR metabolomics,X23412.Phospholipids in VLDL,REG1A,Lithostathine-1-alpha,42575,-0.0297778679857062,0.00524347080925448,-0.040055070771845,-0.0195006651995674,1.38272754688392e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0233573305165685,0.00411328899318487,0.0152952840899261,0.0314193769432108,1.39242515015023e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3C,Protein FAM3C,42613,0.0175988755115025,0.00312268462805818,0.0114784136405085,0.0237193373824966,1.77739261035556e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2,Ataxin-2,40136,0.0626689533437104,0.0111315356851092,0.0408511434008963,0.0844867632865244,1.84802311312291e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CCL14,C-C motif chemokine 14,42618,0.0227607617863392,0.00404606803810131,0.0148304684316606,0.0306910551410177,1.88773575549359e-08
NMR metabolomics,X23412.Phospholipids in VLDL,COLEC12,Collectin-12,42618,0.0157810863760859,0.00280766256503532,0.0102780677486167,0.0212841050035552,1.93949830022393e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0227090553875287,0.00404175653311203,0.0147872125826291,0.0306308981924283,1.97071510783988e-08
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0274664516077083,0.00489548386655784,0.017871303229255,0.0370615999861617,2.06524459935818e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM2,Myomesin-2,40116,-0.0285098151610421,0.00508592408717786,-0.0384782263719107,-0.0185414039501735,2.12532438316398e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0135017840636824,0.0024096200943336,-0.0182246394485763,-0.00877892867878855,2.14448120426033e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.023558401496475,0.00420932762972941,0.0153081193422054,0.0318086836507447,2.23548110394832e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0119284880628716,0.00213194648737265,0.00774987294762117,0.016107103178122,2.24797137352819e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LUZP2,Leucine zipper protein 2,40451,0.0258838109937103,0.00462646762671555,0.0168159344453478,0.0349516875420728,2.26134006810382e-08
NMR metabolomics,X23412.Phospholipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0313414908233822,0.00560698663017084,0.0203517970282474,0.0423311846185171,2.32729455566359e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0269378450737274,0.00482085931477013,0.0174889608167779,0.0363867293306768,2.35337617990225e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN2,Alpha-actinin-2,40116,-0.0335338145641546,0.0060018829987163,-0.0452975052416386,-0.0217701238866707,2.36266442329414e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL8,Interleukin-8,42494,0.0389870465438191,0.00699507340665095,0.0252767026667832,0.0526973904208549,2.54526371340271e-08
NMR metabolomics,X23412.Phospholipids in VLDL,NRP2,Neuropilin-2,42611,-0.0160426514652187,0.0028843486630126,-0.0216959748447234,-0.010389328085714,2.71851838102647e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0241498957456645,0.00434206841636743,0.0156394416495843,0.0326603498417446,2.72017142538745e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0158294793578144,0.00284915669137712,0.0102451322427152,0.0214138264729135,2.82678350401578e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DSC2,Desmocollin-2,42488,-0.0197555687040135,0.00356054038931651,-0.0267342278670739,-0.0127769095409532,2.93681519701683e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CD101,Immunoglobulin superfamily member 2,40449,0.0242753162735817,0.00438504701891106,0.015680624116516,0.0328700084306473,3.16518885516029e-08
NMR metabolomics,X23412.Phospholipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0190587740448419,0.00344824579742609,0.0123002122818867,0.025817335807797,3.31666305036814e-08
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO1,R-spondin-1,42495,0.0188529359626512,0.00341116866109244,0.01216704538691,0.0255388265383924,3.3221175340022e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC1,MANSC domain-containing protein 1,42679,-0.0155740091124984,0.0028199494611402,-0.0211011100563332,-0.0100469081686636,3.39818996610839e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,42346,0.030139894492808,0.0054582016842719,0.0194418191916351,0.040837969793981,3.41624505929139e-08
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0215425900770665,0.00390747881903185,0.013883931591764,0.0292012485623689,3.5906072125896e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0217262902310138,0.00394099012061782,0.0140019495946029,0.0294506308674247,3.59496950799959e-08
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0235069418089729,0.0042699889121718,0.0151377635411161,0.0318761200768296,3.75631973005242e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0191128512863613,0.00347944156525795,0.0122931458184557,0.0259325567542669,4.02100405537973e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CD93,Complement component C1q receptor,42141,-0.017773930443185,0.00324110069623842,-0.0241264878078123,-0.0114213730785577,4.23809966464293e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1,Programmed cell death protein 1,42689,0.0248065377063659,0.0045254705852708,0.0159366153592352,0.0336764600534967,4.29216446510278e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0196117923983304,0.00358636238279731,0.0125825221280477,0.0266410626686132,4.62062668438819e-08
NMR metabolomics,X23412.Phospholipids in VLDL,LCP1,Plastin-2,40527,0.0263717164869238,0.00482977647871501,0.0169053545886424,0.0358380783852053,4.85531879247899e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,42613,0.0443687923912241,0.0081285790387217,0.0284367774753296,0.0603008073071186,4.89061077610999e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PROK1,Prokineticin-1,42594,0.0303021867256455,0.00555397700336213,0.0194163917990557,0.0411879816522353,4.95784262032009e-08
NMR metabolomics,X23412.Phospholipids in VLDL,EGFLAM,Pikachurin,40449,0.0170208917333586,0.00311976194743074,0.0109061583163943,0.0231356251503228,4.97764570564166e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0133000243164264,0.00243867919793498,0.00852021308847385,0.018079835544379,5.01787429864912e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0230489308600885,0.00423292432251762,0.014752399187954,0.0313454625322231,5.26887769090265e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TGFA,Protransforming growth factor alpha,42594,0.0259268666637137,0.00476211504944861,0.0165931211667945,0.035260612160633,5.28952764728041e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3B,Protein FAM3B,42587,0.019274769534059,0.00354205746670856,0.0123323368993102,0.0262172021688078,5.37064077024558e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0238379607284657,0.00439336451691966,0.0152269662753031,0.0324489551816282,5.86840763973842e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0255580245166227,0.00471597150163561,0.0163147203734169,0.0348013286598285,6.08370205771406e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PZP,Pregnancy zone protein,40539,0.0278171367903056,0.00513474913355111,0.0177530284885454,0.0378812450920658,6.16974209305375e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CR2,Complement receptor type 2,42689,0.0260438842087418,0.00481264887210501,0.016611092419416,0.0354766759980676,6.35490302059305e-08
NMR metabolomics,X23412.Phospholipids in VLDL,FGF16,Fibroblast growth factor 16,40199,0.0258184900175539,0.00477687144954582,0.0164558219764441,0.0351811580586637,6.61999186657159e-08
NMR metabolomics,X23412.Phospholipids in VLDL,MMP12,Macrophage metalloelastase,42592,0.0304351625432293,0.00563251819963955,0.0193954268719358,0.0414748982145229,6.64804990710887e-08
NMR metabolomics,X23412.Phospholipids in VLDL,HEPH,Hephaestin,40511,0.014383190167789,0.00266585671072627,0.00915811101476547,0.0196082693208124,6.97742844931506e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CD80,T-lymphocyte activation antigen CD80,40511,0.0189410088256639,0.00351140118267667,0.0120586625076176,0.0258233551437102,7.02368707706664e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0146413269036644,0.00271731377806649,0.00931539189865405,0.0199672619086747,7.23818753011274e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ITGBL1,Integrin beta-like protein 1,40527,0.0211057592668067,0.00391725476545679,0.0134279399265114,0.028783578607102,7.27144866850457e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0203218338386003,0.00377868375564688,0.0129156136775324,0.0277280539996682,7.65701689513059e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0181678004190555,0.00337874407614838,0.0115454620298047,0.0247901388083064,7.72459389196039e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,40116,0.0247170385012432,0.00460579985203825,0.0156896707912482,0.0337444062112382,8.19201010629926e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CA7,Carbonic anhydrase 7,40302,-0.0190435683242196,0.00355057102417876,-0.02600268753161,-0.0120844491168293,8.32521916979396e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CRH,Corticoliberin,42322,0.0462799608296915,0.00863045435714271,0.0293642702896918,0.0631956513696912,8.3514306385876e-08
NMR metabolomics,X23412.Phospholipids in VLDL,C1QA,Complement C1q subcomponent subunit A,42701,-0.011798706570583,0.00221304916238337,-0.0161362829288544,-0.00746113021231161,9.90134889315657e-08
NMR metabolomics,X23412.Phospholipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0371436033221211,0.00697155399241236,0.0234793574969929,0.0508078491472493,1.01322505964937e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CA1,Carbonic anhydrase 1,42362,0.0321227318480498,0.0060405747480124,0.0202832053419454,0.0439622583541541,1.06730932384074e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GDF15,Growth/differentiation factor 15,42794,-0.0246903922490305,0.00464717980517958,-0.0337988646671825,-0.0155819198308786,1.09545449914547e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SAA4,Serum amyloid A-4 protein,40539,0.017335463535422,0.00326410547622617,0.0109378168020187,0.0237331102688253,1.11123766311889e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MUC16,Mucin-16,42587,0.102337159131868,0.0192876045901607,0.0645334541351527,0.140140864128583,1.13935440297176e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CILP,Cartilage intermediate layer protein 1,40527,0.029485540135806,0.00555755507591939,0.018592732187004,0.040378348084608,1.14490122903439e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL12,Stromal cell-derived factor 1,42370,0.0214409860490132,0.00404240479431279,0.0135178726521601,0.0293640994458662,1.15113907504708e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PKD1,Polycystin-1,40511,0.0143323652627774,0.00270343142734252,0.00903363966518608,0.0196310908603688,1.16987336181886e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GRN,Progranulin,42552,0.0130509379418467,0.00246542077600762,0.00821871322087173,0.0178831626628216,1.21834114870858e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CAPG,Macrophage-capping protein,42461,0.0310440207615682,0.00587762304262389,0.0195238795980253,0.042564161925111,1.29991710677057e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,42311,0.0453773728930299,0.00860071931192617,0.0285199630416546,0.0622347827444052,1.34137662162431e-07
NMR metabolomics,X23412.Phospholipids in VLDL,KLK6,Kallikrein-6,42656,0.0167838634220951,0.003184687455183,0.0105418760099365,0.0230258508342538,1.38397458322036e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0276534655777051,0.00525558670116141,0.0173525156434287,0.0379544155119815,1.44949819816544e-07
NMR metabolomics,X23412.Phospholipids in VLDL,APOD,Apolipoprotein D,40033,-0.0230911075997789,0.00439534116533054,-0.0317059762838268,-0.014476238915731,1.52032502341228e-07
NMR metabolomics,X23412.Phospholipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,42587,0.0220920910575519,0.00421564844719222,0.0138294201010552,0.0303547620140487,1.62576591684541e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0206446922452987,0.00394212247174845,0.0129181322006717,0.0283712522899256,1.6628894873707e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0186835513831638,0.00357297863983745,0.0116805132490824,0.0256865895172452,1.72873825310707e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,42559,0.0113491249338934,0.00217397517418594,0.00708813359248898,0.0156101162752979,1.81166080415648e-07
NMR metabolomics,X23412.Phospholipids in VLDL,S100A13,Protein S100-A13,40199,0.0187018729250805,0.00358886670754302,0.0116676941782962,0.0257360516718648,1.91142409572239e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0170726129575575,0.00328002662668142,0.0106437607692619,0.023501465145853,1.96848086157704e-07
NMR metabolomics,X23412.Phospholipids in VLDL,AOC3,Membrane primary amine oxidase,42689,-0.0157861936212906,0.00303498788025578,-0.0217347698665919,-0.00983761737598926,2.0068481375623e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA6,Corticosteroid-binding globulin,40539,0.00822918940497307,0.00158240730838288,0.00512767108054264,0.0113307077294035,2.02296818907387e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN1,Nectin-1,40199,0.0171455953980714,0.0033001314469004,0.0106773377621467,0.0236138530339962,2.07903363566946e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0238818609684187,0.0046003923354527,0.0148650919909314,0.032898629945906,2.12509839035748e-07
NMR metabolomics,X23412.Phospholipids in VLDL,AZU1,Azurocidin,42216,0.0397766974010698,0.00766937527985317,0.0247447218525576,0.054808672949582,2.17576140768264e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH1,Neurexophilin-1,42311,0.0202759806732818,0.00391150906753999,0.0126094229009034,0.0279425384456602,2.20792212309556e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CDH3,Cadherin-3,42711,0.0195077975848616,0.0037667706380594,0.0121249271342652,0.026890668035458,2.26382401972922e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CA12,Carbonic anhydrase 12,42587,-0.0172280474105725,0.00332661652755508,-0.0237482158045805,-0.0107078790165646,2.26495272908904e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0217986682574664,0.00420990031966626,0.0135472636309205,0.0300500728840122,2.27652455275857e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0204388743652254,0.00395393600114144,0.0126891598029882,0.0281885889274626,2.39171749772706e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0299661808194264,0.00580327267159131,-0.0413405952557454,-0.0185917663831074,2.45624876377974e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R1,Interleukin-1 receptor type 1,42590,-0.0122213786836319,0.00236799697650169,-0.0168626527575752,-0.0075801046096886,2.49065449398089e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CYTL1,Cytokine-like protein 1,40527,0.0132937343690388,0.00257593593539231,0.00824489993566991,0.0183425688024078,2.50138467359674e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.016510946157938,0.00319962782945101,-0.022782216703662,-0.0102396756122141,2.50602659962398e-07
NMR metabolomics,X23412.Phospholipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,42794,0.0196046010314876,0.0038122033754696,0.0121326824155672,0.0270765196474081,2.7474042306334e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IL1B,Interleukin-1 beta,42293,0.0293667192564827,0.00571554513096842,0.0181642507997846,0.0405691877131808,2.81605191060312e-07
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,40302,0.0231227808136578,0.00450946086582668,0.0142842375166375,0.0319613241106781,2.98376338384826e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FOSB,Protein fosB,42311,0.0197627258543867,0.00385546959186257,0.0122060054543361,0.0273194462544373,3.00343145231731e-07
NMR metabolomics,X23412.Phospholipids in VLDL,RALY,RNA-binding protein Raly,40451,0.0244106667335918,0.00476812433144983,0.0150651430439501,0.0337561904232334,3.11317529035151e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAV,Integrin alpha-V,42721,0.00842269112263046,0.00164610956325698,0.00519631637864679,0.0116490658666141,3.15143493966924e-07
NMR metabolomics,X23412.Phospholipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,40483,0.0251227152798802,0.00491522108392024,0.0154888819553965,0.0347565486043639,3.25343568560983e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FABP1,"Fatty acid-binding protein, liver",42618,-0.0481801564915047,0.00946078033255583,-0.0667232859433142,-0.0296370270396953,3.57935486056411e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0272657281303092,0.00536653531289325,0.0167473189170384,0.03778413734358,3.81068359129404e-07
NMR metabolomics,X23412.Phospholipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0333400427167318,0.00657166815674859,-0.046220512303959,-0.0204595731295046,3.96128773042113e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GFAP,Glial fibrillary acidic protein,42326,0.0249024290379017,0.00491705391577828,0.0152650033629763,0.0345398547128271,4.15022060651365e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0209533082005969,0.00413818497099071,0.0128424656574551,0.0290641507437387,4.18329992997937e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CDH17,Cadherin-17,42636,-0.0353512944815264,0.00698465186122645,-0.0490412121295303,-0.0216613768335226,4.21948818312626e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PI3,Elafin,42446,0.0288100703700056,0.00570852441485621,0.0176213625168874,0.0399987782231238,4.55106076084371e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,40483,0.121498535206116,0.0241332690142829,0.0741973279381211,0.16879974247411,4.86532001776064e-07
NMR metabolomics,X23412.Phospholipids in VLDL,INSL3,Insulin-like 3,40483,0.0395832454448315,0.00787377925245094,0.0241506381100277,0.0550158527796354,5.0526760469014e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA5,Protein disulfide-isomerase A5,40080,0.03100624659412,0.00618011360903119,0.0188932239204189,0.0431192692678211,5.3285580423633e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PSME2,Proteasome activator complex subunit 2,42441,0.018217018666019,0.0036339379508801,0.011094500282294,0.025339537049744,5.4273417813073e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CD5L,CD5 antigen-like,40479,0.0241179754567342,0.00481204796991803,0.0146863614356948,0.0335495894777735,5.46847577165249e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD2,Sushi domain-containing protein 2,42611,-0.0145086449837491,0.00290035288795558,-0.020193336644142,-0.00882395332335614,5.73454618896777e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ALPP,"Alkaline phosphatase, placental type",42587,0.0506429688922574,0.0101251527878721,0.0307976694280282,0.0704882683564866,5.75469973163252e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SEL1L,Protein sel-1 homolog 1,40223,0.0164406047201416,0.00329008710002466,0.00999203400409322,0.0228891754361899,5.91187536317693e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NME3,Nucleoside diphosphate kinase 3,42638,0.0120135480858535,0.00240536183760062,0.00729903888415624,0.0167280572875507,5.97326296974274e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IFNG,Interferon gamma,42370,0.0567062840694132,0.0113548580909193,0.0344507622112114,0.0789618059276151,5.98950250119816e-07
NMR metabolomics,X23412.Phospholipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.038262808364114,0.00766440320646938,0.023240578079434,0.053285038648794,6.05877797487622e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA7,Thyroxine-binding globulin,40539,0.00928900169049783,0.00186126010544872,0.00564093188381834,0.0129370714971773,6.1051777158981e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DLL4,Delta-like protein 4,40223,0.0431471221148976,0.00864920095373428,0.0261946882455784,0.0600995559842168,6.17558218018669e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0198358083929021,0.00397668002074583,0.0120415155522402,0.0276301012335639,6.17618381854402e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0345602700601416,0.00693519307778043,0.020967291627692,0.0481532484925913,6.32891144270002e-07
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX1,Heme oxygenase 1,42500,-0.0240405533963468,0.00485494989427706,-0.0335562551891299,-0.0145248516035638,7.44466547974035e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ALCAM,CD166 antigen,42794,0.00976435024004118,0.0019743395500214,0.00589464472199924,0.0136340557580831,7.68047169023667e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CD86,T-lymphocyte activation antigen CD86,40449,0.0151184385320014,0.00305781937482864,0.00912511255733723,0.0211117645066655,7.75642565158965e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0139340705667554,0.00282894796627309,0.00838933255286018,0.0194788085806507,8.51288691012266e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SELL,L-selectin,40539,0.0118432301422582,0.00240538983758648,0.00712866606058873,0.0165577942239277,8.61531544657889e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0191771042177534,0.00389779264875843,0.0115374306261868,0.0268167778093199,8.7803141581047e-07
NMR metabolomics,X23412.Phospholipids in VLDL,BRD1,Bromodomain-containing protein 1,40302,-0.0151680387686249,0.00308459862581179,-0.021213852075216,-0.00912222546203382,8.89809298612705e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ACE,Angiotensin-converting enzyme,40532,-0.0132912742584701,0.00270453544880077,-0.0185921637381196,-0.00799038477882057,9.02825189574641e-07
NMR metabolomics,X23412.Phospholipids in VLDL,XG,Glycoprotein Xg,42734,0.0170198255050083,0.00346385270442571,0.0102306742043339,0.0238089768056827,9.0486262711047e-07
NMR metabolomics,X23412.Phospholipids in VLDL,BAX,Apoptosis regulator BAX,42292,0.0438027078681678,0.00891506759292124,0.0263291753860422,0.0612762403502935,9.06228154429224e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0335000356600631,0.00682174895446777,0.0201294077093062,0.0468706636108199,9.1786080795907e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GZMH,Granzyme H,42357,0.0381393907349445,0.00779604971594608,0.0228591332916902,0.0534196481781988,1.00923772574683e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS1,Nephrin,40199,0.0165643893050478,0.00339080019255632,0.00991842092763738,0.0232103576824581,1.04833588103646e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0167695769911671,0.00343517208280218,0.0100366397088748,0.0235025142734594,1.06373870270625e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GBA,Lysosomal acid glucosylceramidase,40182,0.027252786807174,0.0055857954340567,0.0163046277564229,0.0382009458579252,1.08152012824926e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0131377017559878,0.00269356048748864,-0.0184170803114655,-0.00785832320051008,1.08959897076012e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CLASP1,CLIP-associating protein 1,40080,0.0357246733977709,0.00732645127907735,0.0213648288907793,0.0500845179047625,1.09720950804406e-06
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,40223,0.019458041081706,0.00399357308090238,0.0116306378431373,0.0272854443202747,1.11818954700731e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FGA,Fibrinogen alpha chain,40284,0.0151889455857509,0.00312057240059259,0.00907262368058941,0.0213052674909124,1.14657968245721e-06
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0169341541692653,0.0035058291346561,0.0100627290653393,0.0238055792731912,1.37841008367638e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH3,Neurexophilin-3,40199,0.0149588878357322,0.0031016683044327,0.00887961795904416,0.0210381577124203,1.4341633079583e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0199142405403734,0.00413510785583141,0.0118094291429439,0.028019051937803,1.48175079644838e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ASS1,Argininosuccinate synthase,40116,0.0376876777580493,0.00783020691427415,0.022340472206072,0.0530348833100267,1.50587458643983e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SCGN,Secretagogin,42370,-0.0218753786352019,0.00454900272774266,-0.0307914239815775,-0.0129593332888263,1.53495394272968e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CLPS,Colipase,42590,0.0351463668403834,0.00732537916768597,0.0207886236717189,0.0495041100090479,1.62074005773569e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0271255456807932,0.00565565066022015,0.0160404703867617,0.0382106209748247,1.63789922837802e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0286776910608219,0.00598082908297288,0.016955266058195,0.0404001160634487,1.64506430458999e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LYZL2,Lysozyme-like protein 2,40080,0.0173534827108738,0.00362830014071456,0.0102420144350732,0.0244649509866743,1.75126163381059e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SNU13,NHP2-like protein 1,40116,0.0305488061650687,0.00639332775255977,0.0180178837700516,0.0430797285600858,1.79146527300139e-06
NMR metabolomics,X23412.Phospholipids in VLDL,BCAM,Basal cell adhesion molecule,42611,-0.0118070704579331,0.00247735648945567,-0.0166626891772662,-0.00695145173859999,1.89894504596879e-06
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB4,Ephrin type-B receptor 4,42794,-0.0126348397688757,0.00265181568166685,-0.0178323985049427,-0.00743728103280869,1.9118502458196e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0166652373203724,0.0035001247368692,0.00980499283610874,0.023525481804636,1.94317830813963e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0127327420239106,0.00268386559588653,0.00747236545597298,0.0179931185918482,2.11532121798233e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GUCA2A,Guanylin,42563,-0.0173729790411019,0.00366238040720456,-0.0245512446392228,-0.010194713442981,2.12091912299604e-06
NMR metabolomics,X23412.Phospholipids in VLDL,UMOD,Uromodulin,42764,-0.0262909136379597,0.00554330874462463,-0.037155798777424,-0.0154260284984954,2.1290899019848e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PRL,Prolactin,42711,-0.0356428000054247,0.00751987774732352,-0.0503817603901788,-0.0209038396206706,2.16097977996694e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA1,Alpha-1-antitrypsin,40327,-0.0039117939323354,0.000825395374506116,-0.00552956886636739,-0.00229401899830341,2.17116035724582e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0210517128476465,0.00445524582388465,-0.0297839946624605,-0.0123194310328326,2.32263236502614e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA2,GDNF family receptor alpha-2,42587,0.0100907256840752,0.00214061475527677,0.00589512076373274,0.0142863306044177,2.45421762579881e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0255543068225365,0.00542356721553763,0.0149241150800827,0.0361844985649903,2.48152975539377e-06
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB6,Heat shock protein beta-6,42721,0.018642624858208,0.003961992524492,0.0108771195102037,0.0264081302062123,2.5592038418223e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0124104062099805,0.00263790729442962,-0.0175807045070625,-0.00724010791289841,2.57443777883919e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0161675682917568,0.00343906781634289,0.00942699537172478,0.0229081412117889,2.61255376523522e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SCN4B,Sodium channel subunit beta-4,40223,0.0207521930925034,0.0044380722963486,0.0120535713916601,0.0294508147933467,2.96071326131894e-06
NMR metabolomics,X23412.Phospholipids in VLDL,KLK8,Kallikrein-8,42154,0.0175719020814891,0.00375884910914874,0.0102045578275576,0.0249392463354206,2.97193343434837e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SIL1,Nucleotide exchange factor SIL1,40223,0.0145325107238095,0.00312283178917668,0.00841176041702319,0.0206532610305958,3.29937360565091e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0192244737311234,0.00414379457554551,-0.0273463110991926,-0.0111026363630542,3.53585990774208e-06
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,42594,0.0226612740167786,0.00488678523610522,0.0130831749540124,0.0322393730795448,3.56401808763972e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN2,Nectin-2,42613,0.0146820812760447,0.00316662560601236,0.00847549508826048,0.0208886674638289,3.57688491210102e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1,Integrin beta-1,42638,0.00995391521732134,0.00214710666624215,0.00574558615148673,0.0141622442831559,3.5861599218069e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0501946605248661,0.0108299001525306,0.028968056225906,0.0714212648238261,3.61356927686712e-06
NMR metabolomics,X23412.Phospholipids in VLDL,INSL5,Insulin-like peptide INSL5,40449,0.0459086814239827,0.00992196209246484,0.0264616357227516,0.0653557271252138,3.75185614488568e-06
NMR metabolomics,X23412.Phospholipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0183121266622626,0.00397691517917004,0.0105173729110893,0.0261068804134359,4.17120562558392e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0198848934495249,0.00433044163799434,0.011397227839056,0.0283725590599938,4.43324116411266e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LIF,Leukemia inhibitory factor,42311,0.0237303974353884,0.00517100108403863,0.0135952353106727,0.0338655595601041,4.49225141565395e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GZMB,Granzyme B,42594,0.0305994640482957,0.0066722925650788,0.0175217706207413,0.0436771574758502,4.55801974761555e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3,Galectin-3,42669,0.0137576057765605,0.00300191432055605,0.0078738537082706,0.0196413578448503,4.62592209221735e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CENPF,Centromere protein F,40302,0.025153471823603,0.0054922599917522,0.0143886422397687,0.0359183014074373,4.70474031959336e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF7,SLAM family member 7,42594,-0.0273747858427905,0.00598095189725426,-0.0390974515614089,-0.0156521201241722,4.75942274472498e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0528223185081598,0.0115411983380478,0.0302015697655862,0.0754430672507335,4.76322701759264e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RPA2,Replication protein A 32 kDa subunit,40199,0.0146261343772218,0.00319739842061211,0.00835923347282208,0.0208930352816215,4.82837607768218e-06
NMR metabolomics,X23412.Phospholipids in VLDL,MPO,Myeloperoxidase,42611,0.0213456282839287,0.00466969499663883,0.0121930260905166,0.0304982304773408,4.89511018618056e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0137836422382363,0.00301887869326186,0.00786663999944305,0.0197006444770296,5.01957901921222e-06
NMR metabolomics,X23412.Phospholipids in VLDL,KIF1C,Kinesin-like protein KIF1C,40116,0.0165264478241607,0.00362521414296865,0.00942102810394215,0.0236318675443792,5.20179504774509e-06
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0225484228308945,0.00495599729348602,0.0128346681356619,0.0322621775261271,5.42954259840216e-06
NMR metabolomics,X23412.Phospholipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0175660099691124,0.00386797416491196,0.00998478060588494,0.0251472393323398,5.6479226222926e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0197706244421081,0.0043542661408314,0.0112362628060785,0.0283049860781376,5.66036472316438e-06
NMR metabolomics,X23412.Phospholipids in VLDL,DCC,Netrin receptor DCC,40182,0.0105791759841567,0.0023361674864675,0.00600028771068043,0.015158064257633,6.00484951767463e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VWF,von Willebrand factor,42794,-0.0326701487075372,0.00721927512279689,-0.0468199279482191,-0.0185203694668553,6.07907385218951e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAP,Cartilage-associated protein,40182,0.0218135651490615,0.0048287342994145,0.0123492459222091,0.031277884375914,6.32415868371192e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CD55,Complement decay-accelerating factor,42201,0.0123099808475778,0.00273851126913673,0.00694249876006978,0.0176774629350857,7.01260966302688e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM4,Intercellular adhesion molecule 4,42594,-0.0237931157745523,0.0053029755379247,-0.0341869478288847,-0.0133992837202199,7.29205163678767e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0309267339129572,0.00689674468154849,0.0174091143371222,0.0444443534887922,7.39111398999678e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AGXT,Serine--pyruvate aminotransferase,42636,0.0338849867184677,0.00755777862080618,0.0190717406216876,0.0486982328152478,7.4050671775044e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GBP4,Guanylate-binding protein 4,42311,0.0222185132374429,0.00496423517741017,0.012488612289719,0.0319484141851668,7.67968182891636e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0344363399455922,0.0076954759744613,0.0193532070356481,0.0495194728555364,7.72198443442256e-06
NMR metabolomics,X23412.Phospholipids in VLDL,DDI2,Protein DDI1 homolog 2,40283,0.0353042813480667,0.00789624112599765,0.0198276487411113,0.0507809139550221,7.86192082854101e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CFC1,Cryptic protein,42346,0.0212283944765956,0.00476024298838601,0.011898318219359,0.0305584707338322,8.28244470592189e-06
NMR metabolomics,X23412.Phospholipids in VLDL,DSG4,Desmoglein-4,42543,0.0223164069772378,0.00503333374404911,0.0124510728389015,0.0321817411155741,9.33591642425505e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0162759411734323,0.00367479893095974,0.00907333526875121,0.0234785470781134,9.55538498416943e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FGF5,Fibroblast growth factor 5,42370,-0.0146741207262113,0.00332444888202349,-0.0211900405349773,-0.00815820091744523,1.02284470035876e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.044624667525663,0.0101357921239015,0.024758514962816,0.06449082008851,1.07937252839288e-05
NMR metabolomics,X23412.Phospholipids in VLDL,C1QL2,Complement C1q-like protein 2,40199,0.019557745347268,0.0044487905187301,0.010838115930557,0.028277374763979,1.11198959667879e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RAB39B,Ras-related protein Rab-39B,40116,0.0407185772116769,0.00932048035582523,0.0224504357142594,0.0589867187090943,1.26129582637868e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB6,Ephrin type-B receptor 6,42476,0.0147398071874285,0.00338138311141869,0.00811229628904782,0.0213673180858091,1.31576899738762e-05
NMR metabolomics,X23412.Phospholipids in VLDL,HMBS,Porphobilinogen deaminase,42721,0.0189045443076403,0.00433704228881542,0.010403941421562,0.0274051471937185,1.31708961069016e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0122912816540776,0.00282219938010122,0.0067597708690792,0.017822792439076,1.33945889283327e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD6,Programmed cell death protein 6,42636,-0.0308105150779237,0.0070781117232089,-0.0446836140554131,-0.0169374161004342,1.35323544680218e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RAB44,Ras-related protein Rab-44,40451,0.0183617561250868,0.00422416752084399,0.0100823877842326,0.026641124465941,1.39329354363723e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0297366418712301,0.00684156222968497,-0.0431461038414127,-0.0163271799010476,1.39366886609195e-05
NMR metabolomics,X23412.Phospholipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0119099233178596,0.00274192481088339,0.0065357506885281,0.017284095947191,1.41167380319379e-05
NMR metabolomics,X23412.Phospholipids in VLDL,F3,Tissue factor,42636,-0.0119127419227704,0.00274303895996623,-0.0172890982843042,-0.00653638556123658,1.41644559127043e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0126169350437217,0.00290599163189418,-0.0183126786422343,-0.00692119144520914,1.42420957186333e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CD300E,CMRF35-like molecule 2,42677,0.018847609821628,0.00434413959178539,0.0103330962217286,0.0273621234215274,1.44417375663941e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN2,Prefoldin subunit 2,42311,0.0241435244216235,0.00556727605658086,0.013231663350725,0.0350553854925219,1.45727348393098e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.0127557659715846,0.00294487261762304,0.00698381564104348,0.0185277163021258,1.49160752977222e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CD59,CD59 glycoprotein,42130,0.0108694067777937,0.00251257381619618,0.00594476209804922,0.0157940514575382,1.52976684542724e-05
NMR metabolomics,X23412.Phospholipids in VLDL,YAP1,Transcriptional coactivator YAP1,40483,0.0125142534225101,0.0028960036941192,0.00683808618203646,0.0181904206629837,1.56501028803715e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0140903552976639,0.0032683242967253,0.00768443967608229,0.0204962709192455,1.63791286397158e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BCAN,Brevican core protein,42495,0.0149755141073963,0.00348456122501497,0.00814577410636695,0.0218052541084256,1.73825958520947e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171B,Protein FAM171B,40451,0.01141616195964,0.00266167999872657,0.0061992691621359,0.016633054757144,1.80910584150393e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0341330425840038,0.00796894939869902,0.0185139017625538,0.0497521834054539,1.85707828850974e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CLGN,Calmegin,40182,0.0200357207153575,0.00468123400490172,0.0108605020657501,0.0292109393649648,1.88470948067572e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NCAN,Neurocan core protein,42711,0.0163211460132557,0.0038183714133898,0.00883713804301172,0.0238051539834997,1.92989176618792e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,42611,-0.014279186900217,0.0033537618270612,-0.0208525600812569,-0.00770581371917702,2.07980545691027e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,42713,0.0123825587797559,0.00290832665340295,0.0066822385390861,0.0180828790204257,2.08006759109255e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CALCB,Calcitonin gene-related peptide 2,40483,0.0175679439543453,0.0041312993888807,0.00947059715213909,0.0256652907565514,2.13192890675885e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0119227030146529,0.00281471267614845,0.00640586616940197,0.0174395398599039,2.29199424128947e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ARG1,Arginase-1,42488,0.0220398677500846,0.00520658464068715,0.0118349618543378,0.0322447736458314,2.32064823909942e-05
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,42357,0.0235840955582327,0.00557371903730459,0.0126596062451157,0.0345085848713496,2.33914582389291e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0189202356062099,0.0044722499397579,0.0101546257242845,0.0276858454881354,2.34929151349641e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0183530208565891,0.00434024129907903,0.00984614791039418,0.026859893802784,2.36766883384512e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.0157553703806703,0.0037260475055795,0.00845231726973445,0.0230584234916061,2.37163531111401e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.0116797752476407,0.00276668714979327,0.00625706843404589,0.0171024820612355,2.44191566044657e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0172609265383469,0.00409485149207076,0.00923501761388824,0.0252868354628056,2.51407571128107e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GPC1,Glypican-1,42721,0.0126454893975461,0.00300430299381249,0.00675705552967366,0.0185339232654186,2.58016298147214e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0167935167121357,0.00399096248795266,-0.0246158031885229,-0.00897123023574847,2.59756214224965e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GSAP,Gamma-secretase-activating protein,42346,0.036185083333793,0.00860948115746108,0.0193105002651693,0.0530596664024168,2.65217650456374e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,40451,0.0248936223016797,0.00592554398030065,0.0132795561002904,0.0365076885030689,2.67704687956776e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA1,Annexin A1,40235,0.0175759433318575,0.00418764710549985,0.00936815500507784,0.0257837316586372,2.72480436952014e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BST2,Bone marrow stromal antigen 2,42711,0.0215323584679605,0.00513696456524282,0.0114639079200846,0.0316008090158364,2.78694517749585e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,42587,0.0109960685318105,0.00262830319807037,0.00584459426359262,0.0161475428000285,2.88613139084196e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD9,Enhancer of filamentation 1,40199,0.0140009413774051,0.00336043736287671,0.00741448414616679,0.0205873986086435,3.11805514468076e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,42600,0.0201005825955539,0.00483606744527507,0.0106218904028148,0.029579274788293,3.2532385539662e-05
NMR metabolomics,X23412.Phospholipids in VLDL,L1CAM,Neural cell adhesion molecule L1,42679,0.0122225024227886,0.00294137757845779,0.00645740236901135,0.0179876024765659,3.26769733779283e-05
NMR metabolomics,X23412.Phospholipids in VLDL,STX3,Syntaxin-3,40483,0.0161475038436686,0.00390889960206116,0.00848606062362868,0.0238089470637084,3.63857212042466e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB1,Lamin-B1,40434,0.0248496926521819,0.00601789022971969,0.0130546278019313,0.0366447575024325,3.66494903183379e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0331630232295464,0.00804879445098179,0.0173873861056221,0.0489386603534707,3.81267686273425e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PTGR1,Prostaglandin reductase 1,40511,0.0347529935797299,0.0084366434091241,0.0182171724978467,0.0512888146616132,3.82742599441051e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0182819357885621,0.0044397515499561,0.00958002275064814,0.0269838488264761,3.8530247214772e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0114028865030983,0.00277608610299222,0.00596175774123352,0.016844015264963,4.02255548811104e-05
NMR metabolomics,X23412.Phospholipids in VLDL,STC2,Stanniocalcin-2,42591,0.010204234737057,0.00250030676372916,0.00530363348014786,0.0151048359939662,4.50649011758699e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM26,Tripartite motif-containing protein 26,40080,0.0231298248042904,0.00567224788688298,0.0120122189459997,0.034247430662581,4.5803604896581e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BRK1,Protein BRICK1,42311,0.0184121198333171,0.00451768026759977,0.00955746650882155,0.0272667731578126,4.61722970697044e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SPP1,Osteopontin,42771,-0.0193442744013852,0.00474739771177962,-0.0286491739164733,-0.0100393748862972,4.63334932219004e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PRUNE2,Protein prune homolog 2,40302,0.0123472813065892,0.00303213233314164,0.00640430193363155,0.0182902606795468,4.6905399813707e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RCC1,Regulator of chromosome condensation,40451,0.0215078492519422,0.00528799819286882,0.0111433727939193,0.0318723257099651,4.78860952096465e-05
NMR metabolomics,X23412.Phospholipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0269379225971585,0.00664153793743508,0.0139205082397857,0.0399553369545312,5.02618750831874e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.021456358306988,0.00529316344259135,0.011081757959509,0.031830958654467,5.07855330326977e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0182321186971212,0.00450381986849611,0.00940463175486883,0.0270596056393736,5.19784908161028e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RAB37,Ras-related protein Rab-37,42370,0.0328907104881036,0.00812844358660919,0.0169589610583496,0.0488224599178576,5.23142949915221e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GBP2,Guanylate-binding protein 2,42370,0.0246775832302477,0.00610747402369144,0.0127069341438125,0.0366482323166829,5.36275712427341e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY2,Protein canopy homolog 2,42357,0.0250553015886537,0.00620102305722114,0.0129012963965003,0.0372093067808071,5.36378766342856e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS53,Serine protease 53,40483,0.0151142897047227,0.0037588300287931,0.00774698284828819,0.0224815965611571,5.83263757989124e-05
NMR metabolomics,X23412.Phospholipids in VLDL,APOBR,Apolipoprotein B receptor,40223,-0.0172372427985878,0.0042996111488134,-0.0256644806502621,-0.00881000494691353,6.13717671768389e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DKK3,Dickkopf-related protein 3,42794,-0.0121358908440172,0.00303263249320309,-0.0180798505306953,-0.00619193115733918,6.32042686525532e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,40483,0.0155811499893865,0.00389850735924638,0.0079400755652636,0.0232222244135094,6.46409907912783e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RPS10,40S ribosomal protein S10,40116,-0.0164265908769917,0.00411177566805654,-0.0244856711863826,-0.00836751056760093,6.51155877556017e-05
NMR metabolomics,X23412.Phospholipids in VLDL,QSOX1,Sulfhydryl oxidase 1,40342,0.0174366770668283,0.0043733687282683,0.00886487435942245,0.0260084797742342,6.73372636753408e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAM,Integrin alpha-M,42611,-0.0126616655775564,0.00317974997916686,-0.0188939755367235,-0.00642935561838937,6.87071202546243e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SLC16A1,Monocarboxylate transporter 1,42311,0.0229892058147293,0.00577704145679803,0.0116662045594052,0.0343122070700534,6.94587911024954e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NEO1,Neogenin,40482,0.00890184163200819,0.00223875998609896,0.00451387205925423,0.0132898112047621,7.0450762557433e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0182763003717772,0.00459980750384281,-0.0272919230793091,-0.00926067766424532,7.1257761941517e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CD48,CD48 antigen,42654,0.0123577751081943,0.00311456528045523,0.00625322715850207,0.0184623230578866,7.29346625917436e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0729918917148101,0.0184077268209468,0.0369127471457544,0.109071036283866,7.36897863913879e-05
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0136850084940103,0.00345739156372511,0.00690852102910911,0.0204614959589115,7.59844068062293e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EFHD1,EF-hand domain-containing protein D1,40482,0.0143673038612367,0.00363617907343611,0.00724039287730192,0.0214942148451715,7.82307492983424e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0120711991663956,0.0030555613771929,0.00608229886709755,0.0180600994656937,7.83688091989242e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PEPD,Xaa-Pro dipeptidase,40532,0.0105013607693202,0.00266358363971471,0.0052807368354794,0.0157219847031611,8.10982258468529e-05
NMR metabolomics,X23412.Phospholipids in VLDL,STX5,Syntaxin-5,40199,0.0163292840209029,0.00414369340295616,0.00820764495110882,0.024450923090697,8.17274597855585e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM2,Neural cell adhesion molecule 2,42611,-0.0107476501492128,0.00273180410596809,-0.0161019861969102,-0.00539331410151533,8.3870946871685e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,42721,0.0332645441387505,0.00845512270406107,0.0166925036387908,0.0498365846387102,8.38748079346257e-05
NMR metabolomics,X23412.Phospholipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.0111321218670705,0.00283798681099705,0.00556966771751624,0.0166945760166247,8.80540274338615e-05
NMR metabolomics,X23412.Phospholipids in VLDL,HSBP1,Heat shock factor-binding protein 1,40223,0.0373942144889874,0.00953275564544772,0.0187100134239099,0.056078415554065,8.80901991166423e-05
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0137701670356772,0.00351186039183017,0.00688692066769006,0.0206534134036643,8.8700183855843e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0118092470699802,0.0030260519173442,0.00587818531198558,0.0177403088279749,9.5669645298423e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0149115767854562,0.00382181437261012,-0.022402332955772,-0.00742082061514034,9.60887093499021e-05
NMR metabolomics,X23412.Phospholipids in VLDL,EBI3_IL27,Interleukin-27,42689,-0.0120949551846512,0.00310107611732126,-0.0181730643746009,-0.00601684599470157,9.65613157220138e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO4,Roundabout homolog 4,40223,-0.00715638480036503,0.00183700650900714,-0.010756917558019,-0.00355585204271104,9.8503013652525e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.0129929541354955,0.00333924449808598,-0.019537873351744,-0.00644803491924697,0.000100408836548526
NMR metabolomics,X23412.Phospholipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0276737772474042,0.00712225371018046,-0.0416333945193579,-0.0137141599754505,0.000102687478330039
NMR metabolomics,X23412.Phospholipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0200563995968084,0.00516564940349524,0.00993172676595776,0.0301810724276591,0.000103929817117891
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB2,Plexin-B2,42743,0.00939334180936504,0.002423365831014,0.00464354478057761,0.0141431388381525,0.000106620465079945
NMR metabolomics,X23412.Phospholipids in VLDL,SBSN,Suprabasin,40511,-0.0136586926631657,0.00352696869327508,-0.0205715513019848,-0.00674583402434653,0.000108267131683938
NMR metabolomics,X23412.Phospholipids in VLDL,PMS1,PMS1 protein homolog 1,40182,0.0202501154410856,0.00524153576579706,0.00997670534012333,0.0305235255420478,0.000112465022355046
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,40470,0.015941870833005,0.00412804967291082,0.00785089347409979,0.0240328481919102,0.00011316485415461
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP7,GTPase IMAP family member 7,40283,-0.012370647400791,0.00320950806072895,-0.0186612831998197,-0.00608001160176224,0.000116680316611891
NMR metabolomics,X23412.Phospholipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0217005265840549,0.00563333584970815,-0.0327418648494829,-0.0106591883186269,0.000117748407044692
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0126282797824111,0.00327982241738918,-0.0190567317204939,-0.00619982784432834,0.000118649380990483
NMR metabolomics,X23412.Phospholipids in VLDL,PROCR,Endothelial protein C receptor,40116,-0.013519679582081,0.0035282831693247,-0.0204351145939574,-0.00660424457020458,0.000127921264967872
NMR metabolomics,X23412.Phospholipids in VLDL,MST1,Hepatocyte growth factor-like protein,40370,0.0252633850191755,0.00659368246507976,0.0123397673876191,0.0381870026507318,0.000128085922885138
NMR metabolomics,X23412.Phospholipids in VLDL,HYAL1,Hyaluronidase-1,42544,-0.00892424565610391,0.00233109320924571,-0.0134931883462255,-0.00435530296598232,0.000129593226477738
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,40283,0.0107531323474617,0.00281323469891069,0.00523919233759677,0.0162670723573267,0.000132915324266521
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,42654,-0.017130170533445,0.00449721238027207,-0.0259447067987782,-0.0083156342681117,0.000140113644303753
NMR metabolomics,X23412.Phospholipids in VLDL,GM2A,Ganglioside GM2 activator,40269,0.0156984269481143,0.00412233824989347,0.00761864397832314,0.0237782099179056,0.000140773718553744
NMR metabolomics,X23412.Phospholipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,42292,0.0215299617519153,0.00565972351923644,0.0104369036542119,0.0326230198496187,0.000142987069242546
NMR metabolomics,X23412.Phospholipids in VLDL,CLIC5,Chloride intracellular channel protein 5,40182,-0.0121140686158426,0.00319007193434483,-0.0183666096071584,-0.00586152762452671,0.00014699221357073
NMR metabolomics,X23412.Phospholipids in VLDL,CENPJ,Centromere protein J,40302,0.0271283757774942,0.00714764741760718,0.0131189868389841,0.0411377647160042,0.000148172654791561
NMR metabolomics,X23412.Phospholipids in VLDL,TCN2,Transcobalamin-2,42771,-0.0117550382500336,0.00309995015458732,-0.0178309405530248,-0.00567913594704248,0.000150080900206745
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.010899299552227,0.00287471771348473,0.00526485283379689,0.016533746270657,0.000150428644590446
NMR metabolomics,X23412.Phospholipids in VLDL,PCDHB15,Protocadherin beta-15,40451,-0.0153764763102602,0.00406026840477517,-0.0233346023836196,-0.0074183502369009,0.000153233584848792
NMR metabolomics,X23412.Phospholipids in VLDL,FMR1,Synaptic functional regulator FMR1,42346,0.0134760509161376,0.00356365792199397,0.00649128138902938,0.0204608204432457,0.000156562210264285
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0147386748440779,0.00390799960102354,0.00707899562607177,0.022398354062084,0.000163029848361258
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D17,TBC1 domain family member 17,42311,0.0171887383860227,0.00455801134690994,0.00825503614607927,0.0261224406259662,0.000163240096115256
NMR metabolomics,X23412.Phospholipids in VLDL,VIM,Vimentin,42357,0.0437588161058975,0.0116468198577621,0.0209310491846838,0.0665865830271112,0.000172603050416694
NMR metabolomics,X23412.Phospholipids in VLDL,ERC2,ERC protein 2,40182,0.0287203388503046,0.00765112309153968,0.0137241375908869,0.0437165401097224,0.000175112228908062
NMR metabolomics,X23412.Phospholipids in VLDL,CD109,CD109 antigen,42611,-0.0126391539300262,0.00338242288230544,-0.0192687027793449,-0.00600960508070757,0.000187212469170397
NMR metabolomics,X23412.Phospholipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.0154212520879894,0.0041355959164054,0.00731548409183478,0.0235270200841439,0.000193092853402434
NMR metabolomics,X23412.Phospholipids in VLDL,MILR1,Allergin-1,42370,-0.0192942062845335,0.00518142930915081,-0.029449807730469,-0.00913860483859787,0.000197124746828082
NMR metabolomics,X23412.Phospholipids in VLDL,EXTL1,Exostosin-like 1,40116,0.0177662102772511,0.00478034249765418,0.00839673898184894,0.0271356815726533,0.000202998994487383
NMR metabolomics,X23412.Phospholipids in VLDL,DGCR6,Protein DGCR6,40136,0.0166092753476872,0.00447153457648232,0.0078450675777818,0.0253734831175925,0.0002046619717611
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,42676,0.0103784355648903,0.00279496657223808,0.00490030108330368,0.0158565700464769,0.000205431773937811
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,40136,0.0166456177626127,0.00448364868701178,0.00785766633606964,0.0254335691891558,0.000206227713858752
NMR metabolomics,X23412.Phospholipids in VLDL,MB,Myoglobin,42794,-0.0197749601384778,0.00533558297767882,-0.0302327027747283,-0.00931721750222735,0.000211192111326178
NMR metabolomics,X23412.Phospholipids in VLDL,SATB1,DNA-binding protein SATB1,40482,0.0109325785742134,0.00295072217514049,0.00514916311093805,0.0167159940374888,0.000212356788681978
NMR metabolomics,X23412.Phospholipids in VLDL,KEL,Kell blood group glycoprotein,42311,0.0135015846931009,0.00364699351939125,0.00635347739509408,0.0206496919911078,0.000214686602513939
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0146937023347892,0.00398024073694781,0.00689243049037148,0.0224949741792069,0.000223696670399902
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0137550017991767,0.00373098108778906,0.00644227886711013,0.0210677247312432,0.000228094422418494
NMR metabolomics,X23412.Phospholipids in VLDL,NDRG1,Protein NDRG1,42311,0.0241478975516824,0.00655094243650781,0.0113080503761271,0.0369877447272377,0.000228570482530199
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0124108256593232,0.00337878620955607,0.00578840468859325,0.0190332466300531,0.00024070443241688
NMR metabolomics,X23412.Phospholipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.02010896424465,0.00547818238452885,0.00937172677097346,0.0308462017183265,0.000242967678923379
NMR metabolomics,X23412.Phospholipids in VLDL,PREB,Prolactin regulatory element-binding protein,42370,0.0108664932965823,0.00296535943884463,0.00505438879644677,0.0166785977967177,0.000248816549393229
NMR metabolomics,X23412.Phospholipids in VLDL,CCL28,C-C motif chemokine 28,42538,0.0214991654803997,0.00590366845976827,0.00992797529925394,0.0330703556615456,0.000271908841954821
NMR metabolomics,X23412.Phospholipids in VLDL,YY1,Transcriptional repressor protein YY1,40199,0.0103414036371098,0.00284676192554817,0.00476175026303535,0.0159210570111842,0.000281757669263241
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0151330308768031,0.00417203919391609,0.00695583405672755,0.0233102276968786,0.000287506680526473
NMR metabolomics,X23412.Phospholipids in VLDL,TK1,"Thymidine kinase, cytosolic",40302,0.0165326133490874,0.00457877473069291,0.00755821487692933,0.0255070118212455,0.000306708720193404
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR1,Interferon gamma receptor 1,42676,0.00790821089318737,0.00220004448617954,0.00359612370027548,0.0122202980860993,0.000326088805854511
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3,Granulocyte colony-stimulating factor,42370,0.0176600874950168,0.00491409250184591,0.00802846619139878,0.0272917087986347,0.000327124340368927
NMR metabolomics,X23412.Phospholipids in VLDL,PADI4,Protein-arginine deiminase type-4,42292,0.0259398894321337,0.00722582250332677,0.0117772773256133,0.0401025015386542,0.000332029852425884
NMR metabolomics,X23412.Phospholipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0127206355123066,0.00354357526741977,0.00577522798816386,0.0196660430364493,0.000332147146128834
NMR metabolomics,X23412.Phospholipids in VLDL,KLK11,Kallikrein-11,42543,0.0117888418511765,0.00328923411500606,0.00534194298576459,0.0182357407165883,0.000339488441288924
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA11,Integrin alpha-11,42594,-0.0121719074716178,0.00341226555422661,-0.0188599479579019,-0.00548386698533362,0.000362206736098027
NMR metabolomics,X23412.Phospholipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0203281344765146,0.0057185729734801,0.00911973144849359,0.0315365375045356,0.000379654100407044
NMR metabolomics,X23412.Phospholipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,42679,0.015604992934605,0.00439445266318553,0.00699186571476139,0.0242181201544487,0.00038498131862712
NMR metabolomics,X23412.Phospholipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0120941739112132,0.0034091121917585,-0.0187760338070598,-0.00541231401536652,0.00039008408527733
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,40511,-0.00994905752755793,0.00280832572985569,-0.0154533759580751,-0.00444473909704078,0.000397646524196973
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,42594,0.0221135056813196,0.0062557162575448,0.00985230181653176,0.0343747095461074,0.000409261842785909
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB2A2,Mammaglobin-A,40116,-0.0112953099534237,0.00321086675400452,-0.0175886087912725,-0.00500201111557482,0.000436845423026366
NMR metabolomics,X23412.Phospholipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,40482,0.0114949334600771,0.00327685305316491,0.0050723014758739,0.0179175654442804,0.000453384401986743
NMR metabolomics,X23412.Phospholipids in VLDL,COMP,Cartilage oligomeric matrix protein,42511,0.0118332133536677,0.00338317288346994,0.00520219450206658,0.0184642322052687,0.000470876776266092
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH12,Protocadherin-12,40482,0.00907257869592529,0.00259914891741111,0.00397824681779952,0.0141669105740511,0.0004837851377606
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.0109248939181508,0.0031358418053312,0.00477864397970164,0.0170711438565999,0.000496124729476036
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0123540240419117,0.00354830306158265,0.00539935004120966,0.0193086980426136,0.00049988299740204
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0152824460306725,0.00440625543230908,0.00664618538334669,0.0239187066779983,0.000525388455442016
NMR metabolomics,X23412.Phospholipids in VLDL,AMPD3,AMP deaminase 3,40483,0.0246894878809909,0.00712827092866909,0.0107180768607995,0.0386608989011823,0.00053497332473259
NMR metabolomics,X23412.Phospholipids in VLDL,NRTN,Neurturin,42370,0.0171188229523044,0.00495169145764684,0.00741350769531657,0.0268241382092922,0.000547609815259703
NMR metabolomics,X23412.Phospholipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,42315,0.010101985155985,0.00292893167622456,0.00436127907058489,0.0158426912413852,0.000564363120790253
NMR metabolomics,X23412.Phospholipids in VLDL,CASP1,Caspase-1,42311,0.0239412376011016,0.00695108935424899,0.0103171024667735,0.0375653727354296,0.000574452050758523
NMR metabolomics,X23412.Phospholipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0131288355465423,0.00381468350629777,-0.0206056152188859,-0.0056520558741987,0.000579925305830391
NMR metabolomics,X23412.Phospholipids in VLDL,REG1B,Lithostathine-1-beta,42794,-0.020210712167941,0.00588724838215606,-0.0317497189969669,-0.00867170533891512,0.000598799446616474
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL14,C-X-C motif chemokine 14,42370,0.0194510712955959,0.00568045271181912,0.00831738398043042,0.0305847586107614,0.000618463950727029
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM25,Transmembrane protein 25,40482,-0.0157278854941868,0.00459628138249852,-0.0247365970038839,-0.00671917398448966,0.000624121850303056
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR3,Small proline-rich protein 3,40483,0.0241489798054741,0.00705786163391111,0.0103155710030084,0.0379823886079399,0.000624809998591069
NMR metabolomics,X23412.Phospholipids in VLDL,INHBB,Inhibin beta B chain,40283,0.018795699052365,0.0055014603972593,0.00801283667373681,0.0295785614309933,0.000636610293312894
NMR metabolomics,X23412.Phospholipids in VLDL,CBS,Cystathionine beta-synthase,40223,0.0176880281960632,0.00517729302894708,0.00754053385932696,0.0278355225327995,0.000636692811832251
NMR metabolomics,X23412.Phospholipids in VLDL,CPA2,Carboxypeptidase A2,42670,0.0225830656096092,0.00663295366345545,0.00958247642923655,0.0355836547899819,0.000664354072071703
NMR metabolomics,X23412.Phospholipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0204834654878933,0.00602411222559044,0.00867620552573603,0.0322907254500505,0.000675238711151167
NMR metabolomics,X23412.Phospholipids in VLDL,NGF,Beta-nerve growth factor,42495,0.00410219395105686,0.00120807099406877,0.00173437480268207,0.00647001309943164,0.000686644583828226
NMR metabolomics,X23412.Phospholipids in VLDL,IL18BP,Interleukin-18-binding protein,42689,0.0110155988660602,0.00324802904837963,0.00464946193123608,0.0173817358008842,0.000697177630012154
NMR metabolomics,X23412.Phospholipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0126457233323538,0.00372945585188927,-0.0199554568020568,-0.00533598986265087,0.00069935108909795
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00875756234767609,0.00258772679618061,-0.0138295068681901,-0.0036856178271621,0.000716167730452296
NMR metabolomics,X23412.Phospholipids in VLDL,CDH15,Cadherin-15,42692,0.0211980965743895,0.00626873499417832,0.00891137598579994,0.033484817162979,0.00072280276211743
NMR metabolomics,X23412.Phospholipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0282402710918411,0.00836076287835623,0.0118531758502629,0.0446273663334194,0.000732989633336469
NMR metabolomics,X23412.Phospholipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.00985297586602113,0.00291969935125376,0.00413036513756377,0.0155755865944785,0.000741665753118515
NMR metabolomics,X23412.Phospholipids in VLDL,SPESP1,Sperm equatorial segment protein 1,40511,0.0107972492138273,0.00320339406818418,0.00451859684018626,0.0170759015874683,0.000752649347672551
NMR metabolomics,X23412.Phospholipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0220150151551336,0.00653364653888967,0.00920906793890981,0.0348209623713573,0.0007556725892381
NMR metabolomics,X23412.Phospholipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0139207560545343,0.00413711984773469,0.00581200115297436,0.0220295109560943,0.000768415332052312
NMR metabolomics,X23412.Phospholipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00786596514882178,0.00234129872754981,0.00327701964282415,0.0124549106548194,0.000782545831801117
NMR metabolomics,X23412.Phospholipids in VLDL,TLR4,Toll-like receptor 4,40199,0.00993335068583073,0.00295929319014322,0.00413313603315002,0.0157335653385114,0.000791562821275856
NMR metabolomics,X23412.Phospholipids in VLDL,SDC1,Syndecan-1,42636,0.01365822391457,0.00408660241347776,0.00564848318415361,0.0216679646449864,0.000833452494790339
NMR metabolomics,X23412.Phospholipids in VLDL,EP300,Histone acetyltransferase p300,40199,0.0104307978975487,0.00312627132434477,0.00430330610183297,0.0165582896932645,0.000851219990918887
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0146705773351886,0.00440193911843093,-0.0232983780073133,-0.00604277666306402,0.000862240392570593
NMR metabolomics,X23412.Phospholipids in VLDL,RNASET2,Ribonuclease T2,42749,0.00925211252429427,0.0027784192171511,0.00380641085867812,0.0146978141899104,0.000870803830862039
NMR metabolomics,X23412.Phospholipids in VLDL,UROS,Uroporphyrinogen-III synthase,40182,0.0227723190061608,0.00684091357966264,0.00936412839002197,0.0361805096222995,0.000874947058856382
NMR metabolomics,X23412.Phospholipids in VLDL,LXN,Latexin,42461,-0.0226603672290134,0.00681401275137327,-0.036015832221705,-0.00930490223632174,0.000884824258077018
NMR metabolomics,X23412.Phospholipids in VLDL,CST1,Cystatin-SN,39042,0.0369813361576663,0.0111305474240084,0.0151654632066099,0.0587972091087228,0.000895370800608148
NMR metabolomics,X23412.Phospholipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0281566555139359,0.00847793435666492,0.0115399041748727,0.0447734068529991,0.000899334033987463
NMR metabolomics,X23412.Phospholipids in VLDL,MELTF,Melanotransferrin,40511,0.0100832504650681,0.00304390920021793,0.00411718843264097,0.0160493124974953,0.000927232291281057
NMR metabolomics,X23412.Phospholipids in VLDL,SPON1,Spondin-1,42638,0.0112763411327651,0.00340521079434708,0.00460212797584487,0.0179505542896854,0.000930432294662338
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L15,Bcl-2-like protein 15,40199,0.0187529640936469,0.00567777756669511,0.00762452006292444,0.0298814081243693,0.000960057937075072
NMR metabolomics,X23412.Phospholipids in VLDL,SOX9,Transcription factor SOX-9,40182,0.00920600005680595,0.00279338160327523,0.00373097211438651,0.0146810279992254,0.000985064035324086
NMR metabolomics,X23412.Phospholipids in VLDL,IL34,Interleukin-34,42292,0.0121190128947768,0.00367851243964304,0.00490912851307645,0.0193288972764772,0.000988439658659202
NMR metabolomics,X23412.Phospholipids in VLDL,IL17C,Interleukin-17C,42370,-0.024765297189347,0.00751708646242763,-0.0394987866557052,-0.0100318077229889,0.000988451349913452
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK2,Protein AHNAK2,40223,0.0100321028636397,0.0030500551793377,0.00405399471213777,0.0160102110151416,0.00100803735683806
NMR metabolomics,X23412.Phospholipids in VLDL,CTSB,Cathepsin B,42659,0.0177411618783139,0.00539684520855994,0.00716334526953638,0.0283189784870913,0.0010140455736362
NMR metabolomics,X23412.Phospholipids in VLDL,GUK1,Guanylate kinase,40116,-0.0127246859582317,0.00388096127564365,-0.0203313700584932,-0.00511800185797011,0.0010459557744377
NMR metabolomics,X23412.Phospholipids in VLDL,TSC1,Hamartin,40199,0.0242908650349073,0.00741257180090127,0.00976222430514082,0.0388195057646738,0.00105248052069211
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO3,R-spondin-3,42721,0.0097747354234039,0.00298902831509623,0.00391623992581528,0.0156332309209925,0.00107738293867122
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,40199,0.0210358292020308,0.00644566970885612,0.00840231657267278,0.0336693418313888,0.00110357609028308
NMR metabolomics,X23412.Phospholipids in VLDL,AGT,Angiotensinogen,40532,0.0078435944364943,0.00240756407635888,0.00312476884683089,0.0125624200261577,0.00112571620463965
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,42721,0.019426940565143,0.00597123436522209,0.00772332120930772,0.0311305599209783,0.00114304089140625
NMR metabolomics,X23412.Phospholipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0231999014817234,0.00717203134520146,0.00914272004512849,0.0372570829183182,0.00122031609412344
NMR metabolomics,X23412.Phospholipids in VLDL,COL1A1,Collagen alpha-1(I) chain,42794,-0.00814734918436884,0.00252069145496179,-0.013087904436094,-0.00320679393264372,0.00123138726749903
NMR metabolomics,X23412.Phospholipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,42587,-0.013341614464651,0.00412820128953382,-0.0214328889921373,-0.00525033993716471,0.00123300758845369
NMR metabolomics,X23412.Phospholipids in VLDL,FABP9,Fatty acid-binding protein 9,42594,0.0184310419620048,0.00571157907042738,0.00723634698396712,0.0296257369400425,0.00125413239884436
NMR metabolomics,X23412.Phospholipids in VLDL,TFF3,Trefoil factor 3,42613,-0.013880106168495,0.00432966037983654,-0.0223662405129746,-0.00539397182401534,0.00134994258468993
NMR metabolomics,X23412.Phospholipids in VLDL,MSLN,Mesothelin,42553,0.0191852181843843,0.00599284835751604,0.00743923540365282,0.0309312009651157,0.00137104394612701
NMR metabolomics,X23412.Phospholipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.00758100630204393,0.00237395707011707,0.00292805044461447,0.0122339621594734,0.00140933133137315
NMR metabolomics,X23412.Phospholipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0190414255670844,0.00596320881953999,0.00735353628078603,0.0307293148533828,0.0014112986596465
NMR metabolomics,X23412.Phospholipids in VLDL,KIF20B,Kinesin-like protein KIF20B,40136,0.0252217244829498,0.00790061302662471,0.00973652295076538,0.0407069260151342,0.001415068380518
NMR metabolomics,X23412.Phospholipids in VLDL,SAFB2,Scaffold attachment factor B2,40482,0.00883343269719498,0.00276791420295224,0.00340832085940859,0.0142585445349814,0.00141988615028008
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,40116,0.0141655309026865,0.00444912208323198,0.00544525161955186,0.0228858101858212,0.00145716217760218
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD1,Leiomodin-1,40482,-0.0114647428634555,0.00360187208509893,-0.0185244121502494,-0.00440507357666155,0.00146155187907549
NMR metabolomics,X23412.Phospholipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.022576243259675,0.00709469008805804,-0.0364818358322687,-0.00867065068708123,0.00146529413459231
NMR metabolomics,X23412.Phospholipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",40116,0.0181239026534498,0.00570160758544748,0.00694875178597272,0.0292990535209268,0.00148331592931189
NMR metabolomics,X23412.Phospholipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.0125648017013668,0.00396093545297112,0.00480136821354342,0.0203282351891902,0.00151640339794491
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR2,TGF-beta receptor type-2,42679,0.0114335702705714,0.00360438035239406,0.00436898477987909,0.0184981557612638,0.00151663426817328
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN4,Contactin-4,42611,-0.00766911217236875,0.00241844883480919,-0.0124092718885948,-0.00292895245614273,0.00152211295137604
NMR metabolomics,X23412.Phospholipids in VLDL,CST6,Cystatin-M,42332,0.0161639641350729,0.00509766748482729,0.00617253586481146,0.0261553924053344,0.00152340222567847
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2,Apoptosis regulator Bcl-2,40449,0.0182560904041147,0.00576408428723246,0.00695848520113908,0.0295536956070903,0.0015431789992124
NMR metabolomics,X23412.Phospholipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0179767864843475,0.00569675164879601,0.00681115325270736,0.0291424197159877,0.00160518186782059
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL6,Fc receptor-like protein 6,42594,0.022212628291337,0.00704852399294017,0.00839752126517427,0.0360277353174997,0.0016285474438381
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0227746634917935,0.00722952426618278,-0.0369445310535118,-0.00860479593007529,0.00163566877700826
NMR metabolomics,X23412.Phospholipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0213179282469171,0.00681117304535695,0.00796802907801752,0.0346678274158168,0.00175350570469005
NMR metabolomics,X23412.Phospholipids in VLDL,B2M,Beta-2-microglobulin,40539,0.00989718105572969,0.00316580053869877,0.00369221199988009,0.0161021501115793,0.00177479652300337
NMR metabolomics,X23412.Phospholipids in VLDL,SULT1A1,Sulfotransferase 1A1,42711,-0.0398670853525086,0.0128087688642851,-0.0649722723265075,-0.0147618983785097,0.00185907119084726
NMR metabolomics,X23412.Phospholipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0179939808965024,0.00578197842690891,0.00666130317976098,0.0293266586132439,0.0018624528907938
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL3,Follistatin-related protein 3,42574,0.0105497490115107,0.00340002856614903,0.00388569302185859,0.0172138050011628,0.001920716658844
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0164481565009728,0.00530497677135303,0.00605040202912084,0.0268459109728247,0.00193668311933759
NMR metabolomics,X23412.Phospholipids in VLDL,CPA4,Carboxypeptidase A4,40060,0.0138047627222456,0.00445922797607003,0.00506467588914836,0.0225448495553429,0.00196799189341285
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0224993923491891,0.00730100408194253,0.00818942434858178,0.0368093603497965,0.00206328430531885
NMR metabolomics,X23412.Phospholipids in VLDL,CCL15,C-C motif chemokine 15,42794,0.0138270478270248,0.00449329565763709,0.00502018833805607,0.0226339073159935,0.00209326938621752
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,40223,0.017270731878794,0.00561908860604571,0.0062573182109444,0.0282841455466436,0.00212021559116175
NMR metabolomics,X23412.Phospholipids in VLDL,SLC51B,Organic solute transporter subunit beta,40116,-0.0238602914473961,0.00778340310063313,-0.039115761524637,-0.00860482137015518,0.00217811712540438
NMR metabolomics,X23412.Phospholipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0196509783449022,0.00641597403563294,-0.0322262874547428,-0.00707566923506163,0.00219787604664283
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAC1,Cartilage acidic protein 1,42794,0.0091965000579048,0.00300319549892125,0.00331023688001916,0.0150827632357905,0.00220117519177882
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF8,SLAM family member 8,42346,0.0170235241216076,0.00556526155253089,0.00611561147864708,0.0279314367645682,0.00222605342314676
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0100398215931649,0.00328268574902824,-0.0164738856612603,-0.00360575752506958,0.00223040289385171
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0178455763483883,0.00583773977554437,0.00640360638832133,0.0292875463084553,0.00224062493150895
NMR metabolomics,X23412.Phospholipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0127368013117191,0.00416691668633684,-0.0209039580169393,-0.0045696446064989,0.00224267141744706
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN10,Ataxin-10,42311,0.022173736601181,0.00726164768675987,0.00794090713513163,0.0364065660672303,0.00226611199924066
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0329380678747649,0.0107918748722793,0.0117859931250975,0.0540901426244323,0.00227681520349963
NMR metabolomics,X23412.Phospholipids in VLDL,MMP13,Collagenase 3,42311,-0.0101970756218528,0.00335589276645515,-0.0167746254441049,-0.00361952579960068,0.00238180945626999
NMR metabolomics,X23412.Phospholipids in VLDL,ULBP2,UL16-binding protein 2,42495,0.0122136329543264,0.00402229720227864,0.00432993043786022,0.0200973354707925,0.00239819767892547
NMR metabolomics,X23412.Phospholipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0113350369294368,0.00373344987593085,0.00401747517261231,0.0186525986862612,0.00240238417612205
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00658122415238099,0.00216939955261167,0.00232920102926213,0.0108332472754999,0.00242156161265038
NMR metabolomics,X23412.Phospholipids in VLDL,NMI,N-myc-interactor,40421,0.0219535089237533,0.00724857165267496,0.0077463084845104,0.0361607093629962,0.00246193479671999
NMR metabolomics,X23412.Phospholipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0124856428315227,0.00413129688978482,0.00438830092754448,0.020582984735501,0.00251501404345798
NMR metabolomics,X23412.Phospholipids in VLDL,CA9,Carbonic anhydrase 9,42721,-0.0147102331689887,0.00487387778563708,-0.0242630336288374,-0.00515743270914003,0.00254772526269355
NMR metabolomics,X23412.Phospholipids in VLDL,CD99,CD99 antigen,42611,-0.00612884560380315,0.00203187607897307,-0.0101113227185904,-0.00214636848901594,0.00256318517035132
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL9,C-X-C motif chemokine 9,42676,0.0203706824665083,0.00680393480294756,0.00703497025273108,0.0337063946802855,0.00275885028252409
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.00980409975587655,0.00327831972997201,-0.0162296064266217,-0.00337859308513142,0.00279061780749491
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0181872686654151,0.00608336011685423,0.00626388283638078,0.0301106544944494,0.00279781883226557
NMR metabolomics,X23412.Phospholipids in VLDL,MKI67,Proliferation marker protein Ki-67,40199,0.0116792976844921,0.00391067041723017,0.00401438366672095,0.0193442117022632,0.00282793267052875
NMR metabolomics,X23412.Phospholipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,42676,0.00868761136834341,0.00290987581441908,0.00298425477208202,0.0143909679646048,0.00283566991261241
NMR metabolomics,X23412.Phospholipids in VLDL,NTF4,Neurotrophin-4,42346,0.0117211835746107,0.00392663758692986,0.00402497390422815,0.0194173932449932,0.00284059604899969
NMR metabolomics,X23412.Phospholipids in VLDL,SLC12A2,Solute carrier family 12 member 2,40116,-0.00820529067069552,0.00275164359697162,-0.0135985121207599,-0.00281206922063115,0.00287041593280868
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0063951813621478,0.00215054982585793,-0.0106102590208293,-0.00218010370346627,0.00294725083473104
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,40302,0.0212265814665579,0.00714382100448957,0.00722469229775838,0.0352284706353575,0.00297157235312791
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00900498467177581,0.00303430000710794,0.00305775665784424,0.0149522126857074,0.00300653911443003
NMR metabolomics,X23412.Phospholipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.0105613313896247,0.0035645576257768,0.00357479844310221,0.0175478643361472,0.00305434368971422
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00865050762587991,0.00292333366968181,-0.0143802416184563,-0.00292077363330356,0.00309165543840929
NMR metabolomics,X23412.Phospholipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0196657540230045,0.00665541251922088,0.0066211454853316,0.0327103625606774,0.0031336427762161
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.0112254874182145,0.00380582515538224,0.00376607011366531,0.0186849047227637,0.00318897439744892
NMR metabolomics,X23412.Phospholipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0106610218763357,0.00361762623840392,-0.0177515693036074,-0.00357047444906404,0.00321457316467843
NMR metabolomics,X23412.Phospholipids in VLDL,APOF,Apolipoprotein F,40532,-0.00706608674281102,0.00239847808987593,-0.0117671037989679,-0.00236506968665419,0.00322493104290572
NMR metabolomics,X23412.Phospholipids in VLDL,CTRC,Chymotrypsin-C,42626,0.019589747552861,0.00664975757069372,0.00655622271430127,0.0326232723914207,0.00322533640958379
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,40502,0.00451447336068902,0.00153305367465616,0.00150968815836295,0.00751925856301509,0.00323864520813417
NMR metabolomics,X23412.Phospholipids in VLDL,NME1,Nucleoside diphosphate kinase A,40199,-0.00653220108150359,0.00222318221465778,-0.0108896382222328,-0.00217476394077434,0.00330786457816736
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0246686454721567,0.00840865476730135,0.00818768212824605,0.0411496088160673,0.00335616504310468
NMR metabolomics,X23412.Phospholipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.010996059042255,0.00375133628582426,-0.0183486781624706,-0.00364343992203949,0.00338309799054533
NMR metabolomics,X23412.Phospholipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0125513156970237,0.00428615270663514,-0.0209521750020286,-0.00415045639201885,0.00341482545873199
NMR metabolomics,X23412.Phospholipids in VLDL,TTN,Titin,40116,-0.0194138800244164,0.00663030257955772,-0.0324092730803496,-0.0064184869684833,0.00341795737381683
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0142624951130556,0.00487635810720542,0.00470483322293297,0.0238201570031782,0.00345354270582717
NMR metabolomics,X23412.Phospholipids in VLDL,CEP112,Centrosomal protein of 112 kDa,40116,0.0132298654831103,0.0045320493588591,0.00434704873974644,0.0221126822264741,0.00351670788503562
NMR metabolomics,X23412.Phospholipids in VLDL,APOH,Beta-2-glycoprotein 1,42611,-0.01067525073333,0.00366276537454437,-0.0178542708674369,-0.00349623059922301,0.00356809785950981
NMR metabolomics,X23412.Phospholipids in VLDL,UNG,Uracil-DNA glycosylase,40451,0.0100216595998723,0.00343951967625308,0.00328020103441623,0.0167631181653283,0.00357898759901557
NMR metabolomics,X23412.Phospholipids in VLDL,CEP152,Centrosomal protein of 152 kDa,40080,0.0122431932922783,0.00420746938406254,0.00399655329951572,0.0204898332850409,0.0036231019948347
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0205450374016819,0.00706431010824502,0.00669898958952163,0.0343910852138421,0.0036400317994875
NMR metabolomics,X23412.Phospholipids in VLDL,GSTP1,Glutathione S-transferase P,42237,-0.0205140474564175,0.00705710781886613,-0.0343459787813951,-0.00668211613143988,0.00365687458760708
NMR metabolomics,X23412.Phospholipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00578684502689528,0.00199459069793626,-0.00969624279485034,-0.00187744725894021,0.00372368659665604
NMR metabolomics,X23412.Phospholipids in VLDL,CLC,Galectin-10,42611,-0.019191438474722,0.00661940081174021,-0.0321654640657328,-0.0062174128837112,0.00374637608094045
NMR metabolomics,X23412.Phospholipids in VLDL,PLAU,Urokinase-type plasminogen activator,42611,0.00858355373991439,0.00296375454053716,0.00277459484046155,0.0143925126393672,0.00378350994926585
NMR metabolomics,X23412.Phospholipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.0153214729392051,0.0052905611858158,-0.025690972863404,-0.00495197301500611,0.00378560936896505
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.0082930745568452,0.00286354924265397,0.00268051804124342,0.013905631072447,0.00378576662789187
NMR metabolomics,X23412.Phospholipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0434142484379233,0.0150194531628228,0.0139761202387906,0.072852376637056,0.00385218125757819
NMR metabolomics,X23412.Phospholipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0116636047638527,0.00403889493637504,-0.0195798388391478,-0.00374737068855762,0.00388682522387255
NMR metabolomics,X23412.Phospholipids in VLDL,TNC,Tenascin,42689,-0.0140125577323308,0.00485427970402119,-0.0235269459522123,-0.00449816951244928,0.00389997347649815
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB7,Integrin beta-7,42721,0.0133618001571548,0.0046337637455343,0.00427962321590755,0.022443977098402,0.00393810379925227
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0153452791267367,0.0053246696266456,0.00490892665851129,0.0257816315949621,0.00395899773517908
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0122402895132602,0.00424790928478893,0.0039143873150739,0.0205661917114465,0.00396429851104508
NMR metabolomics,X23412.Phospholipids in VLDL,NPTXR,Neuronal pentraxin receptor,42636,0.00981596852840138,0.00341592847751342,0.00312074871247508,0.0165111883443277,0.00406474890448382
NMR metabolomics,X23412.Phospholipids in VLDL,BOC,Brother of CDO,42357,-0.00675313424991323,0.00235563022858213,-0.0113701694979342,-0.00213609900189226,0.00415295280480581
NMR metabolomics,X23412.Phospholipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00943227203921098,0.00329046751074266,0.00298295571815537,0.0158815883602666,0.00415772884987025
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA6C,Semaphorin-6C,40199,0.00759649607358606,0.00265088362990925,0.00240076415896392,0.0127922279882082,0.00416946953534547
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00754625657189962,0.00263355005911831,-0.0127080146877715,-0.00238449845602773,0.00417210808998966
NMR metabolomics,X23412.Phospholipids in VLDL,CCL25,C-C motif chemokine 25,42754,0.0137331132211821,0.00481551115500071,0.00429471135738071,0.0231715150849835,0.00435313538682014
NMR metabolomics,X23412.Phospholipids in VLDL,TMOD4,Tropomodulin-4,40080,-0.0118407401843876,0.00416504335050128,-0.0200042251513701,-0.00367725521740505,0.00447903760381909
NMR metabolomics,X23412.Phospholipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.00854515796965686,0.00301240717839109,0.00264083990001033,0.0144494760393034,0.00456586044171891
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB2,Lamin-B2,40483,0.00818695386768483,0.00288758565058233,0.00252728599254347,0.0138466217428262,0.0045874866584295
NMR metabolomics,X23412.Phospholipids in VLDL,PRKCQ,Protein kinase C theta type,42370,0.0124976861300606,0.00440947392180457,0.00385511724332362,0.0211402550167975,0.00459988419096236
NMR metabolomics,X23412.Phospholipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.017574885641457,0.00621299515681094,-0.0297523561488065,-0.00539741513410756,0.00468176090209902
NMR metabolomics,X23412.Phospholipids in VLDL,NINJ1,Ninjurin-1,42346,0.015312958403193,0.0054300439856392,0.00467007219134019,0.0259558446150459,0.00480890291975983
NMR metabolomics,X23412.Phospholipids in VLDL,CTSF,Cathepsin F,42679,0.0112056038194286,0.00397721016039735,0.00341027190504975,0.0190009357338074,0.00484765537138069
NMR metabolomics,X23412.Phospholipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0185211728468588,0.00657619927293823,0.00563182227189988,0.0314105234218177,0.00486515928670286
NMR metabolomics,X23412.Phospholipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.0107668403372606,0.00383116016720924,-0.0182759142649907,-0.00325776640953047,0.00495779859845981
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G1B,Phospholipase A2,42782,-0.0128780719759188,0.00458481988437142,-0.0218643189492868,-0.00389182500255082,0.00497897539612312
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.0105124744901289,0.00374266505954981,0.00317685097341125,0.0178480980068465,0.00498108038215755
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN7,Septin-7,40302,0.0154209902149176,0.005491394430027,0.00465785713206469,0.0261841232977705,0.00499046100991294
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN2,Neuroligin-2,40136,-0.0136204931945083,0.00485380056818425,-0.0231339423081494,-0.00410704408086716,0.0050225896216701
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE6,Ribonuclease K6,40468,0.00960423998132628,0.00342916713874832,0.00288307238937956,0.016325407573273,0.00510708031304993
NMR metabolomics,X23412.Phospholipids in VLDL,CAPS,Calcyphosin,40483,0.0291514974746395,0.0104352678773481,0.00869837243503719,0.0496046225142419,0.00522199478164554
NMR metabolomics,X23412.Phospholipids in VLDL,CEP164,Centrosomal protein of 164 kDa,42370,0.0185543780810373,0.00664355054862043,0.00553301900574123,0.0315757371563333,0.0052322762978508
NMR metabolomics,X23412.Phospholipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0151980007606558,0.00544953849923008,0.00451690530216482,0.0258790962191467,0.00529824710555592
NMR metabolomics,X23412.Phospholipids in VLDL,CX3CL1,Fractalkine,42495,-0.009638542510733,0.00346477130338017,-0.0164294942653581,-0.00284759075610787,0.00541228396041082
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0140084852781202,0.00503840858559661,0.0041332044503508,0.0238837661058895,0.00543923195259818
NMR metabolomics,X23412.Phospholipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.0099143355202484,0.00357999908662808,0.00289753731045737,0.0169311337300394,0.00562591961738698
NMR metabolomics,X23412.Phospholipids in VLDL,SHISA5,Protein shisa-5,40527,0.0077615684035683,0.00280546624921558,0.00226285455510576,0.0132602822520308,0.0056738141322175
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.0108516009130331,0.00392557072019101,-0.0185457195246075,-0.00315748230145874,0.00571342019735269
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.014170084255613,0.00514614126356417,0.00408364737902719,0.0242565211321987,0.0059049894093423
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B4,Protein ATP1B4,40080,-0.0117342131679996,0.0042686226617268,-0.0201007135849842,-0.00336771275101511,0.00598858033480959
NMR metabolomics,X23412.Phospholipids in VLDL,CHI3L1,Chitinase-3-like protein 1,42416,0.0227467512343189,0.00828100524947662,0.00651598094534468,0.038977521523293,0.00602504952635036
NMR metabolomics,X23412.Phospholipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,40116,0.0111541153515442,0.00406750932412936,0.00318179707625069,0.0191264336268378,0.00611198246320776
NMR metabolomics,X23412.Phospholipids in VLDL,BLVRB,Flavin reductase,42611,0.0180988523092972,0.00660704581174753,0.00514904251827201,0.0310486621003223,0.00616466095046688
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN5,Contactin-5,42640,0.0104717012007794,0.00383142994206779,0.0029620985143265,0.0179813038872322,0.00628222987261714
NMR metabolomics,X23412.Phospholipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.0093270332096126,0.00341341036927254,0.00263674888583842,0.0160173175333868,0.00629596532981379
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC4,MANSC domain-containing protein 4,40116,0.0197023913061411,0.00723288801368733,0.00552593079931391,0.0338788518129682,0.00645989522477291
NMR metabolomics,X23412.Phospholipids in VLDL,IL25,Interleukin-25,40036,0.00961224803018405,0.00352960932940621,0.00269421374454788,0.0165302823158202,0.00647332885126044
NMR metabolomics,X23412.Phospholipids in VLDL,BRD3,Bromodomain-containing protein 3,40116,0.0136536508843376,0.00502405528026236,0.00380650253502333,0.0235007992336518,0.00658499552150902
NMR metabolomics,X23412.Phospholipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0138557123287373,0.00511128782960229,0.00383758818271685,0.0238738364747578,0.00672071137441456
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0175579798000082,0.00648479055437159,0.00484779031343985,0.0302681692865765,0.00678840120865376
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0122074437261909,0.00451719864171119,0.00335373438843701,0.0210611530639449,0.00689396557139497
NMR metabolomics,X23412.Phospholipids in VLDL,CD7,T-cell antigen CD7,40166,0.0121875229888839,0.00451270569540265,0.00334261982589467,0.021032426151873,0.00692972176001716
NMR metabolomics,X23412.Phospholipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,40199,0.0276084281783773,0.0102615503881442,0.00749578941761469,0.04772106693914,0.0071458439866335
NMR metabolomics,X23412.Phospholipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0102236092557795,0.00382343170282268,0.00272968311824703,0.0177175353933119,0.00750750616790846
NMR metabolomics,X23412.Phospholipids in VLDL,CALB1,Calbindin,42587,0.0122547804051545,0.00458699037679579,0.00326427926663474,0.0212452815436742,0.00755732009806646
NMR metabolomics,X23412.Phospholipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0330001483572456,0.0123539488845312,0.00878640854356432,0.0572138881709268,0.00756685311424606
NMR metabolomics,X23412.Phospholipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.0065109085036627,0.00245738104543366,0.00169444165461273,0.0113273753527127,0.00807186400695545
NMR metabolomics,X23412.Phospholipids in VLDL,LHB,Lutropin subunit beta,42346,0.0224122942971709,0.00847580557327012,0.00579971537356146,0.0390248732207803,0.00819652061978073
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0138847786089396,0.00525543330808692,0.00358412932508923,0.0241854278927899,0.00825355609823797
NMR metabolomics,X23412.Phospholipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0144093180411803,0.00545557968582519,-0.0251022542253977,-0.00371638185696296,0.00827285091022337
NMR metabolomics,X23412.Phospholipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0193700413846305,0.00733813115301438,0.00498730432472227,0.0337527784445386,0.00830893771086404
NMR metabolomics,X23412.Phospholipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00775443674565473,0.00293824714178154,0.00199547234776292,0.0135134011435466,0.00832345042057843
NMR metabolomics,X23412.Phospholipids in VLDL,CD27,CD27 antigen,42679,-0.0117166716089589,0.00445040582927284,-0.0204394670343336,-0.00299387618358411,0.00848007490999201
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK3,NT-3 growth factor receptor,42711,-0.00574526678012871,0.00218779913463417,-0.0100333530840117,-0.00145718047624574,0.00864798433670802
NMR metabolomics,X23412.Phospholipids in VLDL,CCL21,C-C motif chemokine 21,42676,0.0111096962573651,0.00423896761414206,0.00280131973364666,0.0194180727810835,0.00878093748601699
NMR metabolomics,X23412.Phospholipids in VLDL,TERF1,Telomeric repeat-binding factor 1,40199,-0.00779929745644936,0.00298692476365936,-0.0136536699932217,-0.00194492491967701,0.00903616981320986
NMR metabolomics,X23412.Phospholipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00947850143658113,0.00363182841545708,0.00236011774228525,0.016596885130877,0.00906864544252525
NMR metabolomics,X23412.Phospholipids in VLDL,LIFR,Leukemia inhibitory factor receptor,42594,-0.0063368204592518,0.00242886984134739,-0.0110974053482927,-0.00157623557021091,0.00909191426612085
NMR metabolomics,X23412.Phospholipids in VLDL,BMP10,Bone morphogenetic protein 10,40283,0.00756233580856076,0.00290052179892116,0.00187731308267528,0.0132473585344462,0.0091399482101726
NMR metabolomics,X23412.Phospholipids in VLDL,JAM2,Junctional adhesion molecule B,42711,0.00742231146818829,0.00285813896619044,0.00182035909445501,0.0130242638419216,0.00941701917569153
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2B,Sodium channel subunit beta-2,40182,-0.00763358321212597,0.00293941745807547,-0.0133948414299539,-0.00187232499429804,0.00941750646196634
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0174088064773297,0.00671284009511573,0.00425163989090285,0.0305659730637565,0.00951501048683169
NMR metabolomics,X23412.Phospholipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0106408948230991,0.00412125453677433,-0.0187185537151768,-0.00256323593102145,0.00983713322761563
NMR metabolomics,X23412.Phospholipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.00731771203563372,0.00284318692918615,0.00174506565442887,0.0128903584168386,0.0100703686105347
NMR metabolomics,X23412.Phospholipids in VLDL,C9orf40,Uncharacterized protein C9orf40,40449,0.0210525914835804,0.00819027750640962,0.00499964757101752,0.0371055353961432,0.0101697724283052
NMR metabolomics,X23412.Phospholipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.0100570396364719,0.00394110144814032,-0.0177815984748269,-0.00233248079811689,0.0107292304557664
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,40199,0.0105595011098709,0.00415013633483026,0.00242523389360354,0.0186937683261382,0.010960907870517
NMR metabolomics,X23412.Phospholipids in VLDL,LAYN,Layilin,42476,-0.00968898977148573,0.00381177944594301,-0.017160077485534,-0.00221790205743744,0.0110378610631701
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX2,Neuronal pentraxin-2,40527,-0.00841864210423734,0.00331221595064758,-0.0149105853675066,-0.00192669884096809,0.0110448486683872
NMR metabolomics,X23412.Phospholipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0119350756291492,0.00470860162467846,0.00270621644477942,0.021163934813519,0.0112665458467558
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM1,Myomesin-1,40136,0.0123091909486476,0.00486095259918631,0.00278172385424245,0.0218366580430528,0.0113468900298361
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0109182481009599,0.00432174455980173,0.00244762876374852,0.0193888674381713,0.011538948956269
NMR metabolomics,X23412.Phospholipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.013926585724199,0.0055311012665293,0.0030856272418016,0.0247675442065964,0.0118185114660077
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00692476458319201,0.00275370351182118,-0.0123220234663615,-0.0015275057000225,0.0119268848326132
NMR metabolomics,X23412.Phospholipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0234325713027331,0.00932898248320449,0.00514776563565227,0.0417173769698139,0.0120259466278826
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.00927979123964891,0.0037066188651876,0.00201481826388121,0.0165447642154166,0.0123091024673877
NMR metabolomics,X23412.Phospholipids in VLDL,DBH,Dopamine beta-hydroxylase,40515,0.0276669506698511,0.0110527453570946,0.00600356976994571,0.0493303315697564,0.0123224547556347
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0156227714178441,0.00624382450139309,0.00338487539511364,0.0278606674405745,0.0123598340973158
NMR metabolomics,X23412.Phospholipids in VLDL,LTO1,Protein LTO1 homolog,42370,0.0105776468614944,0.00423785665866339,0.00227144781051417,0.0188838459124747,0.0125727489323379
NMR metabolomics,X23412.Phospholipids in VLDL,GBP6,Guanylate-binding protein 6,40116,-0.011626498934671,0.00466135161989244,-0.0207627481096602,-0.00249024975968183,0.0126376166024309
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN8,Septin-8,40470,0.00813388347128279,0.00326963389561227,0.00172540103588274,0.0145423659066828,0.0128713808851374
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN3,Neuronal-specific septin-3,40482,-0.0187781911201679,0.00755115350752827,-0.0335784519949233,-0.00397793024541248,0.0129042058857428
NMR metabolomics,X23412.Phospholipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0219047814035667,0.00885215168595573,0.00455456409909348,0.0392549987080399,0.0133568684217612
NMR metabolomics,X23412.Phospholipids in VLDL,SPARCL1,SPARC-like protein 1,42644,-0.00687917042573022,0.00278296811708403,-0.0123337879352149,-0.00142455291624552,0.0134526487877942
NMR metabolomics,X23412.Phospholipids in VLDL,TBR1,T-box brain protein 1,40182,0.012038909963247,0.00489559074934593,0.00244355209452901,0.0216342678319651,0.0139425917623246
NMR metabolomics,X23412.Phospholipids in VLDL,HMCN2,Hemicentin-2,40269,-0.0145082885252593,0.00590039068518273,-0.0260730542682175,-0.00294352278230118,0.0139527265773444
NMR metabolomics,X23412.Phospholipids in VLDL,TPSAB1,Tryptase alpha/beta-1,42741,0.0129035456541483,0.00526864877857264,0.00257699404814592,0.0232300972601507,0.014333207065968
NMR metabolomics,X23412.Phospholipids in VLDL,PRR4,Proline-rich protein 4,40198,-0.0171884537685996,0.00702043830976627,-0.0309485128557414,-0.00342839468145768,0.0143669249757572
NMR metabolomics,X23412.Phospholipids in VLDL,NRXN3,Neurexin-3,40182,0.00877626745923163,0.00358669535334703,0.00174634456667144,0.0158061903517918,0.0144248292032378
NMR metabolomics,X23412.Phospholipids in VLDL,CEP350,Centrosome-associated protein 350,40080,0.0093855639489669,0.00383841583213663,0.00186226891797911,0.0169088589799547,0.0144942840241956
NMR metabolomics,X23412.Phospholipids in VLDL,JCHAIN,Immunoglobulin J chain,42370,-0.0153953906859951,0.00630446296396955,-0.0277521380953754,-0.00303864327661477,0.0146198949895644
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.0121665896889208,0.00498262190297547,0.00240065075908887,0.0219325286187527,0.0146292930515944
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB118,Beta-defensin 118,40136,0.0140431856858097,0.00575854342418115,0.00275644057441463,0.0253299307972048,0.0147572246920105
NMR metabolomics,X23412.Phospholipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.012935981724945,0.00531208814568065,-0.0233476744904791,-0.00252428895941095,0.0148965696859372
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA1,Ephrin-A1,42590,0.00741209759011057,0.00304756236289067,0.00143887535884486,0.0133853198213763,0.0150229244254326
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0111610570644878,0.00459089468226199,-0.0201592106417214,-0.00216290348725434,0.0150648626705193
NMR metabolomics,X23412.Phospholipids in VLDL,TEF,Thyrotroph embryonic factor,40116,0.0106163985635813,0.00438889079240222,0.00201417261047295,0.0192186245166897,0.0155826763915591
NMR metabolomics,X23412.Phospholipids in VLDL,JUN,Transcription factor AP-1,42370,0.0116503200901535,0.00482028002643713,0.00220257123833672,0.0210980689419703,0.0156651566150656
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00635087892114075,0.00263005771998235,0.00119596578997535,0.0115057920523061,0.0157602174744312
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.00700752498260862,0.00290622798817682,0.00131131812578205,0.0127037318394352,0.0159156163456806
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0187417632087908,0.00777527982329997,0.00350221475512288,0.0339813116624588,0.0159474219606142
NMR metabolomics,X23412.Phospholipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00659724804935654,0.00273969043641759,0.00122745479397807,0.011967041304735,0.0160549346811777
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00641304587923776,0.00267380627688515,0.00117238557654287,0.0116537061819327,0.0164804514699797
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.0126390938856048,0.00528273993969397,0.00228492360380457,0.0229932641674049,0.0167493447851658
NMR metabolomics,X23412.Phospholipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0208295130749528,0.00871464738683214,0.00374880419676184,0.0379102219531438,0.0168570096227512
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1B,Protein phosphatase 1B,40199,0.0147175275848969,0.00616244386296726,0.00263913761348102,0.0267959175563127,0.0169450478911906
NMR metabolomics,X23412.Phospholipids in VLDL,MRC1,Macrophage mannose receptor 1,40532,0.00702794874620759,0.00294452483571839,0.00125668006819955,0.0127992174242156,0.0170127067184893
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE1,Ribonuclease pancreatic,40532,0.00635605380437581,0.00266445587266202,0.00113372029395824,0.0115783873147934,0.0170723427221744
NMR metabolomics,X23412.Phospholipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00942410812277455,0.00395823136811042,-0.017182241604271,-0.00166597464127813,0.0172879729557218
NMR metabolomics,X23412.Phospholipids in VLDL,IL5,Interleukin-5,42370,0.0333622830285183,0.0140339762827885,0.00585568951425276,0.0608688765427838,0.0174564081201669
NMR metabolomics,X23412.Phospholipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0151692000769145,0.00639482428267745,0.00263534448286675,0.0277030556709623,0.017703625875035
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0106863455067019,0.00451005907114271,-0.0195260612861416,-0.00184662972726218,0.0178287824865468
NMR metabolomics,X23412.Phospholipids in VLDL,MUC2,Mucin-2,40527,0.0221658430788305,0.0093749926259211,0.00379085753202511,0.0405408286256358,0.0180780893662419
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00730301063280876,0.00308998204333848,0.00124664582786533,0.0133593754377522,0.0181202463680129
NMR metabolomics,X23412.Phospholipids in VLDL,ENOPH1,Enolase-phosphatase E1,40451,0.0131019422579909,0.00554401147589432,0.00223567976523804,0.0239682047507438,0.0181318382682748
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5A,Cytochrome b5,40080,0.0174263445687791,0.00738017470327,0.00296120215036986,0.0318914869871883,0.0182315829909625
NMR metabolomics,X23412.Phospholipids in VLDL,RGMA,Repulsive guidance molecule A,42711,-0.00760334052402307,0.00322083676914916,-0.0139161805915554,-0.00129050045649072,0.0182559528049078
NMR metabolomics,X23412.Phospholipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.0122447609986357,0.00520035453025395,0.00205206611933794,0.0224374558779334,0.0185602525410079
NMR metabolomics,X23412.Phospholipids in VLDL,IL31,Interleukin-31,40199,0.0133788487148834,0.00569296190871585,0.0022206433738003,0.0245370540559664,0.0187875351671076
NMR metabolomics,X23412.Phospholipids in VLDL,TP73,Tumor protein p73,40182,0.00818148159080445,0.00348833618846474,0.00134434266141355,0.0150186205201953,0.0190252738403635
NMR metabolomics,X23412.Phospholipids in VLDL,SOD3,Extracellular superoxide dismutase,40532,-0.0138123086033139,0.0058901388158777,-0.0253569806824342,-0.00226763652419364,0.0190448110318021
NMR metabolomics,X23412.Phospholipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00858260696310804,0.00366037994084123,0.00140826227905923,0.0157569516471568,0.0190585060298108
NMR metabolomics,X23412.Phospholipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,40302,0.0128136196786489,0.00548069416812712,0.00207145910911972,0.023555780248178,0.0194072051472298
NMR metabolomics,X23412.Phospholipids in VLDL,DNPEP,Aspartyl aminopeptidase,40483,0.0134431881615312,0.00575342718039456,0.00216647088795789,0.0247199054351046,0.0194798330676951
NMR metabolomics,X23412.Phospholipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.00965589594676916,0.00413503127466041,-0.0177605572451036,-0.00155123464843476,0.0195504132419852
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.011728636554887,0.00504381546306096,0.00184275824728756,0.0216145148624865,0.020071440012883
NMR metabolomics,X23412.Phospholipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,42636,0.00408935011153604,0.00175904834235497,0.000641615360520304,0.00753708486255178,0.0201000736451824
NMR metabolomics,X23412.Phospholipids in VLDL,IL17A,Interleukin-17A,42347,-0.0100988718568146,0.00434650840806716,-0.0186180283366262,-0.00157971537700297,0.0201704417124403
NMR metabolomics,X23412.Phospholipids in VLDL,LEG1,Protein LEG1 homolog,39926,-0.0163862376517469,0.00707144798628037,-0.0302462757048564,-0.00252619959863737,0.0205094181114074
NMR metabolomics,X23412.Phospholipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00837678277150005,0.00361527218493308,0.00129084928903121,0.0154627162539689,0.0205157589188164
NMR metabolomics,X23412.Phospholipids in VLDL,PRR5,Proline-rich protein 5,40199,0.0111864470297933,0.00482824810656565,0.00172308074092465,0.020649813318662,0.0205288105148932
NMR metabolomics,X23412.Phospholipids in VLDL,CFD,Complement factor D,40539,0.00489804164300346,0.0021154760993929,0.000751708488193365,0.00904437479781355,0.0206122052922059
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00889489098703587,0.0038479991431612,0.00135281266643991,0.0164369693076318,0.0208200054502367
NMR metabolomics,X23412.Phospholipids in VLDL,ELAVL4,ELAV-like protein 4,40136,0.0198131639357501,0.0085780103999479,0.00300026355185225,0.036626064319648,0.0209198461049292
NMR metabolomics,X23412.Phospholipids in VLDL,TXNL1,Thioredoxin-like protein 1,40124,0.0229899133446696,0.00995464911675746,0.00347880107582497,0.0425010256135142,0.0209363419514385
NMR metabolomics,X23412.Phospholipids in VLDL,GAL,Galanin peptides,42676,0.0148582254553218,0.00645452560021934,0.00220735527889193,0.0275090956317517,0.0213511458943735
NMR metabolomics,X23412.Phospholipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00953085918930736,0.00415680642687574,0.00138351859263091,0.0176781997859838,0.0218729718890821
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX2,Peroxiredoxin-2,40333,0.014428376072173,0.00630115496830002,0.00207811233430496,0.026778639810041,0.0220516022453846
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0113544981232267,0.0049601995118828,-0.021076489166517,-0.00163250707993645,0.0220877115478542
NMR metabolomics,X23412.Phospholipids in VLDL,MTR,Methionine synthase,40116,0.01531476626005,0.00670492913255764,0.00217310516023705,0.028456427359863,0.022384425682258
NMR metabolomics,X23412.Phospholipids in VLDL,SOX2,Transcription factor SOX-2,40461,0.005489724328073,0.00241271486088849,0.000760803200731561,0.0102186454554144,0.0229047920692186
NMR metabolomics,X23412.Phospholipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0133288218305777,0.00586217385271694,0.00183896107925254,0.0248186825819029,0.0230034449215364
NMR metabolomics,X23412.Phospholipids in VLDL,POF1B,Protein POF1B,40199,-0.0106956734863005,0.00471188177732881,-0.0199309617698649,-0.00146038520273599,0.0232306773570792
NMR metabolomics,X23412.Phospholipids in VLDL,IFNW1,Interferon omega-1,40116,-0.00842747984236635,0.00372448905565742,-0.0157274783914549,-0.00112748129327781,0.02367244327175
NMR metabolomics,X23412.Phospholipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0195450399719757,0.00863944147290467,-0.0364783452588689,-0.00261173468508257,0.0236951110336547
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0087105265193724,0.00385258249518958,-0.016261588209944,-0.00115946482880084,0.0237778167484793
NMR metabolomics,X23412.Phospholipids in VLDL,ENO1,Alpha-enolase,42588,0.017871593620394,0.00790496710055744,0.00237785810330142,0.0333653291374866,0.0237872774084563
NMR metabolomics,X23412.Phospholipids in VLDL,DUOX2,Dual oxidase 2,42357,0.016258154148486,0.00719263555963394,0.00216058845160345,0.0303557198453685,0.0238133852592348
NMR metabolomics,X23412.Phospholipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00988254844885928,0.00438367897689781,-0.018474559243579,-0.00129053765413957,0.0241906645150743
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA4,Ephrin type-A receptor 4,40283,0.00662715445215581,0.00294186769819586,0.000861093763691929,0.0123932151406197,0.0242973436527544
NMR metabolomics,X23412.Phospholipids in VLDL,OLFM4,Olfactomedin-4,39870,0.0280271887678908,0.0124559449036658,0.00361353675670578,0.0524408407790759,0.0244625328309463
NMR metabolomics,X23412.Phospholipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,40136,0.020615798930435,0.00917533604350804,0.00263214028515926,0.0385994575757108,0.024668107255908
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.00710202897969436,0.00316129877163244,0.000905883387294773,0.013298174572094,0.0246877810867545
NMR metabolomics,X23412.Phospholipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00733899842204025,0.00327463110374565,0.000920721458698778,0.0137572753853817,0.0250351667748619
NMR metabolomics,X23412.Phospholipids in VLDL,PGA4,Pepsin A-4,40532,0.0182299958023006,0.0081360684170376,0.00228330170490688,0.0341766898996943,0.0250687242984256
NMR metabolomics,X23412.Phospholipids in VLDL,FABP3,"Fatty acid-binding protein, heart",40511,0.0118294642802782,0.00529013674977787,0.00146079625071363,0.0221981323098429,0.0253622874106837
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.0123594142117952,0.00554412637708137,-0.0232259019108747,-0.0014929265127157,0.0258154510748648
NMR metabolomics,X23412.Phospholipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0139443715673633,0.00625804943160745,0.00167859468141272,0.0262101484533139,0.0258820285482274
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF1,Formylglycine-generating enzyme,40199,0.0144276569864453,0.00648214764915501,0.00172264759410145,0.0271326663787891,0.0260509353076352
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.00931493801431319,0.00419170497780695,-0.0175306797708148,-0.00109919625781157,0.0262844053456954
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1,Methionine aminopeptidase 1,42311,0.0065235175244645,0.00293857776887071,0.000763905097477906,0.0122831299514511,0.0264386876775036
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.00645498178386755,0.00291110493261139,-0.0121607474517859,-0.000749216115949223,0.0266146370671328
NMR metabolomics,X23412.Phospholipids in VLDL,CCND2,G1/S-specific cyclin-D2,40302,0.00822706928035594,0.00372534138692701,0.000925400161978995,0.0155287383987329,0.0272362739816991
NMR metabolomics,X23412.Phospholipids in VLDL,GAST,Gastrin,40483,0.0321496636394341,0.0146504241081291,0.0034348323875011,0.0608644948913671,0.0282231760371106
NMR metabolomics,X23412.Phospholipids in VLDL,ARTN,Artemin,42370,0.0098697229884716,0.00450086300781993,0.00104803149314454,0.0186914144837987,0.028335518979543
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,40199,0.0045701649399152,0.00209148642350514,0.000470851549845124,0.00866947832998528,0.0289004981331026
NMR metabolomics,X23412.Phospholipids in VLDL,CDH4,Cadherin-4,40136,0.0109704269878662,0.00502445538598796,0.00112249443132976,0.0208183595444026,0.0290270809853084
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00601623498544222,0.00275627661802976,0.000613932814103893,0.0114185371567805,0.0290720123840199
NMR metabolomics,X23412.Phospholipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0112874930232604,0.00521351423764152,0.00106900511748306,0.0215059809290378,0.0304018304633008
NMR metabolomics,X23412.Phospholipids in VLDL,CEP290,Centrosomal protein of 290 kDa,40302,0.0118800308534653,0.00550446507079415,0.00109127931470875,0.0226687823922218,0.0309294882714673
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0143744044998495,0.00666479603032298,0.00131140428041646,0.0274374047192826,0.0310450176641487
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,40136,0.0169622639181903,0.00787032332777002,0.0015364301957611,0.0323880976406196,0.0311665084802868
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL5,Fc receptor-like protein 5,42611,-0.0127174238055365,0.00593033920257117,-0.024340888642576,-0.00109395896849698,0.0320132996607333
NMR metabolomics,X23412.Phospholipids in VLDL,PTTG1,Securin,40302,0.00884244727504103,0.00413472307936365,0.000738390039488281,0.0169465045105938,0.0324912265060678
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.00742391521870038,0.00349704084307694,0.000569715166269566,0.0142781152711312,0.0337795693307345
NMR metabolomics,X23412.Phospholipids in VLDL,IGLON5,IgLON family member 5,40080,-0.0202937293293403,0.00956942577410996,-0.0390498038465958,-0.00153765481208477,0.0339709405037067
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0114364485432448,0.0054131719785562,0.00082663146527465,0.022046265621215,0.0346477749608293
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00588758074690071,0.00278803948834498,0.000423023349744559,0.0113521381440569,0.0347285880245706
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX1,Neuronal pentraxin-1,42611,0.00849958460441424,0.00403076860899849,0.000599278130777195,0.0163998910780513,0.0349910523064537
NMR metabolomics,X23412.Phospholipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0178497549749514,0.00848254414516507,0.00122396845042783,0.0344755414994749,0.0353755871464727
NMR metabolomics,X23412.Phospholipids in VLDL,CCN3,CCN family member 3,42779,0.00750181997119816,0.00356771598075015,0.000509096648927869,0.0144945432934685,0.0355107551475118
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0125719674341471,0.0059817320857714,0.000847772546035122,0.024296162322259,0.0356000466243957
NMR metabolomics,X23412.Phospholipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0186822187470723,0.00889002729885945,0.00125776524130776,0.0361066722528368,0.0356216591893897
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00729819240678489,0.00347616144171203,0.000484915981029316,0.0141114688325405,0.0357914442167098
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_DRA,,42549,-0.00778566790381555,0.00371605044624449,-0.0150691267784548,-0.00050220902917636,0.0361768096884706
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL1,Follistatin-related protein 1,40223,-0.00478560373345726,0.00228619987213049,-0.00926655548283302,-0.0003046519840815,0.0363490092391008
NMR metabolomics,X23412.Phospholipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.0126020083741372,0.00602352951839058,0.000795890518091646,0.0244081262301827,0.0364459733079355
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0158997054843323,0.00760775216176627,0.000988511247270431,0.0308108997213942,0.0366459863762787
NMR metabolomics,X23412.Phospholipids in VLDL,RBM19,Probable RNA-binding protein 19,40116,-0.010179196914262,0.00487866725433472,-0.019741384732758,-0.000617009095765956,0.0369591327775332
NMR metabolomics,X23412.Phospholipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.00632191729931932,0.00303584964785941,0.000371651989514883,0.0122721826091238,0.0373229863287573
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP2,Dipeptidase 2,42587,0.00617487078755215,0.00296841620651165,0.000356775022789317,0.011992966552315,0.0375270423137181
NMR metabolomics,X23412.Phospholipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0202642981594141,0.00974295989325656,0.00116809676863127,0.039360499550197,0.0375580693037255
NMR metabolomics,X23412.Phospholipids in VLDL,IL11,Interleukin-11,42370,0.0131042585218353,0.00630896640676757,0.000738684364570814,0.0254698326790997,0.0378130567444788
NMR metabolomics,X23412.Phospholipids in VLDL,MAG,Myelin-associated glycoprotein,40182,0.010264528594859,0.00495032106509957,0.000561899307263844,0.0199671578824542,0.0381483040707172
NMR metabolomics,X23412.Phospholipids in VLDL,OGN,Mimecan,42611,0.00923360761779617,0.00445781091103069,0.000496298232176028,0.0179709170034163,0.0383468243139207
NMR metabolomics,X23412.Phospholipids in VLDL,TLR1,Toll-like receptor 1,40199,0.00559536451180859,0.00270443552627661,0.000294670880306437,0.0108960581433107,0.0385732869615594
NMR metabolomics,X23412.Phospholipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.0121176981754465,0.00586183645592465,0.000628498721834186,0.0236068976290588,0.0387370072057704
NMR metabolomics,X23412.Phospholipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0114123292673469,0.00552558894698846,0.000582174931249478,0.0222424836034442,0.0389135966126029
NMR metabolomics,X23412.Phospholipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0180132624851422,0.00874143329061834,0.000880053235530264,0.0351464717347542,0.0393576568390536
NMR metabolomics,X23412.Phospholipids in VLDL,DKKL1,Dickkopf-like protein 1,42587,-0.0181895835354353,0.00884307367007412,-0.0355220079287806,-0.000857159142090062,0.039712282945923
NMR metabolomics,X23412.Phospholipids in VLDL,GPA33,Cell surface A33 antigen,42587,-0.0287039138284036,0.0139689263068989,-0.0560830093899254,-0.0013248182668818,0.0399137796008972
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB2,Integrin beta-2,42569,0.00589366804083137,0.00287698581907651,0.000254775835441403,0.0115325602462213,0.0405249763419233
NMR metabolomics,X23412.Phospholipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0148766761160694,0.00726908730685046,0.000629264994642454,0.0291240872374962,0.0407237040481433
NMR metabolomics,X23412.Phospholipids in VLDL,FGF9,Fibroblast growth factor 9,40065,0.0085003852591494,0.00416056546627745,0.000345676945245602,0.0166550935730532,0.0410681739510688
NMR metabolomics,X23412.Phospholipids in VLDL,CDK1,Cyclin-dependent kinase 1,40080,0.00756128528107607,0.0037210713702285,0.000267985395428201,0.0148545851667239,0.0421760304739155
NMR metabolomics,X23412.Phospholipids in VLDL,CST7,Cystatin-F,42642,0.0191036953053062,0.00941291503248525,0.000654381841635125,0.0375530087689773,0.0424250488632446
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L,Seizure 6-like protein,42679,0.00572535427396521,0.00282185914643024,0.000194510346961935,0.0112561982009685,0.042485041370563
NMR metabolomics,X23412.Phospholipids in VLDL,TCN1,Transcobalamin-1,40337,0.00694653662525337,0.00344250979738928,0.000199217422370391,0.0136938558281364,0.0436287416185669
NMR metabolomics,X23412.Phospholipids in VLDL,IL6,Interleukin-6,42587,0.0156013399168166,0.00773231475240404,0.000446003002104704,0.0307566768315286,0.0436444621001058
NMR metabolomics,X23412.Phospholipids in VLDL,TNPO1,Transportin-1,40302,0.00721146474301583,0.00357703755792048,0.000200471129491685,0.01422245835654,0.0438194134699867
NMR metabolomics,X23412.Phospholipids in VLDL,KLK4,Kallikrein-4,42721,-0.0128895597336877,0.00639451219862768,-0.025422803642998,-0.000356315824377474,0.0438487758770676
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT2,Angiopoietin-2,42721,-0.00765831818725536,0.00379951844294975,-0.0151053743354369,-0.000211262039073846,0.0438613141698615
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN2,Calsyntenin-2,42754,-0.00802226785762103,0.00398862237116248,-0.0158399677050995,-0.000204568010142576,0.0443148076347232
NMR metabolomics,X23412.Phospholipids in VLDL,INSL4,Early placenta insulin-like peptide,40451,-0.00983114196225979,0.00491020435234567,-0.0194551424928573,-0.000207141431662268,0.0452886859964768
NMR metabolomics,X23412.Phospholipids in VLDL,ANPEP,Aminopeptidase N,42666,0.00557330415121052,0.00278898991289197,0.000106883921942267,0.0110397243804788,0.0457016591613664
NMR metabolomics,X23412.Phospholipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00567189522428861,0.00285431055872458,7.74465291884362e-05,0.0112663439193888,0.0469279027337905
NMR metabolomics,X23412.Phospholipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0123238797900799,0.00622323545511651,-0.0245214212821083,-0.000126338298051556,0.0476947171103887
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG4,Proteasome assembly chaperone 4,40199,0.0113454285896059,0.00575043922926159,7.45677002531881e-05,0.0226162894789586,0.0485242735424362
NMR metabolomics,X23412.Phospholipids in VLDL,MATN3,Matrilin-3,42475,0.00649972086216782,0.00329645640328971,3.86663117199941e-05,0.0129607754126156,0.0486611968188667
NMR metabolomics,X23412.Phospholipids in VLDL,SNX18,Sorting nexin-18,40449,0.00870264363164496,0.00441755374151078,4.42382982838233e-05,0.0173610489650061,0.0488612208798893
NMR metabolomics,X23412.Phospholipids in VLDL,SCG3,Secretogranin-3,42638,-0.00673949226824263,0.00343365834371253,-0.0134694626219192,-9.52191456606716e-06,0.0496931329249775
NMR metabolomics,X23412.Phospholipids in VLDL,NOP56,Nucleolar protein 56,40116,0.0221696739579701,0.0113069339065483,8.08350113551057e-06,0.0443312644148047,0.0499376655173272
NMR metabolomics,X23412.Phospholipids in VLDL,DLL1,Delta-like protein 1,42679,-0.00616329521534644,0.00316322989662743,-0.0123632258127362,3.66353820433294e-05,0.0513856386484096
NMR metabolomics,X23412.Phospholipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00782527283584386,0.00402503082265829,-6.37875765663876e-05,0.0157143332482541,0.0519019001022282
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00617268284288008,0.00318211468222275,-6.42619342765037e-05,0.0124096276200367,0.0524246933446868
NMR metabolomics,X23412.Phospholipids in VLDL,PCARE,Photoreceptor cilium actin regulator,40136,0.0164592929620867,0.00849046915459884,-0.000182026580927072,0.0331006125051004,0.0525804916612164
NMR metabolomics,X23412.Phospholipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,42594,0.00944225745985183,0.00490767590708724,-0.000176787318039153,0.0190613022377428,0.0543785738879826
NMR metabolomics,X23412.Phospholipids in VLDL,S100A14,Protein S100-A14,40482,0.0106079510730435,0.0055255191744146,-0.000222066508809076,0.0214379686548962,0.0549069844643734
NMR metabolomics,X23412.Phospholipids in VLDL,SLC13A1,Solute carrier family 13 member 1,40451,0.0121066780867285,0.0063092550192115,-0.000259461750926034,0.024472817924383,0.0550252856709376
NMR metabolomics,X23412.Phospholipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,42636,0.00610765319328343,0.00318368969024433,-0.000132378599595455,0.0123476849861623,0.0550789660753836
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD7,FERM domain-containing protein 7,40182,0.00646975981598274,0.00337745380832393,-0.00015004964833216,0.0130895692802976,0.0554453761369347
NMR metabolomics,X23412.Phospholipids in VLDL,DRAXIN,Draxin,42495,0.0084073252244944,0.0044141482803953,-0.000244405405080387,0.0170590558540692,0.0568495575948943
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00942520522463665,0.00496188914419464,-0.0191505079472582,0.000300097497984845,0.0575175756409358
NMR metabolomics,X23412.Phospholipids in VLDL,SPRING1,SREBP regulating gene protein,40080,0.0112878041732158,0.0059746627740399,-0.000422534863902426,0.022998143210334,0.0588810222764715
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFD,Vascular endothelial growth factor D,42734,-0.00685328326879806,0.0036281273182282,-0.0139644128125253,0.000257846274929203,0.0589223853504066
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,42495,-0.00691378743091473,0.00366620053847769,-0.014099540486331,0.000271965624501535,0.0593412381697269
NMR metabolomics,X23412.Phospholipids in VLDL,PIGR,Polymeric immunoglobulin receptor,42464,0.00677865938540201,0.00360211923687418,-0.000281494318871378,0.0138388130896754,0.0598778258425215
NMR metabolomics,X23412.Phospholipids in VLDL,NOS1,"Nitric oxide synthase, brain",42311,-0.0102492560366513,0.00545976329014926,-0.0209503920853438,0.000451880012041288,0.0605081354374249
NMR metabolomics,X23412.Phospholipids in VLDL,CDH23,Cadherin-23,40483,-0.00492689171527795,0.00263281177846359,-0.0100872028010666,0.000233419370510681,0.0613235120378379
NMR metabolomics,X23412.Phospholipids in VLDL,MYH7B,Myosin-7B,40080,-0.00843697629166814,0.0045294910164993,-0.0173147786840068,0.000440826100670481,0.062534716072647
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,40080,0.00783000638042742,0.00421980017020204,-0.000440801953168582,0.0161008147140234,0.0635462176958505
NMR metabolomics,X23412.Phospholipids in VLDL,EDN1,Endothelin-1,40223,0.00569118962245334,0.00307146294318718,-0.000328877746193524,0.0117112569911002,0.063919842195074
NMR metabolomics,X23412.Phospholipids in VLDL,CA11,Carbonic anhydrase-related protein 11,42346,0.00605304882490576,0.00326828343771949,-0.000352786713024447,0.012458884362836,0.0640399613091663
NMR metabolomics,X23412.Phospholipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.0124619657141833,0.00672958642766652,-0.000728023684043075,0.0256519551124097,0.0640744939797488
NMR metabolomics,X23412.Phospholipids in VLDL,CRNN,Cornulin,42209,0.0128255850999783,0.00695954767459388,-0.000815128342225725,0.0264662985421823,0.0653698079628745
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,40283,0.00986980550718178,0.00536027722505745,-0.000636337853930821,0.0203759488682944,0.0656062947887075
NMR metabolomics,X23412.Phospholipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00440071838921946,0.00239308468590517,-0.00909116437359361,0.000289727595154677,0.0659515393785006
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00893711334437043,0.00488386694021915,-0.000635265858459117,0.0185094925472,0.0672836617963353
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GL3,Endophilin-A3,40250,0.0157335835033124,0.00861594990292422,-0.00115367830641906,0.0326208453130439,0.0678622020118346
NMR metabolomics,X23412.Phospholipids in VLDL,IL36G,Interleukin-36 gamma,40154,0.0126741448839937,0.00695398087474602,-0.000955657630508486,0.0263039473984959,0.0683951670671834
NMR metabolomics,X23412.Phospholipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.00915664862839276,0.00503449517828448,-0.0190242591778303,0.00071096192104482,0.0689719216245837
NMR metabolomics,X23412.Phospholipids in VLDL,BTLA,B- and T-lymphocyte attenuator,40080,0.0161416748587887,0.00889309635483879,-0.00128879399669531,0.0335721437142728,0.0695392343317535
NMR metabolomics,X23412.Phospholipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00626819745728823,0.00347306729136375,-0.000539014433784728,0.0130754093483612,0.0711332782535166
NMR metabolomics,X23412.Phospholipids in VLDL,RALB,Ras-related protein Ral-B,40199,0.00545404899498591,0.00302814488212255,-0.000481114973974289,0.0113892129639461,0.0717115047482529
NMR metabolomics,X23412.Phospholipids in VLDL,CD248,Endosialin,40527,-0.00739083385181266,0.00410983511691153,-0.0154461106809593,0.000664442977333934,0.0721515585217793
NMR metabolomics,X23412.Phospholipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.0115535990628249,0.00642550894824908,-0.00104039847574331,0.0241475966013931,0.0721906232640105
NMR metabolomics,X23412.Phospholipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00943726821242642,0.00525494574446295,-0.0197369618715738,0.000862425446720954,0.0725408705492464
NMR metabolomics,X23412.Phospholipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00773633825671825,0.00432025537201467,-0.000731362272430501,0.016204038785867,0.0733668504486281
NMR metabolomics,X23412.Phospholipids in VLDL,IL9,Interleukin-9,40302,0.0101572472047283,0.00567815372972985,-0.000971934105542168,0.0212864285149988,0.0736695663037654
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00963940839187351,0.00541304680523102,-0.000970163346379282,0.0202489801301263,0.0749772539852025
NMR metabolomics,X23412.Phospholipids in VLDL,UNC5D,Netrin receptor UNC5D,40199,0.0047058225613449,0.00264313223890816,-0.000474716626915089,0.00988636174960489,0.0750387262559904
NMR metabolomics,X23412.Phospholipids in VLDL,RRP15,RRP15-like protein,40136,-0.0164863355743432,0.00927659343549172,-0.034668458707907,0.00169578755922055,0.0755635773418263
NMR metabolomics,X23412.Phospholipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.0105236748851854,0.00592865236025869,-0.00109648374092166,0.0221438335112924,0.0759169967227424
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3G,Semaphorin-3G,40283,0.00800729916007045,0.00451655475555901,-0.000845148160825215,0.0168597464809661,0.0762764223101392
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.00919466498007702,0.00518848810549119,-0.0193641016668397,0.000974771706685707,0.0764011362547913
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.00808072519053871,0.00456080697901772,-0.000858456488336011,0.0170199068694134,0.0764547534091008
NMR metabolomics,X23412.Phospholipids in VLDL,PDCL2,Phosducin-like protein 2,40080,0.00947605582903338,0.00535735440520487,-0.00102435880516817,0.0199764704632349,0.0769562717201014
NMR metabolomics,X23412.Phospholipids in VLDL,NOS2,"Nitric oxide synthase, inducible",40116,-0.00710920804615783,0.00402520740046905,-0.0149986145510772,0.000780198458761519,0.0773949510093173
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1,DNA topoisomerase 1,40449,0.0199580658509962,0.0113144912206682,-0.0022183369415135,0.0421344686435059,0.0777694711596567
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN8,Tetraspanin-8,40449,0.0182035129267374,0.010325469085162,-0.00203440648018011,0.0384414323336549,0.0779323453293497
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00560931452629657,0.00319930235195515,-0.0118799471361287,0.000661318083535524,0.0795796026366954
NMR metabolomics,X23412.Phospholipids in VLDL,IGFL4,Insulin growth factor-like family member 4,40199,0.0130296075381091,0.00743709031590139,-0.00154708948105764,0.0276063045572758,0.0798056977596918
NMR metabolomics,X23412.Phospholipids in VLDL,SKIV2L,Helicase SKI2W,40116,-0.0070469298911252,0.00402315301730511,-0.0149323098050432,0.000838450022792825,0.0798717447737187
NMR metabolomics,X23412.Phospholipids in VLDL,CHGB,Secretogranin-1,42664,-0.00756320321071294,0.00432553096003619,-0.0160412438923839,0.000914837470957997,0.0803997716537105
NMR metabolomics,X23412.Phospholipids in VLDL,MMP9,Matrix metalloproteinase-9,42594,-0.0105471250429745,0.00604131943622606,-0.0223881111379776,0.00129386105202859,0.0808631738392215
NMR metabolomics,X23412.Phospholipids in VLDL,EPN1,Epsin-1,40302,0.00782576010590759,0.00449342707003229,-0.00098135695135569,0.0166328771631709,0.0816058501250542
NMR metabolomics,X23412.Phospholipids in VLDL,MYO6,Unconventional myosin-VI,40482,0.00636333712177415,0.00366468852170573,-0.000819452380769079,0.0135461266243174,0.0825217665818243
NMR metabolomics,X23412.Phospholipids in VLDL,PAPPA,Pappalysin-1,42370,0.00816746880143626,0.00470406444016103,-0.00105249750127936,0.0173874351041519,0.0825416273222352
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,40199,0.00574774980930819,0.00331439879464287,-0.000748471828191841,0.0122439714468082,0.082914918102514
NMR metabolomics,X23412.Phospholipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.0115184526143206,0.00664303956196859,-0.00150190492713785,0.024538810155779,0.0829612672497779
NMR metabolomics,X23412.Phospholipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00362903224213067,0.00209937743026456,-0.00774381200544921,0.000485747521187858,0.0839048399945903
NMR metabolomics,X23412.Phospholipids in VLDL,CHP1,Calcineurin B homologous protein 1,40136,0.012928853219019,0.0074868743527239,-0.00174542051231984,0.0276031269503579,0.0842193681145699
NMR metabolomics,X23412.Phospholipids in VLDL,OSM,Oncostatin-M,42534,0.0121456982610973,0.00703530051278943,-0.00164349074397004,0.0259348872661645,0.0842997667565141
NMR metabolomics,X23412.Phospholipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0112098215937012,0.00650589441789698,-0.00154173146537688,0.0239613746527793,0.0849120158900926
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.00368301733816303,0.00214099709082972,-0.000513336959863213,0.00787937163618927,0.0854170995904506
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RA,Interleukin-17 receptor A,42611,0.00760837815941422,0.00442489137466861,-0.00106440893493626,0.0162811652537647,0.0855555822780198
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN2,Contactin-2,42721,0.00770768986705063,0.00448503702315676,-0.00108298269833661,0.0164983624324379,0.0857220892287144
NMR metabolomics,X23412.Phospholipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0122609791860949,0.00713705000175811,-0.00172763881735104,0.0262495971895407,0.0858365662302585
NMR metabolomics,X23412.Phospholipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0104040470406962,0.00605919805033928,-0.0222800752193612,0.00147198113796881,0.085995340806936
NMR metabolomics,X23412.Phospholipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,40182,0.00626266292546578,0.00365321638319587,-0.000897641185598127,0.0134229670365297,0.0865041510784199
NMR metabolomics,X23412.Phospholipids in VLDL,MYL4,Myosin light chain 4,40223,-0.00902460444603149,0.00526810859550576,-0.0193500972932228,0.00130088840115981,0.0867289663030465
NMR metabolomics,X23412.Phospholipids in VLDL,SHPK,Sedoheptulokinase,40302,-0.00710094146265676,0.00414622688997266,-0.0152275461670032,0.00102566324168965,0.086809031087475
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6,Seizure protein 6 homolog,40182,-0.00539052034763389,0.00316596684310628,-0.0115958153601222,0.000814774664854425,0.0886626448893301
NMR metabolomics,X23412.Phospholipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.00688897342215258,0.00405893575549134,-0.0148444875029156,0.00106654065861045,0.089675832123341
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP1,Dipeptidase 1,42476,-0.00853560649247066,0.00503093782842208,-0.0183962446361779,0.00132503165123662,0.0897913277840679
NMR metabolomics,X23412.Phospholipids in VLDL,RBP7,Retinoid-binding protein 7,40449,0.0102261341804692,0.00604912995501598,-0.0016301605313621,0.0220824288923005,0.0909575006219305
NMR metabolomics,X23412.Phospholipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00583171766451704,0.00345352589320754,-0.000937193086169742,0.0126006284152038,0.0913185206350332
NMR metabolomics,X23412.Phospholipids in VLDL,PMCH,Pro-MCH,40116,-0.0144286104275441,0.00856285904157806,-0.0312118141490371,0.00235459329394895,0.0920127927752473
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD2,Leiomodin-2,40136,0.0105070013723759,0.00630107898548262,-0.00184311343917002,0.0228571161839219,0.0954451489683368
NMR metabolomics,X23412.Phospholipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.00445293409870085,0.00267227670894531,-0.00969059644823366,0.000784728250831953,0.0956681650540992
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,42592,0.0081855018928561,0.00493705613266365,-0.00149112812716465,0.0178621319128768,0.0973464848338811
NMR metabolomics,X23412.Phospholipids in VLDL,IL21R,Interleukin-21 receptor,40199,0.00936041440006317,0.00565342298120543,-0.00172029464309948,0.0204411234432258,0.0978095946878221
NMR metabolomics,X23412.Phospholipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00508291641813695,0.00308902403133163,-0.000971570683273038,0.0111374035195469,0.099895463092386
NMR metabolomics,X23412.Phospholipids in VLDL,CD33,Myeloid cell surface antigen CD33,42679,0.0132533581511582,0.00805820903471266,-0.00254073155687858,0.029047447859195,0.100054444366078
NMR metabolomics,X23412.Phospholipids in VLDL,ZPR1,Zinc finger protein ZPR1,40136,0.0161955761438623,0.00984850010346309,-0.00310748405892537,0.0354986363466499,0.100107606462876
NMR metabolomics,X23412.Phospholipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00664071651655364,0.00403824846229463,-0.00127425046954383,0.0145556835026511,0.100110821624808
NMR metabolomics,X23412.Phospholipids in VLDL,THBS2,Thrombospondin-2,42611,0.00641570379941902,0.00390430399826017,-0.00123673203717091,0.014068139636009,0.100356967632553
NMR metabolomics,X23412.Phospholipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00483429661030457,0.00294750429515659,-0.000942811808202348,0.0106114050288115,0.101002349971247
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0106828088192189,0.006537782872556,-0.00213124561099085,0.0234968632494287,0.102279930687435
NMR metabolomics,X23412.Phospholipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0198567539685878,0.012191943366154,-0.00403945502907404,0.0437529629662496,0.103409920438533
NMR metabolomics,X23412.Phospholipids in VLDL,PALM3,Paralemmin-3,40116,0.0117663837686449,0.0072296764417699,-0.00240378205722407,0.0259365495945139,0.103657287952902
NMR metabolomics,X23412.Phospholipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0163936323389028,0.0100995435611104,-0.0361887377186792,0.00340147304087357,0.104574391001757
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A14,Zinc transporter ZIP14,42311,-0.00563281616213992,0.00347422188736558,-0.0124422910613765,0.00117665873709662,0.104973635006933
NMR metabolomics,X23412.Phospholipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.00786756261606267,0.0048690904932651,-0.0174109799828623,0.00167585475073694,0.106157782220287
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.0065845530858343,0.00409067956566112,-0.0014331788628615,0.0146022850345301,0.107503197365399
NMR metabolomics,X23412.Phospholipids in VLDL,NEFL,Neurofilament light polypeptide,42262,0.00749008821349324,0.00465505052232584,-0.00163381081026541,0.0166139872372519,0.107635239683563
NMR metabolomics,X23412.Phospholipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00367990380344166,0.00228791157067706,-0.000804402875085378,0.00816421048196871,0.10776824641516
NMR metabolomics,X23412.Phospholipids in VLDL,AMBN,Ameloblastin,42370,-0.00463271900104081,0.00288443635185322,-0.0102862142506731,0.0010207762485915,0.108273940240086
NMR metabolomics,X23412.Phospholipids in VLDL,MET,Hepatocyte growth factor receptor,42654,-0.00320378119966919,0.00199537454378714,-0.00711471530549198,0.000707152906153614,0.108384421390057
NMR metabolomics,X23412.Phospholipids in VLDL,SAT1,Diamine acetyltransferase 1,40116,-0.00829275085489117,0.00519250620876633,-0.0184700630240732,0.00188456131429083,0.110280967082811
NMR metabolomics,X23412.Phospholipids in VLDL,CGA,Glycoprotein hormones alpha chain,42611,-0.0101204347573653,0.00633809061271845,-0.0225430923582935,0.00230222284356285,0.110341879440014
NMR metabolomics,X23412.Phospholipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.00766401958507375,0.00481910657508756,-0.0171094684722454,0.00178142930209786,0.111781422244654
NMR metabolomics,X23412.Phospholipids in VLDL,WIF1,Wnt inhibitory factor 1,42721,0.00551250093979676,0.00346764196851246,-0.00128407731848765,0.0123090791980812,0.11192643088932
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.00832122760814125,0.0052365183387822,-0.00194234833587187,0.0185848035521544,0.112066917029985
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,42346,0.0075895406966576,0.00478461108389515,-0.00178829702777688,0.0169673784210921,0.112708955106214
NMR metabolomics,X23412.Phospholipids in VLDL,LY6D,Lymphocyte antigen 6D,42548,0.00649963373129735,0.00410282759970533,-0.0015419083641251,0.0145411758267198,0.113175538576456
NMR metabolomics,X23412.Phospholipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00469991936941801,0.00297038322873474,-0.0105218704977381,0.00112203175890207,0.113618182490399
NMR metabolomics,X23412.Phospholipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.00764293989495188,0.00484290959172171,-0.0171350426947264,0.00184916290482267,0.114555270494054
NMR metabolomics,X23412.Phospholipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.00682865585495183,0.00432964999032622,-0.00165745812608756,0.0153147698359912,0.114776707105856
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.00450800257372941,0.00286288881068545,-0.00110325949521407,0.0101192646426729,0.115364311972531
NMR metabolomics,X23412.Phospholipids in VLDL,KLK15,Kallikrein-15,40429,0.00847386015140767,0.0053825534557671,-0.00207594462189584,0.0190236649247112,0.11544170573861
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00514265736089459,0.0032753090489723,-0.00127694837509112,0.0115622630968803,0.116413157220868
NMR metabolomics,X23412.Phospholipids in VLDL,TLR2,Toll-like receptor 2,40302,0.00370945268968216,0.00236399915649323,-0.000923985657044559,0.00834289103640888,0.116643109479916
NMR metabolomics,X23412.Phospholipids in VLDL,ACRV1,Acrosomal protein SP-10,40199,0.0126827630331881,0.00809853479667976,-0.00319036516830422,0.0285558912346805,0.117364143348549
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,42594,0.00755323199810523,0.00482587415205817,-0.00190548133992878,0.0170119453361392,0.117570623719924
NMR metabolomics,X23412.Phospholipids in VLDL,GPR158,Probable G-protein coupled receptor 158,40482,0.00567788369257493,0.00363114538336424,-0.00143916125881899,0.0127949286439688,0.117925021934024
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0181602060141414,0.0116205137075286,-0.00461600085261474,0.0409364128808975,0.118134415614151
NMR metabolomics,X23412.Phospholipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0117289734790051,0.00752718289454783,-0.0264822519523188,0.00302430499430867,0.119211132239811
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.00386409035865998,0.00249563089568218,-0.00875552691419705,0.00102734619687708,0.121563223878826
NMR metabolomics,X23412.Phospholipids in VLDL,IL4,Interleukin-4,42370,0.01457177880475,0.00943071964478855,-0.00391243169903554,0.0330559893085356,0.122336505443046
NMR metabolomics,X23412.Phospholipids in VLDL,KLK14,Kallikrein-14,42721,0.00731168669738435,0.00474242672970741,-0.00198346969284218,0.0166068430876109,0.123155170435233
NMR metabolomics,X23412.Phospholipids in VLDL,STX1B,Syntaxin-1B,40182,0.00629195045821945,0.00409412612769364,-0.00173253675206008,0.014316437668499,0.12436525762712
NMR metabolomics,X23412.Phospholipids in VLDL,CDH6,Cadherin-6,42636,-0.00597344063656115,0.00389182931351474,-0.01360142609105,0.00165454481792774,0.124840020301948
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN4,Alpha-actinin-4,42370,0.00505890302285677,0.00329638150065099,-0.00140200471841917,0.0115198107641327,0.124885547106733
NMR metabolomics,X23412.Phospholipids in VLDL,S100A16,Protein S100-A16,42292,-0.00938056921412194,0.00611245463602404,-0.0213609803007291,0.00259984187248519,0.124890329997561
NMR metabolomics,X23412.Phospholipids in VLDL,MBL2,Mannose-binding protein C,40379,0.0168380734072801,0.010989062173067,-0.00470048845193127,0.0383766352664915,0.125487175584971
NMR metabolomics,X23412.Phospholipids in VLDL,TG,Thyroglobulin,40451,-0.0177494702068545,0.0116138091289218,-0.0405125360995412,0.00501359568583226,0.12646433502347
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.0124196419035843,0.00816078345229227,-0.0284147774700772,0.00357549366290854,0.128065561025296
NMR metabolomics,X23412.Phospholipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00598008593068011,0.00395766445850755,-0.0137371082693549,0.00177693640799468,0.130813844466478
NMR metabolomics,X23412.Phospholipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00559833594205277,0.00371925653936839,-0.00169140687510928,0.0128880787592148,0.13229342783729
NMR metabolomics,X23412.Phospholipids in VLDL,NRCAM,Neuronal cell adhesion molecule,42636,0.00438499318968277,0.00292213533534415,-0.00134239206759177,0.0101123784469573,0.133479269769969
NMR metabolomics,X23412.Phospholipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.00459598432285463,0.00306492515258176,-0.0106032376219149,0.00141126897620562,0.133756482461594
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0112254256509289,0.00751454489061724,-0.00350308233468093,0.0259539336365387,0.135248874759228
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.0096359713954182,0.00646429702810038,-0.00303405077965854,0.0223059935704949,0.136083722931366
NMR metabolomics,X23412.Phospholipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0105662260655299,0.00710706123029006,-0.0244960660768984,0.00336361394583866,0.137116195177055
NMR metabolomics,X23412.Phospholipids in VLDL,LCN15,Lipocalin-15,40482,-0.0093315209252672,0.0063112790023874,-0.0217016277699465,0.0030385859194121,0.139289401756275
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.00408262872952252,0.00276794711327998,-0.00134254761250624,0.00950780507155129,0.140244750691203
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0211088994666655,0.0143245933338946,-0.0491851024010989,0.00696730346776789,0.140613733915914
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.0115203593543741,0.00782078431787938,-0.00380837790866953,0.0268490966174176,0.140763084794063
NMR metabolomics,X23412.Phospholipids in VLDL,SCP2,Non-specific lipid-transfer protein,42346,0.0109045476888827,0.0074413674528945,-0.00368053251879052,0.0254896278965559,0.142836901403186
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD9,COMM domain-containing protein 9,40451,0.00583299111834269,0.00400218015339276,-0.00201128198230712,0.0136772642189925,0.145019157245929
NMR metabolomics,X23412.Phospholipids in VLDL,NUP50,Nuclear pore complex protein Nup50,40116,-0.00510163716609315,0.00350796142228926,-0.0119772415537801,0.00177396722159379,0.145891185086248
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH17,Protocadherin-17,42636,0.00544227518996921,0.00374452143862999,-0.00189698682974558,0.012781537209684,0.14613698045657
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC1,Sialoadhesin,42676,0.0063064570025984,0.00434049593282063,-0.00220091502573003,0.0148138290309268,0.146265168887775
NMR metabolomics,X23412.Phospholipids in VLDL,DENND2B,DENN domain-containing protein 2B,40116,-0.00730658125043637,0.00504764170046005,-0.0171999589833381,0.00258679648246533,0.147778990808378
NMR metabolomics,X23412.Phospholipids in VLDL,CLNS1A,Methylosome subunit pICln,40182,0.00484914056782342,0.00336549416107042,-0.0017472279878746,0.0114455091235214,0.149658219527098
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.00930742238807581,0.00646235329581972,-0.00335879007173084,0.0219736348478825,0.149823623011946
NMR metabolomics,X23412.Phospholipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0164661277729789,0.0114731016504628,-0.0060211514619282,0.038953407007886,0.151255531386079
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00705310488167447,0.00491467289766739,-0.0166858637611026,0.00257965399775361,0.151283886693287
NMR metabolomics,X23412.Phospholipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.0103823461888413,0.00724238441221363,-0.00381272725909746,0.02457741963678,0.151728320334486
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAX,Integrin alpha-X,40302,0.00783893676799616,0.00549471590633202,-0.00293070640841461,0.0186085799444069,0.153714141551693
NMR metabolomics,X23412.Phospholipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.0111935533076346,0.00784802587311536,-0.00418857740367149,0.0265756840189407,0.153813602710316
NMR metabolomics,X23412.Phospholipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.00545854899629028,0.00383017550911665,-0.00204859500157834,0.0129656929941589,0.154143425893386
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.00575548742580951,0.00406097153959384,-0.00220401679179441,0.0137149916434134,0.156427402530529
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00796332986307299,0.00564628582689525,-0.0190300500837877,0.0031033903576417,0.158459930420262
NMR metabolomics,X23412.Phospholipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.0056044935458494,0.0040003914407548,-0.0134452607697288,0.00223627367803,0.161246309854367
NMR metabolomics,X23412.Phospholipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.006678780690529,0.00476813715801848,-0.00266676813918722,0.0160243295202452,0.161328799561408
NMR metabolomics,X23412.Phospholipids in VLDL,SYT1,Synaptotagmin-1,40483,0.00597324685025472,0.00427176941019982,-0.00239942119373693,0.0143459148942464,0.162048239976992
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00482901744632902,0.00345479162939144,-0.0116004090399362,0.00194237414727821,0.162204330377194
NMR metabolomics,X23412.Phospholipids in VLDL,GFRAL,GDNF family receptor alpha-like,40109,-0.00885995244352448,0.00634134443499094,-0.0212889875361067,0.00356908264905776,0.162390087029641
NMR metabolomics,X23412.Phospholipids in VLDL,ITM2A,Integral membrane protein 2A,42594,-0.00866225250078228,0.00621112784721697,-0.0208360630813275,0.00351155807976298,0.163149237472787
NMR metabolomics,X23412.Phospholipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.0100219680882359,0.00719273572055617,-0.00407579392405424,0.024119730100526,0.163543431354593
NMR metabolomics,X23412.Phospholipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00683958059751278,0.00491378732622427,-0.0164706037569124,0.00279144256188679,0.163976092718277
NMR metabolomics,X23412.Phospholipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00478039266995717,0.00343667465566125,-0.0115162749950532,0.00195548965513889,0.16425563191906
NMR metabolomics,X23412.Phospholipids in VLDL,NTF3,Neurotrophin-3,42594,0.00501966887674784,0.00361022139825696,-0.0020563650638358,0.0120957028173315,0.164429105521448
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN4,Nectin-4,42679,-0.00480964128980555,0.00347128505147961,-0.0116133599907056,0.00199407741109448,0.165907068617755
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.0053153886766644,0.00383882417075715,-0.00220870669801962,0.0128394840513484,0.166190767420735
NMR metabolomics,X23412.Phospholipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,40136,0.0155930516103525,0.011314604591794,-0.00658357338956375,0.0377696766102688,0.168189817684957
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D2,DCN1-like protein 2,40080,0.0111386130534681,0.00809318538330366,-0.00472403029780706,0.0270012564047433,0.168758534453334
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.00415750556075396,0.00302298298322479,-0.0100825522078746,0.00176754108636662,0.169061719341328
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.00643042747909392,0.00468050504191554,-0.0156042173612484,0.00274336240306054,0.169503366108048
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR1,Folate receptor alpha,42600,0.00418698401416635,0.00305402484470425,-0.00179890468145398,0.0101728727097867,0.170406485353711
NMR metabolomics,X23412.Phospholipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00521157153614511,0.00380429748627663,-0.00224485153695709,0.0126679946092473,0.170739961128183
NMR metabolomics,X23412.Phospholipids in VLDL,DLGAP5,Disks large-associated protein 5,40482,0.00699299752487307,0.00512313274810171,-0.00304834266140627,0.0170343377111524,0.172285081594522
NMR metabolomics,X23412.Phospholipids in VLDL,CA14,Carbonic anhydrase 14,42721,0.0049374812787488,0.00361729834298752,-0.00215242347350673,0.0120273860310043,0.172287130905482
NMR metabolomics,X23412.Phospholipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00874182843256066,0.006425210970363,-0.00385158506935081,0.0213352419344721,0.173683171185551
NMR metabolomics,X23412.Phospholipids in VLDL,GAGE2A,G antigen 2A,40080,0.00912364906067066,0.00673214503085944,-0.00407135519981385,0.0223186533211552,0.17537031942347
NMR metabolomics,X23412.Phospholipids in VLDL,FCRLB,Fc receptor-like B,42346,0.00885459713958687,0.00653730097566151,-0.0039585127727097,0.0216677070518834,0.175608815563523
NMR metabolomics,X23412.Phospholipids in VLDL,CLINT1,Clathrin interactor 1,40080,0.00630916087403286,0.00466490326259704,-0.00283404952065735,0.0154523712687231,0.176251788985166
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6B,Ras-related protein Rab-6B,42311,0.00670268210127122,0.00496020226850188,-0.00301931434499246,0.0164246785475349,0.176625189111831
NMR metabolomics,X23412.Phospholipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00767029718317202,0.00567633646520865,-0.00345532228863693,0.018795916654981,0.17663497703697
NMR metabolomics,X23412.Phospholipids in VLDL,KLK3,Prostate-specific antigen,40527,0.0133660924709332,0.00990504887584782,-0.00604780332572852,0.0327799882675949,0.177228362243339
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.00497415008174424,0.00369528195170069,-0.0122169027070776,0.00226860254358912,0.17829902814977
NMR metabolomics,X23412.Phospholipids in VLDL,RTKN2,Rhotekin-2,40116,-0.00701811592483027,0.00521475328540447,-0.017239032364223,0.00320280051456249,0.178388715406263
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2B,Alpha-amylase 2B,41779,-0.00678787828984484,0.0050504791219234,-0.0166868173688147,0.00311106078912502,0.178970415546555
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.00362201757644821,0.00270088211418257,-0.00167171136734963,0.00891574652024605,0.179931248374642
NMR metabolomics,X23412.Phospholipids in VLDL,HRAS,GTPase Hras,40286,0.013456200692165,0.0100605923364848,-0.00626256028734526,0.0331749616716753,0.181081769299396
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0108230234006036,0.00810016241555027,-0.0266993417350821,0.00505329493387491,0.181523714534742
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.00949999841556902,0.00712549061451242,-0.00446596318887532,0.0234659600200134,0.182479530724022
NMR metabolomics,X23412.Phospholipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,40532,-0.003656901321477,0.00275559640632714,-0.0090578702778782,0.00174406763492419,0.184508410668123
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB1,Scavenger receptor class B member 1,42311,0.00774611199714872,0.00585317574452564,-0.00372611246212153,0.019218336456419,0.185724366516999
NMR metabolomics,X23412.Phospholipids in VLDL,CD2,T-cell surface antigen CD2,40116,0.00514201438663511,0.00389285793003113,-0.00248798715622591,0.0127720159294961,0.186567665047854
NMR metabolomics,X23412.Phospholipids in VLDL,BRD2,Bromodomain-containing protein 2,40136,0.00476526325544461,0.00361241683844273,-0.00231507374790314,0.0118456002587924,0.187151794232381
NMR metabolomics,X23412.Phospholipids in VLDL,GH2,Growth hormone variant,42346,0.0221238316502024,0.0167896604706785,-0.0107839028723275,0.0550315661727322,0.187625131094187
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3A,Uroplakin-3a,40136,0.00679101598808932,0.00516345299919398,-0.00332935189033088,0.0169113838665095,0.188467482880488
NMR metabolomics,X23412.Phospholipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00709231645981964,0.00539413214063177,-0.00348018253581864,0.0176648154554579,0.188597783461437
NMR metabolomics,X23412.Phospholipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.0076620974401981,0.00585503487340842,-0.0038137709116824,0.0191379657920786,0.190680746805081
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,42311,0.005320812733053,0.00406720088618589,-0.00265090100387135,0.0132925264699774,0.190820024171243
NMR metabolomics,X23412.Phospholipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,40519,-0.0033271981411645,0.00255664930063307,-0.00833823077040532,0.00168383448807631,0.19315142709423
NMR metabolomics,X23412.Phospholipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",40483,0.00788146079204777,0.00605870686665289,-0.00399360466659191,0.0197565262506874,0.193336809213016
NMR metabolomics,X23412.Phospholipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,42721,0.00762379833667841,0.00588247740010579,-0.00390585736752893,0.0191534540408857,0.194991293543498
NMR metabolomics,X23412.Phospholipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,40302,0.0104129014719247,0.00806643681597878,-0.00539731468739372,0.0262231176312431,0.196767878504471
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00984906159788692,0.00763821289627008,-0.00512183567880243,0.0248199588745763,0.19727040010443
NMR metabolomics,X23412.Phospholipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00598315586663739,0.00465096543478495,-0.0150990481188159,0.0031327363855411,0.198319057662669
NMR metabolomics,X23412.Phospholipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00657798876524411,0.00514093180679283,-0.00349823757606984,0.0166542151065581,0.200736657572269
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR1,Cadherin-related family member 1,42311,0.00549035997228626,0.00430733510517663,-0.00295201683385993,0.0139327367784324,0.202454474538502
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00647112308232486,0.00508119580965291,-0.00348802070459484,0.0164302668692446,0.202852356248288
NMR metabolomics,X23412.Phospholipids in VLDL,SHH,Sonic hedgehog protein,40199,-0.00542284154568639,0.00426805628817909,-0.0137882318705174,0.00294254877914462,0.203910420069699
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.00394143598614927,0.00311657050402853,-0.0100499141740452,0.00216704220174664,0.206015516099401
NMR metabolomics,X23412.Phospholipids in VLDL,RGS8,Regulator of G-protein signaling 8,42370,0.00819932634047177,0.00649230742263563,-0.00452559620789407,0.0209242488888376,0.206636878486607
NMR metabolomics,X23412.Phospholipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.00441861254265571,0.00350068949555867,-0.00244273886863928,0.0112799639539507,0.20689438125642
NMR metabolomics,X23412.Phospholipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.00490139200343046,0.00389411271717792,-0.00273106892223826,0.0125338529290992,0.208172532275423
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00235536430045688,0.00189036124523685,-0.00134974374020735,0.0060604723411211,0.212795137061936
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00563714699194114,0.00452682625378543,-0.00323543246547831,0.0145097264493606,0.213052548970924
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,40504,0.00617503940994322,0.00498600230083916,-0.00359752509970153,0.015947603919588,0.215565674929041
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.00424138314906602,0.00342725716905728,-0.00247604090228624,0.0109588072004183,0.215906861892552
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN1,Contactin-1,42794,-0.00346274770656667,0.00279874556198569,-0.00894828900805862,0.00202279359492528,0.216015677835507
NMR metabolomics,X23412.Phospholipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.00926089973859992,0.00750385453242859,-0.00544665514496012,0.02396845462216,0.217167742746093
NMR metabolomics,X23412.Phospholipids in VLDL,AGR2,Anterior gradient protein 2 homolog,42215,0.01252115253619,0.0101934600967579,-0.00745802925345546,0.0325003343258355,0.219337227748707
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB5,Serpin B5,42357,0.00598498815568661,0.00489662120803399,-0.00361238941206001,0.0155823657234332,0.221627815794652
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0061979210767056,0.00509861799603104,-0.00379537019551523,0.0161912123489264,0.224156085785581
NMR metabolomics,X23412.Phospholipids in VLDL,SLC4A1,Band 3 anion transport protein,40527,-0.00572347084107347,0.004730299627801,-0.0149948581115634,0.00354791642941649,0.226319681314701
NMR metabolomics,X23412.Phospholipids in VLDL,RBP1,Retinol-binding protein 1,40182,0.00833893599255151,0.00689658708697417,-0.00517837469791786,0.0218562466830209,0.226635265145196
NMR metabolomics,X23412.Phospholipids in VLDL,CTNNA1,Catenin alpha-1,40136,-0.00428383281762136,0.00355301566865402,-0.0112477435281832,0.00268007789294051,0.227963400599992
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0105216684325853,0.00873025529546818,-0.00658963194653231,0.0276329688117029,0.228148943436237
NMR metabolomics,X23412.Phospholipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.013349186011268,0.0111396884482371,-0.00848460334727665,0.0351829753698127,0.230808874078051
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3B,Sodium channel subunit beta-3,40136,0.00582802748920335,0.00486391236679786,-0.00370524074972045,0.0153612957281272,0.230858100531727
NMR metabolomics,X23412.Phospholipids in VLDL,CD70,CD70 antigen,42594,0.00521741419577261,0.00435652917049046,-0.0033213829783887,0.0137562113699339,0.231090843127969
NMR metabolomics,X23412.Phospholipids in VLDL,TEX101,Testis-expressed protein 101,40182,0.00639289553451448,0.00534007777082934,-0.00407365689631102,0.01685944796534,0.231272356785159
NMR metabolomics,X23412.Phospholipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00865226272006914,0.00723660391800501,-0.00553148095922067,0.022836006399359,0.231868832037444
NMR metabolomics,X23412.Phospholipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00400650171234076,0.00336933705588317,-0.00259739891719026,0.0106104023418718,0.234419080375904
NMR metabolomics,X23412.Phospholipids in VLDL,CORO6,Coronin-6,40136,-0.00446309411623027,0.00375885831977296,-0.0118304564229853,0.00290426819052474,0.235113932489673
NMR metabolomics,X23412.Phospholipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.00345829226096359,0.00292131560408004,-0.00918407084496047,0.00226748632303328,0.236508132391482
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO1,Amphoterin-induced protein 1,40182,0.00603451236738892,0.00510286338295331,-0.00396709986319958,0.0160361245979774,0.237003702855115
NMR metabolomics,X23412.Phospholipids in VLDL,CD160,CD160 antigen,42754,0.0058012863872934,0.00493365699426442,-0.00386868132146486,0.0154712540960517,0.23967175472981
NMR metabolomics,X23412.Phospholipids in VLDL,OTOA,Otoancorin,40136,-0.00648593259397799,0.00551996879104749,-0.0173050714244311,0.00433320623647509,0.240022511696554
NMR metabolomics,X23412.Phospholipids in VLDL,MUCL3,Mucin-like protein 3,40080,-0.00505137111021175,0.00429919295021628,-0.0134777892926357,0.00337504707221217,0.240037222248974
NMR metabolomics,X23412.Phospholipids in VLDL,VASN,Vasorin,42449,0.00325097266665008,0.00276900986839557,-0.00217628667540523,0.0086782320087054,0.240393686974722
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC8,Histone deacetylase 8,40199,0.00699397064009815,0.00597186315429064,-0.00471088114231152,0.0186988224225078,0.241562290853202
NMR metabolomics,X23412.Phospholipids in VLDL,CCNE1,G1/S-specific cyclin-E1,40199,0.0104813778073188,0.00895403338572719,-0.00706852762870652,0.0280312832433441,0.241794541065607
NMR metabolomics,X23412.Phospholipids in VLDL,OMD,Osteomodulin,42676,-0.00496095588816058,0.00424359819693053,-0.0132784083541444,0.00335649657782325,0.242406300024759
NMR metabolomics,X23412.Phospholipids in VLDL,COL3A1,Collagen alpha-1(III) chain,40527,-0.0027532037491747,0.0023551478598437,-0.00736929355446835,0.00186288605611896,0.242422077423468
NMR metabolomics,X23412.Phospholipids in VLDL,GLI2,Zinc finger protein GLI2,40199,-0.00377939633884823,0.00324260111665245,-0.010134894527487,0.00257610184979056,0.243823864195312
NMR metabolomics,X23412.Phospholipids in VLDL,CD58,Lymphocyte function-associated antigen 3,42600,0.00207365075310239,0.00178287649264214,-0.00142078717247622,0.00556808867868099,0.244812568544447
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00791888608062285,0.00681108167335914,-0.00543083399916106,0.0212686061604068,0.244997859887167
NMR metabolomics,X23412.Phospholipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,42587,0.00532277598110892,0.00457839228032148,-0.00365087288832119,0.014296424850539,0.24501812110352
NMR metabolomics,X23412.Phospholipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00369134501318387,0.00318554601926603,-0.00993501521094528,0.00255232518457754,0.246571546835844
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN7,Tetraspanin-7,40136,-0.0109758772971882,0.00952154413959401,-0.0296381038107925,0.00768634921641603,0.249041760864169
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1,Huntingtin-interacting protein 1,40116,0.00386997633906179,0.00337653285285243,-0.00274802805252897,0.0104879807306526,0.251762709807634
NMR metabolomics,X23412.Phospholipids in VLDL,FBN2,Fibrillin-2,40182,0.00700985702244286,0.00614507478471839,-0.00503448955560518,0.0190542036004909,0.254008117774154
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.00579215289773123,0.00508137887723826,-0.00416734970165576,0.0157516554971182,0.254357871246831
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00498759431989967,0.00437656205828551,-0.0135656559541393,0.00359046731433992,0.254471863248082
NMR metabolomics,X23412.Phospholipids in VLDL,LPO,Lactoperoxidase,42134,-0.00696236287053895,0.00612230098155152,-0.0189620727943799,0.00503734705330202,0.255470133314051
NMR metabolomics,X23412.Phospholipids in VLDL,PADI2,Protein-arginine deiminase type-2,42370,0.00636931752055119,0.00560766471511958,-0.00462170532108318,0.0173603403621856,0.256051087226212
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN1,Cerebellin-1,40136,0.0108797076775172,0.00958660462148754,-0.00791003738059838,0.0296694527356328,0.256447758088271
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00387673542616054,0.00342981648375312,-0.0105991757343167,0.00284570488199556,0.2583729536934
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,42357,-0.0039837811443938,0.00353100041593249,-0.0109045419596215,0.00293697967083388,0.259243295176841
NMR metabolomics,X23412.Phospholipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.00744645453929387,0.00660739444679287,-0.00550403857642015,0.0203969476550079,0.259768152186325
NMR metabolomics,X23412.Phospholipids in VLDL,AKAP12,A-kinase anchor protein 12,40283,-0.0025064044650903,0.00222425962148305,-0.00686595332319708,0.00185314439301649,0.259830763200681
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.00556850965877907,0.00494609364558007,-0.00412583388655786,0.015262853204116,0.260253359533686
NMR metabolomics,X23412.Phospholipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,40136,0.00693169384971288,0.00616222146586877,-0.00514626022338989,0.0190096479228157,0.260669090038396
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00418397993223307,0.00372003926201784,-0.0031072970213219,0.011475256885788,0.26073485014918
NMR metabolomics,X23412.Phospholipids in VLDL,GPR101,Probable G-protein coupled receptor 101,40136,-0.00677844090609773,0.0061013946213593,-0.0187371743639619,0.0051802925517665,0.266607471350762
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.0035334351267274,0.00318709168317933,-0.00978013482575889,0.00271326457230408,0.267591876750269
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.00345312921547416,0.00313227162492471,-0.00268612316937826,0.00959238160032658,0.270291728508707
NMR metabolomics,X23412.Phospholipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00533598498039632,0.0048535703596001,-0.00417701292441987,0.0148489828852125,0.271620582345177
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00672391657789885,0.00611697086890752,-0.00526534632515989,0.0187131794809576,0.271694885872283
NMR metabolomics,X23412.Phospholipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.00399893021963098,0.00364094640306995,-0.00313732473038612,0.0111351851696481,0.272084135868903
NMR metabolomics,X23412.Phospholipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00222892633268407,0.00203146614000098,-0.00621059996708599,0.00175274730171785,0.272573165085898
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,40182,0.00544087910930512,0.00497182002309854,-0.00430388813596802,0.0151856463545783,0.273828325739852
NMR metabolomics,X23412.Phospholipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00492108757527944,0.00451492252610946,-0.00392816057589509,0.013770335726454,0.275753775974368
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.00544118099328752,0.00499516411479054,-0.015231702658277,0.00434934067170194,0.276049938326993
NMR metabolomics,X23412.Phospholipids in VLDL,IL33,Interleukin-33,42370,0.00424239737219669,0.0039022212590271,-0.00340595629549643,0.0118907510398898,0.276979367239043
NMR metabolomics,X23412.Phospholipids in VLDL,GSN,Gelsolin,40488,0.00212396069066764,0.00195679838920972,-0.00171136415218342,0.0059592855335187,0.277755998978293
NMR metabolomics,X23412.Phospholipids in VLDL,REG4,Regenerating islet-derived protein 4,42638,0.00573372390456028,0.00528855117006761,-0.00463183638877224,0.0160992841978928,0.2783059069297
NMR metabolomics,X23412.Phospholipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,42689,0.00300971003656335,0.0027844534255995,-0.00244781867761168,0.00846723875073838,0.279761820372336
NMR metabolomics,X23412.Phospholipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00432583527088048,0.0040299473444193,-0.00357286152418135,0.0122245320659423,0.283105264553555
NMR metabolomics,X23412.Phospholipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.0044031577602989,0.004104129400146,-0.00364093586398726,0.0124472513845851,0.283357432518383
NMR metabolomics,X23412.Phospholipids in VLDL,IL2,Interleukin-2,42370,-0.00345584391347557,0.00323042438419092,-0.00978747570648977,0.00287578787953863,0.284737871628377
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00549438802875015,0.00514401373260752,-0.0155766549446609,0.00458787888716059,0.285493141547112
NMR metabolomics,X23412.Phospholipids in VLDL,IL17F,Interleukin-17F,42370,0.0081158172321611,0.0076098494540037,-0.00679948769768616,0.0230311221620084,0.286222397514061
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.0065629683642548,0.00617411959025215,-0.018664242761149,0.00553830603263941,0.287810390238199
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA3,GDNF family receptor alpha-3,42474,0.00307390533367282,0.00289763940355654,-0.00260546789729799,0.00875327856464364,0.288786061992752
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA1,Laminin subunit alpha-1,40116,-0.005748173532923,0.00544872760104387,-0.016427679630969,0.00493133256512298,0.291468309273238
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0078559573293511,0.00751298427578127,-0.0225814065098824,0.00686949185118019,0.295745426793903
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR1B,Cornifin-B,40302,-0.00874641926669929,0.00838560711047319,-0.0251822092032267,0.00768937066982816,0.296958230731642
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,40451,0.00384983693110065,0.00369228292947852,-0.00338703761067725,0.0110867114728786,0.297123009785429
NMR metabolomics,X23412.Phospholipids in VLDL,ENG,Endoglin,42794,0.00181878402799583,0.00174862467384954,-0.00160852033274928,0.00524608838874093,0.298301439231719
NMR metabolomics,X23412.Phospholipids in VLDL,TPSG1,Tryptase gamma,40199,0.00279075327667797,0.0026864083672351,-0.00247460712310283,0.00805611367645877,0.298901145616409
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00396625040187544,0.00382035114729091,-0.00352163784681475,0.0114541386505656,0.299204584930772
NMR metabolomics,X23412.Phospholipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00281608313890016,0.0027164118609957,-0.00250808410865141,0.00814025038645172,0.299902329506692
NMR metabolomics,X23412.Phospholipids in VLDL,CASP4,Caspase-4,40302,0.0180718874493688,0.0174392743405035,-0.0161090902580181,0.0522528651567557,0.300096332196564
NMR metabolomics,X23412.Phospholipids in VLDL,MERTK,Tyrosine-protein kinase Mer,42754,-0.00265608836344865,0.00256889906724771,-0.00769113053525415,0.00237895380835686,0.301182495881667
NMR metabolomics,X23412.Phospholipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.00618134782235452,0.00598181030556889,-0.00554300037656051,0.0179056960212695,0.301459522292745
NMR metabolomics,X23412.Phospholipids in VLDL,HEPACAM2,HEPACAM family member 2,40483,-0.00437578805300839,0.0042473014036548,-0.0127004988041718,0.00394892269815502,0.302914096850672
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0304522405420895,0.0298008032684802,-0.0279573338641318,0.0888618149483107,0.306865712746596
NMR metabolomics,X23412.Phospholipids in VLDL,ISM2,Isthmin-2,40527,0.00444586541827194,0.0043715811153276,-0.00412243356777016,0.013014164404314,0.309178684503045
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00496920398485015,0.00489124646249671,-0.0145560470513437,0.0046176390816434,0.309681334542039
NMR metabolomics,X23412.Phospholipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00465542195465442,0.00459046708093854,-0.00434189352398512,0.013652737433294,0.31052991309699
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0129287971204833,0.0127690984732799,-0.0120986358871452,0.0379562301281119,0.311314494947576
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00330789580360761,0.00326846547990136,-0.00971408814421427,0.00309829653699905,0.311525766544555
NMR metabolomics,X23412.Phospholipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.003789745194068,0.00375260527576004,-0.00356536114642167,0.0111448515345577,0.312566588596419
NMR metabolomics,X23412.Phospholipids in VLDL,CPE,Carboxypeptidase E,42588,0.00390300481811452,0.0038845057771285,-0.00371062650505735,0.0115166361412864,0.315029489814934
NMR metabolomics,X23412.Phospholipids in VLDL,PGM2,Phosphoglucomutase-2,40182,0.00605655602991855,0.00603413144620526,-0.00577034160464377,0.0178834536644809,0.315537485333572
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.00697461161242939,0.00698072867119675,-0.020656839807975,0.00670761658311624,0.317752802245125
NMR metabolomics,X23412.Phospholipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.0044122591236117,0.00443013080772881,-0.00427079725953678,0.0130953155067602,0.319288135697268
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00849352208461008,0.00854172538163975,-0.025235303832624,0.00824825966340384,0.320071329369292
NMR metabolomics,X23412.Phospholipids in VLDL,S100A3,Protein S100-A3,40451,0.00433266938801171,0.00438880165127517,-0.00426938184848762,0.012934720624511,0.323560861556484
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00407798531771101,0.00413648664024988,-0.0121854991326008,0.00402952849717876,0.324224877889972
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,40483,0.00307641201348776,0.00312065957661719,-0.00304008075668194,0.00919290478365745,0.324242044210957
NMR metabolomics,X23412.Phospholipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.00639426842270631,0.00650115100488842,-0.006347987546875,0.0191365243922876,0.325353924489012
NMR metabolomics,X23412.Phospholipids in VLDL,MLLT1,Protein ENL,40080,0.00656942728134737,0.00670438193867653,-0.00657116131845864,0.0197100158811534,0.327171733482153
NMR metabolomics,X23412.Phospholipids in VLDL,PKLR,Pyruvate kinase PKLR,42636,0.00640882975279883,0.00655126400445676,-0.00643164769593642,0.0192493072015341,0.327964090795381
NMR metabolomics,X23412.Phospholipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00526301757921533,0.00542079663881914,-0.00536174383287018,0.0158877789913008,0.331622528523333
NMR metabolomics,X23412.Phospholipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00479233609921939,0.00494763965300418,-0.00490503762066879,0.0144897098191076,0.332760810388573
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00275447625787574,0.00284775542499701,-0.0028271243751184,0.00833607689086989,0.333439086218522
NMR metabolomics,X23412.Phospholipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00277309911425263,0.00287299372973465,-0.00285796859602729,0.00840416682453255,0.334450942282285
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.00326547176949994,0.00338491764715753,-0.00336896681892882,0.00989991035792871,0.334710072645053
NMR metabolomics,X23412.Phospholipids in VLDL,ACTA2,"Actin, aortic smooth muscle",42357,-0.00423571847350769,0.00442163144600921,-0.0129021161076857,0.00443067916067036,0.338103669376354
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.00309470493402242,0.00324897816256289,-0.00327329226460085,0.00946270213264568,0.340852319254192
NMR metabolomics,X23412.Phospholipids in VLDL,PRND,Prion-like protein doppel,40483,-0.00501457643647093,0.00527775611752819,-0.0153589784268262,0.00532982555388432,0.342064422024086
NMR metabolomics,X23412.Phospholipids in VLDL,CDH1,Cadherin-1,42188,0.0037873023990381,0.00400202353838497,-0.00405666373619644,0.0116312685342727,0.343989298518309
NMR metabolomics,X23412.Phospholipids in VLDL,CDC123,Cell division cycle protein 123 homolog,40080,0.0060110304665445,0.00637634909992488,-0.00648661376930826,0.0185086747023973,0.345851588761446
NMR metabolomics,X23412.Phospholipids in VLDL,TFF1,Trefoil factor 1,42556,-0.00783318362701969,0.00834330294334551,-0.0241860573959769,0.00851969014193751,0.347820200390893
NMR metabolomics,X23412.Phospholipids in VLDL,FGF3,Fibroblast growth factor 3,40199,0.00275645978970262,0.00293989017689915,-0.00300572495701972,0.00851864453642495,0.348467306671707
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.00320999146276475,0.00343364078457433,-0.00993992740053043,0.00351994447500093,0.34987453668184
NMR metabolomics,X23412.Phospholipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",40136,0.00764136405119816,0.00818665901424308,-0.00840448761671828,0.0236872157191146,0.350638077875877
NMR metabolomics,X23412.Phospholipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00757786686209572,0.00813489291416815,-0.0235222569738653,0.00836652324967385,0.351601621229556
NMR metabolomics,X23412.Phospholipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0253287752085734,0.0273645269971041,-0.0283056977057506,0.0789632481228975,0.354670934556266
NMR metabolomics,X23412.Phospholipids in VLDL,CADPS,Calcium-dependent secretion activator 1,40182,0.00399627707779754,0.00432264454787843,-0.00447610623604419,0.0124686603916393,0.355247293212443
NMR metabolomics,X23412.Phospholipids in VLDL,PGR,Progesterone receptor,40199,0.00912184406291978,0.00988281230229237,-0.0102484680495733,0.0284921561754128,0.356027002608761
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.0041595646886946,0.00450791917974307,-0.0046759569036018,0.012995086280991,0.356167625298381
NMR metabolomics,X23412.Phospholipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00340141932670979,0.00368748643830427,-0.00382605409236658,0.0106288927457862,0.356325288123933
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.00291373738210342,0.00316164846568517,-0.00328309361063952,0.00911056837484635,0.356759851987261
NMR metabolomics,X23412.Phospholipids in VLDL,FH,"Fumarate hydratase, mitochondrial",40136,0.00796481357142404,0.00864725916209455,-0.00898381438628127,0.0249134415291293,0.357029203215748
NMR metabolomics,X23412.Phospholipids in VLDL,CDH22,Cadherin-22,40302,-0.00261027144020941,0.00283740491639678,-0.00817158507634709,0.00295104219592827,0.357618720431748
NMR metabolomics,X23412.Phospholipids in VLDL,IKZF2,Zinc finger protein Helios,42346,0.00813906758542608,0.00885370414333029,-0.00921419253550129,0.0254923277063535,0.35796396124774
NMR metabolomics,X23412.Phospholipids in VLDL,TNXB,Tenascin-X,42611,0.00236473059959779,0.00259676929825,-0.0027249372249722,0.00745439842416779,0.362499700128019
NMR metabolomics,X23412.Phospholipids in VLDL,SELENOP,Selenoprotein P,40539,0.00210915184946833,0.00232280238772992,-0.00244354083048231,0.00666184452941897,0.363886754463594
NMR metabolomics,X23412.Phospholipids in VLDL,TJP3,Tight junction protein ZO-3,40136,-0.0038548226941471,0.00425046536750321,-0.0121857348144534,0.00447608942615918,0.364470239497576
NMR metabolomics,X23412.Phospholipids in VLDL,KLK12,Kallikrein-12,42346,0.0127258398323432,0.0140515667005265,-0.0148152309006887,0.0402669105653751,0.36513627668658
NMR metabolomics,X23412.Phospholipids in VLDL,TCP11,T-complex protein 11 homolog,40302,0.00539148015243337,0.00597670130260122,-0.00632285440066502,0.0171058147055318,0.367032381591724
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,40182,0.00381756094839117,0.00424126887260567,-0.00449532604191594,0.0121304479386983,0.368087409763872
NMR metabolomics,X23412.Phospholipids in VLDL,CLSPN,Claspin,42292,0.00317352743377407,0.00353129390634883,-0.00374780862266963,0.0100948634902178,0.368835997794797
NMR metabolomics,X23412.Phospholipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.0067140236736361,0.00747654924019437,-0.0213680601844171,0.00794001283714487,0.369199133458384
NMR metabolomics,X23412.Phospholipids in VLDL,RETN,Resistin,42598,0.00390670861621809,0.00436265593513319,-0.00464409701664296,0.0124575142490792,0.370542042416639
NMR metabolomics,X23412.Phospholipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",40116,0.00560203080620756,0.00625903291263161,-0.0066656737025504,0.0178697353149655,0.370790042307301
NMR metabolomics,X23412.Phospholipids in VLDL,TUBB3,Tubulin beta-3 chain,40136,-0.00253696518592582,0.00284163852024534,-0.00810657668560668,0.00303264631375504,0.371993285218329
NMR metabolomics,X23412.Phospholipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.00543142762767017,0.0060961218352836,-0.00651697116948569,0.017379826424826,0.372967886822447
NMR metabolomics,X23412.Phospholipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00350899584527325,0.00397931851670524,-0.00429046844746902,0.0113084601380155,0.377899381392831
NMR metabolomics,X23412.Phospholipids in VLDL,PI16,Peptidase inhibitor 16,40532,-0.00221626831997858,0.00253217279532417,-0.00717932699881395,0.00274679035885679,0.381459853522934
NMR metabolomics,X23412.Phospholipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00264843762292848,0.0030315980256526,-0.00329349450735061,0.00859036975320757,0.382348601103283
NMR metabolomics,X23412.Phospholipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00619047530563743,0.00711830435107737,-0.00776140122247422,0.0201423518337491,0.384507275784606
NMR metabolomics,X23412.Phospholipids in VLDL,TNNI3,"Troponin I, cardiac muscle",42357,0.00735827025098739,0.00848400442244702,-0.00927037841700877,0.0239869189189836,0.38578744850513
NMR metabolomics,X23412.Phospholipids in VLDL,STEAP4,Metalloreductase STEAP4,40136,0.00637521518032072,0.00735673363191969,-0.00804398273824188,0.0207944130988833,0.386189914563026
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.00276742865467168,0.00320545776361639,-0.00351526856201645,0.00905012587135981,0.387961088194574
NMR metabolomics,X23412.Phospholipids in VLDL,MORN4,MORN repeat-containing protein 4,40080,-0.00668181750559523,0.00776521816079278,-0.0219016451007491,0.00853801008955862,0.389543270722614
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2A,Pancreatic alpha-amylase,42114,-0.0042011598240061,0.00492609199414559,-0.0138563001325315,0.00545398048451926,0.393764801736091
NMR metabolomics,X23412.Phospholipids in VLDL,HEBP1,Heme-binding protein 1,42357,0.00450876752422667,0.00530562918499096,-0.00589026567835561,0.014907800726809,0.395447150679949
NMR metabolomics,X23412.Phospholipids in VLDL,PITHD1,PITH domain-containing protein 1,40065,-0.00690973835224555,0.00815307927573238,-0.022889773732681,0.00907029702818992,0.396734894422608
NMR metabolomics,X23412.Phospholipids in VLDL,ESPL1,Separin,40080,0.0049125253270378,0.00580926907562006,-0.00647364206117751,0.0162986927152531,0.3977745893343
NMR metabolomics,X23412.Phospholipids in VLDL,EDNRB,Endothelin receptor type B,40199,0.00380363602261109,0.00450489192048116,-0.00502595214153199,0.0126332241867542,0.398500822220126
NMR metabolomics,X23412.Phospholipids in VLDL,LY96,Lymphocyte antigen 96,42495,-0.00303430056024059,0.00359508788827499,-0.0100806728212596,0.00401207170077838,0.398677375262739
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA2,Ephrin type-A receptor 2,42125,0.00284872435157545,0.00339001775401441,-0.0037957104462928,0.00949315914944369,0.400740454660922
NMR metabolomics,X23412.Phospholipids in VLDL,CAPN3,Calpain-3,40451,-0.00323835394037674,0.00385574270754337,-0.0107956096471618,0.00431890176640827,0.400994562796913
NMR metabolomics,X23412.Phospholipids in VLDL,RBM25,RNA-binding protein 25,40080,-0.00401130060751326,0.00479399094678128,-0.0134075228632046,0.00538492164817804,0.40275983864853
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00351897057643458,0.00421096339505334,-0.0117724588307391,0.00473451767786997,0.403356172185344
NMR metabolomics,X23412.Phospholipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00332911911024108,0.00398388836449809,-0.00447930208417517,0.0111375403046573,0.403372541025815
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS2,Podocin,40199,-0.00886777065131421,0.0106135062123967,-0.0296702428276118,0.0119347015249834,0.403444511593005
NMR metabolomics,X23412.Phospholipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.00229376134927763,0.00274694996820643,-0.00309026058840698,0.00767778328696224,0.403723388820767
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00459238204616639,0.0054998904307845,-0.015372167290504,0.00618740319817122,0.40373840956696
NMR metabolomics,X23412.Phospholipids in VLDL,PRC1,Protein regulator of cytokinesis 1,40451,0.00373289472934662,0.00449040696745105,-0.00506830292685744,0.0125340923855507,0.405819364608367
NMR metabolomics,X23412.Phospholipids in VLDL,SLC44A4,Choline transporter-like protein 4,40182,-0.00597737209109632,0.00719710655988779,-0.0200837009484764,0.00812895676628374,0.40626044351523
NMR metabolomics,X23412.Phospholipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00654246250413907,0.00792989026572243,-0.00900012241667688,0.022085047424955,0.409367805903026
NMR metabolomics,X23412.Phospholipids in VLDL,EPO,Erythropoietin,42594,0.00612965230956243,0.00743533543738454,-0.00844360514771126,0.0207029097668361,0.409729908644257
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.00222568324988767,0.00273791210058853,-0.00759199096704119,0.00314062446726586,0.416285245195922
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC1,Plexin domain-containing protein 1,42346,-0.00257878658894708,0.00317338068533207,-0.00879861273219794,0.00364103955430379,0.416444529632681
NMR metabolomics,X23412.Phospholipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00410097223004043,0.00506646895691664,-0.0140312513855971,0.00582930692551619,0.418282913481711
NMR metabolomics,X23412.Phospholipids in VLDL,CD177,CD177 antigen,42595,-0.0106024402375662,0.0132581909700278,-0.0365884945388206,0.0153836140636883,0.423904711807557
NMR metabolomics,X23412.Phospholipids in VLDL,PXDNL,Peroxidasin-like protein,40451,-0.00449196875062581,0.00562120314316848,-0.015509526911236,0.00652558940998442,0.424242552389243
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA10,Annexin A10,42311,-0.00691941092476707,0.00868392536867929,-0.0239399046473785,0.0101010827978443,0.425577657544013
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00462261213825435,0.00581320136521128,-0.0160164868140685,0.00677126253755976,0.426518981092234
NMR metabolomics,X23412.Phospholipids in VLDL,IL24,Interleukin-24,42370,0.00401796778051377,0.00508908949210914,-0.00595664762402014,0.0139925831850477,0.429818926159971
NMR metabolomics,X23412.Phospholipids in VLDL,RYR1,Ryanodine receptor 1,40116,-0.00273462471587128,0.00348568281747515,-0.00956656303812256,0.00409731360638001,0.432745868539317
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0038545471941056,0.00492589369893918,-0.0058002044558152,0.0135092988440264,0.433930643073379
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.00381963844075051,0.00488133698229521,-0.0133870589260491,0.00574778204454809,0.433938469079399
NMR metabolomics,X23412.Phospholipids in VLDL,IL13,Interleukin-13,42370,-0.00372452651843289,0.00478103079628904,-0.0130953468791594,0.00564629384229363,0.435980949916016
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM1,Neural cell adhesion molecule 1,42689,-0.0023670474121067,0.00303950672536655,-0.00832448059382513,0.00359038576961172,0.436134535466151
NMR metabolomics,X23412.Phospholipids in VLDL,BMP4,Bone morphogenetic protein 4,42475,-0.00364930008052344,0.00469021920165924,-0.0128421297157756,0.00554352955472867,0.436543967544352
NMR metabolomics,X23412.Phospholipids in VLDL,DCLRE1C,Protein artemis,40080,0.0024526963764842,0.00315605701914223,-0.00373317538103457,0.00863856813400297,0.437093395366507
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM132A,Transmembrane protein 132A,40223,0.00490987648785506,0.00632891202973985,-0.00749479109043505,0.0173145440661452,0.437892439462629
NMR metabolomics,X23412.Phospholipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,42311,0.00436100713707783,0.00566061772388179,-0.00673380360173048,0.0154558178758861,0.441069484303494
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC2,MAM domain-containing protein 2,40511,0.00283381478354436,0.00368392514321831,-0.00438667849716352,0.0100543080642522,0.441768158095556
NMR metabolomics,X23412.Phospholipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,40449,0.00361202857048025,0.00469680297322824,-0.0055937052570471,0.0128177623980076,0.441885802116885
NMR metabolomics,X23412.Phospholipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.00611027241403791,0.00795460057723662,-0.00948074471734586,0.0217012895454217,0.442418616103699
NMR metabolomics,X23412.Phospholipids in VLDL,HCG22,Protein PBMUCL2,40116,-0.00441357609321524,0.00576063703990788,-0.0157044246914347,0.0068772725050042,0.443597000538493
NMR metabolomics,X23412.Phospholipids in VLDL,MYH4,Myosin-4,40116,-0.00349982206292881,0.00458269396170331,-0.0124819022278673,0.00548225810200968,0.445060107090128
NMR metabolomics,X23412.Phospholipids in VLDL,SHD,SH2 domain-containing adapter protein D,40083,-0.00673568291654365,0.00888356987834483,-0.0241474798780995,0.0106761140450122,0.448336874325024
NMR metabolomics,X23412.Phospholipids in VLDL,GKN1,Gastrokine-1,42017,0.00213669719081647,0.00282901337462008,-0.00340816902343888,0.00768156340507183,0.450094875000546
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL2,Interferon lambda-2,40136,0.00471789057826308,0.00625416167630531,-0.00754026630729533,0.0169760474638215,0.450649204392171
NMR metabolomics,X23412.Phospholipids in VLDL,IL1A,Interleukin-1 alpha,42370,0.00439119696410639,0.00587012858829829,-0.00711425506895825,0.015896648997171,0.454438493133448
NMR metabolomics,X23412.Phospholipids in VLDL,RAP1A,Ras-related protein Rap-1A,40199,0.00534930467447917,0.00717397290496649,-0.00871168221925515,0.0194102915682135,0.455892119547025
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00219688311589283,0.00296151593864178,-0.00360768812384507,0.00800145435563072,0.458218091367596
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL2,Podocalyxin-like protein 2,42679,0.00210868643964149,0.00284431136537076,-0.0034661638364852,0.00768353671576818,0.458482183790089
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.00457696887258976,0.0062180030688912,-0.00761031714243699,0.0167642548876165,0.461692921847176
NMR metabolomics,X23412.Phospholipids in VLDL,OSTN,Osteocrin,40182,-0.00309079863463005,0.00422203507890994,-0.0113659873892935,0.00518439012003343,0.464145300116547
NMR metabolomics,X23412.Phospholipids in VLDL,ACHE,Acetylcholinesterase,40283,0.00241968569360001,0.00335615924465253,-0.00415838642591895,0.00899775781311898,0.470943984941369
NMR metabolomics,X23412.Phospholipids in VLDL,TSLP,Thymic stromal lymphopoietin,42357,0.00442216431863433,0.00614032219430877,-0.00761286718221085,0.0164571958194795,0.471424249062377
NMR metabolomics,X23412.Phospholipids in VLDL,CDSN,Corneodesmosin,42710,0.00321541588833887,0.00448164076284866,-0.0055686000068445,0.0119994317835222,0.473100243713771
NMR metabolomics,X23412.Phospholipids in VLDL,HBZ,Hemoglobin subunit zeta,40511,0.00763523717315358,0.010731580911165,-0.0133986614127299,0.0286691357590371,0.476805430458797
NMR metabolomics,X23412.Phospholipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,40080,0.00244724692826915,0.00345083156934012,-0.00431638294763749,0.0092108768041758,0.478230452634262
NMR metabolomics,X23412.Phospholipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00418724213087112,0.00590711146931092,-0.0157651806107205,0.00739069634897829,0.478434121014063
NMR metabolomics,X23412.Phospholipids in VLDL,IL22,Interleukin-22,40451,0.00498626946216033,0.00705954065543491,-0.00885043022249208,0.0188229691468128,0.480006004136579
NMR metabolomics,X23412.Phospholipids in VLDL,CDC25A,M-phase inducer phosphatase 1,40080,-0.00276743056738998,0.00393712596541462,-0.0104841974596026,0.00494933632482267,0.482129188023991
NMR metabolomics,X23412.Phospholipids in VLDL,CD82,CD82 antigen,40302,-0.00290479622772405,0.00413576878412437,-0.0110109030446078,0.00520131058915971,0.482469753247166
NMR metabolomics,X23412.Phospholipids in VLDL,TYMP,Thymidine phosphorylase,42563,0.00458155547577033,0.00652700324488742,-0.00821137088420902,0.0173744818357497,0.482729679222447
NMR metabolomics,X23412.Phospholipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00339322881775996,0.00487325022142376,-0.0129447992517505,0.00615834161623061,0.486257757482234
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00636014745545252,0.00913622455710068,-0.0242671475873699,0.0115468526764648,0.486351686424226
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,40182,0.00714465106736736,0.010383043549407,-0.0132061142894704,0.0274954164242051,0.491399557374289
NMR metabolomics,X23412.Phospholipids in VLDL,GAD2,Glutamate decarboxylase 2,40199,-0.00320124403694074,0.00465917956284484,-0.0123332359801166,0.00593074790623516,0.492044773920247
NMR metabolomics,X23412.Phospholipids in VLDL,TFF2,Trefoil factor 2,42654,0.00400565228926178,0.00585061467971496,-0.00746155248297953,0.0154728570615031,0.493573473008194
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.00482020891765177,0.00705194575727937,-0.00900160476661579,0.0186420226019193,0.494286934937802
NMR metabolomics,X23412.Phospholipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.0032439150382978,0.00478869837928136,-0.0126297638616893,0.00614193378509365,0.49815706895501
NMR metabolomics,X23412.Phospholipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,40451,0.00358487323671713,0.00531405217424964,-0.00683066902481216,0.0140004154982464,0.499942155519873
NMR metabolomics,X23412.Phospholipids in VLDL,EPB41L5,Band 4.1-like protein 5,40182,0.00416597074303586,0.00618446815066601,-0.00795558683226951,0.0162875283183412,0.500568202693911
NMR metabolomics,X23412.Phospholipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.0029779029750575,0.00450573071683921,-0.0118091351800624,0.00585332922994735,0.508681031064874
NMR metabolomics,X23412.Phospholipids in VLDL,SAG,S-arrestin,40136,-0.00347697657267862,0.00529349821654914,-0.0138522330771149,0.00689827993175768,0.511298198021853
NMR metabolomics,X23412.Phospholipids in VLDL,CNTF,Ciliary neurotrophic factor,40136,-0.00227924326984904,0.00347208624923923,-0.00908453231835794,0.00452604577865986,0.511549868378517
NMR metabolomics,X23412.Phospholipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00382995751783201,0.00584818494419261,-0.0076324849727855,0.0152924000084495,0.512548047414084
NMR metabolomics,X23412.Phospholipids in VLDL,FZD8,Frizzled-8,40136,0.00301328540978094,0.00462238789293646,-0.00604659486037453,0.0120731656799364,0.514486252051452
NMR metabolomics,X23412.Phospholipids in VLDL,MSLNL,Mesothelin-like protein,40182,-0.0025864831491157,0.00397257802854125,-0.0103727360850566,0.00519976978682515,0.515005691641485
NMR metabolomics,X23412.Phospholipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0112861319194753,0.0173475428842106,-0.0227150521335775,0.0452873159725282,0.51532270786833
NMR metabolomics,X23412.Phospholipids in VLDL,RASA1,Ras GTPase-activating protein 1,42311,0.00212011071699108,0.0032606382099032,-0.00427074017441919,0.00851096160840136,0.515565762091456
NMR metabolomics,X23412.Phospholipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00626115726625956,0.00966648690600136,-0.0126851570695031,0.0252074716020222,0.517180994509861
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171A2,Protein FAM171A2,40482,0.0104312180370487,0.0161263264535596,-0.0211763818119281,0.0420388178860255,0.517746043237091
NMR metabolomics,X23412.Phospholipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.00212069544134541,0.0033254290364354,-0.00439714547006798,0.0086385363527588,0.523666271177888
NMR metabolomics,X23412.Phospholipids in VLDL,ADA2,Adenosine deaminase 2,42572,-0.00284327290620249,0.00446182899026116,-0.0115884577271144,0.00590191191470939,0.523976949878102
NMR metabolomics,X23412.Phospholipids in VLDL,TXK,Tyrosine-protein kinase TXK,40302,0.004820129571998,0.00757546007641647,-0.0100277721777783,0.0196680313217743,0.524605686197531
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN6,Prefoldin subunit 6,40182,0.00415693800813784,0.00653818340597516,-0.00865790146757348,0.0169717774838492,0.524923917332552
NMR metabolomics,X23412.Phospholipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00404878038032319,0.00639568857438126,-0.00848676922546408,0.0165843299861105,0.526715338694151
NMR metabolomics,X23412.Phospholipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.00239594563511475,0.00378870171252262,-0.00502990972142959,0.00982180099165909,0.527141782522944
NMR metabolomics,X23412.Phospholipids in VLDL,EFNB2,Ephrin-B2,40182,0.00344459116336349,0.00550653535432573,-0.00734821813111493,0.0142374004578419,0.531625759327671
NMR metabolomics,X23412.Phospholipids in VLDL,TNN,Tenascin-N,40527,0.00277709274390903,0.00444487522381834,-0.00593486269477491,0.011489048182593,0.532124551674536
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA5,Annexin A5,42261,-0.00192754257617528,0.00308769178120655,-0.00797941846734013,0.00412433331498957,0.532463471683164
NMR metabolomics,X23412.Phospholipids in VLDL,EXOSC10,Exosome component 10,40116,0.00380017704353921,0.00610381970037707,-0.00816330956919986,0.0157636636562783,0.533566989027962
NMR metabolomics,X23412.Phospholipids in VLDL,IL19,Interleukin-19,42261,0.00452422129306979,0.00727096468732831,-0.0097268694940937,0.0187753120802333,0.533800691109694
NMR metabolomics,X23412.Phospholipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,40199,-0.00778174515408468,0.0126663453504011,-0.0326077820408709,0.0170442917327015,0.538987595028387
NMR metabolomics,X23412.Phospholipids in VLDL,BSND,Barttin,40080,0.00211545137551839,0.00344795564282169,-0.00464254168441212,0.0088734444354489,0.539533566883028
NMR metabolomics,X23412.Phospholipids in VLDL,EVI2B,Protein EVI2B,40080,-0.00253448258283969,0.00413501933750339,-0.0106391204843463,0.00557015531866695,0.539934601707077
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.00213608248730718,0.00348763668077523,-0.00469968540701227,0.00897185038162662,0.540235293973332
NMR metabolomics,X23412.Phospholipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.00305289839893273,0.00500702804795181,-0.00676087657505281,0.0128666733729183,0.54205823332109
NMR metabolomics,X23412.Phospholipids in VLDL,KLK1,Kallikrein-1,42505,-0.00793032505748221,0.0130394039991541,-0.0334875568958242,0.0176269067808598,0.543077440461195
NMR metabolomics,X23412.Phospholipids in VLDL,KCNIP4,Kv channel-interacting protein 4,42311,0.00301963624348738,0.0049650798635696,-0.00671192028910904,0.0127511927760838,0.543082104356004
NMR metabolomics,X23412.Phospholipids in VLDL,ABO,Histo-blood group ABO system transferase,40532,0.00888998173602734,0.0146528643361379,-0.019829632362803,0.0376095958348577,0.544058141028642
NMR metabolomics,X23412.Phospholipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00330335908717832,0.00545711902314318,-0.00739259419818232,0.013999312372539,0.544971968809127
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00225236631208443,0.00374494084876646,-0.00959245037566668,0.00508771775149782,0.54755775524281
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN1,Calsyntenin-1,42311,0.00319792025468046,0.00534962878072339,-0.00728735215553738,0.0136831926648983,0.549994666903152
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D1,DCN1-like protein 1,40136,-0.00445462516362481,0.00757062147900314,-0.019293043262471,0.0103837929352214,0.556269646169105
NMR metabolomics,X23412.Phospholipids in VLDL,MMP8,Neutrophil collagenase,42681,0.00431415789907604,0.00733978933616071,-0.010071829199799,0.018700144997951,0.556691958025985
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.00339541999110307,0.0057818544376603,-0.00793701470671111,0.0147278546889173,0.557042633981441
NMR metabolomics,X23412.Phospholipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00267679275543433,0.00456737257051959,-0.0116288429936527,0.00627525748278406,0.557841698169934
NMR metabolomics,X23412.Phospholipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00414790728001221,0.00708869326357944,-0.00974593151660349,0.0180417460766279,0.558462871599406
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4C,Semaphorin-4C,42587,-0.00163319159105015,0.00279798627458023,-0.0071172446892274,0.00385086150712709,0.559430312821674
NMR metabolomics,X23412.Phospholipids in VLDL,PYDC1,Pyrin domain-containing protein 1,40223,-0.0024900839274806,0.00432236554416266,-0.0109619203940394,0.00598175253907821,0.564564172551552
NMR metabolomics,X23412.Phospholipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.00415216653423223,0.00720986863111821,-0.0182835090512239,0.00997917598275947,0.564692090639814
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00172010603375821,0.0029961646499415,-0.00415237668012713,0.00759258874764354,0.565908147420567
NMR metabolomics,X23412.Phospholipids in VLDL,TPBGL,Trophoblast glycoprotein-like,40182,-0.00240638962830741,0.00423949055148025,-0.0107157911092087,0.00590301185259388,0.570309426296157
NMR metabolomics,X23412.Phospholipids in VLDL,FZD10,Frizzled-10,40182,0.00347490169149443,0.00612395047502368,-0.00852804123955199,0.0154778446225408,0.570434943360651
NMR metabolomics,X23412.Phospholipids in VLDL,DNLZ,DNL-type zinc finger protein,40136,0.00520005949762102,0.00919686124881758,-0.0128257885500614,0.0232259075453035,0.571801919919737
NMR metabolomics,X23412.Phospholipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00294197844304029,0.00521128670361518,-0.013156100382126,0.00727214349604547,0.572398434454653
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA11,Serpin A11,42794,-0.00231976712196136,0.00411051954218854,-0.0103763854246509,0.00573685118072818,0.572526024904182
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00384695907154089,0.00683099796259558,-0.0172357150782282,0.00954179693514645,0.57333607699069
NMR metabolomics,X23412.Phospholipids in VLDL,COL5A1,Collagen alpha-1(V) chain,40283,-0.00233678071566222,0.00416730155044252,-0.0105046917545296,0.00583113032320511,0.574984807763572
NMR metabolomics,X23412.Phospholipids in VLDL,MYL6B,Myosin light chain 6B,40182,0.00513085067168987,0.0091798853069614,-0.0128617245299545,0.0231234258733342,0.576225540426832
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00399516302646971,0.00719309470793303,-0.0180936286540184,0.010103302601079,0.578621207754283
NMR metabolomics,X23412.Phospholipids in VLDL,THY1,Thy-1 membrane glycoprotein,42711,0.0016738356220473,0.00302916168286654,-0.00426332127637112,0.00761099252046572,0.580564369367461
NMR metabolomics,X23412.Phospholipids in VLDL,AREG,Amphiregulin,42587,-0.00234787764023121,0.00428204547210501,-0.010740686765557,0.00604493148509461,0.583489918573284
NMR metabolomics,X23412.Phospholipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.00221911833563524,0.00405451758999572,-0.00572773614075637,0.0101659728120269,0.584170043808022
NMR metabolomics,X23412.Phospholipids in VLDL,CLMP,CXADR-like membrane protein,42721,0.00120798860384875,0.00220890356954431,-0.00312146239245809,0.00553743960015559,0.584475354970945
NMR metabolomics,X23412.Phospholipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00156960932475256,0.00287525165315649,-0.00720510256493928,0.00406588391543417,0.585143160029162
NMR metabolomics,X23412.Phospholipids in VLDL,UBQLN3,Ubiquilin-3,40116,-0.00297172199739147,0.00548256710074911,-0.0137175535148597,0.00777410952007677,0.587808124079303
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00187605104022053,0.00346594922255091,-0.00491720943597924,0.00866931151642031,0.588323183956295
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF174,Zinc finger protein 174,40199,0.0020426349080455,0.00378274965900573,-0.00537155442360573,0.00945682423969672,0.589217057494358
NMR metabolomics,X23412.Phospholipids in VLDL,CD200,OX-2 membrane glycoprotein,42594,-0.00147251077751203,0.00276210340033898,-0.00688623344217643,0.00394121188715236,0.593964816354496
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN3,Perilipin-3,42636,0.00223930297627955,0.00422674693785443,-0.00604512102191514,0.0105237269744742,0.596263875143279
NMR metabolomics,X23412.Phospholipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00296713726866737,0.00560794877651472,-0.0139587168706362,0.00802444233330149,0.596750385924592
NMR metabolomics,X23412.Phospholipids in VLDL,OMP,Olfactory marker protein,40136,-0.00265792615223646,0.00508393310983413,-0.0126224350475114,0.00730658274303843,0.601117738474149
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00333784495073697,0.00639874495067734,-0.0158793850540646,0.00920369515259062,0.601931012158298
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM3,Intercellular adhesion molecule 3,42794,-0.00140225168162722,0.00270530846032441,-0.00670465626386306,0.00390015290060863,0.604234118780597
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN4,Prefoldin subunit 4,40080,0.00274565772464818,0.00530337726244253,-0.00764896170973918,0.0131402771590355,0.604665050632206
NMR metabolomics,X23412.Phospholipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00172434640706948,0.00334585383934156,-0.00483352711803998,0.00828221993217894,0.606304459529258
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00225109039167669,0.00436845050329295,-0.0108132533781309,0.0063110725947775,0.60634935526736
NMR metabolomics,X23412.Phospholipids in VLDL,IL15,Interleukin-15,42594,-0.00171410883079632,0.00333886298750113,-0.00825828028629854,0.00483006262470589,0.607693295197826
NMR metabolomics,X23412.Phospholipids in VLDL,COPE,Coatomer subunit epsilon,42311,0.00244837027164886,0.00477572263933836,-0.00691204610145433,0.0118087866447521,0.608190731145168
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00266886460961193,0.00525244867564879,-0.0076259347946597,0.0129636640138836,0.611380734964261
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.00240087253225793,0.00478004456332978,-0.00696801481186844,0.0117697598763843,0.615487631484677
NMR metabolomics,X23412.Phospholipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00317271457925502,0.00632419590083299,-0.0155681385448877,0.00922270938637763,0.615903620995498
NMR metabolomics,X23412.Phospholipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00142220151853319,0.00285240125334044,-0.00701290797508045,0.00416850493801407,0.618072338926739
NMR metabolomics,X23412.Phospholipids in VLDL,MYOC,Myocilin,42611,-0.00223860950709082,0.00449620667968374,-0.0110511745992709,0.0065739555850893,0.618570807985445
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00196747856034319,0.00395298150732952,-0.00578036519402266,0.00971532231470904,0.618689607790119
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00239021272458759,0.00481431996115776,-0.0118262798484568,0.00704585439928163,0.619565943826162
NMR metabolomics,X23412.Phospholipids in VLDL,PRG3,Proteoglycan 3,40527,0.00248768831685727,0.00502478872635746,-0.00736089758680334,0.0123362742205179,0.620551013534972
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.001447786430832,0.00293181383827131,-0.00719414155384377,0.00429856869217977,0.621443671820136
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA10,Ephrin type-A receptor 10,42311,-0.00331663225690362,0.00674231448354775,-0.0165315686446572,0.00989830413084996,0.622789067861556
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,42370,0.00299294171238268,0.00609866400101156,-0.00896043972959997,0.0149463231543653,0.623608857921295
NMR metabolomics,X23412.Phospholipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,40449,-0.00251445900419052,0.00515039329374121,-0.0126092298599233,0.00758031185154225,0.625412607657287
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB116,Beta-defensin 116,40136,0.00379660804499555,0.00777913778185892,-0.0114505020074479,0.019043718097439,0.62552421853494
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00180857175210876,0.00371233951101115,-0.00908475719369061,0.0054676136894731,0.626141695912278
NMR metabolomics,X23412.Phospholipids in VLDL,NEB,Nebulin,40116,-0.00188300191832612,0.0038807398930075,-0.00948925210862082,0.00572324827196858,0.627531982774802
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC9,Histone deacetylase 9,40136,0.00319894037164687,0.00662975336204365,-0.00979537621795869,0.0161932569612524,0.629451412120716
NMR metabolomics,X23412.Phospholipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00245438063532793,0.00510563389027627,-0.00755266178961355,0.0124614230602694,0.630725131985949
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00168159121094943,0.00350750455102153,-0.00855630013095163,0.00519311770905278,0.63164290492438
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.0018832677354418,0.00394543625256316,-0.00584978731958199,0.0096163227904656,0.633138029269623
NMR metabolomics,X23412.Phospholipids in VLDL,PSCA,Prostate stem cell antigen,40449,0.0128127999426665,0.0268440227958803,-0.0398014847372589,0.0654270846225919,0.633153857294832
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN15,Tetraspanin-15,40116,0.00250521078121959,0.00526662387281996,-0.00781737200950753,0.0128277935719467,0.634314166341249
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.0015784586852089,0.00336040886142757,-0.00500794268318914,0.00816486005360694,0.638562856400592
NMR metabolomics,X23412.Phospholipids in VLDL,KDM3A,Lysine-specific demethylase 3A,40199,-0.00415459400751966,0.00885460838870002,-0.0215096264493717,0.0132004384343324,0.638935031986521
NMR metabolomics,X23412.Phospholipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00231697716313388,0.00494650406398426,-0.00737817080227528,0.012012125128543,0.639502835317945
NMR metabolomics,X23412.Phospholipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00119206633710766,0.00254672159216414,-0.00618364065774937,0.00379950798353404,0.639737624170797
NMR metabolomics,X23412.Phospholipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.00242838748527729,0.00518916993213468,-0.00774238558170669,0.0125991605522613,0.639814015728736
NMR metabolomics,X23412.Phospholipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.00153740440917231,0.00329595725376548,-0.00492267180820803,0.00799748062655266,0.640900022993567
NMR metabolomics,X23412.Phospholipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,40223,0.00186863320812234,0.00403958481837964,-0.00604895303590175,0.00978621945214643,0.643674206835101
NMR metabolomics,X23412.Phospholipids in VLDL,DHODH,Dihydroorotate dehydrogenase,40116,0.00225902167125136,0.00491511071327659,-0.00737459532677075,0.0118926386692735,0.645807133740729
NMR metabolomics,X23412.Phospholipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.00138180647191737,0.00302585734230062,-0.00731248686282659,0.00454887391899185,0.647918424619665
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00169932266340079,0.00374271843196292,-0.00903505079004811,0.00563640546324654,0.649812845779712
NMR metabolomics,X23412.Phospholipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00316480336413771,0.00702939084325395,-0.0169424094169154,0.01061280268864,0.652557571074198
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00142890476061116,0.00319762148935112,-0.00483843335851703,0.00769624287973935,0.65498146311336
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,40302,0.00179866866277491,0.00403180753355996,-0.00610367410300262,0.00970101142855243,0.655519497613022
NMR metabolomics,X23412.Phospholipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,42311,0.00169983069435212,0.00384499955798526,-0.005836368439299,0.00923602982800324,0.658432340045241
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF830,Zinc finger protein 830,40451,-0.00344942298820168,0.00782027468438756,-0.0187771613696013,0.011878315393198,0.659158347712048
NMR metabolomics,X23412.Phospholipids in VLDL,CYTH3,Cytohesin-3,40080,-0.00329044258216369,0.00754365232149839,-0.0180760011323005,0.0114951159679732,0.662709756366754
NMR metabolomics,X23412.Phospholipids in VLDL,KLHL41,Kelch-like protein 41,40482,-0.00207744826349655,0.00483189840786189,-0.0115479691429059,0.00739307261591274,0.667244203224927
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00258738709424472,0.00605385260354506,-0.014452938197193,0.00927816400870361,0.669099982653379
NMR metabolomics,X23412.Phospholipids in VLDL,ANK2,Ankyrin-2,40116,0.00317941695991691,0.00744096696661936,-0.011404878294657,0.0177637122144908,0.669179848265812
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN1,Neuroligin-1,40182,0.00299517538287495,0.00705246059808024,-0.0108276473893623,0.0168179981551122,0.671064178272702
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL1,Interferon lambda-1,42311,0.00194751299690252,0.00460917659721735,-0.0070864731336435,0.0109814991274485,0.672645512491415
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS5,Transmembrane protease serine 5,42438,0.00160462018954217,0.00383490331045075,-0.0059117902989413,0.00912103067802565,0.67564304872798
NMR metabolomics,X23412.Phospholipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00232950412319016,0.00561103092994915,-0.00866811649951018,0.0133271247458905,0.678029239771769
NMR metabolomics,X23412.Phospholipids in VLDL,ALMS1,Alstrom syndrome protein 1,40302,-0.00185623433311395,0.00450269267826049,-0.0106815119825045,0.00696904331627661,0.680164265686565
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00179598581981235,0.00439681095622414,-0.0104137352940117,0.00682176365438696,0.68293318488894
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.001681450256086,0.00411901411797536,-0.00639181741514571,0.0097547179273177,0.68312126870828
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.00185806861356397,0.00459031192373107,-0.00713894275694893,0.0108550799840769,0.685646680691119
NMR metabolomics,X23412.Phospholipids in VLDL,PCNA,Proliferating cell nuclear antigen,40080,0.00254783476884515,0.00631670485270912,-0.00983290674246473,0.014928576280155,0.686699632766836
NMR metabolomics,X23412.Phospholipids in VLDL,FGF12,Fibroblast growth factor 12,40199,0.00189043170849803,0.00473130133749987,-0.00738291891300172,0.0111637823299978,0.689489475279181
NMR metabolomics,X23412.Phospholipids in VLDL,CPLX2,Complexin-2,40080,-0.00127585765467523,0.00320700613974038,-0.00756158968856636,0.00500987437921591,0.690759992266756
NMR metabolomics,X23412.Phospholipids in VLDL,H2AP,Huntingtin-interacting protein M,40080,-0.002096950205156,0.00531949397720363,-0.0125231584004751,0.00832925799016311,0.693440319173359
NMR metabolomics,X23412.Phospholipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.00150155115893169,0.00381353579604605,-0.00897608131918194,0.00597297900131857,0.693778838655431
NMR metabolomics,X23412.Phospholipids in VLDL,MSMB,Beta-microseminoprotein,42559,-0.00279806066113536,0.00728085775829985,-0.0170685418674031,0.0114724205451323,0.700759471407004
NMR metabolomics,X23412.Phospholipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00139915663041194,0.00367851611366474,-0.00860904821319483,0.00581073495237095,0.703686313174442
NMR metabolomics,X23412.Phospholipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.0023911572328084,0.00639901644883543,-0.010150915006909,0.0149332294725258,0.708652782907189
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP29,Dual specificity phosphatase 29,40182,0.00252262716051206,0.00679665984894791,-0.0107988261434258,0.01584408046445,0.710527832726072
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.0028508955557204,0.00772796018493245,-0.0122959064067472,0.017997697518188,0.712204277890741
NMR metabolomics,X23412.Phospholipids in VLDL,CGN,Cingulin,40182,0.00153399854188786,0.00415919350858395,-0.00661802073493669,0.00968601781871241,0.712268143306145
NMR metabolomics,X23412.Phospholipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.00552166862657737,0.0151794370005043,-0.0242300278944111,0.0352733651475659,0.716043139543598
NMR metabolomics,X23412.Phospholipids in VLDL,TPSD1,Tryptase delta,40482,-0.00140679771910473,0.00387241706501475,-0.00899673516653363,0.00618313972832417,0.716397510529166
NMR metabolomics,X23412.Phospholipids in VLDL,CRX,Cone-rod homeobox protein,42357,0.00387127208975243,0.0106935473712869,-0.0170880807579699,0.0248306249374748,0.717343310602125
NMR metabolomics,X23412.Phospholipids in VLDL,NENF,Neudesin,40451,0.00399898352435116,0.0110995902952651,-0.0177562134543685,0.0257541805030708,0.71864295524243
NMR metabolomics,X23412.Phospholipids in VLDL,TET2,Methylcytosine dioxygenase TET2,40286,0.00370339290208388,0.0103324010875972,-0.0165481132296067,0.0239548990337744,0.720031958691373
NMR metabolomics,X23412.Phospholipids in VLDL,OPTC,Opticin,42587,-0.00166437391168381,0.00466049929914556,-0.0107989525380091,0.00747020471464149,0.721004964665294
NMR metabolomics,X23412.Phospholipids in VLDL,FGF7,Fibroblast growth factor 7,40080,0.00284268023875674,0.00800752868487583,-0.0128520759835999,0.0185374364611134,0.722595761651075
NMR metabolomics,X23412.Phospholipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.000994528966710221,0.00282203650661649,-0.00652572051967854,0.0045366625862581,0.724532358143513
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.0014121632660947,0.00402617510090402,-0.00647913993167717,0.00930346646386658,0.725784704028757
NMR metabolomics,X23412.Phospholipids in VLDL,TEX33,Testis-expressed protein 33,40302,0.00134899489540165,0.00385204531307538,-0.00620101391822611,0.0088990037090294,0.726193566152507
NMR metabolomics,X23412.Phospholipids in VLDL,IL10,Interleukin-10,42370,0.0029597797261124,0.00855230388115814,-0.0138027358809576,0.0197222953331824,0.729288259900286
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3D,Protein FAM3D,40449,-0.00297802157465578,0.00864595621217383,-0.0199240957505165,0.0139680526012049,0.730521114756336
NMR metabolomics,X23412.Phospholipids in VLDL,CA3,Carbonic anhydrase 3,42770,0.00205184128048195,0.00599214155053888,-0.00969275615857426,0.0137964387195382,0.73203861204543
NMR metabolomics,X23412.Phospholipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00241425700869,0.0070650768716629,-0.0162618076771493,0.0114332936597693,0.73257043713661
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.00181506398896969,0.00534254245776886,-0.0122864472061966,0.00865631922825728,0.734060279227231
NMR metabolomics,X23412.Phospholipids in VLDL,EPGN,Epigen,40451,0.00155783335178431,0.00458953492052159,-0.00743765509243801,0.0105533217960066,0.734290920788195
NMR metabolomics,X23412.Phospholipids in VLDL,DCN,Decorin,42357,0.00080796411494847,0.00241811377231159,-0.00393153887878224,0.00554746710867918,0.738286860833111
NMR metabolomics,X23412.Phospholipids in VLDL,HBQ1,Hemoglobin subunit theta-1,42721,0.00201273997760038,0.00606135056668062,-0.00986750713309363,0.0138929870882944,0.739848113076546
NMR metabolomics,X23412.Phospholipids in VLDL,APOA4,Apolipoprotein A-IV,40539,0.00118017542147213,0.00364078429366018,-0.00595576179410182,0.00831611263704608,0.745827290914737
NMR metabolomics,X23412.Phospholipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,40182,0.00250362647946578,0.0077761515011357,-0.0127376304627602,0.0177448834216917,0.747487491327979
NMR metabolomics,X23412.Phospholipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00116933976859663,0.0036640397671224,-0.00835085771215653,0.00601217817496327,0.749626845532395
NMR metabolomics,X23412.Phospholipids in VLDL,MAGEA3,Melanoma-associated antigen 3,40302,-0.0027757841502276,0.0087657374887486,-0.0199566296281749,0.0144050613277197,0.751505327555434
NMR metabolomics,X23412.Phospholipids in VLDL,WNT9A,Protein Wnt-9a,42370,0.000939874579156057,0.00298876836520991,-0.00491811141665536,0.00679786057496748,0.753169943288242
NMR metabolomics,X23412.Phospholipids in VLDL,PAEP,Glycodelin,42495,0.00281717738433506,0.00907056480669026,-0.0149611296367778,0.020595484405448,0.756121332529832
NMR metabolomics,X23412.Phospholipids in VLDL,FBLN2,Fibulin-2,40527,-0.00101795288496739,0.00329419195788083,-0.00747456912241381,0.00543866335247903,0.757316222519865
NMR metabolomics,X23412.Phospholipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.000802443126461946,0.00261401633556038,-0.00432102889123639,0.00592591514416029,0.758866663099803
NMR metabolomics,X23412.Phospholipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.00194491754135335,0.00635373700310644,-0.0105084069847353,0.014398242067442,0.75952961385031
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,42754,-0.00186162863173633,0.00611783850514862,-0.0138525921018276,0.010129334838355,0.760907703500076
NMR metabolomics,X23412.Phospholipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.000974074153401902,0.00320645010368093,-0.00725871635661652,0.00531056804981272,0.761295857265343
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.00128345827484474,0.00429013716206096,-0.00712521056279474,0.00969212711248422,0.764819910540573
NMR metabolomics,X23412.Phospholipids in VLDL,RUVBL1,RuvB-like 1,42346,0.00317728627930918,0.0106371244137737,-0.0176714775716873,0.0240260501303057,0.765175310520811
NMR metabolomics,X23412.Phospholipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00155707185736453,0.00522809028863226,-0.0118041288230838,0.0086899851083547,0.7658400469644
NMR metabolomics,X23412.Phospholipids in VLDL,SCIN,Adseverin,40136,0.00212260544697137,0.00736680827235517,-0.0123163387668448,0.0165615496607875,0.773251961332592
NMR metabolomics,X23412.Phospholipids in VLDL,PSMA1,Proteasome subunit alpha type-1,42346,0.00132850762308999,0.00465294796004052,-0.00779127037858942,0.0104482856247694,0.775250622488914
NMR metabolomics,X23412.Phospholipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00162708317747152,0.00579143641993705,-0.00972413220560509,0.0129782985605481,0.778756837605436
NMR metabolomics,X23412.Phospholipids in VLDL,SHC1,SHC-transforming protein 1,40080,0.00329259476922422,0.0119313451660522,-0.0200928417562381,0.0266780312946866,0.782582691151329
NMR metabolomics,X23412.Phospholipids in VLDL,HSP90B1,Endoplasmin,42247,-0.00185273853772935,0.00671586633143983,-0.0150158365473514,0.0113103594718927,0.782648567655574
NMR metabolomics,X23412.Phospholipids in VLDL,IL3,Interleukin-3,40080,0.00168884907875527,0.00624089846729973,-0.0105433119171522,0.0139210100746627,0.786696190250785
NMR metabolomics,X23412.Phospholipids in VLDL,MMP15,Matrix metalloproteinase-15,40511,0.00132941651241916,0.00492891070230328,-0.00833124846409528,0.0109900814889336,0.78738203936451
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00474727871604445,0.0176663059087273,-0.029878680865061,0.0393732382971499,0.7881505647047
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00113193890924,0.00421301585440791,-0.00938944998387951,0.00712557216539951,0.788183572210736
NMR metabolomics,X23412.Phospholipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00101819400039528,0.00382938193461677,-0.00852378259224416,0.00648739459145359,0.790329018341356
NMR metabolomics,X23412.Phospholipids in VLDL,NCLN,Nicalin,42370,-0.00138013593434391,0.00522047446668299,-0.0116122658890426,0.00885199402035475,0.791499093746956
NMR metabolomics,X23412.Phospholipids in VLDL,MAPT,Microtubule-associated protein tau,42311,-0.00141591695448762,0.00535897798555558,-0.0119195138061766,0.00908767989720132,0.791619182660487
NMR metabolomics,X23412.Phospholipids in VLDL,ENPEP,Glutamyl aminopeptidase,40116,0.00127006100708669,0.00482077566239882,-0.008178659291215,0.0107187813053884,0.792204305115304
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR1,TGF-beta receptor type-1,40199,0.000558685347951161,0.00218372219541898,-0.00372141015507005,0.00483878085097237,0.798078509347516
NMR metabolomics,X23412.Phospholipids in VLDL,OBP2B,Odorant-binding protein 2b,42462,0.00158127833996562,0.00618326341796081,-0.0105379179592376,0.0137004746391688,0.798159248296618
NMR metabolomics,X23412.Phospholipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00112974750114489,0.00443150876219318,-0.00981550467504352,0.00755600967275374,0.798777880627527
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.00163580936120297,0.00658584023415596,-0.0145440562201486,0.0112724374977427,0.803842026202813
NMR metabolomics,X23412.Phospholipids in VLDL,VCAN,Versican core protein,42711,-0.00075287129620886,0.0030737721974377,-0.00677746480318676,0.00527172221076904,0.806511259101574
NMR metabolomics,X23412.Phospholipids in VLDL,FGF6,Fibroblast growth factor 6,40199,-0.00102309347691244,0.0041906572422401,-0.00923678167170304,0.00719059471787816,0.807129455318136
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB5,Integrin beta-5,42679,0.000906252258884626,0.00373901696439416,-0.00642222099132793,0.00823472550909718,0.808491627694155
NMR metabolomics,X23412.Phospholipids in VLDL,MN1,Transcriptional activator MN1,40182,-0.00143762496317911,0.0059840174531343,-0.0131662991713223,0.0102910492449641,0.810145499630329
NMR metabolomics,X23412.Phospholipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.000714351517685952,0.00299548201524697,-0.00515679323219812,0.00658549626757002,0.811516023663936
NMR metabolomics,X23412.Phospholipids in VLDL,PALLD,Palladin,40199,0.0009383476940565,0.00393807113700416,-0.00678027173447165,0.00865696712258465,0.811671499242545
NMR metabolomics,X23412.Phospholipids in VLDL,CD209,CD209 antigen,42668,-0.000924694704732194,0.00390311952998547,-0.00857480898350372,0.00672541957403933,0.812728890364253
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC2,Plexin domain-containing protein 2,40483,0.000650386840300242,0.00275209024815008,-0.00474371004607392,0.0060444837266744,0.813185026812951
NMR metabolomics,X23412.Phospholipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00136517502741275,0.00582447336698021,-0.0100507927718685,0.012781142826694,0.814689732582311
NMR metabolomics,X23412.Phospholipids in VLDL,TAP1,Antigen peptide transporter 1,40302,0.00137730311662456,0.00622064327934403,-0.0108151577108897,0.0135697639441389,0.82477846705447
NMR metabolomics,X23412.Phospholipids in VLDL,TAGLN3,Transgelin-3,40080,0.00134703505234375,0.00619080133409198,-0.0107869355624765,0.013481005667164,0.827755349474015
NMR metabolomics,X23412.Phospholipids in VLDL,ARG2,"Arginase-2, mitochondrial",40451,-0.000922320240654725,0.00430897930249809,-0.00936791967355099,0.00752327919224154,0.83051497958942
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.00181781966247844,0.00856424519709848,-0.0186037402487915,0.0149681009238346,0.831910583703196
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.000953038211817265,0.00456995055158326,-0.00800406486928593,0.00991014129292046,0.834807575920694
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L2,Seizure 6-like protein 2,42587,-0.00049655862015588,0.00238830613022518,-0.00517763863539724,0.00418452139508548,0.835300475741683
NMR metabolomics,X23412.Phospholipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.00188919492880053,0.00915157657489689,-0.0160478951579974,0.0198262850155984,0.836455872564102
NMR metabolomics,X23412.Phospholipids in VLDL,ESR1,Estrogen receptor,40199,-0.00114906085994719,0.0055886346287368,-0.0121027847322713,0.00980466301237693,0.837101927418332
NMR metabolomics,X23412.Phospholipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.000772436890771339,0.00379461402038549,-0.00820988037072691,0.00666500658918423,0.838699357579499
NMR metabolomics,X23412.Phospholipids in VLDL,FGF20,Fibroblast growth factor 20,40199,0.000926045558639463,0.00456001122474752,-0.00801157644186568,0.0098636675591446,0.83907651884157
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00164647464835367,0.00819082015621933,-0.0177004821545436,0.0144075328578362,0.840690818192454
NMR metabolomics,X23412.Phospholipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.000596182128078925,0.00298482034137115,-0.00644642999716638,0.00525406574100853,0.841689059829926
NMR metabolomics,X23412.Phospholipids in VLDL,IL36A,Interleukin-36 alpha,40199,0.00115967150728517,0.00581698294948165,-0.0102416150736989,0.0125609580882692,0.841985128555507
NMR metabolomics,X23412.Phospholipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.00144107744394128,0.00740970003916289,-0.013081934632818,0.0159640895207005,0.845799546202025
NMR metabolomics,X23412.Phospholipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.000779620207247808,0.00404896806151827,-0.007156357193328,0.00871559760782362,0.847316532282158
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,40449,0.00286817101991897,0.0149873298074516,-0.0265069954026862,0.0322433374425241,0.848236784714381
NMR metabolomics,X23412.Phospholipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.000901556180737878,0.00480865715947705,-0.00852341185183715,0.0103265242133129,0.851283035729946
NMR metabolomics,X23412.Phospholipids in VLDL,S100G,Protein S100-G,40482,0.00090773400280616,0.00486405962107105,-0.0086258228544931,0.0104412908601054,0.85196142292837
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR3,Folate receptor gamma,42629,0.00343328386266969,0.0186472071290025,-0.0331152421101752,0.0399818098355146,0.85392377487521
NMR metabolomics,X23412.Phospholipids in VLDL,DAND5,DAN domain family member 5,40199,0.00101598274537409,0.00560073975387325,-0.00996146717221748,0.0119934326629657,0.856055760883004
NMR metabolomics,X23412.Phospholipids in VLDL,TNR,Tenascin-R,42495,0.000761287921822448,0.00426746328549675,-0.00760294011775118,0.00912551596139608,0.858416631850506
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA2,Protein disulfide-isomerase A2,40080,0.000740475571381687,0.00425622222662671,-0.00760171999280666,0.00908267113557004,0.861888472172252
NMR metabolomics,X23412.Phospholipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.00250176159661909,0.0144728452281297,-0.0258650150505151,0.0308685382437533,0.862765470983745
NMR metabolomics,X23412.Phospholipids in VLDL,EVPL,Envoplakin,40302,-0.0006123289059299,0.0035537229867238,-0.00757762595990855,0.00635296814804876,0.863199860439639
NMR metabolomics,X23412.Phospholipids in VLDL,TP53BP1,TP53-binding protein 1,40199,-0.00146605466397567,0.00877134017993831,-0.0186578814166548,0.0157257720887034,0.867261809994547
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.000725843534191468,0.00436791183923942,-0.00928695073910073,0.0078352636707178,0.868021220476591
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.000800701641257769,0.00494458976161946,-0.0104920975740319,0.00889069429151637,0.871360125805044
NMR metabolomics,X23412.Phospholipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,40080,0.000496617646904543,0.00309309085071174,-0.00556584042049047,0.00655907571429955,0.872445237580721
NMR metabolomics,X23412.Phospholipids in VLDL,SLC1A4,Neutral amino acid transporter A,40182,0.00083707654911428,0.00525935716881057,-0.00947126350175443,0.011145416599983,0.873546152763424
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,40080,0.00092063544072788,0.0057979147155926,-0.0104432774018336,0.0122845482832894,0.873839370966021
NMR metabolomics,X23412.Phospholipids in VLDL,FOS,Proto-oncogene c-Fos,40065,-0.000570743599369858,0.00360864503829916,-0.00764368787443622,0.00650220067569651,0.874333594469888
NMR metabolomics,X23412.Phospholipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.000753273055780361,0.00481717579812167,-0.0101949376200988,0.0086883915085381,0.875742437441891
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.00179289365874259,0.0119383918023439,-0.0251921415913367,0.0216063542738515,0.880625788706533
NMR metabolomics,X23412.Phospholipids in VLDL,RLN1,Prorelaxin H1,40482,-0.000726287660065869,0.0048824204198852,-0.0102958316830409,0.00884325636290913,0.881749098623057
NMR metabolomics,X23412.Phospholipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00092354763482631,0.00644370170932988,-0.0117061077154603,0.0135532029851129,0.886035650774618
NMR metabolomics,X23412.Phospholipids in VLDL,BTNL10,Butyrophilin-like protein 10,40080,-0.000616825274969214,0.004307275540185,-0.00905908533373182,0.0078254347837934,0.886130586677374
NMR metabolomics,X23412.Phospholipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.000365615147798159,0.00287075037234247,-0.00526105558199308,0.0059922858775894,0.898658798552885
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.000537222448882811,0.00428064349306837,-0.0078528387975312,0.00892728369529682,0.900129275241133
NMR metabolomics,X23412.Phospholipids in VLDL,HK2,Hexokinase-2,42357,0.00033650420535062,0.00277632007389742,-0.00510508313948833,0.00577809155018957,0.903530419578558
NMR metabolomics,X23412.Phospholipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.000501900117401035,0.00423495580941908,-0.00880241350386244,0.00779861326906037,0.905662846894336
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.000531659634112317,0.00452800278436489,-0.0094065450914675,0.00834322582324287,0.90653255999953
NMR metabolomics,X23412.Phospholipids in VLDL,NPTN,Neuroplastin,42346,0.000906326774493924,0.0079160251161047,-0.0146090824530713,0.0164217360020591,0.90884901209495
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.000635656117046249,0.00573462369500334,-0.0118755185592528,0.0106042063251603,0.911740676938391
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,40511,0.000438366460130683,0.0039828996669092,-0.00736811688701134,0.00824484980727271,0.91236204527097
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD4,Sushi domain-containing protein 4,40451,-0.000445522654578103,0.00423313870311552,-0.00874247451268451,0.00785142920352831,0.91618215992137
NMR metabolomics,X23412.Phospholipids in VLDL,CBX2,Chromobox protein homolog 2,40116,0.000426663734638041,0.00405656089863913,-0.00752419562669466,0.00837752309597074,0.916235956455306
NMR metabolomics,X23412.Phospholipids in VLDL,NXPE4,NXPE family member 4,40116,0.000356695857266894,0.00340689954888351,-0.00632082725854478,0.00703421897307857,0.916617304359121
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM2,Intercellular adhesion molecule 2,42794,-0.000330428228072189,0.00326103655434017,-0.00672205987457891,0.00606120341843453,0.919293064439009
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB2,Beta-crystallin B2,40483,0.000811166047506691,0.00823359088697552,-0.0153266720909653,0.0169490041859787,0.92152184722417
NMR metabolomics,X23412.Phospholipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.000541237839405627,0.00581586188424989,-0.0108578514537242,0.0119403271325354,0.925855417917519
NMR metabolomics,X23412.Phospholipids in VLDL,IL20,Interleukin-20,42370,0.000426082084715842,0.00495120447290128,-0.00927827868217066,0.0101304428516023,0.931423010416393
NMR metabolomics,X23412.Phospholipids in VLDL,SSB,Lupus La protein,42311,0.000490772499678489,0.00586322172647227,-0.0110011420842072,0.0119826870835641,0.933293408245213
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_A,,40482,-0.000275621640357486,0.00334519972428936,-0.00683221309996463,0.00628096981924966,0.934335520693173
NMR metabolomics,X23412.Phospholipids in VLDL,CDAN1,Codanin-1,40483,0.000185450106059324,0.00228080492199086,-0.00428492754104277,0.00465582775316141,0.935197609781408
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.000625531052887347,0.00792558314685423,-0.0161596740207216,0.0149086119149469,0.937093279502677
NMR metabolomics,X23412.Phospholipids in VLDL,NRN1,Neuritin,40482,-0.000281312842208674,0.00366830358676788,-0.00747118787227372,0.00690856218785637,0.938873548923008
NMR metabolomics,X23412.Phospholipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.00044044239695513,0.00575404041600385,-0.0108374768184124,0.0117183616123227,0.93898700024379
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD5,Sushi domain-containing protein 5,40235,0.000255833078778007,0.00351034421618068,-0.00662444158493613,0.00713610774249214,0.941903112543321
NMR metabolomics,X23412.Phospholipids in VLDL,PRTN3,Myeloblastin,42276,-0.000352579476430388,0.0049096671981901,-0.00997552718488298,0.0092703682320222,0.942751574237347
NMR metabolomics,X23412.Phospholipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.000478326128222561,0.00666532388847499,-0.0135423609496335,0.0125857086931884,0.942791539611022
NMR metabolomics,X23412.Phospholipids in VLDL,FSHB,Follitropin subunit beta,40223,-0.000362237936208201,0.0054678609258588,-0.0110792453508915,0.0103547694784751,0.94718113371832
NMR metabolomics,X23412.Phospholipids in VLDL,KHDC3L,KH domain-containing protein 3,40080,-0.000430897699104155,0.00697092098721837,-0.0140939028340522,0.0132321074358439,0.950712410323027
NMR metabolomics,X23412.Phospholipids in VLDL,CASQ2,Calsequestrin-2,40116,0.000300838463480974,0.00496287727696753,-0.00942640099937538,0.0100280779263373,0.951664744643272
NMR metabolomics,X23412.Phospholipids in VLDL,RELB,Transcription factor RelB,40199,0.000303908060481157,0.00502051927789887,-0.00953630972420062,0.0101441258451629,0.951732079613344
NMR metabolomics,X23412.Phospholipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.000224792971259664,0.00411787697784629,-0.00784624590531907,0.0082958318478384,0.956466445778246
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2BP,LRP2-binding protein,40182,-0.00046274364855009,0.00870936631189933,-0.0175331016198728,0.0166076143227726,0.957627920789792
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.000277798079951091,0.00553923664984996,-0.011134701913657,0.0105791057537548,0.960002994361043
NMR metabolomics,X23412.Phospholipids in VLDL,TPT1,Translationally-controlled tumor protein,42370,-0.000266464092635308,0.00658111208901006,-0.013165443787095,0.0126325156018244,0.967703714963218
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,40284,-0.000216565167320766,0.0054031154003429,-0.0108066713519929,0.0103735410173513,0.968028843182617
NMR metabolomics,X23412.Phospholipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000137335177110813,0.00349344403081051,-0.00698448547749942,0.00670981512327779,0.968642153665253
NMR metabolomics,X23412.Phospholipids in VLDL,ERVV_1,,40116,0.00016786376194271,0.00441053134237199,-0.00847677766910638,0.0088125051929918,0.969640730943082
NMR metabolomics,X23412.Phospholipids in VLDL,REST,RE1-silencing transcription factor,40080,0.000125423529649759,0.00346456058757237,-0.00666511522199208,0.0069159622812916,0.971122068446952
NMR metabolomics,X23412.Phospholipids in VLDL,BEX3,Protein BEX3,40080,0.00017286257011521,0.00482843488318069,-0.00929086980091895,0.00963659494114937,0.971441729620924
NMR metabolomics,X23412.Phospholipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,0.000192483956683883,0.00544029123145581,-0.0104704868569695,0.0108554547703373,0.971776431998581
NMR metabolomics,X23412.Phospholipids in VLDL,CA8,Carbonic anhydrase-related protein,40199,-0.000102130577787945,0.00289376799043785,-0.00577391583904613,0.00556965468347024,0.971846518061235
NMR metabolomics,X23412.Phospholipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,42346,0.000152222371827916,0.00486120209727048,-0.00937573373882223,0.00968017848247807,0.975019815664306
NMR metabolomics,X23412.Phospholipids in VLDL,CHIT1,Chitotriosidase-1,42699,0.000454813029992455,0.0155122832300349,-0.0299492621008759,0.0308588881608608,0.976610175073957
NMR metabolomics,X23412.Phospholipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.000128472150859845,0.00504502063486536,-0.0100167125951959,0.00975976829347625,0.97968440610632
NMR metabolomics,X23412.Phospholipids in VLDL,GJA8,Gap junction alpha-8 protein,40080,0.000163322032976039,0.00659058541100312,-0.0127542253725901,0.0130808694385422,0.98023001135816
NMR metabolomics,X23412.Phospholipids in VLDL,TFRC,Transferrin receptor protein 1,42673,-9.02038826182993e-05,0.00380465641171599,-0.00754733044958163,0.00736692268434504,0.98108522818075
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,7.09720833464734e-05,0.00340134025665288,-0.00659565481969317,0.00673759898638612,0.983352996185383
NMR metabolomics,X23412.Phospholipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,6.30380886451191e-05,0.00304896705563019,-0.00591293734039005,0.00603901351768029,0.98350510707398
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.000190062411578984,0.00972352581594075,-0.0188680481876649,0.0192481730108229,0.984405376483398
NMR metabolomics,X23412.Phospholipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-4.04204607877799e-05,0.00212070038772099,-0.00419699322072092,0.00411615229914536,0.98479361911188
NMR metabolomics,X23412.Phospholipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-5.26464044991525e-05,0.00296542124328636,-0.00586487204134042,0.00575957923234211,0.985835867272525
NMR metabolomics,X23412.Phospholipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-4.41876900203706e-05,0.00254990889814511,-0.0050420091303848,0.00495363375034405,0.986174355754489
NMR metabolomics,X23412.Phospholipids in VLDL,GAD1,Glutamate decarboxylase 1,40080,-4.57858504084128e-05,0.00264328050090276,-0.00522661563217781,0.00513504393136099,0.98618037044781
NMR metabolomics,X23412.Phospholipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,40199,7.57795055776532e-05,0.00627554543988125,-0.0122242895565896,0.0123758485677449,0.990365705243123
NMR metabolomics,X23412.Phospholipids in VLDL,HMMR,Hyaluronan mediated motility receptor,40059,-4.80891663733732e-05,0.00501862586763137,-0.00988459586693086,0.00978841753418412,0.992354852833587
NMR metabolomics,X23412.Phospholipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,5.02279857224996e-05,0.0061941572159473,-0.0120903201575342,0.0121907761289792,0.993530229151354
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF75D,Zinc finger protein 75D,40302,5.00683502110126e-05,0.0061944125649305,-0.0120909802770528,0.0121911169774748,0.9935510544226
NMR metabolomics,X23412.Phospholipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-3.04015475030015e-05,0.00676792562507929,-0.0132955357726584,0.0132347326776524,0.996415992253514
